#11 Cogno Dr Hduib | 37.2 MiB | | April 4, 2020 |
#12 Cogno Dr Hduib | 41.0 MiB | | April 4, 2020 |
#U062a#U0641#U0631#U064a#U063a 10 #U062f #U0643#U0645#U0627#U0644 #U0633#U0648#U064a#U062f#U0627#U0646 | 5.8 MiB | | April 4, 2020 |
#U062a#U0641#U0631#U064a#U063a 2 #U062f #U0643#U0645#U0627#U0644 #U0633#U0648#U064a#U062f#U0627#U0646 | 6.6 MiB | | April 4, 2020 |
#U062a#U0641#U0631#U064a#U063a 3 #U062f #U0643#U0645#U0627#U0644 #U0633#U0648#U064a#U062f#U0627#U0646 | 9.2 MiB | | April 4, 2020 |
#U062a#U0641#U0631#U064a#U063a 5 #U062f #U0643#U0645#U0627#U0644 #U0633#U0648#U064a#U062f#U0627#U0646 | 8.0 MiB | | April 4, 2020 |
#U062a#U0641#U0631#U064a#U063a 7 #U062f #U0643#U0645#U0627#U0644 #U0633#U0648#U064a#U062f#U0627#U0646 | 4.3 MiB | | April 4, 2020 |
#U062a#U0641#U0631#U064a#U063a 8 #U062f #U0643#U0645#U0627#U0644 #U0633#U0648#U064a#U062f#U0627#U0646 | 6.2 MiB | | April 4, 2020 |
#U062a#U0641#U0631#U064a#U063a 9 #U062f #U0643#U0645#U0627#U0644 #U0633#U0648#U064a#U062f#U0627#U0646 | 9.7 MiB | | April 4, 2020 |
#U062a#U0641#U0631#U064a#U063a1 #U062f #U0643#U0645#U0627#U0644 #U0633#U0648#U064a#U062f#U0627#U0646[1] | 8.3 MiB | | April 4, 2020 |
%D8%A7%D9%86%D8%A7%D9%84%D8%A7%D8%AA%D9%8A%D9%83%D8%A7%D9%84-1 | 1.4 MiB | | December 31, 2020 |
%D8%A7%D9%86%D8%A7%D9%84%D8%A7%D8%AA%D9%8A%D9%83%D8%A7%D9%84-2 | 2.7 MiB | | December 31, 2020 |
%D8%A7%D9%86%D8%A7%D9%84%D8%A7%D8%AA%D9%8A%D9%83%D8%A7%D9%84-3 | 3.4 MiB | | December 31, 2020 |
%D8%A7%D9%86%D8%A7%D9%84%D8%A7%D8%AA%D9%8A%D9%83%D8%A7%D9%84-4 | 1.9 MiB | | December 31, 2020 |
%D8%AA%D9%81%D8%B1%D9%8A%D8%BA-%D9%85%D8%AD%D8%A7%D8%B6%D8%B1%D8%A9-%D9%A6- | 2.5 MiB | | December 31, 2020 |
%D9%83%D9%88%D8%AC%D9%86%D9%889 | 31.9 MiB | | April 4, 2020 |
%E2%80%8Fl03 Physiology1 Dr Loai | 17.6 MiB | | December 31, 2020 |
%E2%80%8Fl04 Physiology1 Dr Loai | 17.2 MiB | | December 31, 2020 |
%E2%80%8Fl07 Physiology1 Dr Loai | 21.0 MiB | | December 31, 2020 |
%E2%80%8Fl09 Physiology1 Respiratorysystem Dr Yaanal | 20.1 MiB | | December 31, 2020 |
%E2%80%8Fl11 Physiology1 Respiratorysystem3 Dr Yanal | 22.0 MiB | | December 31, 2020 |
%E2%80%8FL18-cosmo-hair-anatomy | 13.7 MiB | | April 4, 2020 |
%E2%80%8FL20-cosmo-hair-cleansing-producs | 16.9 MiB | | April 4, 2020 |
0 E-Syllabus Therapy 1 Fall Semester 2020-2021 | 0.2 MiB | Marwa Abdeen | October 14, 2020 |
00 Micro-1-Syllabus Pharmacy | 0.8 MiB | | April 4, 2020 |
00 Micro1Syllabus Pharmacy | 0.8 MiB | | April 4, 2020 |
00-1203577-Clinical-PK-outline PharmD 2015 | 26 KiB | | April 4, 2020 |
00-additional-slids-supp-phyto1 | 0.7 MiB | | April 4, 2020 |
00-Assaf -Immuno-summary | 1.3 MiB | | April 4, 2020 |
00-Bioequivalence-Notes-Kinetics | 6.4 MiB | | April 4, 2020 |
00-Bioequivalence-Notes-Kinetics | 6.4 MiB | | April 4, 2020 |
00-Course-description-documnet-immuno-and-genetics | 0.3 MiB | | April 4, 2020 |
00-Course-description-Pathophysiology | 0.1 MiB | | April 4, 2020 |
00-EBM-Course-Outline-Spring-2018-new-ILOs | 0.1 MiB | | April 4, 2020 |
00-final-Correction1-phyto1 | 0.7 MiB | | April 4, 2020 |
00-Out-Line-Techno1 | 0.1 MiB | | April 4, 2020 |
00-outline Fall 2015 Shortened-Biopharma | 54 KiB | | April 4, 2020 |
00-Pathology-pharmacy-outline | 17 KiB | | April 4, 2020 |
00-Pharm-D-First-Aid-syll | 0.3 MiB | | December 31, 2020 |
00-Quiz-Material Highlighted-Micro1 | 2.5 MiB | | April 4, 2020 |
00-Quiz-Material Highlighted-Micro1 | 2.5 MiB | | April 4, 2020 |
00-Summary-1st-Chapter-Micro2 | 17 KiB | | April 4, 2020 |
00-Supplementary-Phenloics-Phyto1 2 | 13.3 MiB | | April 4, 2020 |
00-Syllabus Phsio2 | 25 KiB | | April 4, 2020 |
00-syllabus-for-anatomy-2015-2016 | 47 KiB | | December 31, 2020 |
00-Syllabus-Micro2 | 2.8 MiB | | April 4, 2020 |
00-Therapy-I-outline-2014 | 31 KiB | | April 4, 2020 |
00-Training-Manual-1 | 1.0 MiB | | April 4, 2020 |
01 Biocides | 0.8 MiB | | April 4, 2020 |
01 Bioenergetics And Oxidative Phosphorylation Biochem | 19.6 MiB | iSpatula | April 4, 2020 |
01 Bioenergetics And Oxidative Phosphorylation Biochem | 19.6 MiB | | December 31, 2020 |
01 Distribution Dr Samer Physical2 | 0.8 MiB | iSpatula | April 4, 2020 |
01 Dr Loai Nervous System | 13.7 MiB | | April 4, 2020 |
01 Dr Rana Biopharma1 | 20.4 MiB | | April 4, 2020 |
01 Dr Samer Physical2 | 36.5 MiB | iSpatula | April 4, 2020 |
01 Drug-Metabolism | 2.8 MiB | | April 4, 2020 |
01 Endocrine Dr Salem Physio2 | 0.8 MiB | | April 4, 2020 |
01 GI Dr Khatatbeh | 8.8 MiB | | April 4, 2020 |
01 GI Dr Khatatbeh | 8.8 MiB | | April 4, 2020 |
01 Inflammation Pathophysio | 40.5 MiB | | April 4, 2020 |
01 Intoduction Dr[1] Khatabeh Physio2 | 2.3 MiB | | April 4, 2020 |
01 Introduction | 0.1 MiB | | April 4, 2020 |
01 Introduction Anatomy | 5.4 MiB | iSpatula | April 4, 2020 |
01 Introduction Anatomy | 5.4 MiB | | December 31, 2020 |
01 Introduction Pharmacognosy | 30.9 MiB | | April 4, 2020 |
01 Introduction Techno | 0.8 MiB | | April 4, 2020 |
01 Introduction To Medical Terminology Medical | 2.6 MiB | | April 4, 2020 |
01 Microscope Lab-Biology | 2.6 MiB | | December 31, 2020 |
01 Pathophysiology Cellular Respnses | 0.5 MiB | | April 4, 2020 |
01 Pathophysiology-of-cardiovascular-diseases THOMBOSIS | 1.0 MiB | | April 4, 2020 |
01 Pharma 1 | 1.1 MiB | | April 4, 2020 |
01 Pharma Organic | 2.8 MiB | iSpatula | April 4, 2020 |
01 Pharma Organic | 2.8 MiB | | December 31, 2020 |
01 Practice1 Introduction | 2.0 MiB | | April 4, 2020 |
01 Practice2 Basic-Communication-Skills-in-Pharmacy-Practice | 0.9 MiB | | April 4, 2020 |
01 Practice2-Notes- Communication-Skills | 7.7 MiB | | April 4, 2020 |
01 Self Care | 4.4 MiB | | April 4, 2020 |
01 Sheet Analytical | 0.4 MiB | iSpatula | April 4, 2020 |
01 Sheet Dr Khanfr Analytical | 5.7 MiB | iSpatula | April 4, 2020 |
01 Zeeraa Home-Gardens | 4.1 MiB | | October 27, 2020 |
01 Zeeraa Numbers-Requested | 74 KiB | | October 27, 2020 |
01 Zeeraa Past-Papers | 7.9 MiB | | October 27, 2020 |
01-ALKALOIDS -Nicotine-medicinal-Plant | 3.4 MiB | | April 4, 2020 |
01-all-material-slides-Phyto1 | 6.3 MiB | | April 4, 2020 |
01-Basic-communication-skills-Training1 | 1.2 MiB | | April 4, 2020 |
01-Basic-concepts-Stat | 0.6 MiB | | April 4, 2020 |
01-basic-principles-of-pharmacology | 7.2 MiB | | April 4, 2020 |
01-Cancer-introduction-2014-1- | 1.2 MiB | | April 4, 2020 |
01-Cellular-respnses-Pathophysiology | 0.6 MiB | | April 4, 2020 |
01-ClinPK Intro | 0.7 MiB | | April 4, 2020 |
01-ClinPK Intro 2014 | 0.7 MiB | | April 4, 2020 |
01-Disinfection-and-antisepsis | 0.4 MiB | | April 4, 2020 |
01-Dr Rana-Biopharma | 20.4 MiB | | April 4, 2020 |
01-gamma-scintigraphy-Biopharma1 | 1.6 MiB | | April 4, 2020 |
01-GIT-Pathology | 0.8 MiB | | April 4, 2020 |
01-hematolymphoid-Patho | 1.8 MiB | | April 4, 2020 |
01-Hypertension 2014 | 5.9 MiB | | April 4, 2020 |
01-Hypothalamic-and-Pituitary-Hormone-Pharma2 | 1.5 MiB | | April 4, 2020 |
01-Hypothalamic-and-Pituitary-Hormone-Pharma2 | 1.5 MiB | | October 19, 2020 |
01-introduction | 4.5 MiB | | December 31, 2020 |
01-Introduction-pharmacognosy | 1.4 MiB | | April 4, 2020 |
01-Introduction-Techno1 | 0.5 MiB | | April 4, 2020 |
01-introduction-to-first-aid | 1.1 MiB | | December 31, 2020 |
01-Introduction-to-the-Immune-system-and-Innate-Immunity | 3.2 MiB | | April 4, 2020 |
01-Introduction-to-the-Immune-system-and-Innate-Immunity | 3.2 MiB | | April 4, 2020 |
01-Lipids-and-lipid-disorder | 3.5 MiB | | April 4, 2020 |
01-Major-Depression | 1.5 MiB | | April 4, 2020 |
01-Medical-Genetics-Introduction-Immuno | 8.5 MiB | | April 4, 2020 |
01-Pain-management-2016 | 1.0 MiB | | April 4, 2020 |
01-Parenteral-Drug-Delivery-Biopharma | 2.1 MiB | | April 4, 2020 |
01-Primary-and-secondary-metabolites-Phyto | 0.3 MiB | | April 4, 2020 |
01-Scope-and-History-Micro1 | 0.6 MiB | | April 4, 2020 |
01-Scope-and-History-of-microbiology | 0.7 MiB | | April 4, 2020 |
01-Secondary-Metabolites-and-Phenols-Phyto1 | 1.9 MiB | | April 4, 2020 |
01-tablet-coating-techno2 | 28.5 MiB | | April 4, 2020 |
01-Tablet-coating-Techno2 | 3.6 MiB | | April 4, 2020 |
01-Tablet-CoatingReasons-Techno2 | 2.1 MiB | | April 4, 2020 |
01-The-Endocrine-System-physio2 | 1.8 MiB | | April 4, 2020 |
0102-Cell-Injury-Patho | 4.0 MiB | | April 4, 2020 |
02 Anatomy | 3.4 MiB | iSpatula | April 4, 2020 |
02 Anatomy | 3.4 MiB | | December 31, 2020 |
02 Bioavailability-physicochemical-and-dosage-form-factors | 0.1 MiB | | April 4, 2020 |
02 Complexation Dr Samer Physical2 | 1.5 MiB | iSpatula | April 4, 2020 |
02 Diagnosis And History Taking In The Pharmacy | 0.6 MiB | | April 4, 2020 |
02 Endocrine Dr Saleem Physio2 | 0.6 MiB | | April 4, 2020 |
02 GI Dr Khatatbeh | 0.2 MiB | | April 4, 2020 |
02 GI Dr Khatatbeh | 0.2 MiB | | April 4, 2020 |
02 Inflammation Pathophysio | 43.4 MiB | | April 4, 2020 |
02 Mode-of-Action | 0.3 MiB | | April 4, 2020 |
02 Movements Dr[1] Khatabeh Physio2 | 1.3 MiB | | April 4, 2020 |
02 Pathophysiology Inflammation Part 1 | 0.5 MiB | | April 4, 2020 |
02 Pathophysiology Inflammation1 | 0.5 MiB | | April 4, 2020 |
02 Pharmacognosy2 | 45.8 MiB | | April 4, 2020 |
02 Pharmacognosy[1] | 15.2 MiB | | April 4, 2020 |
02 Practice Applied-Pharmaceutical-Practice-1stEdition | 5.0 MiB | | April 4, 2020 |
02 Practice1 Overview-of-the-phara -care-process | 1.1 MiB | | April 4, 2020 |
02 Practice2-Notes Insulin | 13.6 MiB | | April 4, 2020 |
02 Prefixes And Suffixes Medical | 9.7 MiB | | April 4, 2020 |
02 Protoalkaloids Medicinal Plant1 | 4.1 MiB | | April 4, 2020 |
02 Sheet Dr Khanfar Analatical | 5.6 MiB | iSpatula | April 4, 2020 |
02 Techno | 1.8 MiB | | April 4, 2020 |
02 The-Cell Lab-Biology | 1.6 MiB | | December 31, 2020 |
02 Zeeraa Numbers-Requested | 66 KiB | | October 27, 2020 |
02 Zeraa Past-Papers | 0.8 MiB | | October 27, 2020 |
02 Zeraa Plants-Growing | 1.5 MiB | | October 27, 2020 |
02-Acetate-malonate-pathway-Phyto | 0.6 MiB | | April 4, 2020 |
02-Adaptive-Immune-Response-Immuno | 7.3 MiB | | April 4, 2020 |
02-Adaptive-Immune-Response-Immuno | 7.3 MiB | | April 4, 2020 |
02-BioWaiver Lecture-Biopharma1 | 0.2 MiB | | April 4, 2020 |
02-blood-vessels-Patho | 2.0 MiB | | April 4, 2020 |
02-Cancer-VTE-20142 | 0.4 MiB | | April 4, 2020 |
02-Carbohydrates | 1.4 MiB | | April 4, 2020 |
02-cephalos- | 1.6 MiB | | April 4, 2020 |
02-Chromosomes-and-chromosome-abnormalities-Immuno | 8.9 MiB | | April 4, 2020 |
02-ClinPK Dose Adjustment In Hepatic Disease 2014 | 1.0 MiB | | April 4, 2020 |
02-ClinPK Dose-Adjustment-in-Hepatic-Disease | 1.0 MiB | | April 4, 2020 |
02-Disinfection-and-antisepsis | 0.3 MiB | | April 4, 2020 |
02-Dr Rana-Biopharma | 15.6 MiB | | April 4, 2020 |
02-Drug-Receptor-Interactions-and-Pharamacodynamics | 0.5 MiB | | April 4, 2020 |
02-Dyslipidemia-Pathophysiology | 1.3 MiB | | April 4, 2020 |
02-Epithelium-pharmacy | 13.8 MiB | | December 31, 2020 |
02-Hard-Gelatin-Capsule-Techno2 | 1.3 MiB | | April 4, 2020 |
02-Heart-attack-Shock-First-Aid | 0.6 MiB | | December 31, 2020 |
02-Heart-Failure 2014 | 5.3 MiB | | April 4, 2020 |
02-inflammation 1-Pathophysiology | 0.5 MiB | | April 4, 2020 |
02-Insomnia | 0.5 MiB | | April 4, 2020 |
02-Microscopy-and-Staining-Micro1 | 0.9 MiB | | April 4, 2020 |
02-Microscopy-and-Staining-Micro1 | 1.1 MiB | | April 4, 2020 |
02-Online-resources-Training1 | 1.5 MiB | | April 4, 2020 |
02-Part2-Moodle Inflammation 2-Pathophysio | 0.5 MiB | | April 4, 2020 |
02-Perioperative-care-2016 | 1.0 MiB | | April 4, 2020 |
02-Preformulation-Techno1 | 0.9 MiB | | April 4, 2020 |
02-Pulmonary-Drug-Delivery S-Biopharma | 2.4 MiB | | April 4, 2020 |
02-renal-Pathology | 2.0 MiB | | April 4, 2020 |
02-tablet-coating-techno2 | 33.0 MiB | | April 4, 2020 |
02-Tablet-CoatingCapping-and-Lamination-Techno2 | 0.5 MiB | | April 4, 2020 |
02-The-Endocrine-System-Physio2 | 2.3 MiB | | April 4, 2020 |
02-Thyroid-and-anti-thyroid-Drugs-Pharma2 | 1.2 MiB | | April 4, 2020 |
02-Thyroid-and-anti-thyroid-Drugs-Pharma2 | 1.2 MiB | | October 19, 2020 |
0203-Graphical-presentaion-of-data-and-descriptive-statistic | 0.6 MiB | | April 4, 2020 |
02Biomoleculesnew | 1.0 MiB | | December 31, 2020 |
02Biomoleculesnew | 1.0 MiB | iSpatula | April 4, 2020 |
02Biomoleculesnew | 1.0 MiB | | April 4, 2020 |
02Metabolism | 1.3 MiB | iSpatula | April 4, 2020 |
02Metabolism | 1.3 MiB | | April 4, 2020 |
03 AllergicRhinitis Combined 2013 | 6.1 MiB | | April 4, 2020 |
03 Basic Tissues-diagnosis-treatments | 0.7 MiB | | April 4, 2020 |
03 Carbohydrate Biochem | 20.9 MiB | iSpatula | April 4, 2020 |
03 Carbohydrate Biochem | 20.9 MiB | | December 31, 2020 |
03 Dr Loai Vision Physio2 | 7.7 MiB | | April 4, 2020 |
03 Dr Loai Vision Physio2 | 7.7 MiB | | April 4, 2020 |
03 Dr Rana Biopharma M4a1 | 17.6 MiB | | April 4, 2020 |
03 Drug-receptor Interactions & PDs 2 Ppt 22 | 0.3 MiB | | April 4, 2020 |
03 Epithelial Anatomy[1] | 7.8 MiB | iSpatula | April 4, 2020 |
03 Epithelial Anatomy[1] | 7.8 MiB | | December 31, 2020 |
03 Evaluation-of-Antimicrobials | 0.8 MiB | | April 4, 2020 |
03 GI Dr Khatatbeh | 0.1 MiB | | April 4, 2020 |
03 GI Dr Khatatbeh | 0.1 MiB | | April 4, 2020 |
03 Inflammation Pathophysio | 44.8 MiB | | April 4, 2020 |
03 Kinetics Dr Samer Physical2 | 1.3 MiB | iSpatula | April 4, 2020 |
03 Macromolecules Lab-Biology | 1.2 MiB | | December 31, 2020 |
03 Pathophysiology Inflammation Part 2 | 0.5 MiB | | April 4, 2020 |
03 Pathophysiology Inflammation2 | 0.6 MiB | | April 4, 2020 |
03 Pharmacognosy | 31.8 MiB | | April 4, 2020 |
03 Physiologic-factors-related-to-drug-absorption | 0.4 MiB | | April 4, 2020 |
03 Practice1 The-need-for-pharmaceutical-care | 0.6 MiB | | April 4, 2020 |
03 Practice2 Drug-counseling Inhelers | 3.1 MiB | | April 4, 2020 |
03 Practice2-Notes Drug-counseling | 20.8 MiB | | April 4, 2020 |
03 Secretion Dr[1] Khtatbeh Physio2 | 9.0 MiB | | April 4, 2020 |
03 Sheet Dr Khanfar Analatical | 5.0 MiB | iSpatula | April 4, 2020 |
03 Zeraa Zeina-Plants | 2.9 MiB | | October 27, 2020 |
03-04-Inflammation-and-Repair-Patho | 6.7 MiB | | April 4, 2020 |
03-Amino-alkaloids-medicinal-plant | 0.7 MiB | | April 4, 2020 |
03-Angiogenesis-Pathophysio | 0.4 MiB | | April 4, 2020 |
03-Anxiety-Disorders | 1.2 MiB | | April 4, 2020 |
03-Assessment-of-Drug-Release-and-Permeation-across-Skin | 0.7 MiB | | April 4, 2020 |
03-Atherosclerosis-Part-2 | 0.9 MiB | | April 4, 2020 |
03-Cancer-anemia-20143 | 2.9 MiB | | April 4, 2020 |
03-Chemistry-of-Lichens-Phyto1 | 1.4 MiB | | April 4, 2020 |
03-Cholinoceptor-activating-Cholinesterase-inhibiting-drugs-Pharma1 | 0.6 MiB | | April 4, 2020 |
03-ClinPK Dose Adjustment In Renal Disease 2014 | 1.9 MiB | | April 4, 2020 |
03-ClinPK Dose-Adjustment-in-Renal-Disease | 1.9 MiB | | April 4, 2020 |
03-Connective-for-pharmacy | 10.0 MiB | | December 31, 2020 |
03-Cytokines-new-Immuno | 2.5 MiB | | April 4, 2020 |
03-Cytokines-new-Immuno | 2.5 MiB | | April 4, 2020 |
03-heart-Pathology | 1.3 MiB | | April 4, 2020 |
03-Insulin-administration-patient-education-Training1 | 0.3 MiB | | April 4, 2020 |
03-Ischemic-Heart-Disease 2014 | 2.3 MiB | | April 4, 2020 |
03-Nasal-Drug-Delivery S-Biopharma | 1.2 MiB | | April 4, 2020 |
03-Prokar-Eukar-Micro1 | 1.8 MiB | | April 4, 2020 |
03-Prokaryotic-and-Eukaryotic-Cells-Micro1 | 0.7 MiB | | April 4, 2020 |
03-Sepsis-and-septic-shock-2016 | 0.9 MiB | | April 4, 2020 |
03-Single-gene-disorders-Immuno | 8.5 MiB | | April 4, 2020 |
03-Soft-gelatin-Techno2 | 2.3 MiB | | April 4, 2020 |
03-Tumor-markers | 0.5 MiB | | April 4, 2020 |
0304-Endocrine-System-physio2 | 5.2 MiB | | April 4, 2020 |
03Waternew | 1.5 MiB | | December 31, 2020 |
03Waternew | 1.5 MiB | iSpatula | April 4, 2020 |
03Waternew | 1.5 MiB | | April 4, 2020 |
04 Body Organization | 0.7 MiB | | April 4, 2020 |
04 Cholinergic Agonists | 0.4 MiB | | April 4, 2020 |
04 Chronic Inflammation Pathophysio | 42.7 MiB | | April 4, 2020 |
04 Connective Anatomy[1] | 4.9 MiB | iSpatula | April 4, 2020 |
04 Connective Anatomy[1] | 4.9 MiB | | December 31, 2020 |
04 Connective-tissue | 10.0 MiB | | December 31, 2020 |
04 Diffusion Dr Samer Physical2 | 0.4 MiB | iSpatula | April 4, 2020 |
04 Dr Loai Hearing And Equili Physio2 | 7.1 MiB | | April 4, 2020 |
04 Dr Loai Hearing And Equili Physio2 | 7.1 MiB | | April 4, 2020 |
04 GI Dr Khatatbeh | 0.2 MiB | | April 4, 2020 |
04 GI Dr Khatatbeh | 0.2 MiB | | April 4, 2020 |
04 Glycosaminoglucan & Glucoprotein Biochem | 1.8 MiB | iSpatula | April 4, 2020 |
04 Glycosaminoglucan & Glucoprotein Biochem | 1.8 MiB | | December 31, 2020 |
04 Microbial-Spoilage | 0.7 MiB | | April 4, 2020 |
04 Microbial-Spoilage-Micro2 | 0.7 MiB | | April 4, 2020 |
04 Pain And Fever In The Pharmacy | 3.1 MiB | | April 4, 2020 |
04 Pathophysiology Angiogenesis | 0.4 MiB | | April 4, 2020 |
04 Pathophysiology Angiogenesis | 0.3 MiB | | April 4, 2020 |
04 Pharmacognosy | 48.0 MiB | | April 4, 2020 |
04 Physical-Properties-of-The-Cell-Metabolism Lab-Biology | 1.2 MiB | | December 31, 2020 |
04 Practice1 Barriers-to-pharmaceutical-care | 0.7 MiB | | April 4, 2020 |
04 Practice2 Patinet-education-on-insulin-injection | 1.3 MiB | | April 4, 2020 |
04 Practice2-Notes IV-Medication-Preparation | 10.9 MiB | | April 4, 2020 |
04 The-Stomach | 0.8 MiB | | April 4, 2020 |
04 Zeraa Flowers | 1.3 MiB | | October 27, 2020 |
04-Acid-base-disorders-2016 | 0.9 MiB | | April 4, 2020 |
04-Acute-Coronary-Syndromes 2014 | 8.8 MiB | | April 4, 2020 |
04-Alzheimer-disease | 0.6 MiB | | April 4, 2020 |
04-Bone-tissue | 4.2 MiB | | December 31, 2020 |
04-Book Chapter Aminoglycosides | 4.1 MiB | | April 4, 2020 |
04-Cancer-emesis-20144 | 2.8 MiB | | April 4, 2020 |
04-Cholinoceptor-blocking-drugs-Pharma1 | 0.3 MiB | | April 4, 2020 |
04-ClinPK TDM Of Aminoglycosides 2014 | 1.9 MiB | | April 4, 2020 |
04-ClinPK TDM-of-Aminoglycosides | 2.0 MiB | | December 31, 2020 |
04-Descreptive-statistics-indecators-of-despersion | 1.0 MiB | | April 4, 2020 |
04-Dr Rana-biopharma1 | 18.7 MiB | | April 4, 2020 |
04-endocrine-sys- | 1.7 MiB | | April 4, 2020 |
04-Ferns-Phyto1 | 6.3 MiB | | April 4, 2020 |
04-Growth-and-Culturing-Micro1 | 1.5 MiB | | April 4, 2020 |
04-Growth-and-culturing-of-bacteria-Micro1 | 2.5 MiB | | April 4, 2020 |
04-Hemostasis And Thrombosis-Pathophysio | 0.7 MiB | | April 4, 2020 |
04-Inhalers-and-nasal-spray-Training1 | 0.9 MiB | | April 4, 2020 |
04-Ischemic-Heart-Diseases-IHD | 0.6 MiB | | April 4, 2020 |
04-lung-Pathology | 2.0 MiB | | April 4, 2020 |
04-Occular 2015-Biopharma | 0.2 MiB | | April 4, 2020 |
04-Pancreatic-function-test | 1.1 MiB | | April 4, 2020 |
04-Polygenic-and-Multifactorial-Disorders-Immuno | 3.9 MiB | | April 4, 2020 |
04-Polygenic-and-Multifactorial-Disorders-Immuno | 3.9 MiB | | April 4, 2020 |
04-Suspensions-Techno2 | 1.6 MiB | | April 4, 2020 |
04-Vaccines-Immuno | 1.6 MiB | | April 4, 2020 |
04-Vaccines-Immuno | 1.6 MiB | | April 4, 2020 |
04Carbohydrate Biochemistry | 1.7 MiB | | April 4, 2020 |
04Metabolism | 1.3 MiB | | December 31, 2020 |
05 Bone-histology | 4.2 MiB | | December 31, 2020 |
05 Cholinoceptor-blocking-drugs | 0.2 MiB | | April 4, 2020 |
05 Connective-tissue | 2.6 MiB | iSpatula | April 4, 2020 |
05 Connective-tissue | 2.6 MiB | | December 31, 2020 |
05 Dissolution Dr Samer Physical2 | 0.5 MiB | iSpatula | April 4, 2020 |
05 Dr Loai Physio2 | 79.9 MiB | | April 4, 2020 |
05 Gastric-emptying | 0.4 MiB | | April 4, 2020 |
05 Hemostasis And Thrombosis | 1.0 MiB | | April 4, 2020 |
05 Inflammation Pathophysio | 42.9 MiB | | April 4, 2020 |
05 OTC Analgesics | 2.2 MiB | | April 4, 2020 |
05 Pathophysiology Hemostasis & Thrombosis | 1.0 MiB | | April 4, 2020 |
05 Pharmacognosy | 26.2 MiB | | April 4, 2020 |
05 Plant-Tissues Lab-Biology | 3.2 MiB | | December 31, 2020 |
05 Practice1 Providing-Drug-Information | 3.4 MiB | | April 4, 2020 |
05 Practice2 Preventing-medication-errors | 0.9 MiB | | April 4, 2020 |
05 Practice2-Notes Insulin-Initation-and-Titration | 24.2 MiB | | April 4, 2020 |
05 Skeleton | 2.0 MiB | | April 4, 2020 |
05 Sterilization | 0.8 MiB | | April 4, 2020 |
05 Sterilization-Micro2 | 0.8 MiB | | April 4, 2020 |
05-Adrenoceptor-Agonists-Sympathomimetic-Drugs | 0.7 MiB | | April 4, 2020 |
05-axial-skeleton-for-pharmacy | 8.5 MiB | | December 31, 2020 |
05-Cancer-pain-2015-5 | 2.3 MiB | | April 4, 2020 |
05-Cannabis-Phyto1 | 1.4 MiB | | April 4, 2020 |
05-ClinPK Effect Of Dialysis On Drug Pharmacokinetics 2014 | 1.8 MiB | | April 4, 2020 |
05-ClinPK Effect-of-dialysis-on-drug-pharmacokinetics | 1.8 MiB | | December 31, 2020 |
05-Disorders-of-Na-H20-homeostasis-2016 | 0.8 MiB | | April 4, 2020 |
05-Dr Rana-Biopharma1 | 11.0 MiB | | April 4, 2020 |
05-Dyslipidemia-part1-Pathophysio | 0.8 MiB | | April 4, 2020 |
05-Dyslipidemia-part2-Pathophysio | 0.9 MiB | | April 4, 2020 |
05-Endocrine-Syststem | 4.4 MiB | | April 4, 2020 |
05-Epilepsy | 1.6 MiB | | April 4, 2020 |
05-Heamtology-part-1 | 2.6 MiB | | April 4, 2020 |
05-Heart-Failure-Pathophysiology | 1.1 MiB | | April 4, 2020 |
05-Hyperlipidemia 2014 | 3.4 MiB | | April 4, 2020 |
05-Hypersensitivity-reactions Type-I-and-II-Immuno | 3.0 MiB | | April 4, 2020 |
05-Hypersensitivity-reactions Type-I-and-II-Immuno | 3.0 MiB | | April 4, 2020 |
05-Mutation-and-human-disease-Immuno | 4.1 MiB | | April 4, 2020 |
05-Mutation-and-human-disease-Immuno | 4.1 MiB | | April 4, 2020 |
05-Ophthalmic-preparations-training1 | 0.9 MiB | | April 4, 2020 |
05-RCT-appraisal-worksheet | 0.2 MiB | | April 4, 2020 |
05-Statistics-Intro-To-Probability | 1.2 MiB | | April 4, 2020 |
05-Taxonomy-Micro1 | 1.1 MiB | | April 4, 2020 |
05-Taxonomy-Micro1 | 3.2 MiB | | April 4, 2020 |
05Bioenerg | 11.4 MiB | | December 31, 2020 |
05glycongugatesnew | 0.5 MiB | iSpatula | April 4, 2020 |
05glycongugatesnew | 0.5 MiB | | April 4, 2020 |
06 Adrenoceptor-Agonists-and-Sympathomimetic-Drugs Pdf | 0.6 MiB | | April 4, 2020 |
06 Aminoacid And Protein | 9.1 MiB | iSpatula | April 4, 2020 |
06 Aminoacid And Protein | 9.1 MiB | | December 31, 2020 |
06 Aminoacid And Protein(2) | 9.1 MiB | iSpatula | April 4, 2020 |
06 Aminoacid And Protein(2) | 9.1 MiB | | December 31, 2020 |
06 Animal-Tissue Lab-Biology Asma | 1.9 MiB | | December 31, 2020 |
06 Animal-Tissue Lab-Biology Heba | 2.4 MiB | | December 31, 2020 |
06 Ch22 Sterile-Products Summer-2016 | 0.5 MiB | | April 4, 2020 |
06 Circulation | 1.3 MiB | | April 4, 2020 |
06 Dr Loai Motor System Physio2 | 5.9 MiB | | April 4, 2020 |
06 Dr Loai Motor System Physio2 | 5.9 MiB | | April 4, 2020 |
06 Inflammation Pathophysio | 40.6 MiB | | April 4, 2020 |
06 Interfacial Phenomena Dr Samer Physical2 | 0.5 MiB | iSpatula | April 4, 2020 |
06 Intestinal-transit-time | 90 KiB | | April 4, 2020 |
06 NSAIDS-brief | 1.0 MiB | | December 31, 2020 |
06 Pathophysiology Dyslipidemia 1 | 0.8 MiB | | April 4, 2020 |
06 Pathophysiology Dyslipidemia 1 | 0.8 MiB | | April 4, 2020 |
06 Pharmacognosy | 31.9 MiB | | April 4, 2020 |
06 Practice1 Collecting-patient-data-base | 2.2 MiB | | April 4, 2020 |
06 Practice2 IV-Medication-preparation | 1.2 MiB | | April 4, 2020 |
06 Practice2-Notes Sound-a-like-Medications | 3.6 MiB | | April 4, 2020 |
06 Sterile-Products | 0.5 MiB | | April 4, 2020 |
06 Viruses Micro11 | 2.5 MiB | | April 4, 2020 |
06-07 Bone-tissue | 6.4 MiB | iSpatula | April 4, 2020 |
06-07 Bone-tissue | 6.4 MiB | | December 31, 2020 |
06-Adrenoceptor-blockers-Pharma1 | 0.4 MiB | | April 4, 2020 |
06-and-07-Statistics-Probability-Disstributions | 1.5 MiB | | April 4, 2020 |
06-Appendicular-Skeleton-pharmacy | 5.4 MiB | | December 31, 2020 |
06-Arrhythmia-Pathopyhsiology | 0.7 MiB | | April 4, 2020 |
06-Cancer-infections-myeloid-growth-factors-2014 | 3.6 MiB | | April 4, 2020 |
06-CANNABIS2-Addicted-Phyto1 | 2.8 MiB | | April 4, 2020 |
06-ClinPK Pharmacokinetics Considerations In Special Populations 2014 | 1.2 MiB | | April 4, 2020 |
06-ClinPK Pharmacokinetics-Considerations-in-Special-Populations | 1.2 MiB | | December 31, 2020 |
06-Diabetes-Mellitus 2014-MFS | 8.0 MiB | | April 4, 2020 |
06-Genetics-of-population-Immuno | 2.2 MiB | | April 4, 2020 |
06-Genetics-of-population-Immuno | 2.2 MiB | | April 4, 2020 |
06-Hematology-part-2 | 1.3 MiB | | April 4, 2020 |
06-HYPERSENSITIVITY-Type-III-and-IV-Immuno | 2.7 MiB | | April 4, 2020 |
06-HYPERSENSITIVITY-Type-III-and-IV-Immuno | 2.7 MiB | | April 4, 2020 |
06-Neoplasia-Patho | 6.1 MiB | | April 4, 2020 |
06-Pathophysiology Of Atherosclerosis | 0.9 MiB | | April 4, 2020 |
06-Viral-hepatitis | 6.3 MiB | | April 4, 2020 |
06-Viruses-Micro1 | 1.5 MiB | | April 4, 2020 |
06Modlipidsnew | 1.9 MiB | iSpatula | April 4, 2020 |
07 Adrenoceptor-antagonist | 1.6 MiB | | April 4, 2020 |
07 Bioavailability-physicochemical-and-dosage-form-factors | 0.5 MiB | | April 4, 2020 |
07 Cardiovascular Pathophysio | 43.5 MiB | | April 4, 2020 |
07 Ch23 Principles-of-GMP Summer-2016 | 0.3 MiB | | April 4, 2020 |
07 Common Cold-combined 2014 | 4.9 MiB | | April 4, 2020 |
07 Enzyme | 5.7 MiB | iSpatula | April 4, 2020 |
07 Enzyme | 5.7 MiB | | December 31, 2020 |
07 Pathophysiology Dyslipidemia 2 | 0.9 MiB | | April 4, 2020 |
07 Pathophysiology Dyslipidemia 2 | 0.9 MiB | | April 4, 2020 |
07 Pharmacognosy | 47.7 MiB | | April 4, 2020 |
07 Practice1 The-medical-history | 0.6 MiB | | April 4, 2020 |
07 Principles-of-GMP | 0.4 MiB | | April 4, 2020 |
07 Respiratory | 0.7 MiB | | April 4, 2020 |
07 Vertebrate-Anatomy Lab-Biology | 2.1 MiB | | December 31, 2020 |
07-Anti Infectives (part 2) | 0.5 MiB | | April 4, 2020 |
07-Antihypertensive-agents-Diuretics-Pharma1 | 1.5 MiB | | April 4, 2020 |
07-Autoimmunity-Immuno | 3.8 MiB | | April 4, 2020 |
07-Autoimmunity-Immuno | 3.8 MiB | | April 4, 2020 |
07-ClinPK TDM Of Vancomycin 2014 | 0.7 MiB | | April 4, 2020 |
07-ClinPK TDM-of-Vancomycin | 0.7 MiB | | December 31, 2020 |
07-Eukaryotic Parasites-Micro1 | 1.9 MiB | | April 4, 2020 |
07-Executive-summaries | 0.7 MiB | | April 4, 2020 |
07-HOPS-Phyto1 | 0.9 MiB | | April 4, 2020 |
07-LIVER-CIRRHOSIS | 1.5 MiB | | April 4, 2020 |
07-Mapping-disease-loci-Immuno | 3.2 MiB | | April 4, 2020 |
07-Mapping-disease-loci-Immuno | 3.2 MiB | | April 4, 2020 |
07-muscle-tissue | 3.7 MiB | | December 31, 2020 |
07-Parasites-Micro1 | 1.0 MiB | | April 4, 2020 |
07-Pathophysiology Of DIABETES1 | 0.9 MiB | | April 4, 2020 |
07-Pathophysiology Of DIABETES2 | 0.7 MiB | | April 4, 2020 |
07-Pathophysiology Of DIABETES3 | 1.0 MiB | | April 4, 2020 |
07-Pathophysiology Of IHD | 0.2 MiB | | April 4, 2020 |
07-Venous-Thromboembolism 2014 | 8.0 MiB | | April 4, 2020 |
07Axial-skeleton | 8.5 MiB | | December 31, 2020 |
07Biological Membranes | 1.9 MiB | | April 4, 2020 |
07CHO-Metabolism | 1.1 MiB | iSpatula | April 4, 2020 |
07Glycogen-metabolism | 0.8 MiB | iSpatula | April 4, 2020 |
07modMembran-new | 1.9 MiB | iSpatula | April 4, 2020 |
08 The Genetics Of Behavior | 2.1 MiB | | April 4, 2020 |
08 Amino Acids | 1.2 MiB | | April 4, 2020 |
08 Anatomy | 4.0 MiB | iSpatula | April 4, 2020 |
08 Anatomy | 4.0 MiB | | December 31, 2020 |
08 Antihypertensive-agents | 7.0 MiB | | April 4, 2020 |
08 Digestive | 0.5 MiB | | April 4, 2020 |
08 Drugs Used In The Treatment Of Angina Pectoris Antianginal Pharma11 | 0.8 MiB | | April 4, 2020 |
08 Glycolysis | 14.6 MiB | iSpatula | April 4, 2020 |
08 Hemorrhoids | 1.8 MiB | | December 31, 2020 |
08 Pathophysiology Of Atherosclerosis | 0.9 MiB | | April 4, 2020 |
08 Pathophysiology Of Atherosclerosis | 0.9 MiB | | April 4, 2020 |
08 Pharmacognosy | 43.2 MiB | | April 4, 2020 |
08 Practice1 Treatment-related-problems | 1.2 MiB | | April 4, 2020 |
08 Practice2 Pharmacovigilance Students | 4.3 MiB | | April 4, 2020 |
08 Prokaryotes-Protista Lab-Biology | 1.6 MiB | | December 31, 2020 |
08 Transfer Of Salicylic Acid Across Polymeric Membrane Physical Lab | 0.2 MiB | iSpatula | April 4, 2020 |
08-amino-acids | 1.2 MiB | iSpatula | April 4, 2020 |
08-Antibiotics-Pharm D-part1-Mricro1 | 0.2 MiB | | April 4, 2020 |
08-Antibiotics-PHARM-D-Part2-Micro1 | 1.4 MiB | | April 4, 2020 |
08-Antimicrobial-Therapy-I-Micro1 | 0.7 MiB | | April 4, 2020 |
08-Cancer 1-Self-study-Pathophysio | 1.5 MiB | | April 4, 2020 |
08-Cancer 2-Self-study-Pathophysiology | 0.6 MiB | | April 4, 2020 |
08-ClinPK TDM Of Cardioactive Drugs 2014 | 1.6 MiB | | April 4, 2020 |
08-ClinPK TDM-of-Cardioactive-Drugs | 1.6 MiB | | December 31, 2020 |
08-DIGITALIS TOXICITY | 0.3 MiB | | April 4, 2020 |
08-IBD | 2.5 MiB | | April 4, 2020 |
08-Muscle-gross | 7.9 MiB | | December 31, 2020 |
08-NATURAAL-ACETYLENIC-COMPOUNDS-Phyto1 | 0.8 MiB | | April 4, 2020 |
08-Pathophysiology Of Hypertension | 1.3 MiB | | April 4, 2020 |
08-Pregnancy | 0.8 MiB | | April 4, 2020 |
08-Statistics-Probability-Distributions | 1.5 MiB | | April 4, 2020 |
08-The-Genetics-of-Behavior-Immuno | 2.1 MiB | | April 4, 2020 |
08-The-Genetics-of-Behavior-Immuno | 2.1 MiB | | April 4, 2020 |
08-Transplantation-Immuno | 3.2 MiB | | April 4, 2020 |
08-Transplantation-Immuno | 3.2 MiB | | April 4, 2020 |
08cardiovascular Pathophysio | 37.3 MiB | | April 4, 2020 |
09 Biochemical Genetics | 2.1 MiB | | April 4, 2020 |
09 Antianginal-Drugs | 7.5 MiB | | April 4, 2020 |
09 Appendicular Skeleton | 3.2 MiB | iSpatula | April 4, 2020 |
09 Appendicular Skeleton | 3.2 MiB | | December 31, 2020 |
09 Atherosclerosis Pathophysio | 48.7 MiB | | April 4, 2020 |
09 Critical-Micelle-Concentration Physical Lab | 0.1 MiB | iSpatula | April 4, 2020 |
09 Dissolution-and-drug-release-testing | 0.8 MiB | | April 4, 2020 |
09 Endocrine | 1.9 MiB | | April 4, 2020 |
09 GERD | 12.9 MiB | | December 31, 2020 |
09 Gluconeogenesis | 7.2 MiB | iSpatula | April 4, 2020 |
09 Pathophysiology Of IHD | 0.6 MiB | | April 4, 2020 |
09 Pathophysiology Of IHD(2) | 0.6 MiB | | April 4, 2020 |
09 Pharmacognosy | 46.2 MiB | | April 4, 2020 |
09 Practice1 ADRs | 0.3 MiB | | April 4, 2020 |
09 Protista-Fungi Lab-Biology | 4.0 MiB | | December 31, 2020 |
09-Anthraquinone-Phyto1 | 1.5 MiB | | April 4, 2020 |
09-Antimicrobial-Therapy-II-Micro1 | 0.7 MiB | | April 4, 2020 |
09-Biochemical-Genetics-Immuno | 2.1 MiB | | April 4, 2020 |
09-Biochemical-Genetics-Immuno | 2.1 MiB | | April 4, 2020 |
09-Cardiac-function-tests | 0.8 MiB | | April 4, 2020 |
09-ClinPK TDM Of Phenytoin 2014 | 1.5 MiB | | April 4, 2020 |
09-ClinPK TDM-of-PhenytoinVozeh | 2.4 MiB | | December 31, 2020 |
09-DIURETICS TOXICITY | 0.5 MiB | | April 4, 2020 |
09-IMMUNODEFICIENCYprimary-Immuno | 1.8 MiB | | April 4, 2020 |
09-IMMUNODEFICIENCYprimary-Immuno | 1.8 MiB | | April 4, 2020 |
09-nerve-tissue | 4.4 MiB | | December 31, 2020 |
09-Pathophysiology Of Heart Failure1 | 0.5 MiB | | April 4, 2020 |
09-Pathophysiology Of Heart Failure2 | 0.6 MiB | | April 4, 2020 |
09-skin Eye Wounds-Micro1 | 1.1 MiB | | April 4, 2020 |
09-Used-in-Heart-Failure-Pharma1 | 1.3 MiB | | April 4, 2020 |
09Metabolism-of-dietary-lipid | 1.1 MiB | iSpatula | April 4, 2020 |
09structure Of Protein | 1.3 MiB | | April 4, 2020 |
09structure-of-protein | 1.3 MiB | iSpatula | April 4, 2020 |
1 | 5.0 MiB | | April 4, 2020 |
1 | 28.3 MiB | | April 4, 2020 |
1 | 27.9 MiB | | April 4, 2020 |
1 | 0.1 MiB | | April 4, 2020 |
1 Course Outline | 0.1 MiB | iSpatula | April 4, 2020 |
1 Introduction To Pharmaceutical Analysis2(2) | 0.7 MiB | iSpatula | April 4, 2020 |
1 Introduction To Pharmacology | 0.3 MiB | | April 4, 2020 |
1 Lec1 Introduction | 1.1 MiB | iSpatula | April 4, 2020 |
1 Lec1 Introduction | 1.1 MiB | | December 31, 2020 |
1 Lec1 Introduction | 1.1 MiB | iSpatula | April 4, 2020 |
1 NPC Introduction Medicinal Plants | 0.2 MiB | | April 4, 2020 |
1 Nucleotide Metabolismmod | 2.2 MiB | iSpatula | April 4, 2020 |
1 Pathophysiology Cellular Respnses | 0.5 MiB | | April 4, 2020 |
1-1 Introduction | 2.2 MiB | | December 31, 2020 |
1-2 Choking 24-2-2015 | 0.3 MiB | | December 31, 2020 |
1-3 CPR15-2-2015 - Copy | 3.9 MiB | | December 31, 2020 |
1-Asthma 2014 | 2.4 MiB | | April 4, 2020 |
1-Introduction-and-definitions | 3.5 MiB | | April 4, 2020 |
1-Introduction-to-pharmaceutical-care | 1.3 MiB | | April 4, 2020 |
1-Lecture-1-2015 | 4.8 MiB | | April 4, 2020 |
1-Nutraceuticals 1 | 0.7 MiB | Seem Awad | November 4, 2020 |
1-Preventing-Medication-Errors | 1.6 MiB | | April 4, 2020 |
10 Appendicular Skeleton (1) | 3.2 MiB | iSpatula | April 4, 2020 |
10 Appendicular Skeleton (1) | 3.2 MiB | | December 31, 2020 |
10 Citric Acid Cycle | 5.4 MiB | iSpatula | April 4, 2020 |
10 Dosage-form-factors | 0.5 MiB | | April 4, 2020 |
10 Drugs-used-in-heart-failure (1) | 8.2 MiB | | April 4, 2020 |
10 Drugs-used-in-heart-failure (1)(2) | 8.2 MiB | | April 4, 2020 |
10 Heart Failure 1 | 0.5 MiB | | April 4, 2020 |
10 HMP | 0.9 MiB | iSpatula | April 4, 2020 |
10 NPC9 | 91 KiB | | April 4, 2020 |
10 Pancreatic Hormones & Antidiabetic Drugs | 12.6 MiB | | April 4, 2020 |
10 Pancreatic Hormones & Antidiabetic Drugs | 12.6 MiB | | October 19, 2020 |
10 Pathophysio Atherosclerosis | 18.4 MiB | | April 4, 2020 |
10 Pathophysiology Of Hypertension | 1.3 MiB | | April 4, 2020 |
10 Pathophysiology Of Hypertension | 1.3 MiB | | April 4, 2020 |
10 Pharmacognosy | 47.3 MiB | | April 4, 2020 |
10 Pharmacologic Management Of Parkinsonism | 2.5 MiB | | April 4, 2020 |
10 Pharmacologic Management Of Parkinsonism | 2.5 MiB | | October 19, 2020 |
10 Plant-Diversity Lab-Biology | 3.1 MiB | | December 31, 2020 |
10 Practice1 Drug-Interactions | 6.5 MiB | | April 4, 2020 |
10 Treatment Of Acne | 1.4 MiB | | April 4, 2020 |
10-Antibiotics-Phyto1 | 1.1 MiB | | April 4, 2020 |
10-Bites-and-Stings | 0.9 MiB | | December 31, 2020 |
10-ClinPK TDM Of Immunosuppressants2014 | 1.1 MiB | | April 4, 2020 |
10-ClinPK TDM-of-immunosuppressants | 1.1 MiB | | December 31, 2020 |
10-Eocrinology | 1.4 MiB | | April 4, 2020 |
10-Hypoglycemic Agents Toxicology | 0.8 MiB | | April 4, 2020 |
10-IMMUNODEFICIENCY-acquired-Immuno | 2.4 MiB | | April 4, 2020 |
10-IMMUNODEFICIENCY-acquired-Immuno | 2.4 MiB | | April 4, 2020 |
10-Innate-Host-Defenses-Micro1 | 0.8 MiB | | April 4, 2020 |
10-nerve-gross | 16.3 MiB | | December 31, 2020 |
10-Nervous-system-histology | 4.4 MiB | | December 31, 2020 |
10-Pathophysiology Of Arrhythmia | 0.4 MiB | | April 4, 2020 |
10-PharmacoDynamics-1-2 | 2.0 MiB | | April 4, 2020 |
10-PharmacoDynamics-1-2 | 2.0 MiB | | April 4, 2020 |
10-Pharmacogenetics-Immuno | 1.9 MiB | | April 4, 2020 |
10-Pharmacogenetics-Immuno | 1.9 MiB | | April 4, 2020 |
10-urogenital-part1-Micro1 | 0.5 MiB | | April 4, 2020 |
10-urogenital-part2-Micro1 | 0.2 MiB | | April 4, 2020 |
10-UTI 2014 | 7.4 MiB | | April 4, 2020 |
10882092 10202035361044582 1624562688817394774 N | 71 KiB | | April 4, 2020 |
10B-Oxidation And Ketone Bodies | 1.2 MiB | iSpatula | April 4, 2020 |
10B-Oxidation-and-Ketone-bodies | 1.2 MiB | iSpatula | April 4, 2020 |
10Enzymes | 2.2 MiB | iSpatula | April 4, 2020 |
10Enzymes | 2.2 MiB | | April 4, 2020 |
10prt Function1 | 1.1 MiB | | April 4, 2020 |
10prt-function1 | 1.1 MiB | iSpatula | April 4, 2020 |
10prt-function1 | 1.5 MiB | iSpatula | April 4, 2020 |
11 | 27 KiB | | April 4, 2020 |
11 Appendicular Skeleton (1) (1) | 1.2 MiB | iSpatula | April 4, 2020 |
11 Appendicular Skeleton (1) (1) | 1.2 MiB | | December 31, 2020 |
11 Blood Drugs Pdf 2 | 1.1 MiB | | April 4, 2020 |
11 Ciric Acid Cycle | 1.1 MiB | iSpatula | April 4, 2020 |
11 Constipation | 3.7 MiB | | December 31, 2020 |
11 Heart Failure 2 | 0.6 MiB | | April 4, 2020 |
11 Hexosepentose-phosphate-pathway | 6.1 MiB | iSpatula | April 4, 2020 |
11 NPC10 | 0.3 MiB | | April 4, 2020 |
11 Pathophysio Cardiovascular | 25.3 MiB | | April 4, 2020 |
11 Pathophysiology Of Heart Failure1 | 0.5 MiB | | April 4, 2020 |
11 Pathophysiology Of Heart Failure1 | 0.5 MiB | | April 4, 2020 |
11 Pharmacognosy | 46.7 MiB | | April 4, 2020 |
11 Practice1 Care-Plan | 2.7 MiB | | April 4, 2020 |
11 Respiratory Disease Part2 Micro11 | 0.5 MiB | | April 4, 2020 |
11- Cancer Chemotherapy | 5.5 MiB | | April 4, 2020 |
11- Cancer Chemotherapy | 5.5 MiB | | October 19, 2020 |
11-12-13-CVS-GIT-RS | 26.0 MiB | | December 31, 2020 |
11-Adaptive-Immunity-and-Immunization-Micro1 | 1.1 MiB | | April 4, 2020 |
11-Genetics-of-Cancer-Immuno | 3.5 MiB | | April 4, 2020 |
11-Genetics-of-Cancer-Immuno | 3.5 MiB | | April 4, 2020 |
11-Pathophysiology Of DIABETES-1 | 0.9 MiB | | April 4, 2020 |
11-Pathophysiology Of DIABETES-2 | 0.7 MiB | | April 4, 2020 |
11-Pathophysiology Of DIABETES-3 | 1.0 MiB | | April 4, 2020 |
11-Respiratory Disease-Micro1 | 0.3 MiB | | April 4, 2020 |
11-Spinal-cord | 4.5 MiB | | December 31, 2020 |
11-Surgical Antimicrobial Prophylaxis 2014-1 | 2.0 MiB | | April 4, 2020 |
11-Toxic Exposure During Pregnancy | 0.5 MiB | | April 4, 2020 |
11-Tumor-immunolgy | 3.0 MiB | | April 4, 2020 |
11-Tumor-immunolgy | 3.0 MiB | | April 4, 2020 |
11Fibrous Proteins | 29 KiB | | April 4, 2020 |
12 | 0.3 MiB | | April 4, 2020 |
12 Antibacterial Agents | 1.2 MiB | | April 4, 2020 |
12 Antibacterial Agents | 1.2 MiB | | October 19, 2020 |
12 Diarrhea | 4.4 MiB | | December 31, 2020 |
12 Glycogen Metabolism | 0.9 MiB | iSpatula | April 4, 2020 |
12 Muscle Tissue | 2.9 MiB | iSpatula | April 4, 2020 |
12 Muscle Tissue | 2.9 MiB | | December 31, 2020 |
12 NPC11 | 1.0 MiB | | April 4, 2020 |
12 Pathophysio Cardiovascular Diseases | 3.2 MiB | | April 4, 2020 |
12 Pathophysiology Of Arrythmia | 0.4 MiB | | April 4, 2020 |
12 Pathophysiology Of Heart Failure2 | 0.6 MiB | | April 4, 2020 |
12 Pathophysiology Of Heart Failure2 | 0.6 MiB | | April 4, 2020 |
12 Pharmacognosy[2][1] | 30.2 MiB | | April 4, 2020 |
12 Structure-of-glycogen | 12.5 MiB | iSpatula | April 4, 2020 |
12-brain-stem | 2.9 MiB | | December 31, 2020 |
12-Cancer 1-Pathophysiology | 1.5 MiB | | April 4, 2020 |
12-Cancer 2-Pathophysiology | 0.6 MiB | | April 4, 2020 |
12-CNS-Micro1 | 0.3 MiB | | April 4, 2020 |
12-DOPING | 0.6 MiB | | April 4, 2020 |
12-Immune-Disorders-Micro1 | 0.4 MiB | | April 4, 2020 |
12-Immune-Disordersnew-Micro1 | 0.4 MiB | | April 4, 2020 |
12-Immunogenetics-Immuno | 3.6 MiB | | April 4, 2020 |
12-Immunogenetics-Immuno | 3.6 MiB | | April 4, 2020 |
12-Immunotherapy | 2.8 MiB | | April 4, 2020 |
12-Immunotherapy | 2.8 MiB | | April 4, 2020 |
1213563-SELECTED TOPICS IN CLINICAL TOXICOLOGY | 0.3 MiB | | April 4, 2020 |
12Enzymes | 5.0 MiB | iSpatula | April 4, 2020 |
13 Cancer Chemotherapy | 1.2 MiB | | April 4, 2020 |
13 Cancer Chemotherapy | 1.2 MiB | | October 19, 2020 |
13 CHO Metabolism | 1.1 MiB | iSpatula | April 4, 2020 |
13 Choosing Topical Corticosteroids | 4.7 MiB | | December 31, 2020 |
13 DIABETES 1 | 0.9 MiB | | April 4, 2020 |
13 Introduction To The Immune System And Innate Immunity | 3.2 MiB | | April 4, 2020 |
13 Lec(1+2 After Mid) | 3.5 MiB | iSpatula | April 4, 2020 |
13 Metabolism-of-carbohydrates | 8.9 MiB | iSpatula | April 4, 2020 |
13 Muscular-system-1 | 2.7 MiB | iSpatula | April 4, 2020 |
13 Muscular-system-1 | 2.7 MiB | | December 31, 2020 |
13 NPC12 | 0.7 MiB | | April 4, 2020 |
13 Pathophysio Cardiovascular Diseases | 2.4 MiB | | April 4, 2020 |
13 Pathophysiology Of Arrhythmia | 0.4 MiB | | April 4, 2020 |
13 Pathophysiology Of Arrhythmia | 0.4 MiB | | April 4, 2020 |
13 Pharmacognosy[1] (online-audio-converter Com) | 33.1 MiB | | April 4, 2020 |
13 Rectal-drug-administration-self-study-S | 1.2 MiB | | April 4, 2020 |
13 Transdermal-drug-delivery S | 2.2 MiB | | April 4, 2020 |
13-Drug-Related Problems In Older Adult (LAST LECTURE) | 0.5 MiB | | April 4, 2020 |
13-forebrain-and-cerebellun | 1.5 MiB | | December 31, 2020 |
13-Infectious-diseases-Summary-Micro1 | 70 KiB | | April 4, 2020 |
13-oral Amp GIT-part2-Micro1 | 0.3 MiB | | April 4, 2020 |
13-oral GIT-part1-Micro1 | 0.3 MiB | | April 4, 2020 |
13-Pathophysiology Of Asthma | 0.9 MiB | | April 4, 2020 |
13-Skin-and-eyes-infections-Micro1 | 0.4 MiB | | April 4, 2020 |
1394 | 2.5 MiB | | October 19, 2020 |
13synthesis | 3.5 MiB | iSpatula | April 4, 2020 |
13synthesis | 3.5 MiB | iSpatula | April 4, 2020 |
14 Buccal-Delivery-Systems S | 1.8 MiB | | April 4, 2020 |
14 DIABETES 2 | 0.6 MiB | | April 4, 2020 |
14 Lipid-metabolism | 11.4 MiB | iSpatula | April 4, 2020 |
14 Metabolism Of Dietary Lipid | 1.1 MiB | iSpatula | April 4, 2020 |
14 Muscle Tissue | 2.6 MiB | iSpatula | April 4, 2020 |
14 Muscular-system | 2.1 MiB | iSpatula | April 4, 2020 |
14 Muscular-system | 2.1 MiB | | December 31, 2020 |
14 NPC13 | 1.2 MiB | | April 4, 2020 |
14 Pathophysio Cardiovascular Diseases | 2.9 MiB | | April 4, 2020 |
14 Pathophysiology Of Cancer 1 | 1.5 MiB | | April 4, 2020 |
14 Pathophysiology Of DIABETES1 | 0.9 MiB | | April 4, 2020 |
14 Pharmacognosy[1] | 46.9 MiB | | April 4, 2020 |
14-cardiovascular-gross | 1.9 MiB | | December 31, 2020 |
14s Analytical | 3.6 MiB | iSpatula | April 4, 2020 |
14steriod | 2.2 MiB | iSpatula | April 4, 2020 |
14steriod-all | 2.2 MiB | iSpatula | April 4, 2020 |
15 DIABETES 3 | 0.8 MiB | | April 4, 2020 |
15 Fatty-acid-biosynthesis | 25.9 MiB | iSpatula | April 4, 2020 |
15 Muscular System (1) | 3.0 MiB | iSpatula | April 4, 2020 |
15 Muscular System (1) | 3.0 MiB | | December 31, 2020 |
15 Muscular System 1(2) | 0.4 MiB | iSpatula | April 4, 2020 |
15 NPC14 | 0.6 MiB | | April 4, 2020 |
15 Pathophysio Diabetes | 3.3 MiB | | April 4, 2020 |
15 Pathophysiology Of Cancer 2 | 0.6 MiB | | April 4, 2020 |
15 Pathophysiology Of DIABETES2 | 0.7 MiB | | April 4, 2020 |
15 Pharmacognosy (online-audio-converter Com) | 37.4 MiB | | April 4, 2020 |
15-Respiratory-system | 6.6 MiB | | December 31, 2020 |
15Nitrogen Metabolism | 9.5 MiB | iSpatula | April 4, 2020 |
15Nitrogen-metabolism | 9.5 MiB | iSpatula | April 4, 2020 |
15s Analytical | 2.4 MiB | iSpatula | April 4, 2020 |
16 & 17-nerve-tissue-and-spinal-cord- | 6.5 MiB | iSpatula | April 4, 2020 |
16 & 17-nerve-tissue-and-spinal-cord- | 6.5 MiB | | December 31, 2020 |
16 Cancer 1 | 1.5 MiB | | April 4, 2020 |
16 Degradation-of-fatty-acids | 19.8 MiB | iSpatula | April 4, 2020 |
16 Muscular System 2(2) | 0.6 MiB | iSpatula | April 4, 2020 |
16 NPC15 | 0.7 MiB | | April 4, 2020 |
16 Pathophysio Diabetes | 3.5 MiB | | April 4, 2020 |
16 Pathophysiology Of DIABETES1 | 0.9 MiB | | April 4, 2020 |
16 Pathophysiology Of DIABETES3 | 1.0 MiB | | April 4, 2020 |
16 Pharmacognosy | 36.7 MiB | | April 4, 2020 |
16-Histology-of-blood-vessels | 2.2 MiB | | December 31, 2020 |
16-Hypervitaminosis-mod-Copy | 1.2 MiB | | April 4, 2020 |
16-Hypervitaminosis-mod-Copy | 1.4 MiB | | April 4, 2020 |
16N-containing Substances | 6.3 MiB | iSpatula | April 4, 2020 |
16N-containing-substances | 6.3 MiB | iSpatula | April 4, 2020 |
17 Cancer 2 | 0.6 MiB | | April 4, 2020 |
17 CancerOther.2014 | 1.9 MiB | | April 4, 2020 |
17 Cholesterol-and-steroids-biosynthesis | 15.3 MiB | iSpatula | April 4, 2020 |
17 Digestive System 1(3) | 0.8 MiB | iSpatula | April 4, 2020 |
17 NPC16 | 0.4 MiB | | April 4, 2020 |
17 Pathophysiology Of Asthma | 0.9 MiB | | April 4, 2020 |
17 Pathophysiology Of DIABETES2 | 0.7 MiB | | April 4, 2020 |
17 Pharmacognosy | 38.7 MiB | | April 4, 2020 |
17-11 | 20.0 MiB | | April 4, 2020 |
17-Digestive-system | 15.3 MiB | | December 31, 2020 |
171002 L5 Type Of Economic Evaluation 2 EH RM 2017-2018 V2 | 0.8 MiB | | April 4, 2020 |
18 Amino-acids-metabolism | 18.3 MiB | iSpatula | April 4, 2020 |
18 Digestive System 2(2) | 0.9 MiB | iSpatula | April 4, 2020 |
18 NPC17 | 0.7 MiB | | April 4, 2020 |
18 Pathophysiology Of Asthma | 0.9 MiB | | April 4, 2020 |
18 Pathophysiology Of DIABETES3 | 1.0 MiB | | April 4, 2020 |
18 Pharmacognosy | 35.4 MiB | | April 4, 2020 |
19 Cerebrum | 3.8 MiB | iSpatula | April 4, 2020 |
19 Cerebrum | 3.8 MiB | | December 31, 2020 |
19 Conversion-of-amino-acids-to-specialized-products | 8.9 MiB | iSpatula | April 4, 2020 |
19 Digestive System 2 | 1.3 MiB | iSpatula | April 4, 2020 |
19 Pathophysiology Of Asthma | 0.9 MiB | | April 4, 2020 |
19 Pharmacognosy | 38.1 MiB | | April 4, 2020 |
19-11 | 22.6 MiB | | April 4, 2020 |
1Lecture 1سنةرابعة | 1.3 MiB | | April 4, 2020 |
1st-week Pharma-organic Alcohol | 9.6 MiB | | December 31, 2020 |
1st-week-sheet | 2.2 MiB | | April 4, 2020 |
2 | 0.7 MiB | | April 4, 2020 |
2 | 0.1 MiB | | April 4, 2020 |
2 Chromosomes And Chromosome Abnormalities | 8.9 MiB | | April 4, 2020 |
2 NPC1 New Medicinal Plants | 0.5 MiB | | April 4, 2020 |
2 -Pituitary-Hypothalamic-hormones 2016 | 1.0 MiB | | April 4, 2020 |
2 -Pituitary-hypothalamic-hormones 2016 . .part-3 | 0.7 MiB | | April 4, 2020 |
2 -Pituitary-hypothalamic-hormones 2016 . .part-3 2 | 0.7 MiB | | April 4, 2020 |
2 -Pituitary-hypothalamic-hormones 2016-part-2 | 0.7 MiB | | April 4, 2020 |
2 Basic-chromatographic-techniques | 1.8 MiB | | April 4, 2020 |
2 Cell 1 | 1.4 MiB | iSpatula | April 4, 2020 |
2 DNA Structure | 3.8 MiB | iSpatula | April 4, 2020 |
2 DNA Structure | 8.2 MiB | iSpatula | April 4, 2020 |
2 Introduction Alcohol 17Sep13 | 0.1 MiB | iSpatula | April 4, 2020 |
2 Moodle Inflammation 1 | 0.4 MiB | | April 4, 2020 |
2 Pharmaceutical Calculations 2(2) | 0.2 MiB | | December 31, 2020 |
2 Pharmaceutical Calculations 2(2) | 0.2 MiB | iSpatula | April 4, 2020 |
2 Titremetric Analysis(2) | 0.4 MiB | iSpatula | April 4, 2020 |
2-1 Heart Attack8-3-2015 | 0.2 MiB | | December 31, 2020 |
2-2 Fainting First Aid 17-3-2015 | 0.2 MiB | | December 31, 2020 |
2-3 Stroke10-3-2015 | 0.2 MiB | | December 31, 2020 |
2-4 Diabetic ER17-3-2015 | 0.3 MiB | | December 31, 2020 |
2-5 Seizure 17-3-2015 | 0.2 MiB | | December 31, 2020 |
2-Adrenal Hormones June 7th 2018 | 2.1 MiB | | April 4, 2020 |
2-Adrenal Hormones June 7th 2018 | 2.1 MiB | | October 19, 2020 |
2-Adrenocorticosteroids-Adrenocortical-Antagonists | 0.1 MiB | | April 4, 2020 |
2-Adrenocorticosteroids-Adrenocortical-Antagonists | 0.1 MiB | | October 19, 2020 |
2-COPD 2014 | 7.2 MiB | | April 4, 2020 |
2-Lecture-2 | 1.3 MiB | | April 4, 2020 |
2-Nutraceuticals 2 | 2.6 MiB | Seem Awad | November 4, 2020 |
2-Overview-of-the-pharmaceutical-care-process | 1.2 MiB | | April 4, 2020 |
2-Updated-Beers-Crieteria | 0.1 MiB | | April 4, 2020 |
20 And 21 CVS | 5.9 MiB | iSpatula | April 4, 2020 |
20 And 21 CVS | 5.9 MiB | | December 31, 2020 |
20 Digestive System 4 | 5.7 MiB | iSpatula | April 4, 2020 |
20 Liver | 9.1 MiB | iSpatula | April 4, 2020 |
20 Pharmacognosy | 36.0 MiB | | April 4, 2020 |
2011-Fibrous-proteins | 0.1 MiB | iSpatula | April 4, 2020 |
20130316 093250 | 1.5 MiB | | April 4, 2020 |
20130316 093338 | 1.5 MiB | | April 4, 2020 |
20130316 093411 | 1.5 MiB | | April 4, 2020 |
2014 Mid Quiz Final Pathology | 0.3 MiB | | December 31, 2020 |
2014-NSTE-ACS-Slide-Set | 3.7 MiB | Marwa Abdeen | November 15, 2020 |
2014Mid And Final Dr Khaled | 0.3 MiB | | April 4, 2020 |
2014Mid And Final Pharma1 | 0.1 MiB | | April 4, 2020 |
2014Mid Quiz Final Pathophysio | 0.4 MiB | | April 4, 2020 |
20181106 135958 | 102 MiB | iSpatula | April 4, 2020 |
21 Blood Vessels And Urinary System | 1.8 MiB | iSpatula | April 4, 2020 |
21 Pharmacognosy | 34.9 MiB | | April 4, 2020 |
22 Pharmacognosy | 35.0 MiB | | April 4, 2020 |
23 | 2.4 MiB | | December 31, 2020 |
23 Pharmacognosy | 26.4 MiB | | April 4, 2020 |
24 Pharmacognosy | 40.7 MiB | | April 4, 2020 |
25 Pharmacognosy | 36.2 MiB | | April 4, 2020 |
26 Pharmacognosy | 87.0 MiB | | April 4, 2020 |
2nd-week Pharma-organic Alcohol | 11.5 MiB | | December 31, 2020 |
2nd-week-sheet | 2.3 MiB | | April 4, 2020 |
2ndStat-key Past Papers | 0.1 MiB | | April 4, 2020 |
2semilog-ex-hwk | 45 KiB | | April 4, 2020 |
2semilog-ex-hwk | 45 KiB | | April 4, 2020 |
3 | 2.9 MiB | | April 4, 2020 |
3 | 0.1 MiB | | April 4, 2020 |
3 Single Gene Disorders | 8.5 MiB | | April 4, 2020 |
3 -Thyroid-antithyroid-drugs Part-2 | 0.6 MiB | | April 4, 2020 |
3 -Thyroid-antithyroid-drugs-part-1 | 0.8 MiB | | April 4, 2020 |
3 Agent That Affect Bone Mineral Homeostasis June 2018 | 2.1 MiB | | April 4, 2020 |
3 Agent That Affect Bone Mineral Homeostasis June 2018 | 2.1 MiB | | October 19, 2020 |
3 Alcohol Nomenclature | 61 KiB | iSpatula | April 4, 2020 |
3 DNA Replication | 1.8 MiB | iSpatula | April 4, 2020 |
3 DNA Replication | 12.3 MiB | iSpatula | April 4, 2020 |
3 Epi | 1.3 MiB | iSpatula | April 4, 2020 |
3 HPLC-instrumentation-1 | 1.4 MiB | | April 4, 2020 |
3 Moodle Part 2 Inflammation | 0.3 MiB | | April 4, 2020 |
3 Neutralization Titration(2) | 1.8 MiB | iSpatula | April 4, 2020 |
3 NPC2 Medicinal Plants | 0.4 MiB | | April 4, 2020 |
3 Packaging | 1.2 MiB | | December 31, 2020 |
3 Packaging | 1.2 MiB | iSpatula | April 4, 2020 |
3-2bleeding And Shock | 0.4 MiB | | December 31, 2020 |
3-4 Head Neck Spine Inj5-4-2015 | 0.2 MiB | | December 31, 2020 |
3-6 Burns 14-4-2015 | 0.4 MiB | | December 31, 2020 |
3-8 Poisoning19-4-2015 | 0.1 MiB | | December 31, 2020 |
3-AKI 2014 | 2.0 MiB | | April 4, 2020 |
3-Sound-A-Like-Medications | 51 KiB | | April 4, 2020 |
3-The-need-for-pharmaceutical-care | 0.6 MiB | | April 4, 2020 |
3-Vitamins | 6.8 MiB | Seem Awad | November 4, 2020 |
3d-week-sheet | 3.2 MiB | | April 4, 2020 |
3Lecture2 | 0.9 MiB | | April 4, 2020 |
3Lecture2 | 0.9 MiB | | April 4, 2020 |
3rd-week Alcohol | 5.8 MiB | | December 31, 2020 |
4 | 46.0 MiB | | April 4, 2020 |
4 | 0.2 MiB | | April 4, 2020 |
4 Polygenic And Multifactorial Disorders(2) | 3.9 MiB | | April 4, 2020 |
4 -Adrenocorticosteroids-Adrenocortical-Antagonists Part-1 | 0.7 MiB | | April 4, 2020 |
4 -Adrenocorticosteroids-Adrenocortical-Antagonists Part-2 | 0.8 MiB | | April 4, 2020 |
4 Cholinoceptor-blocking-drugs | 2.0 MiB | | April 4, 2020 |
4 Connective | 2.6 MiB | iSpatula | April 4, 2020 |
4 Hemostasis And Thrombosis | 0.8 MiB | | April 4, 2020 |
4 Non-aqueous Acid-Base Titrations | 0.2 MiB | iSpatula | April 4, 2020 |
4 NPC3 Medicinal Plants | 0.4 MiB | | April 4, 2020 |
4 Physical Properties Of Alcohols | 0.3 MiB | iSpatula | April 4, 2020 |
4 Routs Of Administration(2) | 0.1 MiB | | December 31, 2020 |
4 Routs Of Administration(2) | 0.1 MiB | iSpatula | April 4, 2020 |
4 Transcription | 5.1 MiB | iSpatula | April 4, 2020 |
4 Transcription | 8.6 MiB | iSpatula | April 4, 2020 |
4 Van-deemeter-and-resolution-equation | 0.4 MiB | | April 4, 2020 |
4-11 | 33.1 MiB | | April 4, 2020 |
4-A-CKD Modifying Therapies 2014 | 2.4 MiB | | April 4, 2020 |
4-Absorption | 1.3 MiB | | April 4, 2020 |
4-B-CKD Complications 2014 | 3.5 MiB | | April 4, 2020 |
4-Barriers-to-Pharmaceutical-Care | 0.8 MiB | | April 4, 2020 |
4-Bleeding-and-Shock | 1.3 MiB | | December 31, 2020 |
4-Choking-24-2-2015 | 0.3 MiB | | December 31, 2020 |
4-Fat Soluble Vitamins | 3.0 MiB | Seem Awad | November 6, 2020 |
4-Heart-attack | 60 KiB | | December 31, 2020 |
4-High-Alert-Medications | 97 KiB | | April 4, 2020 |
4th-week Phenols Ethers | 16.0 MiB | | December 31, 2020 |
5 | 0.1 MiB | | April 4, 2020 |
5 Mutation And Human Disease(2) | 4.1 MiB | | April 4, 2020 |
5 Bone Histology Pdffilename-UTF-85-Bone-histology | 4.2 MiB | | December 31, 2020 |
5 Bone Tissue | 0.7 MiB | iSpatula | April 4, 2020 |
5 Complexation | 0.4 MiB | iSpatula | April 4, 2020 |
5 Moodle Pathophysiology Dyslipidemia 1 | 1.2 MiB | | April 4, 2020 |
5 NPC4 Medicinal Plants | 0.7 MiB | | April 4, 2020 |
5 Preparation Of Alcohols | 0.2 MiB | iSpatula | April 4, 2020 |
5 Suspensions | 69 KiB | | December 31, 2020 |
5 Suspensions | 69 KiB | iSpatula | April 4, 2020 |
5 Translation | 3.6 MiB | iSpatula | April 4, 2020 |
5 Translation | 11.1 MiB | iSpatula | April 4, 2020 |
5-collecting-patient-data-base | 0.9 MiB | | April 4, 2020 |
5-Diabetic-Emergencies | 0.5 MiB | | December 31, 2020 |
5-Extraction 1 | 10.2 MiB | Seem Awad | November 11, 2020 |
5-Gonadal-hormones-and-inhibitors 2016 | 1.7 MiB | | April 4, 2020 |
5-heart-attack8-3-2015 | 0.2 MiB | | December 31, 2020 |
5-High-Alert-Medications-In-Community-Healthcare | 95 KiB | | April 4, 2020 |
5-Osteopososis 2014 | 5.9 MiB | | April 4, 2020 |
50 211 | 0.3 MiB | | April 4, 2020 |
5th-week Ald Ket C A Ester | 25.2 MiB | | December 31, 2020 |
6 | 0.1 MiB | | April 4, 2020 |
6 Genetics Of Population | 2.2 MiB | | April 4, 2020 |
6 Adrenoceptor-antagonist | 1.6 MiB | | April 4, 2020 |
6 Biotechnology | 5.3 MiB | iSpatula | April 4, 2020 |
6 Emulsions | 0.3 MiB | | December 31, 2020 |
6 Emulsions | 0.3 MiB | iSpatula | April 4, 2020 |
6 Moodle Pathophysiology Dyslipidemia 2 | 1.3 MiB | | April 4, 2020 |
6 NPC5 Medicinal Plants | 0.4 MiB | | April 4, 2020 |
6 Ossification(2) | 0.8 MiB | iSpatula | April 4, 2020 |
6 Precipitation Titrimetry | 0.5 MiB | iSpatula | April 4, 2020 |
6 Reactions Of Alcohols | 0.1 MiB | iSpatula | April 4, 2020 |
6-Appendicular-skeleton | 5.4 MiB | | December 31, 2020 |
6-Axial-skeleton-1 | 3.9 MiB | | December 31, 2020 |
6-Cardiovascular-and-Stroke-Emergencies | 0.8 MiB | | December 31, 2020 |
6-Error-Prone-Abbreviations | 0.2 MiB | | April 4, 2020 |
6-Extraction 2 | 8.3 MiB | Seem Awad | November 11, 2020 |
6-Fainting-First-Aid-17-3-2015 | 0.2 MiB | | December 31, 2020 |
6-seizure-17-3-2015 | 0.2 MiB | | December 31, 2020 |
6-stroke10-3-2015 | 0.2 MiB | | December 31, 2020 |
6-The-medical-history | 0.8 MiB | | April 4, 2020 |
6th-week Heterocyclic | 10.1 MiB | | December 31, 2020 |
7 | 1.8 MiB | | December 31, 2020 |
7 | 2.5 MiB | | April 4, 2020 |
7 Mapping Disease Loci | 3.2 MiB | | April 4, 2020 |
7 Appendicular Skeleton(2) | 2.2 MiB | iSpatula | April 4, 2020 |
7 NPC6 Medicinal Plants | 0.7 MiB | | April 4, 2020 |
7 Oxidation,reduction Reaction And Titration | 1.2 MiB | iSpatula | April 4, 2020 |
7 Pathophysiology Of Atherosclerosis | 0.6 MiB | | April 4, 2020 |
7 Phenols | 0.2 MiB | iSpatula | April 4, 2020 |
7 Regulation Of Gene Expression | 3.6 MiB | iSpatula | April 4, 2020 |
7 Suppositories | 79 KiB | | December 31, 2020 |
7 Suppositories | 79 KiB | iSpatula | April 4, 2020 |
7-Ambulatory-Warfarin-Protocol | 0.2 MiB | | April 4, 2020 |
7-Diabetic-ER17-3-2015 | 0.3 MiB | | December 31, 2020 |
7-muscelskeletal-injuries | 2.4 MiB | | December 31, 2020 |
7-Treatment-related-problems | 1.3 MiB | | April 4, 2020 |
7th-week Cont Heterocyclic | 11.2 MiB | | December 31, 2020 |
8 | 0.3 MiB | | December 31, 2020 |
8 | 2.9 MiB | | April 4, 2020 |
8 | 2.6 MiB | | April 4, 2020 |
8 Antidepressants | 0.6 MiB | | April 4, 2020 |
8 Antidepressants | 0.6 MiB | | October 19, 2020 |
8 Determination Of Metals | 0.2 MiB | iSpatula | April 4, 2020 |
8 Ethers And Epoxides | 0.2 MiB | iSpatula | April 4, 2020 |
8 Glycolysis | 1.8 MiB | iSpatula | April 4, 2020 |
8 Glycolysis | 7.3 MiB | iSpatula | April 4, 2020 |
8 NPC7 Medicinal Plants | 0.3 MiB | | April 4, 2020 |
8 Pathophysiology Of IHD | 0.6 MiB | | April 4, 2020 |
8-1-injuries29-3-2015 | 0.2 MiB | | December 31, 2020 |
8-2-Fractures12-4-2015 | 0.3 MiB | | December 31, 2020 |
8-3-head-neck-spine-inj5-4-2015 | 0.2 MiB | | December 31, 2020 |
8-4-eyenoseear-injuries-1-4-2015 | 0.2 MiB | | December 31, 2020 |
8-5-bleeding-and-shock | 0.4 MiB | | December 31, 2020 |
8-7-Burns-14-4-2015 | 0.4 MiB | | December 31, 2020 |
8-Alternative-Medications-for-Medications-in-the-Use-of-High-Risk | 0.1 MiB | | April 4, 2020 |
8-Antianginal-Drugs | 7.5 MiB | | April 4, 2020 |
8-burn-emergencies | 1.1 MiB | | December 31, 2020 |
8-LRTI 2014 | 5.9 MiB | | April 4, 2020 |
8-muscle-tissue | 3.7 MiB | | December 31, 2020 |
9 | 7.5 MiB | | April 4, 2020 |
9 | 2.8 MiB | | April 4, 2020 |
9 Determination Of Drugs Based On Their Functional Groups | 0.2 MiB | iSpatula | April 4, 2020 |
9 Estrogens And Progestins | 3.7 MiB | | April 4, 2020 |
9 Estrogens And Progestins | 3.7 MiB | | October 19, 2020 |
9 Gluconeogenesis | 1.9 MiB | iSpatula | April 4, 2020 |
9 NPC8 Medicinal Plants | 0.6 MiB | | April 4, 2020 |
9 Pathophysiology Of Hypertension | 0.7 MiB | | April 4, 2020 |
9-heat-and-cold-emergencies | 1.5 MiB | | December 31, 2020 |
9-muscle-groos | 7.9 MiB | | December 31, 2020 |
9-poisoning19-4-2015 | 0.1 MiB | | December 31, 2020 |
A-missed-Page-Num -3-in-Notes-01 | 0.2 MiB | | April 4, 2020 |
AASLD-Guidelines-for-Treatment-of-Chronic-Hepatitis-B-Terrault Et Al-2016-Hepatology | 0.3 MiB | | April 4, 2020 |
AASLD-Guidelines-for-Treatment-of-Chronic-Hepatitis-C-2015 | 0.5 MiB | | April 4, 2020 |
Absorption | 0.7 MiB | | April 4, 2020 |
Accelrys DS Visualizer 2.0 | 54.2 MiB | | April 4, 2020 |
ACE-inhibitors-Bardaweel | 0.1 MiB | | April 4, 2020 |
Acetate - Malonate Pathway(1) | 1.8 MiB | | April 4, 2020 |
Acid-base-disorders | 5.2 MiB | | December 31, 2020 |
Acne | 1.3 MiB | | April 4, 2020 |
Acne | 0.3 MiB | | April 4, 2020 |
Acute-viral-gastroenteritis-in-children-in-resource-rich-countries -Management-and-prevention-UpToDate | 0.4 MiB | | December 31, 2020 |
Addiction | 0.7 MiB | | April 4, 2020 |
Addition-on-viagra Dr-saleem | 0.5 MiB | | April 4, 2020 |
Addition-on-viagra_Dr-saleem | 0.5 MiB | | April 4, 2020 |
Additional Problems For Ethers | 4.3 MiB | iSpatula | April 4, 2020 |
Additional Problems For Phenols And Alcohols | 4.9 MiB | iSpatula | April 4, 2020 |
Additional Slides Ch Biotech Dr Violet | 1.9 MiB | iSpatula | April 4, 2020 |
Adjustment-of-insulin-dosing-case-students | 0.5 MiB | | April 4, 2020 |
Adrenagonist-Bardaweel | 0.4 MiB | Rahaf Darweesh | November 8, 2020 |
Adrenal Hormones Summer 2014 Second Revision | 6.6 MiB | | April 4, 2020 |
Adrenal Hormones Summer 2014 Second Revision | 6.6 MiB | | October 19, 2020 |
Adrenantagonist-Bardaweel | 0.3 MiB | | April 4, 2020 |
Adrenantagonist-Bardaweel | 0.7 MiB | Rahaf Darweesh | November 8, 2020 |
Adrenergic | 0.3 MiB | | April 4, 2020 |
Adrenergic-B2-agonist | 92 KiB | | April 4, 2020 |
Adrenergic-Bardaweel | 0.8 MiB | Rahaf Darweesh | November 8, 2020 |
Adrenoceptor-Agonists-and-Sympathomimetic-Drugs | 2.6 MiB | | April 4, 2020 |
Adrenocorticosteroids-Adrenocortical-Antagonists | 0.7 MiB | | April 4, 2020 |
Adrenocorticosteroids-Adrenocortical-Antagonists | 0.7 MiB | | October 19, 2020 |
ADRs | 0.3 MiB | | April 4, 2020 |
AGA-Institute-Guidelines-for-the-Identification | 4.7 MiB | | April 4, 2020 |
Agents-used-in-cardiac-arrhythmias-5-1 | 0.4 MiB | | April 4, 2020 |
AKI | 2.4 MiB | | April 4, 2020 |
AKI-2020 | 0.9 MiB | | December 31, 2020 |
AKI-checklist | 24 KiB | | December 31, 2020 |
Alcohol Lecture 1 St Ppt- | 1.0 MiB | | December 31, 2020 |
Alcohol Lecture-1-2 St | 0.8 MiB | | December 31, 2020 |
Alcohol Lecture-1-3- | 0.6 MiB | | December 31, 2020 |
Alcohol Lecture-1-4 St | 0.5 MiB | | December 31, 2020 |
Alcohol-Toxicology-Copy | 1.1 MiB | | April 4, 2020 |
Alcohols 20common 20names Dr Khanfar | 12 KiB | iSpatula | April 4, 2020 |
Alcohols And Phenols | 0.8 MiB | iSpatula | April 4, 2020 |
Alcohols Phenol Lecture 6 | 0.9 MiB | | December 31, 2020 |
Aldehyde And Ketones | 2.9 MiB | iSpatula | April 4, 2020 |
Aldehyde And Ketones | 2.9 MiB | | December 31, 2020 |
Aldehydes And Ketones 2 | 0.5 MiB | iSpatula | April 4, 2020 |
Aldehydes-and-Ketones L-Lecture-7 | 1.0 MiB | | December 31, 2020 |
Aldehydes-And-Ketones-L-Lecture-8 | 0.9 MiB | | December 31, 2020 |
Aldehydes-And-Ketones-L-Lecture-9 | 0.4 MiB | | December 31, 2020 |
Alkaloids-ppt- | 2.3 MiB | | April 4, 2020 |
AlkensRxn Notes Organic | 1.1 MiB | | April 4, 2020 |
Alkyl-halides-1 | 0.2 MiB | | December 31, 2020 |
Alkyl-halides-2 | 1.1 MiB | | December 31, 2020 |
Alkynes | 0.2 MiB | | December 31, 2020 |
Alkynsrxn Notes Organic | 1.1 MiB | | April 4, 2020 |
All Sheets Biopharma Dr Rana | 47.1 MiB | | April 4, 2020 |
All-OTC-Second-exam-2009 | 0.3 MiB | | April 4, 2020 |
Allergic Rhinitis 2015 Combined | 7.3 MiB | | April 4, 2020 |
AllergicRhinitis-Combined-2018 | 1.9 MiB | | April 4, 2020 |
Ambulatory Warfarin Protocol | 0.2 MiB | | April 4, 2020 |
Amine Nitro Slides[1] | 15.2 MiB | iSpatula | April 4, 2020 |
Amine Nitro Slides[1] | 15.2 MiB | | December 31, 2020 |
Amino & Nitro Compounds | 7.3 MiB | iSpatula | April 4, 2020 |
Amino & Nitro Compounds | 7.3 MiB | iSpatula | April 4, 2020 |
Amino & Nitro Compounds | 7.3 MiB | | April 4, 2020 |
Amino Acid Metabiolism 2 Urea Cycle 1 | 3.7 MiB | iSpatula | April 4, 2020 |
Amino Acid Metabiolism 2 Urea Cycle 1 | 3.0 MiB | iSpatula | April 4, 2020 |
Amino Acid Metabolism 3 | 1.6 MiB | iSpatula | April 4, 2020 |
Amino Acid Metabolism 3 | 0.9 MiB | iSpatula | April 4, 2020 |
Amino And Nitro Notes & Final Corrections | 1.8 MiB | iSpatula | April 4, 2020 |
Amino And Nitro Notes & Final Corrections | 8.0 MiB | iSpatula | April 4, 2020 |
Amino-Nitro | 11.6 MiB | | December 31, 2020 |
Aminoglycosides | 4.1 MiB | | December 31, 2020 |
Aminoglycosides Dr Lahham | 0.3 MiB | | April 4, 2020 |
Aminonirto Cpd | 11.6 MiB | | December 31, 2020 |
An Introduction To Medicinal Chemistry - GRAHAM L PATRICK | 10.9 MiB | | April 4, 2020 |
An Introduction To Medicinal Chemistry Patrick 4th Edition | 79.3 MiB | | April 4, 2020 |
An-Introduction-to-Medicinal-Chemistry-Fifth-Edition-Graham-L -Patrick- | 21.0 MiB | | April 4, 2020 |
Analtical 7 | 0.2 MiB | iSpatula | April 4, 2020 |
Analytcial 22 | 0.3 MiB | iSpatula | April 4, 2020 |
Analytical 15 | 0.6 MiB | iSpatula | April 4, 2020 |
Analytical 23 | 0.1 MiB | iSpatula | April 4, 2020 |
Analytical 10 | 0.3 MiB | iSpatula | April 4, 2020 |
Analytical 11 | 0.4 MiB | iSpatula | April 4, 2020 |
Analytical 12 And 14 | 0.5 MiB | iSpatula | April 4, 2020 |
Analytical 13 | 0.5 MiB | iSpatula | April 4, 2020 |
Analytical 16 | 0.3 MiB | iSpatula | April 4, 2020 |
Analytical 17 | 43 KiB | iSpatula | April 4, 2020 |
Analytical 18 | 0.5 MiB | iSpatula | April 4, 2020 |
Analytical 19 | 0.3 MiB | iSpatula | April 4, 2020 |
Analytical 20 | 0.5 MiB | iSpatula | April 4, 2020 |
Analytical 21 | 0.2 MiB | iSpatula | April 4, 2020 |
Analytical 24 | 0.5 MiB | iSpatula | April 4, 2020 |
Analytical 4 | 0.3 MiB | iSpatula | April 4, 2020 |
Analytical 5 | 0.3 MiB | iSpatula | April 4, 2020 |
Analytical 6 | 0.4 MiB | iSpatula | April 4, 2020 |
Analytical 8 | 0.5 MiB | iSpatula | April 4, 2020 |
Analytical 9 | 0.3 MiB | iSpatula | April 4, 2020 |
Analytical L-14,15 | 0.8 MiB | iSpatula | April 4, 2020 |
Analytical L014 | 28.6 MiB | iSpatula | April 4, 2020 |
Analytical L015 | 35.2 MiB | iSpatula | April 4, 2020 |
Analytical L016 | 40.2 MiB | iSpatula | April 4, 2020 |
Analytical L1 | 27.7 MiB | iSpatula | April 4, 2020 |
Analytical L10 | 31.1 MiB | iSpatula | April 4, 2020 |
Analytical L11 | 29.7 MiB | iSpatula | April 4, 2020 |
Analytical L2 | 31.1 MiB | iSpatula | April 4, 2020 |
Analytical L20,21,22 | 2.0 MiB | iSpatula | April 4, 2020 |
Analytical L3[1] | 28.1 MiB | iSpatula | April 4, 2020 |
Analytical L4 | 27.9 MiB | iSpatula | April 4, 2020 |
Analytical L5 | 26.5 MiB | iSpatula | April 4, 2020 |
Analytical L6 | 34.0 MiB | iSpatula | April 4, 2020 |
Analytical L7 | 29.7 MiB | iSpatula | April 4, 2020 |
Analytical L8 | 29.0 MiB | iSpatula | April 4, 2020 |
Analytical L9 | 16.9 MiB | iSpatula | April 4, 2020 |
Analytical Pharmaceutical Chemistry SYLLABUS | 51 KiB | iSpatula | April 4, 2020 |
Analytical Reports | 1.3 MiB | | December 31, 2020 |
Analytical Reports | 1.3 MiB | iSpatula | April 4, 2020 |
Analytical#1 | 0.3 MiB | iSpatula | April 4, 2020 |
Analytical#2 | 0.1 MiB | iSpatula | April 4, 2020 |
Analytical#3 | 0.6 MiB | iSpatula | April 4, 2020 |
Analytical-L07-and-L08 | 7.1 MiB | iSpatula | April 4, 2020 |
Analytical-L1 | 0.7 MiB | iSpatula | April 4, 2020 |
Analytical-L11 | 0.4 MiB | iSpatula | April 4, 2020 |
Analytical-L12,13 | 0.4 MiB | iSpatula | April 4, 2020 |
Analytical-L2 | 0.3 MiB | iSpatula | April 4, 2020 |
Analytical-L3 | 0.5 MiB | iSpatula | April 4, 2020 |
Analytical-L4 | 0.3 MiB | iSpatula | April 4, 2020 |
Analytical-L5 | 0.3 MiB | iSpatula | April 4, 2020 |
Analytical-L6 | 0.5 MiB | iSpatula | April 4, 2020 |
Analytical-L7 | 0.6 MiB | iSpatula | April 4, 2020 |
Analytical-L9 | 0.2 MiB | iSpatula | April 4, 2020 |
Analytical-Week-10-part-1 | 6.3 MiB | iSpatula | April 4, 2020 |
Analytical-Week-10-part-2 | 2.5 MiB | iSpatula | April 4, 2020 |
Analytical017 | 32.4 MiB | iSpatula | April 4, 2020 |
Anatomy | 0.5 MiB | | December 31, 2020 |
Anatomy Corrections | 15 KiB | iSpatula | April 4, 2020 |
Anatomy Lec 1 | 0.6 MiB | iSpatula | April 4, 2020 |
Anatomy Lec 2 | 7.5 MiB | iSpatula | April 4, 2020 |
Anatomy Lec 3 | 6.6 MiB | iSpatula | April 4, 2020 |
Anatomy Lec 3 (Edited) | 29 KiB | iSpatula | April 4, 2020 |
Anatomy Lec 4 | 60 KiB | iSpatula | April 4, 2020 |
Anatomy Lec 5 (1) | 93 KiB | iSpatula | April 4, 2020 |
Anatomy Lec 6 | 0.4 MiB | iSpatula | April 4, 2020 |
Anatomy Lec 7 | 1.3 MiB | iSpatula | April 4, 2020 |
Anatomy Lec 8 | 1.8 MiB | iSpatula | April 4, 2020 |
Anatomy S02 Junctions Dr Amjad | 2.5 MiB | | December 31, 2020 |
AnatomyLab | 0.4 MiB | | December 31, 2020 |
ANS Pharmacy F | 2.9 MiB | | April 4, 2020 |
ANS-Pharmacy-1 | 0.1 MiB | | December 31, 2020 |
ANS-PHARMACY-F | 1.9 MiB | | December 31, 2020 |
ANS-Pharmacy-F-1 | 3.6 MiB | | December 31, 2020 |
Anthraquinone 1 | 2.1 MiB | | April 4, 2020 |
Anti-angina-Bardaweel | 0.2 MiB | | April 4, 2020 |
Anti-angina-Bardaweel | 0.3 MiB | Rahaf Darweesh | November 8, 2020 |
Anti-hyperlipidemics-Bardaweel | 1.5 MiB | | April 4, 2020 |
Antianginal-Drugs | 0.3 MiB | | April 4, 2020 |
Antianginal-Drugs-1 | 1.5 MiB | | April 4, 2020 |
Antibacterial-agents-continue . .-2016 | 0.8 MiB | | April 4, 2020 |
Antibiotic-resistance-pattern-of-bacteria-in-urinary-tract-infection-1 | 61 KiB | | December 31, 2020 |
Antibiotic-resistance-pattern-of-bacteria-in-urinary-tract-infection-1 | 61 KiB | | April 4, 2020 |
Antibiotic-resistance-pattern-of-bacteria-in-urinary-tract-yyy | 0.2 MiB | | December 31, 2020 |
Antibiotic-resistance-pattern-of-bacteria-in-urinary-tract-yyy | 0.2 MiB | | April 4, 2020 |
ANTIBIOTICS | 0.6 MiB | | April 4, 2020 |
Anticoagulants | 0.5 MiB | | April 4, 2020 |
Antidepressants | 2.4 MiB | | April 4, 2020 |
AntiDepressants | 0.3 MiB | | April 4, 2020 |
Antidepressants | 2.4 MiB | | October 19, 2020 |
Antiemesis2019 | 1.1 MiB | | December 31, 2020 |
Antiepileptics-adverse-drug-reactions | 0.3 MiB | | December 31, 2020 |
Antiepileptics-adverse-drug-reactions 2 | 0.3 MiB | | December 31, 2020 |
Antifungal-Agents-chapter-48-Katzung-Trevors-Pharmacology-Examination-and-Board-Review-11th-Edition- | 1.1 MiB | | April 4, 2020 |
Antifungal-Agents-chapter-48-Katzung-Trevors-Pharmacology-Examination-and-Board-Review-11th-Edition- | 1.1 MiB | | October 19, 2020 |
Antihisatmine | 0.6 MiB | | April 4, 2020 |
AntiHistamines-Bardaweel (1) | 0.6 MiB | Rahaf Darweesh | November 8, 2020 |
Antihypertensive-agents | 7.0 MiB | | April 4, 2020 |
Antihypertensive-and-diuretics-agents Merged | 1.3 MiB | | April 4, 2020 |
Antiinfectives1 | 0.3 MiB | | April 4, 2020 |
Antiinfectives2 | 0.4 MiB | | April 4, 2020 |
Antiparasitic Agents | 49.1 MiB | Khadijah Aldos | March 29, 2020 |
Antiperspirants-and-Deodorants-cosmo | 0.5 MiB | | April 4, 2020 |
Antiplatelet-modified | 0.6 MiB | | April 4, 2020 |
Antipsychotic Agents | 1.9 MiB | | April 4, 2020 |
Antipsychotic Agents | 1.9 MiB | | October 19, 2020 |
Antiseizure Drugs | 2.0 MiB | | April 4, 2020 |
Antiseizure Drugs | 2.0 MiB | | October 19, 2020 |
Antiviral Agents I | 49.4 MiB | Khadijah Aldos | March 29, 2020 |
Antiviral Agents II | 62.4 MiB | Khadijah Aldos | April 3, 2020 |
Antiviral Agents III | 49.0 MiB | Khadijah Aldos | April 3, 2020 |
Anxiety Disorders 2013 | 4.0 MiB | | April 4, 2020 |
Appendix PathoPhysio Topic1 Inflammation | 0.2 MiB | | April 4, 2020 |
Applied-Biopharmaceutics-and-Pharmacokinetics-7th-Edition | 46.5 MiB | | April 4, 2020 |
Applied-clinical-pharmacokinetics | 3.3 MiB | | April 4, 2020 |
Applied-Pharmaceutical-Practice-1stEdition | 5.0 MiB | | April 4, 2020 |
Applying-and-removing-PPE-gloves-mask-gown-eye-wear | 0.2 MiB | | April 4, 2020 |
Applying-and-Removing-Sterile-Gloves-open-method | 0.2 MiB | | April 4, 2020 |
Applying-sterile-gown-and-gloves-closed-method | 0.2 MiB | | April 4, 2020 |
Arabic100 Notebook | 8.5 MiB | | October 27, 2020 |
Arabic100 Vocabulary | 0.3 MiB | | October 27, 2020 |
Archive Gynecologic Indications(2) | 5.1 MiB | | April 4, 2020 |
Archive ImmuneSystem | 0.5 MiB | | April 4, 2020 |
Archive RespiratorySystem | 43 KiB | | April 4, 2020 |
Archive UTI Part1(2) | 1.5 MiB | | April 4, 2020 |
Archive UTI Part2 | 0.2 MiB | | April 4, 2020 |
Aromatherapy | 23 KiB | | April 4, 2020 |
Aromatherapy | 0.4 MiB | | April 4, 2020 |
Article Quiz Amines Dr Areej | 2.8 MiB | iSpatula | April 4, 2020 |
Article-How-to-Use-a-Noninferiority-Trial | 0.2 MiB | | April 4, 2020 |
Asepsis Theory Part | 6.4 MiB | | April 4, 2020 |
Assessing-apical-pulse-evaluation-sheet | 0.1 MiB | | April 4, 2020 |
Assessing-body-temperature-evaluation-sheet%E2%80%8E | 0.1 MiB | | April 4, 2020 |
Assessing-BP-evaluation-sheet | 0.2 MiB | | April 4, 2020 |
Assessing-peripheral-pulse-evaluation-sheet | 0.2 MiB | | April 4, 2020 |
Assessing-respiration-evaluation-sheet | 0.1 MiB | | April 4, 2020 |
Assignment06 | 0.2 MiB | | April 4, 2020 |
Assignment2 | 19 KiB | | April 4, 2020 |
Assignment3 | 23 KiB | | April 4, 2020 |
Assignment4 | 23 KiB | | April 4, 2020 |
Assignment5 | 12.8 MiB | | April 4, 2020 |
Assignment6 | 3.4 MiB | | April 4, 2020 |
Assignment7 | 2 KiB | | April 4, 2020 |
Attachment | 59 KiB | | April 4, 2020 |
AUD-20180920-WA0002 | 17.0 MiB | | April 4, 2020 |
AUD-20181106-WA0012 | 42.9 MiB | | December 31, 2020 |
AUD-20181119-WA0021 | 43.1 MiB | | December 31, 2020 |
Audio-2 | 36.1 MiB | | December 31, 2020 |
AUDIO-2019-03-15-18-13-37 | 31.9 MiB | | December 31, 2020 |
Audio-3 | 33.7 MiB | | December 31, 2020 |
Ayurveda-notes | 17 KiB | | April 4, 2020 |
B-oxidation | 1.1 MiB | iSpatula | April 4, 2020 |
B-oxidation 2 Energy Yeild | 4.0 MiB | iSpatula | April 4, 2020 |
B-oxidation 3 Unsaturated F A | 0.7 MiB | iSpatula | April 4, 2020 |
Bacterial-Meningitis | 0.4 MiB | | December 31, 2020 |
Bacteriophage | 0.4 MiB | | December 31, 2020 |
Bacteriophage | 0.4 MiB | | April 4, 2020 |
Basic Tools Of AC Modern Analytical Chemistry - David Harvey Chap4 | 0.4 MiB | iSpatula | April 4, 2020 |
Basic-concepts-of-metabolism | 1.1 MiB | | December 31, 2020 |
Basic-ConceptsL.01-L.02 | 1.0 MiB | | April 4, 2020 |
BCS #9 | 60 KiB | | April 4, 2020 |
Bio 2-courseoutline Spring 2011-2012 | 0.3 MiB | iSpatula | April 4, 2020 |
Bioavailability | 0.1 MiB | | April 4, 2020 |
Bioavailability - Physicochemical And Dosage Form Factors #7 | 0.2 MiB | | April 4, 2020 |
BIOAVAILABILITY Membranes | 0.4 MiB | | April 4, 2020 |
Biochem | 0.8 MiB | iSpatula | April 4, 2020 |
Biochem-lab-2 | 2.2 MiB | iSpatula | April 4, 2020 |
Biochem-reports-2 | 12.8 MiB | iSpatula | April 4, 2020 |
Biochem1 Ch02 Biomolecules | 1.0 MiB | | December 31, 2020 |
Biochem1 Ch03 Water | 1.5 MiB | | December 31, 2020 |
Biochem1 Old Pastpapers | 0.6 MiB | | December 31, 2020 |
Biochem1 Pastpapers | 0.6 MiB | | December 31, 2020 |
Biochem1 S04 Carbohydrate | 1.7 MiB | | December 31, 2020 |
Biochem1 S04 Carbohydrate | 1.7 MiB | iSpatula | April 4, 2020 |
Biochem1 S05 Glycongugates | 0.5 MiB | | December 31, 2020 |
Biochem1 S06 Lipids | 1.9 MiB | | December 31, 2020 |
Biochem1 S07 Membrane | 1.9 MiB | | December 31, 2020 |
Biochem1 S08 Amino Acids | 1.2 MiB | | December 31, 2020 |
Biochem1 S09 Structure Of Protein | 1.3 MiB | | December 31, 2020 |
Biochem1 S10 Enzymes | 2.2 MiB | | December 31, 2020 |
Biochem1 S10 Protein Function | 1.1 MiB | | December 31, 2020 |
Biochem1 S11 Fibrous Proteins | 49 KiB | | December 31, 2020 |
Biochem1 S12 Water Soluble Vitamins | 27 KiB | | December 31, 2020 |
Biochem1 S13 Bioenergetics | 2.1 MiB | | December 31, 2020 |
Biochem1 S14 Metabolism | 0.8 MiB | | December 31, 2020 |
Biochem2 Mid | 59.0 MiB | iSpatula | April 4, 2020 |
Biochem2 Past Papers | 0.2 MiB | iSpatula | April 4, 2020 |
Biochem2-Past Papers | 0.2 MiB | iSpatula | April 4, 2020 |
Biochemistry-1-syllbus | 52 KiB | | December 31, 2020 |
Biochemistry-of-amino-acids-and-peptides | 1.2 MiB | | December 31, 2020 |
Biochemistry-of-Carbohydrates | 0.9 MiB | | December 31, 2020 |
Biochemistry-of-lipids | 1.9 MiB | | December 31, 2020 |
Bioenerg-2017 | 11.4 MiB | iSpatula | April 4, 2020 |
Bioenergetics-and-oxidative-Phosphorylation | 2.3 MiB | | December 31, 2020 |
Bioequiv-سنة4 | 0.6 MiB | | April 4, 2020 |
BioequivalenceCorrection | 30 KiB | | April 4, 2020 |
Biology-2-Text-Book-by-Campbell-10ed | 59.3 MiB | | December 31, 2020 |
Biology-Lab-1 -Dr Ales Quizs | 0.6 MiB | | December 31, 2020 |
Biology-Lab-1 -Dr Alia Quizs | 4.9 MiB | | December 31, 2020 |
Biology-Lab-1 -Dr Hanaa | 0.6 MiB | | December 31, 2020 |
Biology-Lab-1 -Dr Mohammad Hazem Quizs | 0.5 MiB | | December 31, 2020 |
Biology-Lab-1 -Dr Rudina-Quizs | 4.9 MiB | | December 31, 2020 |
Biology-Lab-1 -Dr Waleed Gharybeh Quizs | 0.6 MiB | | December 31, 2020 |
Biology-Lab-1 -Final-Biolab | 0.1 MiB | | December 31, 2020 |
Biology-Lab-1 -Mid-Biolab | 0.2 MiB | | December 31, 2020 |
Biology-Lab-1 -Miss Ghena-and-Dr Belal-quizzes | 6.2 MiB | | December 31, 2020 |
Biology-Lab-1 -Past-Quizzes | 0.4 MiB | | December 31, 2020 |
Biology-Lab-1- Biology-Lab-Quizzes-Spring-2018 | 3.1 MiB | | December 31, 2020 |
Biomolecules | 1.0 MiB | | December 31, 2020 |
Biopharma Dr Rana L1 | 36.8 MiB | | April 4, 2020 |
Biopharma Dr Rana L1 | 19.3 MiB | | April 4, 2020 |
Biopharma Dr Rana L1 | 58 KiB | | April 4, 2020 |
Biopharma Dr Rana L1 | 0.3 MiB | | April 4, 2020 |
Biopharma Dr Rana L11 | 16.2 MiB | | April 4, 2020 |
Biopharma Dr Rana L12 | 24.8 MiB | | April 4, 2020 |
Biopharma Dr Rana L2 | 40.4 MiB | | April 4, 2020 |
Biopharma Dr Rana L2 | 21.1 MiB | | April 4, 2020 |
Biopharma Dr Rana L2 | 42 KiB | | April 4, 2020 |
Biopharma Dr Rana L2 | 0.4 MiB | | April 4, 2020 |
Biopharma Dr Rana L3 | 29.4 MiB | | April 4, 2020 |
Biopharma Dr Rana L3 | 15.4 MiB | | April 4, 2020 |
Biopharma Dr Rana L3 | 28 KiB | | April 4, 2020 |
Biopharma Dr Rana L3 | 0.2 MiB | | April 4, 2020 |
Biopharma Dr Rana L4 | 27.7 MiB | | April 4, 2020 |
Biopharma Dr Rana L4 | 40 KiB | | April 4, 2020 |
Biopharma Dr Rana L4 | 35 KiB | | April 4, 2020 |
Biopharma Dr Rana L5 | 45.5 MiB | | April 4, 2020 |
Biopharma Dr Rana L5 | 23.8 MiB | | April 4, 2020 |
Biopharma Dr Rana L5 | 82 KiB | | April 4, 2020 |
Biopharma Dr Rana L5 | 0.2 MiB | | April 4, 2020 |
Biopharma Dr Rana L6 | 40.4 MiB | | April 4, 2020 |
Biopharma Dr Rana L6 | 21.2 MiB | | April 4, 2020 |
Biopharma Dr Rana L6 | 40 KiB | | April 4, 2020 |
Biopharma Dr Rana L6 | 0.4 MiB | | April 4, 2020 |
Biopharma Dr Rana L7 | 36.0 MiB | | April 4, 2020 |
Biopharma Dr Rana L7 | 30 KiB | | April 4, 2020 |
Biopharma Dr Rana L7 | 0.3 MiB | | April 4, 2020 |
Biopharma Dr Rana L8 | 27.7 MiB | | April 4, 2020 |
Biopharma Dr Rana L9 | 18.1 MiB | | April 4, 2020 |
Biopharma Gastric-emptying | 0.4 MiB | | April 4, 2020 |
Biopharma S08 Dissolution-and-drug-release | 1.0 MiB | | April 4, 2020 |
Biopharma S09 BCS | 0.2 MiB | | April 4, 2020 |
Biopharma S10 GITabsorption | 0.9 MiB | | April 4, 2020 |
Biopharma S11 IVIVC | 0.5 MiB | | April 4, 2020 |
Biopharma S12 Administration-of-drugs-via-lung | 1.9 MiB | | April 4, 2020 |
Biopharma-L09-online-audio-converter Com | 40.5 MiB | | April 4, 2020 |
Biopharma-L10-online-audio-converter Com | 27.3 MiB | | April 4, 2020 |
Biophrama Dr Rana L10 | 32.7 MiB | | April 4, 2020 |
Biotech-genetic-diseases | 7.9 MiB | iSpatula | April 4, 2020 |
BiotechGuide2008 | 3.9 MiB | | December 31, 2020 |
BiotechGuide2008 | 3.9 MiB | | April 4, 2020 |
Biotechnol-journals | 20 KiB | | December 31, 2020 |
Biotechnol-journals | 20 KiB | | April 4, 2020 |
Biotechnology-and-Human-Disease | 5.1 MiB | iSpatula | April 4, 2020 |
Blood And Body Fluids-Phar1-Tortora(2) | 5.9 MiB | iSpatula | April 4, 2020 |
Blood And Body Fluids-Phar1-Tortora(2) | 5.9 MiB | | December 31, 2020 |
Blood And Body Fluids-students | 6.7 MiB | | April 4, 2020 |
Blood Transport Oxygen 1 | 92 KiB | iSpatula | April 4, 2020 |
Blood-Drugs | 1.1 MiB | | April 4, 2020 |
Blood-flow | 12.9 MiB | | December 31, 2020 |
Blood-reh2-Tortora-17-18 | 5.9 MiB | | December 31, 2020 |
Body-Fluids-Blood-ph1-lect1-2-fall16 | 0.7 MiB | | December 31, 2020 |
Body-Fluids-Blood-ph1-lect1-2-fall16-fluidsfinal | 3.1 MiB | | December 31, 2020 |
Bone-and-joint-diseases-for-pharmacy | 1.1 MiB | | April 4, 2020 |
Book | 18.6 MiB | | December 31, 2020 |
Book | 7.4 MiB | | December 31, 2020 |
Book | 44.0 MiB | | April 4, 2020 |
Book Examples | 9.6 MiB | iSpatula | April 4, 2020 |
Book-Copy-Cosmo | 3.0 MiB | | April 4, 2020 |
Book-fundamentals-of-nuclear-pharmacy | 8.5 MiB | | April 4, 2020 |
BOOK-PROBLEMS | 35 KiB | | April 4, 2020 |
Bookchapter1 Antibacterial Dr Ghadeer | 26.9 MiB | | April 4, 2020 |
Bookchapter2 Antibacterial Dr Ghadeer | 39.7 MiB | | April 4, 2020 |
Breast-1-2-%D9%85%D8%AD%D9%88%D9%84 | 1.7 MiB | | December 31, 2020 |
Breast-1-recording-1 | 22.4 MiB | | December 31, 2020 |
Breast-2-%D9%85%D8%AD%D9%88%D9%84 | 1.1 MiB | | December 31, 2020 |
Breast-2-recording | 13.2 MiB | | December 31, 2020 |
Breast-pathology-for-pharmacy | 3.0 MiB | | April 4, 2020 |
Brief Syllabus Micro 1 PharmD | 0.1 MiB | | April 4, 2020 |
Buccal Delivery Systems | 0.8 MiB | | April 4, 2020 |
Buffers Calculations | 16.7 MiB | iSpatula | April 4, 2020 |
Burns-Nutrition2 | 0.8 MiB | | April 4, 2020 |
BurnsNutrition | 0.2 MiB | | April 4, 2020 |
C01 Therapy2 Asthma Case Study And Answers | 67 KiB | | April 4, 2020 |
C01 Therapy4 lab Chronic Pain | 86 KiB | AJadallah | February 20, 2020 |
C02 Therapy2 COPD-Case-study-and-answers | 24 KiB | | April 4, 2020 |
C02 Therapy4 lab Perioperative Care | 88 KiB | AJadallah | February 20, 2020 |
C03 Therapy2 AKI-Case-study-and-answers | 57 KiB | | April 4, 2020 |
C03-Therapy4-lab Sepsis And Septic Shock | 1.4 MiB | AJadallah | March 12, 2020 |
C05 Therapy4 lab Acid-base Disorder Docx | 0.3 MiB | AJadallah | March 12, 2020 |
C06 Therapy4 lab Hyponatremia.docx.pdf | 0.4 MiB | AJadallah | March 12, 2020 |
C07 Therapy 4 Lab Hypokalemia | 84 KiB | AJadallah | March 26, 2020 |
C07-hypokalemia | 84 KiB | | May 20, 2020 |
C08 Therapy 4 Lab B12 Deficiency Anemia | 66 KiB | AJadallah | April 10, 2020 |
C08 Therapy 4 Lab IDA | 66 KiB | AJadallah | April 10, 2020 |
C09 Therapy 4 Lab Preeclampsia | 57 KiB | AJadallah | April 10, 2020 |
Caboxylic Acid Ester Amide Slided Pharmaorganic[1] | 22.1 MiB | iSpatula | April 4, 2020 |
Caboxylic Acid Ester Amide Slided Pharmaorganic[1] | 22.1 MiB | | December 31, 2020 |
Caffeine And Pain | 68 KiB | | April 4, 2020 |
Calculation-workshop | 0.2 MiB | | December 31, 2020 |
Calculus-1-First-Exam | 8.6 MiB | | December 31, 2020 |
Calculus-1-Second-Exam | 1.5 MiB | | December 31, 2020 |
Calculus-Earlytranscendentals-6th-edition-James-Stewart | 20.7 MiB | | December 31, 2020 |
CAM Book | 2.4 MiB | Joodjibril98 | February 10, 2020 |
Cancer Infections + Myeloid Growth Factors | 5.8 MiB | | April 4, 2020 |
Cancer Pain | 4.5 MiB | | April 4, 2020 |
Cannabis (1) | 2.3 MiB | | April 4, 2020 |
CANNABIS 2 | 2.2 MiB | | April 4, 2020 |
Cannabis1 | 0.4 MiB | | April 4, 2020 |
CAP-in-Children-2011 | 0.8 MiB | | December 31, 2020 |
Carbamazepine | 0.2 MiB | | December 31, 2020 |
Carbonskeleton | 3.6 MiB | iSpatula | April 4, 2020 |
Carbonskeleton | 3.6 MiB | iSpatula | April 4, 2020 |
Carbonskeleton | 3.6 MiB | iSpatula | April 4, 2020 |
Carboxylic Acids | 0.2 MiB | iSpatula | April 4, 2020 |
Carboxylic-Acids-and-Derivatives-Lecture-10 | 1.6 MiB | | December 31, 2020 |
Cardiac Lect-1 | 0.1 MiB | | December 31, 2020 |
Cardiology-pharmacy-converted | 1.5 MiB | | December 31, 2020 |
Cardiovascular Lecture-2 | 1.4 MiB | | December 31, 2020 |
Cardiovascular Lecture-3 | 1.2 MiB | | December 31, 2020 |
Cardiovascular Lecture-4 | 1.1 MiB | | December 31, 2020 |
Cardiovascular Lecture-5 | 1.1 MiB | | December 31, 2020 |
Cardiovascular Lecture-5 2 | 1.1 MiB | | December 31, 2020 |
Cardiovascular Lecture-6 | 7.2 MiB | | December 31, 2020 |
Cardiovascular Lecture-6 DR IYAD 2 | 1.7 MiB | | December 31, 2020 |
Cardiovascular System | 70 KiB | | April 4, 2020 |
Cardiovascular System | 0.3 MiB | | April 4, 2020 |
Cardiovascular System Lab Notes | 1.4 MiB | | December 31, 2020 |
Cardiovascular System Notes | 6.6 MiB | | December 31, 2020 |
Cardiovascular System- Circulation L5 | 2.3 MiB | iSpatula | April 4, 2020 |
Cardiovascular System- Circulation L6 | 1.5 MiB | iSpatula | April 4, 2020 |
Cardiovascular System- Circulation L7 | 0.8 MiB | iSpatula | April 4, 2020 |
Cardiovascular System- Circulation L8 | 0.6 MiB | iSpatula | April 4, 2020 |
Cardiovascular System- Circulation L9 | 1.0 MiB | iSpatula | April 4, 2020 |
Cardiovascular System- L1 | 9.0 MiB | iSpatula | April 4, 2020 |
Cardiovascular System- L1 | 9.0 MiB | | December 31, 2020 |
Cardiovascular System- L2 | 8.5 MiB | iSpatula | April 4, 2020 |
Cardiovascular System- L2 | 8.5 MiB | | December 31, 2020 |
Cardiovascular System- L3 | 1.8 MiB | iSpatula | April 4, 2020 |
Cardiovascular System- L3 | 1.8 MiB | | December 31, 2020 |
Cardiovascular System- L4 | 1.1 MiB | iSpatula | April 4, 2020 |
Cardiovascular System- L4 | 1.1 MiB | | December 31, 2020 |
Cardiovascular System- L5 | 2.6 MiB | iSpatula | April 4, 2020 |
Cardiovascular System- L5 | 2.6 MiB | | December 31, 2020 |
Cardiovascular System- L6 | 5.3 MiB | iSpatula | April 4, 2020 |
Cardiovascular System- L6 | 5.3 MiB | | December 31, 2020 |
Cardiovascular System- L7 | 2.3 MiB | iSpatula | April 4, 2020 |
Cardiovascular System- L7 | 2.3 MiB | | December 31, 2020 |
Cardiovascular System- L8 | 4.1 MiB | iSpatula | April 4, 2020 |
Cardiovascular System- L8 | 4.1 MiB | | December 31, 2020 |
Cardiovascular System- L9 | 1.9 MiB | iSpatula | April 4, 2020 |
Cardiovascular System- L9 | 1.9 MiB | | December 31, 2020 |
Cardiovascular System-cardiac- L1 | 5.5 MiB | iSpatula | April 4, 2020 |
Cardiovascular System-cardiac- L1 | 5.5 MiB | | December 31, 2020 |
Cardiovascular-online-audio-converter Com | 55.9 MiB | | December 31, 2020 |
Cardiovascular-system Circulation L8 | 4.1 MiB | | December 31, 2020 |
Cardiovascular-system Circulation L9 | 1.9 MiB | | December 31, 2020 |
Care-plan | 2.6 MiB | | April 4, 2020 |
Cell-injury-1-1 | 6.8 MiB | | December 31, 2020 |
CH 10 IMMUNODEFICIENCY Acquired | 2.4 MiB | | April 4, 2020 |
CH 11 Tumor Immunolgy | 3.0 MiB | | April 4, 2020 |
CH 12 Immunotherapy | 2.8 MiB | | April 4, 2020 |
Ch 2 Adaptive Immune Response | 7.3 MiB | | April 4, 2020 |
Ch 4 Vaccines | 1.6 MiB | | April 4, 2020 |
Ch 5 Hypersensitivity Reactions Type I And II | 3.0 MiB | | April 4, 2020 |
Ch 6 HYPERSENSITIVITY Type III And IV | 2.7 MiB | | April 4, 2020 |
Ch 7 Autoimmunity | 3.8 MiB | | April 4, 2020 |
Ch 8 Transplantation | 3.2 MiB | | April 4, 2020 |
CH 9 IMMUNODEFICIENCY,,,primary | 1.8 MiB | | April 4, 2020 |
Ch -1 -Introduction-Clinical-chem-Pharmacy-2011 | 1.5 MiB | | April 4, 2020 |
Ch -2-Body-fluids-and-Electrolytes | 2.2 MiB | | April 4, 2020 |
Ch -22 Sedative-Hypnotic-Drugs 2016 | 1.2 MiB | | April 4, 2020 |
Ch -24 Antiseizure-Drugs 2016 | 1.1 MiB | | April 4, 2020 |
Ch -28 Pharmacologic-Management-of-Parkinsonism 2016 | 0.5 MiB | | April 4, 2020 |
Ch -29 Antipsychotic-Agents-lithium 2016 | 2.0 MiB | | April 4, 2020 |
CH -3 -Potassium-hemostasis | 2.8 MiB | | April 4, 2020 |
Ch -30 Antidepressant-Agents 2016 | 1.2 MiB | | April 4, 2020 |
Ch -4 -Acid-Base-Haemostasis | 4.3 MiB | | April 4, 2020 |
Ch -5a -Kidney-functions | 2.6 MiB | | April 4, 2020 |
Ch -5b -Kidney-Disease | 1.3 MiB | | April 4, 2020 |
CH -6 -calcium-regulation | 2.6 MiB | | April 4, 2020 |
CH -7 -Lipid-disorders | 2.9 MiB | | April 4, 2020 |
CH -8 -Plasma-Protein-disorders | 5.3 MiB | | April 4, 2020 |
CH -9 -Liver-Disorders | 2.3 MiB | | April 4, 2020 |
CH 1 A Nucleotide Metabolism | 2.5 MiB | iSpatula | April 4, 2020 |
CH 1 B DNA Structure | 3.3 MiB | iSpatula | April 4, 2020 |
CH 1 C DNA Replication | 3.3 MiB | iSpatula | April 4, 2020 |
CH 1 D Transcription | 4.6 MiB | iSpatula | April 4, 2020 |
CH 1 E Translation(2) | 4.3 MiB | iSpatula | April 4, 2020 |
CH 1 F Biotechnology(2) | 5.3 MiB | iSpatula | April 4, 2020 |
Ch 1 G Regulation Of Gene Expression | 3.6 MiB | iSpatula | April 4, 2020 |
CH 10 Pharmacogenetics | 1.9 MiB | | April 4, 2020 |
CH 11 Genetics Of Cancer(2) | 3.5 MiB | | April 4, 2020 |
Ch 12 Immunogenetics | 3.6 MiB | | April 4, 2020 |
CH 2 Glycolysis | 2.2 MiB | iSpatula | April 4, 2020 |
CH 3 Gluconeogenesis | 1.6 MiB | iSpatula | April 4, 2020 |
CH 4 Hexose Monophosphate Shunt (HMP) | 1.2 MiB | iSpatula | April 4, 2020 |
Ch 41-Pancreatic-Hormones-Antidiabetic-Drugs Part-2 | 1.9 MiB | | April 4, 2020 |
CH 5 Citric Acid Cycle | 1.1 MiB | iSpatula | April 4, 2020 |
CH 6 Glycogen Metabolism | 1.9 MiB | iSpatula | April 4, 2020 |
CH 7 CHO Metabolism | 0.8 MiB | iSpatula | April 4, 2020 |
CH 8 Metabolism Of Dietary Lipid | 2.4 MiB | iSpatula | April 4, 2020 |
CH 9 Lipid Biosynthesis | 5.8 MiB | iSpatula | April 4, 2020 |
Ch-40 The-Gonadal-hormones-Inhibitors | 1.4 MiB | | April 4, 2020 |
Ch-41 Pancreatic-Hormones-Antidiabetic-Drugs Part-1 | 1.2 MiB | | April 4, 2020 |
CH.10 Oxidation And Ketone Bodies | 2.5 MiB | iSpatula | April 4, 2020 |
CH.11 Steroids And Lipoprotein | 2.6 MiB | iSpatula | April 4, 2020 |
CH.12 Amino Acid Metabolism | 3.7 MiB | iSpatula | April 4, 2020 |
CH.13 N-containing Substances | 3.3 MiB | iSpatula | April 4, 2020 |
Ch.24- Antiseizure Drugs | 3.7 MiB | | April 4, 2020 |
Ch.24- Antiseizure Drugs | 3.7 MiB | | October 19, 2020 |
Ch.38- Thyroid And Antithyroid Drugs | 0.4 MiB | | April 4, 2020 |
Ch.38- Thyroid And Antithyroid Drugs | 0.4 MiB | | October 19, 2020 |
Ch.42 Agents-That-Affect-Bone-Mineral-Homeostasis 2016 | 1.2 MiB | | April 4, 2020 |
Ch00 Revision | 1.0 MiB | | December 31, 2020 |
Ch01 | 85 KiB | | December 31, 2020 |
Ch01 -General-Chemistry -The-Study-of-Change | 0.9 MiB | | December 31, 2020 |
Ch01 Structure And Bonding 2 | 1.4 MiB | | December 31, 2020 |
Ch02 | 0.1 MiB | | December 31, 2020 |
Ch02 -General-Chemistry -Atoms-Molecules-and-Ions | 1.4 MiB | | December 31, 2020 |
Ch02 Alkanes | 1.3 MiB | | December 31, 2020 |
Ch02 Alkanes Part2 | 1.4 MiB | | December 31, 2020 |
Ch02 Arabic100 Elm Al Ihteram | 0.1 MiB | | October 27, 2020 |
Ch03 | 0.1 MiB | | December 31, 2020 |
Ch03 -General-Chemistry -Mass-Relationships-in-Chemical-Reactions | 1.3 MiB | | December 31, 2020 |
Ch03 Alkenes | 2.9 MiB | | December 31, 2020 |
Ch03 Water-and-Life Biology-1 Book | 1.0 MiB | | December 31, 2020 |
Ch04 | 0.2 MiB | | December 31, 2020 |
Ch04 -General-Chemistry -Reactions-in-Aqueous-Solution | 1.2 MiB | | December 31, 2020 |
Ch04 Arabic100 Al Maqamah Al Mousliah | 78 KiB | | October 27, 2020 |
Ch04 Carbon-and-the-Molecular-Diversity-of-Life Biology-1 Book | 0.9 MiB | | December 31, 2020 |
Ch05 | 0.3 MiB | | December 31, 2020 |
Ch05 -General-Chemistry -Gases | 1.3 MiB | | December 31, 2020 |
Ch05 Arabic100 Halima Al-Majnonah | 56 KiB | | October 27, 2020 |
Ch05 Ecology Air Pollution | 1.8 MiB | | October 27, 2020 |
Ch05 The-Structure-and-Function-of-Large-Biological-Molecules Biology-1 Book | 5.4 MiB | | December 31, 2020 |
Ch06 | 0.5 MiB | | December 31, 2020 |
Ch06 -General-Chemistry -Thermochemistry | 1.0 MiB | | December 31, 2020 |
Ch06 A-Tour-of-the-Cell Biology-1 Book | 4.9 MiB | | December 31, 2020 |
Ch06 Ecology Water Sources | 1.7 MiB | | October 27, 2020 |
Ch06-wilson-Antifungal | 1.0 MiB | | April 4, 2020 |
Ch06-wilson-Antiprotozoal-Anthelmintic-AntiTB | 0.9 MiB | | April 4, 2020 |
Ch07 | 0.4 MiB | | December 31, 2020 |
Ch07 -General-Chemistry -Electronic-Structure-of-Atoms | 1.5 MiB | | December 31, 2020 |
Ch07 Ecology Solid Waste | 2.1 MiB | | October 27, 2020 |
Ch07 Membrane-Structure-and-Function Biology-1 Book | 4.8 MiB | | December 31, 2020 |
Ch07-wilson-Antimalarial | 0.6 MiB | | April 4, 2020 |
Ch08 | 0.2 MiB | | December 31, 2020 |
Ch08 -General-Chemistry -Periodic-Relationships | 1.3 MiB | | December 31, 2020 |
Ch08 Ecology Food & Health | 1.4 MiB | | October 27, 2020 |
Ch08 Membrane-Structure-and-Function Biology-1 Book | 2.9 MiB | | December 31, 2020 |
Ch09 | 0.4 MiB | | December 31, 2020 |
Ch09 -General-Chemistry -Chemical-Bonding-I | 1.1 MiB | | December 31, 2020 |
Ch09 Cellular-Respiration-and-Fermentation Biology-1 Book | 1.0 MiB | | December 31, 2020 |
Ch09-Medicinal2-Nucleic-acids-as-drug-targets | 1.0 MiB | | April 4, 2020 |
Ch10 | 0.3 MiB | | December 31, 2020 |
Ch10 Photosynthesis Biology-1 Book | 2.1 MiB | | December 31, 2020 |
Ch11 | 0.3 MiB | | December 31, 2020 |
Ch11 -Biology-2 -Cell-Communication | 6.9 MiB | | December 31, 2020 |
Ch12 | 0.3 MiB | | December 31, 2020 |
Ch12 The-Cell-Cycle Biology-1 Book | 1.3 MiB | | December 31, 2020 |
Ch13 | 0.3 MiB | | December 31, 2020 |
Ch13 Meiosis-and-Sexual Biology-1 Book | 4.3 MiB | | December 31, 2020 |
Ch14-and-15 Self-study-material | 2.1 MiB | | April 4, 2020 |
Ch16 The-Molecular-Basis-of-Inheritance Biology-1 Book | 4.2 MiB | | December 31, 2020 |
Ch17 From-Gene-to-Protein Biology-1 Book | 16.2 MiB | | December 31, 2020 |
Ch17 Microbial Spoilage Part 1 | 0.1 MiB | | April 4, 2020 |
Ch17 Microbial Spoilage Part 2 | 0.7 MiB | | April 4, 2020 |
Ch19 Physiology1 The Cardiovascular System Dr Loai | 6.7 MiB | | December 31, 2020 |
Ch19-Medicinal2-Antibacterial | 0.9 MiB | | April 4, 2020 |
Ch20 Biotechnology Biology-1 Book | 6.4 MiB | | December 31, 2020 |
Ch20-Medicinal2-Antiviral | 1.8 MiB | | April 4, 2020 |
Ch21 Sterilization | 0.9 MiB | | April 4, 2020 |
Ch21-Medicinal2-Anticancer | 1.5 MiB | | April 4, 2020 |
Ch27 -Biology-2 -Bacteria | 9.1 MiB | | December 31, 2020 |
Ch27 Physiology1 Fluid Electrolyte And Acid Base Homeostasis Dr Loai | 1.1 MiB | | December 31, 2020 |
Ch28 -Biology-2 -Protists | 13.2 MiB | | December 31, 2020 |
Ch29 -Biology-2 -Plant-Diversity-1 | 11.3 MiB | | December 31, 2020 |
Ch30 -Biology-2 -Plant-Diversity-2 | 11.9 MiB | | December 31, 2020 |
Ch31 -Biology-2 -Fungi | 11.3 MiB | | December 31, 2020 |
Ch32 -Biology-2 -Animal-Diversity | 4.5 MiB | | December 31, 2020 |
Ch33 -Biology-2 -Invertebrates | 19.6 MiB | | December 31, 2020 |
Ch34 -Biology-2 -Vertebrates | 20.0 MiB | | December 31, 2020 |
Ch39 -Biology-2 -Plant-Response | 10.7 MiB | | December 31, 2020 |
Ch45 -Biology-2 -Endocrine | 6.5 MiB | | December 31, 2020 |
Ch48 -Biology-2 -Nervous-System | 6.3 MiB | | December 31, 2020 |
Ch48-anti-fungalself-study | 0.5 MiB | | April 4, 2020 |
Ch48-anti-fungalself-study | 0.5 MiB | | October 19, 2020 |
Ch49 -Biology-2 -Nervous-System | 8.4 MiB | | December 31, 2020 |
Ch49-anti-viralself-study | 0.2 MiB | | April 4, 2020 |
Ch49-anti-viralself-study | 0.2 MiB | | October 19, 2020 |
Ch52 -Biology-2 -Ecology-Intro | 15.8 MiB | | December 31, 2020 |
Ch6 Cardio Vascular System Dr Iyad | 2.3 MiB | | December 31, 2020 |
Chapter 1 | 0.8 MiB | | April 4, 2020 |
Chapter 1-1 | 0.8 MiB | | April 4, 2020 |
Chapter-1-Answers | 0.3 MiB | | April 4, 2020 |
Chapter-1-Central-Dogma-of-biology | 26.3 MiB | iSpatula | April 4, 2020 |
Chapter-10-Citric-acid-cycle | 5.4 MiB | iSpatula | April 4, 2020 |
Chapter-11-Answers | 0.2 MiB | | April 4, 2020 |
Chapter-11-Hexosepentose-phosphate-pathway | 6.1 MiB | iSpatula | April 4, 2020 |
Chapter-12-Structure-of-glycogen | 12.5 MiB | iSpatula | April 4, 2020 |
Chapter-13-Metabolism-of-carbohydrates | 8.9 MiB | iSpatula | April 4, 2020 |
Chapter-14-Lipid-metabolism | 11.4 MiB | iSpatula | April 4, 2020 |
Chapter-15-Fatty-acid-biosynthesis | 25.9 MiB | iSpatula | April 4, 2020 |
Chapter-16-Degradation-of-fatty-acids | 19.8 MiB | iSpatula | April 4, 2020 |
Chapter-17-Cholesterol-and-steroids-biosynthesis | 15.3 MiB | iSpatula | April 4, 2020 |
Chapter-18-Amino-acids-metabolism | 18.3 MiB | iSpatula | April 4, 2020 |
Chapter-19-Conversion-of-amino-acids-to-specialized-products | 8.9 MiB | iSpatula | April 4, 2020 |
Chapter-2-Structure-of-DNA | 14.7 MiB | iSpatula | April 4, 2020 |
Chapter-20-Liver | 9.1 MiB | iSpatula | April 4, 2020 |
Chapter-3-DNA-replication | 11.3 MiB | iSpatula | April 4, 2020 |
Chapter-4-DNA-Transcription | 12.1 MiB | iSpatula | April 4, 2020 |
Chapter-5-DNA-Translation | 16.4 MiB | iSpatula | April 4, 2020 |
Chapter-6-Biotechnology | 29.6 MiB | iSpatula | April 4, 2020 |
Chapter-8- Alkenes-reaction-and-synthesis | 14.3 MiB | | December 31, 2020 |
Chapter-8-122727696 | 6.7 MiB | | April 4, 2020 |
Chapter-8-Glycolysis | 14.6 MiB | iSpatula | April 4, 2020 |
Chapter-9 -Alkynes | 9.0 MiB | | December 31, 2020 |
Chapter-9-Gluconeogenesis | 8.4 MiB | iSpatula | April 4, 2020 |
Chapter02 Stud Ans | 1.0 MiB | | December 31, 2020 |
Chapter02 Stud Prob-highlighted | 1.0 MiB | | December 31, 2020 |
Chapter1- Structure-and-bonding | 1.2 MiB | | December 31, 2020 |
Chapter10- Organohalides | 12.3 MiB | | December 31, 2020 |
Chapter11- Reactions-of-Alkylhalides | 14.8 MiB | | December 31, 2020 |
Chapter14 Stud Ans | 1.1 MiB | iSpatula | April 4, 2020 |
Chapter14 Stud Prob | 1.9 MiB | iSpatula | April 4, 2020 |
Chapter2- Polar-covalent-bonds-acids-and-bases | 1.8 MiB | | December 31, 2020 |
Chapter3- Part1- Naming-of-alkanes | 4.6 MiB | | December 31, 2020 |
Chapter4- Organic-cycloalkanes-and-their-stereochemistry | 8.8 MiB | | December 31, 2020 |
Chapter5- Part1- Stereochemistry-of-tetrahedral-centers | 7.9 MiB | | December 31, 2020 |
Chapter5- Part2- Stereochemistry-of-tetrahedral-centers | 3.9 MiB | | December 31, 2020 |
Chapter7- Alkenes-structure-and-reactivity | 17.7 MiB | | December 31, 2020 |
Chater3- Part2- Alkanes-and-their-stereochemistry- | 6.3 MiB | | December 31, 2020 |
Chemical-kinetics | 0.1 MiB | iSpatula | April 4, 2020 |
Chemistry Of Lichens Complete | 3.0 MiB | | April 4, 2020 |
Chemistry-Lab-Quizzes-Spring-2018 | 1.2 MiB | | April 4, 2020 |
Chemistry-of-Medicinal-Plants-1201390-Course-Outline | 0.3 MiB | | April 4, 2020 |
Chemistry-of-Medicinal-Plants-1201390-Handouts-group-1 | 2.2 MiB | | April 4, 2020 |
Chemistry-of-Medicinal-Plants-1201390-Handouts-group-2 | 1.9 MiB | | April 4, 2020 |
Chemistry-of-Medicinal-Plants-1201390-Handouts-group-3 | 2.1 MiB | | April 4, 2020 |
Chemistry-of-Medicinal-Plants-1201390-Handouts-group-4 | 2.6 MiB | | April 4, 2020 |
Chemistry-of-Medicinal-Plants-1201390-Handouts-group-5 | 3.4 MiB | | April 4, 2020 |
Chemistry-of-Medicinal-Plants-1201390-Handouts-group-6 | 1.1 MiB | | April 4, 2020 |
Chemistry-of-Medicinal-Plants-1201390-Handouts-group-7 | 0.4 MiB | | April 4, 2020 |
Chemistry-of-Medicinal-Plants-1201390-Handouts-group-8 | 2.4 MiB | | April 4, 2020 |
Chemistry-of-Medicinal-Plants-1201390-Handouts-group-9 | 2.1 MiB | | April 4, 2020 |
Chemistry-of-Terpenes-12 | 0.3 MiB | | April 4, 2020 |
Chemistry-of-Terpenes-12 | 0.3 MiB | | April 4, 2020 |
Chepter 2 | 0.2 MiB | | April 4, 2020 |
Chiropractic | 13 KiB | | April 4, 2020 |
CHM-Chinese-Herbal-Medicine | 14 KiB | | April 4, 2020 |
CHO-Metabolism-Mono-and-di | 1.3 MiB | iSpatula | April 4, 2020 |
Cholesterol Biosynthesis 1 | 1.5 MiB | iSpatula | April 4, 2020 |
Cholesterol Biosynthesis 2 | 1.1 MiB | iSpatula | April 4, 2020 |
Choletereol Uptake By LDL | 3.0 MiB | iSpatula | April 4, 2020 |
Cholinergic-agonists | 1.3 MiB | | April 4, 2020 |
Cholinergic-agonists | 1.3 MiB | | April 4, 2020 |
Cholinergic-agonists | 1.1 MiB | | April 4, 2020 |
Cholinergics And Anticholinergic -Bardaweel | 2.0 MiB | Rahaf Darweesh | November 8, 2020 |
Cholinoceptor-blocking-drugs | 2.0 MiB | | April 4, 2020 |
Chromatography | 0.6 MiB | | April 4, 2020 |
Chromatography | 0.6 MiB | | April 4, 2020 |
Chromo 11 | 1.4 MiB | | April 4, 2020 |
Chromo 12 | 1.5 MiB | | April 4, 2020 |
Chromo 12 Part 2 | 83 KiB | | April 4, 2020 |
Chromo 8 | 2.3 MiB | | April 4, 2020 |
Chromo 9 | 0.2 MiB | | April 4, 2020 |
Chromo Lec8 | 17.3 MiB | | April 4, 2020 |
Chromo-L7 | 18.7 MiB | | April 4, 2020 |
Chromo-L9 | 18.2 MiB | | April 4, 2020 |
Chromo-Sheet 15-part 2 | 0.9 MiB | | April 4, 2020 |
Chromo-sheet-16 | 0.5 MiB | | April 4, 2020 |
Chromo-sheet-18- | 0.6 MiB | | April 4, 2020 |
Chromo-sheet-20- | 0.4 MiB | | April 4, 2020 |
ChromoLec1 | 0.3 MiB | | April 4, 2020 |
ChromoLec14 | 0.5 MiB | | April 4, 2020 |
ChromoLec2 | 0.6 MiB | | April 4, 2020 |
ChromoLec23 | 0.5 MiB | | April 4, 2020 |
ChromoLec3 | 0.7 MiB | | April 4, 2020 |
ChromoLec4 | 0.8 MiB | | April 4, 2020 |
Circulatory-routes- | 3.9 MiB | | December 31, 2020 |
Circulatory-routes1- | 21.2 MiB | | December 31, 2020 |
Ciric-acid-cycle | 1.1 MiB | iSpatula | April 4, 2020 |
Citric Acid Cycle | 1.3 MiB | iSpatula | April 4, 2020 |
Citric Acid Cycle 2 | 0.9 MiB | iSpatula | April 4, 2020 |
Citric Acid Cycle 3 | 1.6 MiB | iSpatula | April 4, 2020 |
Citric Acid Cycle 4 | 0.8 MiB | iSpatula | April 4, 2020 |
CKD | 1.6 MiB | | April 4, 2020 |
CKD-2020 | 2.1 MiB | | December 31, 2020 |
CKDC(3) | 2.6 MiB | | April 4, 2020 |
Clincal-toxi-Lec.8 | 43.6 MiB | | April 4, 2020 |
Clinical PK Outline | 26 KiB | | April 4, 2020 |
Clinical PKS Manual-July 2010 | 0.6 MiB | | April 4, 2020 |
Clinical-biochem-Important-info | 0.6 MiB | | April 4, 2020 |
Clinical-Nutrition-in-Practice | 1.1 MiB | | April 4, 2020 |
Clinical-Nutrition-Management | 5.2 MiB | | April 4, 2020 |
Clinical-Pharmacokinetics-Extravascular | 0.3 MiB | | April 4, 2020 |
Clinical-Pharmacokinetics-Multiple-Dosing | 0.1 MiB | | April 4, 2020 |
Clinical-toxi-14 | 26.3 MiB | | April 4, 2020 |
Clinical-Toxi-Lec.1 | 16.3 MiB | | April 4, 2020 |
Clinical-toxi-Lec.11 | 34.3 MiB | | April 4, 2020 |
Clinical-toxi-Lec.12 | 26.2 MiB | | April 4, 2020 |
Clinical-toxi-Lec.13 | 33.1 MiB | | April 4, 2020 |
Clinical-Toxi-Lec.2 | 29.1 MiB | | April 4, 2020 |
Clinical-Toxi-Lec.3 | 15.1 MiB | | April 4, 2020 |
Clinical-toxi-Lec.4 | 34.6 MiB | | April 4, 2020 |
Clinical-toxi-Lec.5 | 27.3 MiB | | April 4, 2020 |
Clinical-toxi-Lec.6 | 30.5 MiB | | April 4, 2020 |
Clinical-toxi-Lec.9 | 34.2 MiB | | April 4, 2020 |
Clinicaltoxi-L.18 | 21.2 MiB | | April 4, 2020 |
Clinicaltoxi-Lec.15 | 27.9 MiB | | April 4, 2020 |
ClinicalToxi-Lec.17 | 24.3 MiB | | April 4, 2020 |
Clinicaltoxi-Lec.19 | 25.1 MiB | | April 4, 2020 |
ClinicaltoxiLec.16 | 28.0 MiB | | April 4, 2020 |
Clinichal-Biochem-Syllabus | 0.8 MiB | | April 4, 2020 |
Clostridium-spores-rule-in-the-treatment-of-cancer | 0.2 MiB | | December 31, 2020 |
Clostridium-spores-rule-in-the-treatment-of-cancer | 0.2 MiB | | April 4, 2020 |
CNS | 0.1 MiB | | April 4, 2020 |
CNS | 0.3 MiB | | April 4, 2020 |
CNS MCQ Bank | 0.3 MiB | | April 4, 2020 |
CNS-2 | 4.2 MiB | | April 4, 2020 |
CNS-5 | 3.4 MiB | | April 4, 2020 |
CNS-7 | 0.4 MiB | | April 4, 2020 |
CNS-8 | 0.2 MiB | | April 4, 2020 |
CNS-Stimulants-and-Dextromethorphan-Intoxication | 0.9 MiB | | April 4, 2020 |
CNS3 | 0.3 MiB | | April 4, 2020 |
CNS4 | 0.3 MiB | | April 4, 2020 |
CNS6 | 0.3 MiB | | April 4, 2020 |
Coagulation | 0.5 MiB | | April 4, 2020 |
Coating-Defects-handout- | 0.5 MiB | | April 4, 2020 |
Code-of-Ethics | 72 KiB | | April 4, 2020 |
Cogno #13 Dr Hduib | 39.6 MiB | | April 4, 2020 |
Cogno #8 | 35.9 MiB | | April 4, 2020 |
Cogno Dr Hduib #1 | 37.8 MiB | | April 4, 2020 |
Cogno # 6 Dr Hdib | 42.0 MiB | | April 4, 2020 |
Cogno # 7 | 40.3 MiB | | April 4, 2020 |
Cogno # 9 | 42.6 MiB | | April 4, 2020 |
Cogno #1 | 38.5 MiB | | April 4, 2020 |
Cogno #2 | 39.5 MiB | | April 4, 2020 |
Cogno #2 Dr Hduib | 48.6 MiB | | April 4, 2020 |
Cogno #3 | 40.4 MiB | | April 4, 2020 |
Cogno #3 Dr Hduib | 39.5 MiB | | April 4, 2020 |
Cogno #4 | 43.8 MiB | | April 4, 2020 |
Cogno #4 Dr Hduib | 42.9 MiB | | April 4, 2020 |
Cogno #5 | 48.3 MiB | | April 4, 2020 |
Cogno #6 | 41.4 MiB | | April 4, 2020 |
Cogno #7 Dr Hduib | 41.6 MiB | | April 4, 2020 |
Cogno #9 Dr Hdiub | 41.7 MiB | | April 4, 2020 |
Cogno 1 | 32.5 MiB | | April 4, 2020 |
Cogno 2 | 32.2 MiB | | April 4, 2020 |
Cogno 3 | 28.6 MiB | | April 4, 2020 |
Cogno 4 | 34.2 MiB | | April 4, 2020 |
Cogno Dr Hdaib #8 | 39.5 MiB | | April 4, 2020 |
Cogno Final With Notes Part(1) | 9.7 MiB | | April 4, 2020 |
Cogno Final With Notes Part(2) | 9.2 MiB | | April 4, 2020 |
Cogno Note 1 By Kawther Taha | 6.1 MiB | | April 4, 2020 |
Cogno Note 2 By Kawther Taha | 9.1 MiB | | April 4, 2020 |
Cogno Pastpapers | 0.6 MiB | | April 4, 2020 |
Cogno Quiz | 0.1 MiB | | April 4, 2020 |
Cogno17 | 36.0 MiB | | April 4, 2020 |
Cogno7 | 23.1 MiB | | April 4, 2020 |
Cogno8 | 18.5 MiB | | April 4, 2020 |
Cognosy | 0.2 MiB | | April 4, 2020 |
Cognosy #5 Dr Hdiub | 40.9 MiB | | April 4, 2020 |
Cognosy - Supplementary Material - Sugars And Brand Products | 72 KiB | | April 4, 2020 |
Cognosy Quiz Material | 4.4 MiB | | April 4, 2020 |
Cognosy Supplimentary-Material-CHO-Introdn-Photosynth-Stereochem-Reactions | 11.4 MiB | | April 4, 2020 |
Cognosy-Dr-Hudaib-Dietary-Fibers | 0.6 MiB | | April 4, 2020 |
Cognosy-Dr-Hudaib-Dietary-Fibers | 0.6 MiB | | April 4, 2020 |
Cognosy-Dr-Hudaib-Fixed-oils | 3.6 MiB | | April 4, 2020 |
Cognosy-Dr-Hudaib-Fixed-oils | 3.6 MiB | | April 4, 2020 |
Cognosy-Dr-Hudaib-sugars-and-brand-products | 63 KiB | | April 4, 2020 |
Cognosy-Sugars-containing-brand-products | 46 KiB | | April 4, 2020 |
Cognosy-Supplementary-Material-Dr-Hudaib-sugars-and-brand-products | 0.1 MiB | | April 4, 2020 |
Comments On HF Case | 3.3 MiB | | April 4, 2020 |
Common-Cold-2018 Ppt-11 | 3.8 MiB | | April 4, 2020 |
Commonly-abused-drugs-final-2016 | 0.5 MiB | | April 4, 2020 |
Complexation Reactions And Titrations | 0.3 MiB | iSpatula | April 4, 2020 |
Complexation-Protein-Binding1-2 | 2.7 MiB | | April 4, 2020 |
Connective-Tissue-Student-version | 3.3 MiB | | December 31, 2020 |
Consult-form | 25 KiB | | April 4, 2020 |
Consult-note | 7 KiB | | April 4, 2020 |
Consult-note | 25 KiB | | April 4, 2020 |
Controlled Drug Release | 89 KiB | | April 4, 2020 |
COPD | 1.3 MiB | | April 4, 2020 |
Copy Of Missense Mutaion WMV V9 | 2.1 MiB | iSpatula | April 4, 2020 |
Copy-of-Authorized-Book | 6.1 MiB | | April 4, 2020 |
Correction In Sheet 18 | 58 KiB | | April 4, 2020 |
Correction In Sheet 21 | 56 KiB | | April 4, 2020 |
Correction Lec1 And 2 Razan Tayeh | 71 KiB | iSpatula | April 4, 2020 |
Correction Lec3 Sewar Fraij | 38 KiB | iSpatula | April 4, 2020 |
Correction Lec4 Maher Shaheen | 97 KiB | iSpatula | April 4, 2020 |
Correction Lec6 Ronaz Maher | 0.4 MiB | iSpatula | April 4, 2020 |
Correction-for-L-18192324- | 1.9 MiB | | April 4, 2020 |
Correction-part-L14 L15 L16 L17 L20 | 0.2 MiB | | April 4, 2020 |
Corrections | 0.2 MiB | iSpatula | April 4, 2020 |
Corrections | 1.1 MiB | iSpatula | April 4, 2020 |
Corrections | 0.2 MiB | | April 4, 2020 |
Corrections | 0.5 MiB | | April 4, 2020 |
Corrections | 22 KiB | | April 4, 2020 |
Corrections Dr Khanfar Analtical | 0.7 MiB | iSpatula | April 4, 2020 |
Corrections Final | 22 KiB | | April 4, 2020 |
Corrections Of Mid | 0.1 MiB | iSpatula | April 4, 2020 |
Corrections Of Quiz Material | 9 KiB | iSpatula | April 4, 2020 |
Corrections Pharmaorganic[1] | 4.7 MiB | iSpatula | April 4, 2020 |
Corrections Pharmaorganic[1] | 4.7 MiB | | December 31, 2020 |
Corrections-L-2627 | 0.5 MiB | | April 4, 2020 |
Correctionsnew | 14 KiB | iSpatula | April 4, 2020 |
Cortex And Neurotransmitters | 6.7 MiB | | April 4, 2020 |
Cortex And Neurotransmitters (1) | 6.7 MiB | | April 4, 2020 |
Cosmetics-past-paper | 1.0 MiB | | April 4, 2020 |
Cosmo Past-Papers From-group-2012 | 0.1 MiB | | April 4, 2020 |
Cosmotics Book By Dr Bassam Amro | 3.8 MiB | | April 4, 2020 |
Course Description Doc TOXICOLOGY 2016-2017 Summer Semester | 0.5 MiB | | April 4, 2020 |
Course Description Documnet 2014 Tentative | 0.1 MiB | | April 4, 2020 |
Course Description Documnet 2015 | 0.2 MiB | | April 4, 2020 |
Course Outline(2) | 25 KiB | | April 4, 2020 |
Course-description-doc -CLINICALTOXICOLOGY-2017-2018-summer-semester | 68 KiB | | April 4, 2020 |
Course-Outline-ILOS-Medchem-III-summer-2016 | 77 KiB | | April 4, 2020 |
Course-outlines | 1.0 MiB | | April 4, 2020 |
Course-outlines-lec.1 | 1.0 MiB | | April 4, 2020 |
Course-Sylibus-Phytochemistry-2-Fall-2017 | 0.1 MiB | | April 4, 2020 |
Course-Syllabus | 0.1 MiB | | December 31, 2020 |
Course-Syllabus | 4.8 MiB | | December 31, 2020 |
Course-Syllabus-Pharma-II 2017 | 0.7 MiB | | April 4, 2020 |
CPR-2017 | 3.4 MiB | | December 31, 2020 |
Critical Appraisal Workshop | 2.7 MiB | | April 4, 2020 |
Crohns-Disease-Evaluation-and-Treatment-Clinical-Decision-Tool-in-Gastroenterology-2014-147-702 | 0.1 MiB | | April 4, 2020 |
CSF-analysis-in-CNS-infections-UpToDate | 79 KiB | | December 31, 2020 |
CVS-vascular-part | 1.6 MiB | | December 31, 2020 |
Cycloalkanes | 2.2 MiB | | December 31, 2020 |
Cyclosporine Updated | 0.2 MiB | | April 4, 2020 |
Cystic-fibrosis-10th-edition | 1.5 MiB | | December 31, 2020 |
Cytokines New | 2.5 MiB | | April 4, 2020 |
DEMAND Homework1 | 0.1 MiB | | April 4, 2020 |
Depilatories-cosmo | 0.2 MiB | | April 4, 2020 |
Depression 2013 | 5.9 MiB | | April 4, 2020 |
Dermatology-Pharmacy-converted | 0.7 MiB | | December 31, 2020 |
Designing Effective Posters Dr.Eman | 0.3 MiB | Haneen Shawabkeh | March 16, 2020 |
Determination Of Drugs Based On Their Functional Groups | 0.4 MiB | iSpatula | April 4, 2020 |
Determination Of Metals | 0.3 MiB | iSpatula | April 4, 2020 |
Determine-the-creatinine-clearance-rate- | 11 KiB | | April 4, 2020 |
Diabetes-melitus | 4.1 MiB | | April 4, 2020 |
DIABETES-patho | 2.1 MiB | | April 4, 2020 |
DIABETES-patho | 3.8 MiB | | April 4, 2020 |
Diagnosis And History Taking In The Pharmacy 2015-combined | 1.6 MiB | | April 4, 2020 |
Diagnosis-and-history-taking-in-the-pharmacy 2018 | 0.5 MiB | | April 4, 2020 |
Dialysis-2020 | 1.3 MiB | | December 31, 2020 |
Diaper Rash | 0.5 MiB | | April 4, 2020 |
Diaper-rash-exclusions-for-self-treatment | 40 KiB | | April 4, 2020 |
Diarrhoea 2015 Dr Mayyada | 2.4 MiB | | April 4, 2020 |
Diarrhoea-2018 | 2.1 MiB | | April 4, 2020 |
Dietary-Fibers | 0.6 MiB | | April 4, 2020 |
DIFFERENT-TYPES-OF-CLINICAL-TRIALS | 67 KiB | | April 4, 2020 |
Digestive | 11.7 MiB | iSpatula | April 4, 2020 |
Digestive System Glands Notes | 0.2 MiB | | December 31, 2020 |
Digestive System Lab-1 Notes | 3.1 MiB | | December 31, 2020 |
Digestive System Lab-2 Notes | 2.4 MiB | | December 31, 2020 |
Digestive System Notes | 0.3 MiB | | December 31, 2020 |
Digitalis | 0.3 MiB | | April 4, 2020 |
Digoxin | 3.8 MiB | | December 31, 2020 |
Digoxin Updated | 0.2 MiB | | April 4, 2020 |
Dipensing Lecture 19 20 21 | 0.7 MiB | | December 31, 2020 |
Dipensing Lecture 19 20 21 | 0.7 MiB | iSpatula | April 4, 2020 |
Dipensing Lecture 23 And 24a | 0.6 MiB | | December 31, 2020 |
Dipensing Lecture 23 And 24a | 0.6 MiB | iSpatula | April 4, 2020 |
Dipensing Lecture#14-2 | 0.3 MiB | | December 31, 2020 |
Dipensing Lecture#14-2 | 0.3 MiB | iSpatula | April 4, 2020 |
Dipensing Lecture16 | 0.1 MiB | | December 31, 2020 |
Dipensing Lecture16 | 0.1 MiB | iSpatula | April 4, 2020 |
Dipensing-3 | 0.3 MiB | | December 31, 2020 |
Dis 15 | 0.8 MiB | | December 31, 2020 |
Dis 15 | 0.8 MiB | iSpatula | April 4, 2020 |
Dis 18 | 0.2 MiB | | December 31, 2020 |
Dis 18 | 0.2 MiB | iSpatula | April 4, 2020 |
DisBook567 | 18.6 MiB | | December 31, 2020 |
DisBook567 | 18.6 MiB | | December 31, 2020 |
Discounting And Inflation Part2 | 0.5 MiB | | April 4, 2020 |
Discrete-and-continuous-distribution | 2.4 MiB | | April 4, 2020 |
Dispensing | 0.4 MiB | | December 31, 2020 |
Dispensing | 0.1 MiB | | December 31, 2020 |
Dispensing 2 | 59 KiB | | December 31, 2020 |
Dispensing 2 | 59 KiB | iSpatula | April 4, 2020 |
Dispensing Lab Notes .2016 | 11.0 MiB | | December 31, 2020 |
Dispensing Lecture 17 | 0.1 MiB | | December 31, 2020 |
Dispensing Lecture 17 | 0.1 MiB | iSpatula | April 4, 2020 |
Dispensing Lecture12&13 | 0.4 MiB | | December 31, 2020 |
Dispensing Lecture12&13 | 0.4 MiB | iSpatula | April 4, 2020 |
Dispensing Lecture6and7 | 0.4 MiB | | December 31, 2020 |
Dispensing Lecture6and7 | 0.4 MiB | iSpatula | April 4, 2020 |
Dispensing Lecture8and9 | 1.1 MiB | | December 31, 2020 |
Dispensing Lecture8and9 | 1.1 MiB | iSpatula | April 4, 2020 |
Dispensing Old | 0.3 MiB | | December 31, 2020 |
Dispensing Preparations | 10.4 MiB | | December 31, 2020 |
Dispensing Preparations | 10.4 MiB | iSpatula | April 4, 2020 |
Dispensing#4 | 0.2 MiB | | December 31, 2020 |
Dispensing#4 | 0.2 MiB | iSpatula | April 4, 2020 |
Dispensing-3 | 1.3 MiB | | December 31, 2020 |
Dispensing-4 | 2.2 MiB | | December 31, 2020 |
Dispensing-5 -pdf | 3.7 MiB | | December 31, 2020 |
Dispensing-7 | 5.5 MiB | | December 31, 2020 |
Dispensing-8 | 3.8 MiB | | December 31, 2020 |
Dispensing-9 | 4.0 MiB | | December 31, 2020 |
Dispensing-Course-description | 42 KiB | | December 31, 2020 |
Dispensing10and11 | 20 KiB | | December 31, 2020 |
Dissolution And Drug Release Testing #8 | 0.8 MiB | | April 4, 2020 |
Diuretics | 0.3 MiB | | April 4, 2020 |
DM-1-2- | 10.0 MiB | | December 31, 2020 |
DNA Replicatio 2 WMV V9 | 4.2 MiB | iSpatula | April 4, 2020 |
DNA Replication WMV V9 | 5.6 MiB | iSpatula | April 4, 2020 |
DNA Structure WMV V9 | 4.7 MiB | iSpatula | April 4, 2020 |
DNA-replicationPPT | 2.5 MiB | iSpatula | April 4, 2020 |
DNA-structure-2 | 4.0 MiB | iSpatula | April 4, 2020 |
DNA-vacc | 0.2 MiB | | December 31, 2020 |
DNA-vacc | 0.2 MiB | | April 4, 2020 |
DNA-vaccination | 6.1 MiB | | December 31, 2020 |
DNA-vaccination | 6.1 MiB | | April 4, 2020 |
Doping | 0.3 MiB | | April 4, 2020 |
Dosage-form-factors-influencing-drung-ab 20181117103940 | 11.6 MiB | | April 4, 2020 |
DosingRegimen-new | 1.1 MiB | | April 4, 2020 |
DosingRegimen2012 | 0.4 MiB | | April 4, 2020 |
Dr | 0.5 MiB | | April 4, 2020 |
Dr | 2.9 MiB | Mais Maharma | October 26, 2020 |
Dr Bassam Hair Dyes | 1.6 MiB | Mais Maharma | October 26, 2020 |
Dr Bassam Hair Morphology | 6.5 MiB | Mais Maharma | October 26, 2020 |
Dr Mohd 5nfar - Midterm Material - Reham | 24.7 MiB | iSpatula | April 4, 2020 |
Dr -Rana -Protein-Therapeutics-Summary | 0.4 MiB | | December 31, 2020 |
Dr -Rana-newly-approved-strucutres | 1.4 MiB | | December 31, 2020 |
Dr Ebaa L01 Body-Fluids-Blood | 0.3 MiB | | December 31, 2020 |
Dr Ebaa L03 Componnents Of Blood . | 2.8 MiB | | December 31, 2020 |
Dr Ebaa L04 Blood Components | 2.2 MiB | | December 31, 2020 |
Dr Ebaa L05 Vascular System. | 2.5 MiB | | December 31, 2020 |
Dr Ebaa L06 Vascular System. | 1.7 MiB | | December 31, 2020 |
Dr Faisal L01 Respiratory System. | 3.5 MiB | | December 31, 2020 |
Dr Faisal L02 Respiratory System. | 2.4 MiB | | December 31, 2020 |
Dr Faisal L03 Respiratory System. | 1.1 MiB | | December 31, 2020 |
Dr Faisal L04 Respiratory System. | 2.1 MiB | | December 31, 2020 |
Dr Faisal L05 Respiratory System. | 1.5 MiB | | December 31, 2020 |
Dr Khatatbeh Endo PP Pharmacy 1 | 3.6 MiB | | April 4, 2020 |
Dr Khatatbeh Endo PP Pharmacy 3 | 1.5 MiB | | April 4, 2020 |
Dr Khatatbeh L01 ANS | 2.9 MiB | | December 31, 2020 |
Dr Khatatbeh L02L03 Cardiovascular-System | 7.8 MiB | | December 31, 2020 |
Dr Khatatbeh L04L05 Cardiovascular-SYSTEM-4 | 2.2 MiB | | December 31, 2020 |
Dr KhatatbehEndo PP Pharmacy 2 | 1.5 MiB | | April 4, 2020 |
Dr Lahham Aminoglycosides | 0.2 MiB | | April 4, 2020 |
Dr Lahham Anti-Fungal-Agents | 0.3 MiB | | April 4, 2020 |
Dr Lahham Anti-Fungal-Agents1 | 0.6 MiB | | April 4, 2020 |
Dr Lahham Anti-viral | 1.3 MiB | | April 4, 2020 |
Dr Lahham Macrolides | 0.2 MiB | | April 4, 2020 |
Dr Lahham Quinolones-1 | 0.2 MiB | | April 4, 2020 |
Dr Lahham Review-article-1 | 0.2 MiB | | April 4, 2020 |
Dr Lahham Tetracyclines | 0.3 MiB | | April 4, 2020 |
Dr Lahham Tetracyclines | 0.5 MiB | | April 4, 2020 |
Dr Lahham12 | 13.3 MiB | | April 4, 2020 |
Dr Loai L03 Muscle-skeletal-and-smooth | 4.7 MiB | | December 31, 2020 |
Dr Loai .01 Membrane Potential | 3.4 MiB | | December 31, 2020 |
Dr Loai .02 Action Potential Part2 | 11.8 MiB | | December 31, 2020 |
Dr Loai 1st Lec Physio2 | 52.9 MiB | | April 4, 2020 |
Dr Loai 2nd Lecture Physio2 (online-audio-converter Com) | 54.0 MiB | | April 4, 2020 |
Dr Loai 3rd Lec Physio2 | 45.2 MiB | | April 4, 2020 |
Dr Loai 4th Lec Physio2 (online-audio-converter Com) | 69.3 MiB | | April 4, 2020 |
Dr Loai 5th Lec Physio2 | 21.2 MiB | | April 4, 2020 |
Dr Loai 6th Lec Physio2 | 36.9 MiB | | April 4, 2020 |
Dr Loai 7th Lec Physio2 | 42.2 MiB | | April 4, 2020 |
Dr Loai 8th Lec Physio2 | 41.1 MiB | | April 4, 2020 |
Dr Loai 9th Lec Physio2 | 39.3 MiB | | April 4, 2020 |
Dr Loai Lecture (Smell & Tast) | 80.9 MiB | | April 4, 2020 |
Dr Loai Lecture (hearing And Equili) | 6.9 MiB | | April 4, 2020 |
Dr Loai Lecture (vision) | 7.1 MiB | | April 4, 2020 |
Dr Loai Lecture 2 ( Somato-sensory System) Second Version | 8.2 MiB | | April 4, 2020 |
Dr Loai Lecture1 (introuduction) | 13.7 MiB | | April 4, 2020 |
Dr Loai11 Lec Physio2 | 45.6 MiB | | April 4, 2020 |
Dr Mousa Notebook Organic | 11.0 MiB | | April 4, 2020 |
Dr Yehia Tabaza ParT Hallucinogenic Plants - Summer 2019 | 21.3 MiB | AJadallah | June 17, 2019 |
Drug-Calculations-for-Nurses-Step-by-Step-Approach-3rd-Edition-Robert-Lapham-Heather-Agar | 1.2 MiB | | April 4, 2020 |
Drug-design Part1 | 1.4 MiB | | April 4, 2020 |
Drug-design Part2 | 1.4 MiB | | April 4, 2020 |
Drug-Facts-kratom 2 2016 | 0.7 MiB | | April 4, 2020 |
Drug-Facts-treatment-approaches-1 2016 | 0.7 MiB | | April 4, 2020 |
Drug-interactions | 6.5 MiB | | April 4, 2020 |
Drug-interactionsquiz-material | 1.5 MiB | | April 4, 2020 |
Drug-interactionsquiz-material | 1.5 MiB | | April 4, 2020 |
Drugfacts Cocaine | 0.3 MiB | | April 4, 2020 |
Drugs-of-Choice-for-Specific-Seizure-Disorders | 0.2 MiB | | December 31, 2020 |
Drugs-of-Choice-for-Specific-Seizure-Disorders 2 | 0.2 MiB | | December 31, 2020 |
Drugs-self-study-Dr-VIOLET | 0.6 MiB | | December 31, 2020 |
Drugs-self-study-Dr-VIOLET | 0.6 MiB | | December 30, 2020 |
Drugs-used-in-heart-failure | 7.9 MiB | | April 4, 2020 |
Drugs-used-in-heart-failure 2 | 1.1 MiB | | April 4, 2020 |
Drugs-used-in-heart-failure 3 | 0.6 MiB | | April 4, 2020 |
Drugs-used-in-heart-failure 4 | 0.6 MiB | | April 4, 2020 |
Drugs-used-in-heart-failure-1- 3 | 1.1 MiB | | April 4, 2020 |
Drugs-used-in-the-treatment-of-hyperlipidemia | 16.3 MiB | | April 4, 2020 |
Dyslipidemia | 19.8 MiB | | April 4, 2020 |
EBM BSc Case Studies Ethical Resaerch Conduct workshop | 0.3 MiB | Haneen Shawabkeh | March 16, 2020 |
EBM BSc Case Study Study Desgins | 0.3 MiB | Haneen Shawabkeh | March 16, 2020 |
EBM Poster 2010 | 1.0 MiB | Haneen Shawabkeh | March 16, 2020 |
EBM Research Poster 36 X 48 F | 0.3 MiB | Haneen Shawabkeh | March 16, 2020 |
EBM-BSc-Case-studies-ethical-resaerch-conduct | 0.3 MiB | | May 20, 2020 |
Ebola-presentation-1 | 1.2 MiB | | December 31, 2020 |
Ebola-presentation-1 | 1.2 MiB | | April 4, 2020 |
Ebola-virus-disease-and-vaccins | 0.4 MiB | | December 31, 2020 |
Ebola-virus-disease-and-vaccins | 0.4 MiB | | April 4, 2020 |
Economics Lec.1 | 6.6 MiB | | April 4, 2020 |
Economics-1 | 1.5 MiB | | April 4, 2020 |
Economics-2 | 1.1 MiB | | April 4, 2020 |
Economics-3 | 1.2 MiB | | April 4, 2020 |
Economics-4 | 1.3 MiB | | April 4, 2020 |
Economics-5 | 1.3 MiB | | April 4, 2020 |
Economics-6 | 1.5 MiB | | April 4, 2020 |
Economics-7 | 1.8 MiB | | April 4, 2020 |
Economics-8 | 2.2 MiB | | April 4, 2020 |
Emulsions | 18 KiB | | December 31, 2020 |
Endocrin-sys-lec2 | 4.5 MiB | | April 4, 2020 |
Endocrin-sys-lec3 | 2.5 MiB | | April 4, 2020 |
Endocrine | 34 KiB | | April 4, 2020 |
Endocrine | 0.2 MiB | | April 4, 2020 |
Endocrine Dr Saleem | 4.7 MiB | | April 4, 2020 |
Endocrine Slides | 57.3 MiB | | April 4, 2020 |
Endocrine System L3-students (1) | 4.4 MiB | | April 4, 2020 |
Endocrine System-students L1 | 3.6 MiB | | April 4, 2020 |
Endocrine System-students L4 | 6.4 MiB | | April 4, 2020 |
Endocrine-Pharmacy | 2.6 MiB | | December 31, 2020 |
Endocrine-sys-lec1 | 2.4 MiB | | April 4, 2020 |
Endocytosis-paper | 1.3 MiB | | April 4, 2020 |
Energypharm16-17 | 0.2 MiB | | April 4, 2020 |
ENT-Pharmacy | 1.5 MiB | | December 31, 2020 |
Enzyme-lab-10 | 4.0 MiB | iSpatula | April 4, 2020 |
Enzymes | 2.2 MiB | | December 31, 2020 |
Epidemiology-presentation-and-diagnosis-of-type-1-diabetes-mellitus-in-children-and-adolescents-UpToDate | 0.3 MiB | | December 31, 2020 |
Epithelium | 2.1 MiB | | December 31, 2020 |
Equations | 26 KiB | | April 4, 2020 |
Error-prone-abbreviations | 0.2 MiB | | April 4, 2020 |
Establishing-and-Maintaining-a-Sterile-Field | 0.1 MiB | | April 4, 2020 |
Ester & Amide | 0.2 MiB | iSpatula | April 4, 2020 |
Ethosuximide | 0.3 MiB | | December 31, 2020 |
Etiology-clinical-manifestations-and-diagnosis-of-nephrotic-syndrome-in-children | 0.9 MiB | | December 31, 2020 |
Ex02 English100 Exercise Solution | 16 KiB | | October 27, 2020 |
Ex05 English100 Exercise Solution | 14 KiB | | October 27, 2020 |
Ex06 English100 Exercise Solution | 12 KiB | | October 27, 2020 |
Ex07 English100 Exercise Solution | 13 KiB | | October 27, 2020 |
Ex11 English100 Exercise Solution | 14 KiB | | October 27, 2020 |
Exam-tiusse | 24.6 MiB | | December 31, 2020 |
Examples-From-Book | 0.5 MiB | | December 31, 2020 |
Exp -2-Effects-of-Additives-on-the-Physical-Properties-of-Granules-cycle-2 | 0.9 MiB | | April 4, 2020 |
Exp.1 Tablets Preparation And Testing Cycle 3 | 0.8 MiB | | April 4, 2020 |
Exp.1-Characterization-of-Granules-cycle-2 | 0.7 MiB | | April 4, 2020 |
Exp.1-Tablets-Preparation-and-Testing-cycle-32 | 0.8 MiB | | April 4, 2020 |
Exp.3-Quality-Control-of-Tablets-Q C-cycle-2 | 0.8 MiB | | April 4, 2020 |
External-Analgesic-Products 2018 | 1.1 MiB | | April 4, 2020 |
Extra-Examples-Dosing-Regimen-2017 | 29 KiB | | April 4, 2020 |
Extra-L01 -Cardiovascularl-Diabetes Pathophysiology | 56.1 MiB | | April 4, 2020 |
Extra-Material | 3.6 MiB | | April 4, 2020 |
Extra-Topic1 OTC Weightloss | 1.4 MiB | | April 4, 2020 |
Extra-Topic2 OTC OCs | 0.6 MiB | | April 4, 2020 |
F-A Biosyntheis 1 | 0.7 MiB | iSpatula | April 4, 2020 |
F-A Biosyntheis 2 | 2.5 MiB | iSpatula | April 4, 2020 |
Fall2017 Mid And Final Cogno | 0.6 MiB | | April 4, 2020 |
Fall2017 Mid And Final Techno1 | 0.6 MiB | | April 4, 2020 |
Fatty Acid Synthesis Vs Degradation | 25 KiB | iSpatula | April 4, 2020 |
Fatty-acids-waxes-nonnatural-fats | 0.9 MiB | | April 4, 2020 |
Female-reproductive- | 2.9 MiB | | April 4, 2020 |
Ferns | 2.3 MiB | | April 4, 2020 |
Ferns New | 0.1 MiB | | April 4, 2020 |
Fifth-week Analytical | 27.3 MiB | iSpatula | April 4, 2020 |
File One | 0.1 MiB | | April 4, 2020 |
Fina 2010-A Past Papers Stat | 0.1 MiB | | April 4, 2020 |
Final 2010-B Past Papers Stat | 0.2 MiB | | April 4, 2020 |
Final Exam2014 Analytical | 0.4 MiB | iSpatula | April 4, 2020 |
Final Exam2014 Physical2 | 0.3 MiB | iSpatula | April 4, 2020 |
Final Exams Organic Spring2015-2016 | 3.4 MiB | | December 31, 2020 |
Final Lecture | 11.4 MiB | | December 31, 2020 |
Final Makeup2010- Past Papers Stat | 76 KiB | | April 4, 2020 |
Final-Lab-Techno2-Summary | 22.1 MiB | | April 4, 2020 |
Final-slide-for-endocrine | 4.2 MiB | | April 4, 2020 |
Final-So1-hearing-and-vestibular | 6.0 MiB | | April 4, 2020 |
Final-So2-visual | 5.4 MiB | | April 4, 2020 |
Final-So3-motor-system | 4.9 MiB | | April 4, 2020 |
Final-so4-cortex-and-neurotransmitters-for-pharma-2-to-send | 13.5 MiB | | April 4, 2020 |
Final-So6-cortex-and-neurotransmitters-for-part-3-pharma-2-to-send | 3.8 MiB | | April 4, 2020 |
Final-So7-motor-system-regulators | 2.5 MiB | | April 4, 2020 |
Final-So8-Sleep | 6.3 MiB | | April 4, 2020 |
Final-structures | 1.3 MiB | | April 4, 2020 |
FINALes-Novel New Drugs 2015 160128 | 21.0 MiB | | December 31, 2020 |
FINALes-Novel New Drugs 2015 160128 | 21.0 MiB | | April 4, 2020 |
FinalStat-key | 0.2 MiB | | April 4, 2020 |
Finl-So5-cortex-and-neurotransmitters-for-part-2-pharma-2-to-send | 12.6 MiB | | April 4, 2020 |
First Aid Syllabus PHARM D | 22 KiB | | April 4, 2020 |
First Aid-pharma-8-2-15 | 0.2 MiB | | April 4, 2020 |
FIRST-AID-1st-SHEET 2 | 0.8 MiB | | December 31, 2020 |
First-aid-breathing-emergency | 2.9 MiB | | December 31, 2020 |
First-week Analytical | 15.0 MiB | iSpatula | April 4, 2020 |
Fixed-oils | 3.6 MiB | | April 4, 2020 |
Fluid-rehydration | 3.2 MiB | | December 31, 2020 |
Fluorescence Spectrophotometry | 0.3 MiB | | April 4, 2020 |
Fluorescence-Spectrophotometry | 0.3 MiB | | April 4, 2020 |
Fourth-week Analytical | 17.8 MiB | iSpatula | April 4, 2020 |
FP Vs FF | 82 KiB | | April 4, 2020 |
Fundamentals Of Analytical Chemistry 8th Ed | 31.3 MiB | | April 4, 2020 |
Fundamentals Of Nursing For Pharmacy Course Syllabus | 0.2 MiB | | April 4, 2020 |
Gamma Scintigraphy | 1.1 MiB | | April 4, 2020 |
Gas Chromatography | 1.0 MiB | | April 4, 2020 |
Gastrointestinal Absorption Physical 2011 | 0.3 MiB | | April 4, 2020 |
Gastrointestinal-System | 8.7 MiB | | April 4, 2020 |
Gastroretentive Archive | 1.4 MiB | | April 4, 2020 |
Gastroretentive-1 | 0.3 MiB | | April 4, 2020 |
Gatrointestinal Physiology-Totora-Pharmacy II-Ebaa | 5.0 MiB | | April 4, 2020 |
Gene Therapy | 7.4 MiB | | April 4, 2020 |
General-Chemistry-Past-Papers-Midterm | 7.9 MiB | | December 31, 2020 |
General-Chemistry-Past-Quizzes-Spring-2018 | 1.2 MiB | | December 31, 2020 |
General-Chemistry-The-Essential-Concepts-by-Raymond-Chang-5th-ed | 41.6 MiB | | December 31, 2020 |
Genetic Flow WMV V9 | 1.6 MiB | iSpatula | April 4, 2020 |
Genetics Lab-Biology | 1.1 MiB | | December 31, 2020 |
GERD 2014 Dr Alaa | 9.1 MiB | | April 4, 2020 |
GERD 2015 Dr Mayyada | 8.2 MiB | | April 4, 2020 |
GERD-2016 | 8.5 MiB | | April 4, 2020 |
GI Digestion And Absorption Phar | 4.1 MiB | | April 4, 2020 |
GINA-2017-Asthma-children | 2.2 MiB | | December 31, 2020 |
GIT | 0.2 MiB | | April 4, 2020 |
GIT | 0.3 MiB | | April 4, 2020 |
GIT-1-%D9%85%D8%AD%D9%88%D9%84 | 1.2 MiB | | December 31, 2020 |
GIT-2 | 1.1 MiB | | December 31, 2020 |
GIT-2-recording | 42.0 MiB | | December 31, 2020 |
GIT-part-1-recording | 22.3 MiB | | December 31, 2020 |
GIT-pharma | 2.5 MiB | | April 4, 2020 |
GIT-pharmacy | 1.6 MiB | | December 31, 2020 |
GIT-System | 8.7 MiB | | April 4, 2020 |
Gluconeogenesis | 1.7 MiB | iSpatula | April 4, 2020 |
Glycogen-metabolism | 1.0 MiB | iSpatula | April 4, 2020 |
Glycolysis | 1.1 MiB | iSpatula | April 4, 2020 |
Glycolysis | 0.3 MiB | iSpatula | April 4, 2020 |
Glycolysis 1 | 1.9 MiB | iSpatula | April 4, 2020 |
Glycolysis 2 | 3.7 MiB | iSpatula | April 4, 2020 |
Graded Potential L6 Aseel Ibdah | 0.8 MiB | iSpatula | April 4, 2020 |
Graded Potential L6 Aseel Ibdah | 0.8 MiB | | December 31, 2020 |
Granulation images | 0.2 MiB | Raghad Alatrash | November 26, 2019 |
Granulation Report Cycle 1 Fahmi | 0.8 MiB | | April 4, 2020 |
GrowthfactorsanemiaMGF | 2.0 MiB | | December 31, 2020 |
H Pylori | 0.1 MiB | | December 31, 2020 |
H Pylori | 0.5 MiB | | December 31, 2020 |
H Pylori | 0.1 MiB | | April 4, 2020 |
H Pylori | 0.5 MiB | | April 4, 2020 |
H01 Isotopes Radioactivity- | 3.6 MiB | | April 4, 2020 |
H02 Isotpes-Biological-Effects-of-Radiationt | 1.9 MiB | | April 4, 2020 |
H03 Isotpes-In-Utero-Effects-Selfstudy | 55 KiB | | April 4, 2020 |
H04 Instro Dr-emad-spectrometry-2 | 5.1 MiB | | April 4, 2020 |
H04 IsotpesApplication-of-RadioisotopesRadiation | 1.5 MiB | | April 4, 2020 |
H05 Instro Dr-emad-chromatrography | 4.3 MiB | | April 4, 2020 |
H05 Isotpes-RIA | 0.1 MiB | | April 4, 2020 |
H06A Isotopes -Radioisotopes-Production | 1.7 MiB | | April 4, 2020 |
H06A Isotopes -Radioisotopes-Production Updated | 0.7 MiB | | April 4, 2020 |
H06B Isotopes -Radioisotopes-Production | 0.2 MiB | | April 4, 2020 |
H07A Isotopes | 0.2 MiB | | April 4, 2020 |
H07A Isotopes-for-printing- | 12.8 MiB | | April 4, 2020 |
H07b -isotopes-for-printing- | 7.1 MiB | | April 4, 2020 |
H07B Isotopes IAEA | 0.2 MiB | | April 4, 2020 |
H08 Isotopes-Radiopharmceuticals | 0.1 MiB | | April 4, 2020 |
Hair-Dyes-cosmo | 1.0 MiB | | April 4, 2020 |
Hallucinogeniec-plants-assignment | 0.5 MiB | Mohammed Altaweel | October 7, 2019 |
Hand Out1 Git | 0.2 MiB | Dinazyoud | May 3, 2020 |
Hand Out2 Git Secretion | 0.3 MiB | Dinazyoud | May 3, 2020 |
Hand Out3 Git | 0.2 MiB | Dinazyoud | May 9, 2020 |
Hand Out4 Git | 0.3 MiB | Dinazyoud | May 9, 2020 |
Hand-hygiene | 0.2 MiB | | April 4, 2020 |
Hand-out-Instru | 19.2 MiB | | April 4, 2020 |
Handbook-on-injectable-drugs-15th-edition-1 | 42.3 MiB | | April 4, 2020 |
Handout 1 | 33.1 MiB | | April 4, 2020 |
Handout 1 Dr Khatatbeh Physio2 | 9.9 MiB | | April 4, 2020 |
Handout 2 Dr Khatatbrh Physio2 | 10.1 MiB | | April 4, 2020 |
Handout Instru Dr-Imad Hamdan | 14.1 MiB | Batool Alkurdi | June 13, 2019 |
Handout N03 Dr-khatatbeh | 0.1 MiB | | December 31, 2020 |
Handout NO1 Dr Khatatbeh | 14.4 MiB | | December 31, 2020 |
Handout NO2 Dr Khatatbeh | 0.1 MiB | | December 31, 2020 |
Handout-1 Dr Khatatbeh | 0.1 MiB | | December 31, 2020 |
Handout-1 Techno2 Tablet-Coating | 4.9 MiB | | April 4, 2020 |
Handout-1-GI-physiology | 0.2 MiB | | April 4, 2020 |
Handout-2 Heart Dr Khatatbeh | 0.1 MiB | | December 31, 2020 |
Handout-2-GI-secretion | 0.2 MiB | | April 4, 2020 |
Handout-3-GI-absorption | 0.1 MiB | | April 4, 2020 |
Handout-4-Energy- | 0.2 MiB | | April 4, 2020 |
Handout.01 Tablet Coating | 1.8 MiB | | April 4, 2020 |
Handout.2 Emulsions Dr Bani Jaber | 0.6 MiB | | April 4, 2020 |
Handout1 GI-Physiology | 0.2 MiB | | April 4, 2020 |
Handout2 | 3.9 MiB | | December 31, 2020 |
Handout2 Dr Khtatbeh Physio1 | 0.6 MiB | iSpatula | April 4, 2020 |
Handout2 GI-Secretion | 0.2 MiB | | April 4, 2020 |
Handout3 Dr Khtatbeh Physio2 | 5.9 MiB | | April 4, 2020 |
Handout3 GI-Absorption | 0.1 MiB | | April 4, 2020 |
Handout4 Dr Khtatbeh Physio2 | 7.4 MiB | | April 4, 2020 |
Handout4 Energy | 0.2 MiB | | April 4, 2020 |
Handouts-group-1 | 2.1 MiB | | April 4, 2020 |
Handouts-group-2 | 1.9 MiB | | April 4, 2020 |
Handouts-group-3 | 2.3 MiB | | April 4, 2020 |
Handouts-group-4 | 2.0 MiB | | April 4, 2020 |
Handouts-group-5 | 5.9 MiB | | April 4, 2020 |
Handouts-group-6 | 1.2 MiB | | April 4, 2020 |
Hard-Gelatin-Capsules-2015 | 1.3 MiB | | April 4, 2020 |
Health-benefits-of-probiotics | 60 KiB | | December 31, 2020 |
Health-benefits-of-probiotics | 60 KiB | | April 4, 2020 |
Heart Failure Management - 2017 Focused Update - ACC-AHA | 2.8 MiB | Marwa Abdeen | November 15, 2020 |
Heart-Failure-Care-plan-monitoring-sheet 1 | 1.0 MiB | | April 4, 2020 |
Hematolymphoid-recording-part-1 | 17.4 MiB | | December 31, 2020 |
Hemorrhoids-2018 | 2.2 MiB | | April 4, 2020 |
Hemotherapy | 21 KiB | | April 4, 2020 |
HepaticRenalTwocomp | 1.0 MiB | | April 4, 2020 |
Hepatitis B And Breastfeeding | 40 KiB | | April 4, 2020 |
Heterocyclic Compound | 0.7 MiB | iSpatula | April 4, 2020 |
Heterocyclic Dr Areej | 10.3 MiB | iSpatula | April 4, 2020 |
Heterocyclic Dr.5nfar | 18.0 MiB | iSpatula | April 4, 2020 |
Heterocyclic Slides Pharmaoeganic[1] | 2.3 MiB | iSpatula | April 4, 2020 |
Heterocyclic Slides Pharmaoeganic[1] | 2.3 MiB | | December 31, 2020 |
High-alert-medications | 0.1 MiB | | April 4, 2020 |
HMP | 1.0 MiB | iSpatula | April 4, 2020 |
Homeostasis | 0.1 MiB | | December 31, 2020 |
Homework-1-1 | 58 KiB | | April 4, 2020 |
Hops | 0.5 MiB | | April 4, 2020 |
HOPS | 0.9 MiB | | April 4, 2020 |
How To Write Toxic Plants Report. | 0.7 MiB | | April 4, 2020 |
How-to-use-Lantus-SoloSTAR-Pre-filled-Insulin-Pen | 4.1 MiB | | April 4, 2020 |
HPLC | 0.7 MiB | | April 4, 2020 |
HPLC | 0.7 MiB | | April 4, 2020 |
HPLC Detectors | 61 KiB | | April 4, 2020 |
Hugo-and-Russells-Pharmaceutical-Microbiology-8th-Edition-Hugo-W -B | 4.2 MiB | | April 4, 2020 |
Hugo-and-Russells-Pharmaceutical-Microbiology-8th-Edition-Hugo-W -B | 4.2 MiB | | April 4, 2020 |
Hugo-and-Russells-Pharmaceutical-Microbiology-8th-Edition-Hugo-W -B2 | 4.2 MiB | | April 4, 2020 |
HW-2-Eutectic-DrugDeliv.2003-10-179-83 | 0.1 MiB | | April 4, 2020 |
HW-2-Solubility-1 | 0.6 MiB | | April 4, 2020 |
HW-Nov -2017-Stability-1 | 1.0 MiB | | April 4, 2020 |
HW-Nov -2017-TPN | 0.2 MiB | | April 4, 2020 |
HW2+3 | 15 KiB | Ahmadabukaff | February 18, 2020 |
Hyperglycemic-crisis | 0.3 MiB | | December 31, 2020 |
Hypericum | 0.2 MiB | | April 4, 2020 |
Hypertension Managment - ACC-AHA | 3.5 MiB | Marwa Abdeen | November 15, 2020 |
Hypoglycemics | 0.4 MiB | | April 4, 2020 |
ID-evaluation | 63 KiB | | April 4, 2020 |
ILO Course Description Documnet Immuno And Genetics | 0.3 MiB | | April 4, 2020 |
IM-evaluation- | 84 KiB | | April 4, 2020 |
Image | 1.8 MiB | | April 4, 2020 |
Image 2 | 2.0 MiB | | April 4, 2020 |
Image 3 | 1.9 MiB | | April 4, 2020 |
Image 4 | 1.7 MiB | | April 4, 2020 |
Image 5 | 1.6 MiB | | April 4, 2020 |
Image 6 | 1.7 MiB | | April 4, 2020 |
Image 7 | 1.9 MiB | | April 4, 2020 |
Images-1 | 0.2 MiB | | December 31, 2020 |
Immuno Summary | 1.3 MiB | | April 4, 2020 |
Immunosuppressants | 1.7 MiB | | December 31, 2020 |
In 1 | 21.3 MiB | | April 4, 2020 |
In 10 | 39.9 MiB | | April 4, 2020 |
In 11 | 19.7 MiB | | April 4, 2020 |
In 2 | 17.7 MiB | | April 4, 2020 |
In 3 | 21.2 MiB | | April 4, 2020 |
In 4 | 45.3 MiB | | April 4, 2020 |
In 5 | 45.3 MiB | | April 4, 2020 |
In 6 | 34.3 MiB | | April 4, 2020 |
In 7 | 39.2 MiB | | April 4, 2020 |
In 8 | 38.1 MiB | | April 4, 2020 |
In 9 | 38.5 MiB | | April 4, 2020 |
In-Home Testing And Monitoring 2015 Combined | 2.8 MiB | | April 4, 2020 |
In-Home-testing-and-Monitoring-Products | 4.0 MiB | | April 4, 2020 |
In1-p1 | 2.6 MiB | | April 4, 2020 |
In1-p2 | 2.9 MiB | | April 4, 2020 |
In1-p3 | 2.7 MiB | | April 4, 2020 |
In2-p1 | 2.8 MiB | | April 4, 2020 |
In2-p2 | 2.8 MiB | | April 4, 2020 |
In2-p3 | 2.8 MiB | | April 4, 2020 |
In4-p1 | 2.7 MiB | | April 4, 2020 |
In4-p2 | 2.7 MiB | | April 4, 2020 |
In4-p3 | 2.7 MiB | | April 4, 2020 |
In4-p4 | 2.6 MiB | | April 4, 2020 |
In5-p1 | 2.9 MiB | | April 4, 2020 |
In5-p2 | 2.6 MiB | | April 4, 2020 |
In5-p3 | 2.5 MiB | | April 4, 2020 |
Inbound7062891456613141746 | 24.5 MiB | | December 31, 2020 |
Infant Formula 2015 | 3.3 MiB | | April 4, 2020 |
Infant-formula Vit-D-and-iron-recommendations | 43 KiB | | April 4, 2020 |
Infections2019 | 1.5 MiB | | December 31, 2020 |
Infectious Diseases | 0.2 MiB | | April 4, 2020 |
Infectious Diseases | 0.3 MiB | | April 4, 2020 |
Inflammation | 6.6 MiB | | April 4, 2020 |
Inflammatory-bowel-disease-english-2015-update | 0.7 MiB | | April 4, 2020 |
Infrared Spectrophotometry | 0.5 MiB | | April 4, 2020 |
Infusion | 1.0 MiB | | April 4, 2020 |
Injectable-Drugs-Guide | 6.2 MiB | | April 4, 2020 |
Instr | 0.5 MiB | | April 4, 2020 |
Instru 1 | 41.8 MiB | | April 4, 2020 |
Instru 10 | 21.7 MiB | | April 4, 2020 |
Instru 11 | 41.2 MiB | | April 4, 2020 |
Instru 12 | 32.1 MiB | | April 4, 2020 |
Instru 13 | 38.4 MiB | | April 4, 2020 |
Instru 14 | 41.2 MiB | | April 4, 2020 |
Instru 15 | 63.5 MiB | | April 4, 2020 |
Instru 16 | 46.5 MiB | | April 4, 2020 |
Instru 17 | 37.1 MiB | | April 4, 2020 |
Instru 18 | 36.7 MiB | | April 4, 2020 |
Instru 19 | 37.5 MiB | | April 4, 2020 |
Instru 2 | 54.0 MiB | | April 4, 2020 |
Instru 21 | 32.5 MiB | | April 4, 2020 |
Instru 22 | 42.3 MiB | | April 4, 2020 |
Instru 3 | 40.0 MiB | | April 4, 2020 |
Instru 4 | 40.6 MiB | | April 4, 2020 |
Instru 5 | 37.3 MiB | | April 4, 2020 |
Instru 6 | 42.2 MiB | | April 4, 2020 |
Instru 7 | 42.2 MiB | | April 4, 2020 |
Instru 8 | 38.4 MiB | | April 4, 2020 |
Instru 9 | 35.0 MiB | | April 4, 2020 |
Instru Final Pharma.2012 | 1.7 MiB | | April 4, 2020 |
Instru Lec # 15 | 20.4 MiB | | April 4, 2020 |
Instru Lec #14 | 20.6 MiB | | April 4, 2020 |
Instru Lec 16[1] | 36.7 MiB | | April 4, 2020 |
Instru Mid.2017fall DrImad | 1.2 MiB | | April 4, 2020 |
Instru-10 | 28 KiB | | April 4, 2020 |
Instru-11 | 15 KiB | | April 4, 2020 |
Instru-12 | 17 KiB | | April 4, 2020 |
Instru-15 | 19 KiB | | April 4, 2020 |
Instru-16 | 36 KiB | | April 4, 2020 |
Instru-17 | 24 KiB | | April 4, 2020 |
Instru-18 | 15 KiB | | April 4, 2020 |
Instru-19 | 0.4 MiB | | April 4, 2020 |
Instru-20 | 22 KiB | | April 4, 2020 |
Instru-21 | 16 KiB | | April 4, 2020 |
Instru-22 | 0.5 MiB | | April 4, 2020 |
Instru-23 | 15 KiB | | April 4, 2020 |
Instru-3 | 34 KiB | | April 4, 2020 |
Instru-4 | 23 KiB | | April 4, 2020 |
Instru-5 | 21 KiB | | April 4, 2020 |
Instru-6 | 29 KiB | | April 4, 2020 |
Instru-7 | 32 KiB | | April 4, 2020 |
Instru-8 | 29 KiB | | April 4, 2020 |
Instru-9 | 19 KiB | | April 4, 2020 |
Instru-lab-noteall-by-Kawther-Taha | 11.9 MiB | | April 4, 2020 |
Instru-lab-notemid | 5.3 MiB | | April 4, 2020 |
Instru-NMR-examples- | 1.7 MiB | | April 4, 2020 |
Instru13 | 39.8 MiB | | April 4, 2020 |
Instru14 | 42.8 MiB | | April 4, 2020 |
Instru15 | 32.4 MiB | | April 4, 2020 |
Instru16 | 36.9 MiB | | April 4, 2020 |
Instru18 | 31.5 MiB | | April 4, 2020 |
Instru8 | 39.9 MiB | | April 4, 2020 |
Instru9 | 40.2 MiB | | April 4, 2020 |
Instrumental Analysis LEC 14 | 0.4 MiB | | April 4, 2020 |
Instrumental Analysis Lec 13 | 85 KiB | | April 4, 2020 |
Instrumental Analysis Lec 17 | 0.7 MiB | | April 4, 2020 |
Instrumental Quiz .2 Zweri | 0.5 MiB | | April 4, 2020 |
InstrumentalAnalysisLab-Summary | 6.1 MiB | | April 4, 2020 |
Insulin & Glucagon1 | 7.5 MiB | iSpatula | April 4, 2020 |
Insulin-adjustment-case-detailed | 0.3 MiB | | April 4, 2020 |
Insulin-dosing-workshop | 66 KiB | | April 4, 2020 |
Insulin-glucagon1 | 7.0 MiB | iSpatula | April 4, 2020 |
Insulin-glucagon1 | 7.5 MiB | iSpatula | April 4, 2020 |
Integration-summaries | 0.4 MiB | iSpatula | April 4, 2020 |
Intestinal-Entamoeba-histolytica-amebiasis-UpToDate | 0.2 MiB | | December 31, 2020 |
InText Aldehayde And Ketone | 9.8 MiB | iSpatula | April 4, 2020 |
Introduction | 10.0 MiB | | December 31, 2020 |
Introduction | 0.6 MiB | | April 4, 2020 |
Introduction | 0.2 MiB | | April 4, 2020 |
Introduction | 0.2 MiB | | April 4, 2020 |
Introduction Pharmacokinetics | 16.5 MiB | | April 4, 2020 |
Introduction To Alkaloids June 2012 Dr Mayada Shehadeh | 0.2 MiB | | April 4, 2020 |
Introduction To Physiologyand Transport-Ebaa | 5.5 MiB | iSpatula | April 4, 2020 |
Introduction To Physiologyand Transport-Ebaa | 5.5 MiB | | December 31, 2020 |
Introduction To Physiologyand Transport-students2012-2013 | 10.0 MiB | | April 4, 2020 |
Introduction-8-2-2015 | 0.2 MiB | | December 31, 2020 |
Introduction-carb Photosynthesisstereochemistry | 15.1 MiB | | April 4, 2020 |
Introduction-chapter-1-3-2016-Dr -Loai-zgol | 8.8 MiB | | December 31, 2020 |
Introduction-of-CNS | 1.9 MiB | | April 4, 2020 |
Introducton- | 63 KiB | | April 4, 2020 |
Isosterism-4th-grade | 6.1 MiB | | April 4, 2020 |
IV-Bolus-and-Infusion | 0.5 MiB | | April 4, 2020 |
IV-bolus-answers | 0.5 MiB | | April 4, 2020 |
IV-infusion-answers | 0.4 MiB | | April 4, 2020 |
IV-medication-preparation-sheet | 14 KiB | | December 31, 2020 |
IV-medication-preparation-workshop | 0.4 MiB | | April 4, 2020 |
IV-medications-preparation-modified | 0.2 MiB | | December 31, 2020 |
IV-PUSH-evaluation | 0.1 MiB | | April 4, 2020 |
Jacquelyn-G -Black-Microbiology -Principles-and-Explorations-9th-Edition-Wiley-2015 | 70.5 MiB | | April 4, 2020 |
John-E -McMurry-Organic-Chemistry-Brooks-Cole-2012 | 24.3 MiB | | December 31, 2020 |
Jordan-University-Hospital-2 | 33.8 MiB | | December 31, 2020 |
Jordan-University-Hospital-3 | 29.2 MiB | | December 31, 2020 |
July-13th | 25.2 MiB | | April 4, 2020 |
July-14th | 5.0 MiB | | April 4, 2020 |
July-6th (quiz Lec#2) | 32.7 MiB | | April 4, 2020 |
July-7th (quiz Lec#3) | 33.6 MiB | | April 4, 2020 |
July-8th (quiz Lec#4) | 38.5 MiB | | April 4, 2020 |
July-9th (after Quiz Lec#1) | 37.0 MiB | | April 4, 2020 |
Kideny Functions And Disorder | 1.4 MiB | | April 4, 2020 |
Kidney-transplant-2020 | 0.6 MiB | | December 31, 2020 |
Kinetic-1 | 16.0 MiB | | April 4, 2020 |
Kinetics | 45.2 MiB | | April 4, 2020 |
Kinetics Past Papers | 3.2 MiB | | April 4, 2020 |
L 018 Cogno1 | 42.9 MiB | | April 4, 2020 |
L 07 Alcohol PharmaOrganic | 2.9 MiB | iSpatula | April 4, 2020 |
L 07 Alcohol PharmaOrganic | 2.9 MiB | | December 31, 2020 |
L 08 PharmaOrganic | 3.1 MiB | iSpatula | April 4, 2020 |
L 08 PharmaOrganic | 3.1 MiB | | December 31, 2020 |
L(10)-1 Techno 2 Dr Hatem | 47.2 MiB | | April 4, 2020 |
L-04-Techno-1 | 37.3 MiB | | April 4, 2020 |
L-2-GFR | 1.7 MiB | | April 4, 2020 |
L-25-Pharmacognosy-Dr-Mohammad-Hudaib | 0.6 MiB | | April 4, 2020 |
L-3Tubular-Fnctn-1 | 1.5 MiB | | April 4, 2020 |
L.01 OTC | 35 KiB | | April 4, 2020 |
L.01 Pathophysiology Dr Eman[3] | 32.6 MiB | | April 4, 2020 |
L.01 Pharmaorganic-Alcohol,Dr Mohammed Khanfar | 4.2 MiB | iSpatula | April 4, 2020 |
L.01-lectrue1 2016 | 0.5 MiB | | December 31, 2020 |
L.01-medicinal-1- | 38.6 MiB | | April 4, 2020 |
L.02 OTC | 16 KiB | | April 4, 2020 |
L.02 Pathophysiology Dr Eman[1] | 33.1 MiB | | April 4, 2020 |
L.02 Pharmaorganic-alcohol,Dr Mohammed Khanfar | 4.2 MiB | iSpatula | April 4, 2020 |
L.02-Lecture-2-2016 | 0.8 MiB | | December 31, 2020 |
L.02-the-second-week | 6.6 MiB | iSpatula | April 4, 2020 |
L.02-the-second-week | 6.6 MiB | iSpatula | April 4, 2020 |
L.03 Graphical-Presentation-of-Data-Descriptive-Statistics | 2.1 MiB | | April 4, 2020 |
L.03 OTC 2 | 19 KiB | | April 4, 2020 |
L.03 Pharmaorganic-phenol,Dr Mohammed Khanfar | 3.5 MiB | iSpatula | April 4, 2020 |
L.03-basic-tissues-diagnosis-treatments-2016 | 1.6 MiB | | December 31, 2020 |
L.04 Measure-of-central-tendency-for-grouped-data | 1.3 MiB | | April 4, 2020 |
L.04 Micro Microbial-contamination | 0.2 MiB | | April 4, 2020 |
L.04 OTC | 16 KiB | | April 4, 2020 |
L.04 Pharmaorganic Dr Mohammed Khanfar | 2.2 MiB | iSpatula | April 4, 2020 |
L.04-body-organization 2016 | 1.5 MiB | | December 31, 2020 |
L.05 Introduction-to-probability | 0.2 MiB | | April 4, 2020 |
L.05 OTC | 36 KiB | | April 4, 2020 |
L.05 Pharmaorganic Dr Mohammed Khanfar | 0.5 MiB | iSpatula | April 4, 2020 |
L.05-skeleton 2016 | 2.9 MiB | | December 31, 2020 |
L.06 -cont Ether& Aldehyde And Keton-Dr Mohammad K | 2.2 MiB | iSpatula | April 4, 2020 |
L.06 Alcohol PharmaOrganic | 3.8 MiB | iSpatula | April 4, 2020 |
L.06 Alcohol PharmaOrganic | 3.8 MiB | | December 31, 2020 |
L.06 OTC | 30 KiB | | April 4, 2020 |
L.06 Probability-distribution -L.05 | 9.1 MiB | | April 4, 2020 |
L.06-circulation 2016 | 3.3 MiB | | December 31, 2020 |
L.07 Reaction Of Aldehyde-Dr Mohammed Khanfar | 6.5 MiB | iSpatula | April 4, 2020 |
L.07 Sample-mean-distribution | 0.6 MiB | | April 4, 2020 |
L.07-Respiratory 2016 | 1.4 MiB | | December 31, 2020 |
L.08 Carboxylic Acid-Dr Mohammed Khanfar | 23.6 MiB | iSpatula | April 4, 2020 |
L.08 Distributions Of The Difference Between Two Sample Means | 1.4 MiB | | April 4, 2020 |
L.08-Endocrine 2016 | 1.4 MiB | | December 31, 2020 |
L.09 Cont Carboxylic& Esters-Dr Mohammed Khanfar | 25.4 MiB | iSpatula | April 4, 2020 |
L.09 Cont Carboxylic& Esters-Dr Mohammed Khanfar(2) | 25.4 MiB | iSpatula | April 4, 2020 |
L.09 Estimating-a-Single-Population-Mean | 4.9 MiB | | April 4, 2020 |
L.10 Acid Unhydride&amid Dr Mohammed Khanfar | 19.5 MiB | iSpatula | April 4, 2020 |
L.10 Hypothesis-testing | 1.9 MiB | | April 4, 2020 |
L.11 Amine - Dr Mohammed Kanfar | 26.8 MiB | iSpatula | April 4, 2020 |
L.11hypothesis-testing The Difference Between 2 Population Means | 0.8 MiB | | April 4, 2020 |
L.12 Basic Epidemiology | 4.1 MiB | | April 4, 2020 |
L.12 Cont Amine & Heterocycle | 29.8 MiB | iSpatula | April 4, 2020 |
L.12 OTC | 29.1 MiB | | April 4, 2020 |
L.13 Cont Heterocycle | 29.7 MiB | iSpatula | April 4, 2020 |
L.14 Syn Of Quinoline,iso,and Pyrimidine | 27.2 MiB | iSpatula | April 4, 2020 |
L.15 Rxn Of Diazine,[] Excessive Heterocycle | 0.7 MiB | iSpatula | April 4, 2020 |
L.16 Chromo | 7.6 MiB | | April 4, 2020 |
L.17 Chromo | 23.0 MiB | | April 4, 2020 |
L.18 Chromo | 18.2 MiB | | April 4, 2020 |
L.19 Chromo | 18.1 MiB | | April 4, 2020 |
L0 19 Cogno1 | 45.9 MiB | | April 4, 2020 |
L0 21 Cogno1 | 39.9 MiB | | April 4, 2020 |
L0 22 Cogno1 | 36.8 MiB | | April 4, 2020 |
L0 26 Cogno1 | 41.1 MiB | | April 4, 2020 |
L0 27 Cogno1 | 29.6 MiB | | April 4, 2020 |
L0-12-Cogno | 31.6 MiB | | April 4, 2020 |
L0-13-Cogno | 13.0 MiB | | April 4, 2020 |
L0-14-Cogno | 34.7 MiB | | April 4, 2020 |
L0-15-Cogno | 49.7 MiB | | April 4, 2020 |
L0-15-Cogno | 47.0 MiB | | April 4, 2020 |
L0-16-Cogno | 46.0 MiB | | April 4, 2020 |
L0-20-Cogno | 23.3 MiB | | April 4, 2020 |
L0-23-Cogno | 21.4 MiB | | April 4, 2020 |
L0-24-Cogno | 47.3 MiB | | April 4, 2020 |
L0-25-Cogno | 92.1 MiB | | April 4, 2020 |
L00 Advanced Technology Introduction | 33 KiB | | April 4, 2020 |
L00 Advanced-Techno -Introduction | 7.4 MiB | | April 4, 2020 |
L00 Biochem1 Titration-curve | 2.2 MiB | | December 31, 2020 |
L00 Correct-spelling-for-plants | 0.8 MiB | | April 4, 2020 |
L00 Cosmetics Introduction | 18.9 MiB | | April 4, 2020 |
L00 Cosmetics Introduction Dr Samer | 45.5 MiB | | December 31, 2020 |
L00 Dispensing Dispensing-Techniques | 5.1 MiB | | December 31, 2020 |
L00 Dispensing-lab-Notes | 9.4 MiB | | December 31, 2020 |
L00 Microbiology1 Antimicrobial Therapy Tables | 3.4 MiB | | April 4, 2020 |
L00 Nurtition Introduction | 0.6 MiB | | April 4, 2020 |
L00 OTC Acne-medication-ssupplement | 0.6 MiB | | April 4, 2020 |
L00 Outline Biopharma M4a1 | 7.5 MiB | | April 4, 2020 |
L00 OutlineSelected-Physical-Sep-2016 | 28 KiB | | April 4, 2020 |
L00 Pathophysiology 16.09.2014 Introduction | 14.7 MiB | | April 4, 2020 |
L00 pathophysiology introduction Dr Alaa | 34.9 MiB | Afnan Dabobash | September 23, 2019 |
L00 Pharmacology Syllabus | 0.2 MiB | | April 4, 2020 |
L00 Pharmacology Syllabus | 0.2 MiB | | April 4, 2020 |
L00 Physical1 Introduction Dr Dina | 1.8 MiB | | December 31, 2020 |
L00 Physical2 Dr Samer -Introduction- | 11.3 MiB | iSpatula | April 4, 2020 |
L00 Phyto2 PathwaysLecture | 7.8 MiB | | April 4, 2020 |
L00 Phytoanalysis Med-Exam | 20.9 MiB | iSpatula | April 4, 2020 |
L00 Student-questions Phytoanalysis | 0.8 MiB | iSpatula | April 4, 2020 |
L00 Techno2 Dr Hatem | 10.8 MiB | | April 4, 2020 |
L00 Toxicology Self-study-CNS-stimulants | 1.2 MiB | | April 4, 2020 |
L00 Training2 Form | 13 KiB | | April 4, 2020 |
L00 Training2 Form-university-of-jordan-hospital | 25 KiB | | April 4, 2020 |
L00-Enzyme-summary-by-Alaa-Farhan | 0.5 MiB | | December 31, 2020 |
L00-Organic-chemistry-introduction-Dr Mousa | 1.7 MiB | | December 31, 2020 |
L00-Out-line-Pathology | 1.9 MiB | | April 4, 2020 |
L00-Pathophysiology-20.06.2016-Introduction | 10.0 MiB | | April 4, 2020 |
L00-Pharmacology-1 First-semester-2015 Students-version-1 | 25 KiB | | April 4, 2020 |
L00-Pharmacology-2 Syllaubs | 0.1 MiB | | April 4, 2020 |
L00-Pharmacology-2 Syllaubs | 0.1 MiB | | October 19, 2020 |
L00-Physical1-Introduction-Dr Dina | 30.7 MiB | | December 31, 2020 |
L01 | 19 KiB | | December 31, 2020 |
L01 | 9.2 MiB | | April 4, 2020 |
L01 Medicinal1 | 47.6 MiB | RaneenRiyad | June 20, 2019 |
L01 Micro1 Scope And History Dr Randa | 0.7 MiB | | April 4, 2020 |
L01 Practice 1 | 35.2 MiB | GhaidaaMelhem | June 25, 2019 |
L01 -Advanced-Phyto Phytochemical-method | 22 KiB | | April 4, 2020 |
L01 -advanced-techno Introduction- | 21.6 MiB | | April 4, 2020 |
L01 -Antihistamine- Dr Sana Bardaweel | 3.6 MiB | Nour Mohammad | July 6, 2020 |
L01 -Instrumental -Introduction -Dr Lina-dahabiyeh | 0.3 MiB | | April 4, 2020 |
L01 -Introduction -Pathophysiology | 45.6 MiB | | April 4, 2020 |
L01 -kinetics -Introduction | 11.3 MiB | | April 4, 2020 |
L01 -medicinal -Theories | 29.2 MiB | | April 4, 2020 |
L01 -Nutrition -Introductionn | 51.5 MiB | | April 4, 2020 |
L01 -organic Dr Mohammad | 3.4 MiB | | December 31, 2020 |
L01 -OTC -self-care-and-otc-pharmacotherapy Lec2 | 19.3 MiB | | April 4, 2020 |
L01 -Pathophysiology -Dr Eman- | 95.3 MiB | | April 4, 2020 |
L01 -Statistics-1-1 -Basic-Concepts | 33.4 MiB | | April 4, 2020 |
L01 -Therapy-2 -Asthma | 18.4 MiB | | April 4, 2020 |
L01 Adrenergic Dr Khanfar | 7.0 MiB | Reem Hussein | September 28, 2019 |
L01 Adv Technology | 29.3 MiB | | April 4, 2020 |
L01 Adv Technology Introduction | 0.3 MiB | | April 4, 2020 |
L01 Adv-techno-05.02.2017 Solubility-and-dissolution- | 17.4 MiB | | April 4, 2020 |
L01 Advance-Techno -Solubility-dissolution | 20.0 MiB | | April 4, 2020 |
L01 Advance-techno Biavailability | 0.4 MiB | | April 4, 2020 |
L01 Advanced techno Solubility And Dissolution Dr.ahmad (online-audio-converter Com) | 41.8 MiB | jumanamufeed | February 6, 2020 |
L01 Advanced Techno Solubility And Dissolution Dr Ahmad | 0.4 MiB | jumanamufeed | February 12, 2020 |
L01 Advanced Technology Solubility-and-Dissolution | 83 KiB | | April 4, 2020 |
L01 Advanced Technology-7.9.2016 | 20.5 MiB | | April 4, 2020 |
L01 Advanced-physical PM | 4.3 MiB | | April 4, 2020 |
L01 AdvTechno Dr Hatem | 15.9 MiB | | April 4, 2020 |
L01 Alcohol | 14.5 MiB | | December 31, 2020 |
L01 Analytical | 1.5 MiB | iSpatula | April 4, 2020 |
L01 Analytical | 3.5 MiB | iSpatula | April 4, 2020 |
L01 Analytical -Introduction -Dr -Lina | 2.7 MiB | iSpatula | April 4, 2020 |
L01 Analytical Dr Khanfar Amr | 10.3 MiB | iSpatula | April 4, 2020 |
L01 Analytical Dr MKhanfar | 20.3 MiB | iSpatula | April 4, 2020 |
L01 Analytical DrLina | 3.0 MiB | iSpatula | April 4, 2020 |
L01 Analytical Introduction | 3.5 MiB | iSpatula | April 4, 2020 |
L01 Analytical Introduction | 0.3 MiB | shatha zakariyya | October 30, 2020 |
L01 Analytical Sheet1 Introduction | 2.8 MiB | iSpatula | April 4, 2020 |
L01 Anatomy Introduction | 28.4 MiB | | December 31, 2020 |
L01 And L02 Therapy1 DrAlaa Hypertension | 0.6 MiB | | April 4, 2020 |
L01 ASTHMA Summary | 6.3 MiB | | April 4, 2020 |
L01 Asthma.2016 | 6.7 MiB | | April 4, 2020 |
L01 Basic-Concepts Dr Alaaldin-Alkilany | 0.5 MiB | | April 4, 2020 |
L01 Biopharma | 22.0 MiB | | April 4, 2020 |
L01 Biopharma | 3.5 MiB | | April 4, 2020 |
L01 Biopharma | 18.1 MiB | | April 4, 2020 |
L01 Biopharma 4.6.20171 | 36.0 MiB | | April 4, 2020 |
L01 Biopharma Dr Essa | 25.3 MiB | | April 4, 2020 |
L01 Biopharma Dr Rana | 28.7 MiB | | April 4, 2020 |
L01 Biopharma Introduction | 0.1 MiB | | April 4, 2020 |
L01 Biopharma Introduction | 13.7 MiB | | April 4, 2020 |
L01 Biopharma Introduction Dr Essa | 0.2 MiB | | April 4, 2020 |
L01 Biopharma Introduction Dr Mohammad | 26.2 MiB | | April 4, 2020 |
L01 Biopharma Pharmacokinaticdynamic M4a1 | 9.6 MiB | | April 4, 2020 |
L01 Biotechno Introduction Dr Jehad | 0.2 MiB | | December 31, 2020 |
L01 Biotechno Introduction Dr Rana | 12.7 MiB | | December 31, 2020 |
L01 Biotechno Protein-Therapeutics-Summary-and-Pharmacological-Classification | 0.4 MiB | | December 31, 2020 |
L01 Blood-Pressure | 0.3 MiB | | April 4, 2020 |
L01 Body-Fluids-Notes | 1.0 MiB | | December 31, 2020 |
L01 CAM | 26.6 MiB | | April 4, 2020 |
L01 Cam Notes Drtalal | 12.0 MiB | Joodjibril98 | February 10, 2020 |
L01 Cellular Response Pathophysiology | 1.0 MiB | | April 4, 2020 |
L01 Characterization-and-Physical-Stability-of-Spray-Dried-solid-dispersions-of-probucol-and-pvpk30 | 0.9 MiB | | April 4, 2020 |
L01 Chemistry Of Drugs | 35.6 MiB | | April 4, 2020 |
L01 Chromatography | 19.5 MiB | | April 4, 2020 |
L01 Chromatography Dr Muhammed | 0.4 MiB | Rim Shibani | October 18, 2019 |
L01 Chromatography Dr Zweiri | 59.4 MiB | Rana.Zabalawi | February 8, 2020 |
L01 Chromatography Mass-chromatography Dr Muhammaed | 1.1 MiB | doaa mohammad | October 17, 2020 |
L01 Chromo | 33.2 MiB | | April 4, 2020 |
L01 Chromo | 16.4 MiB | | April 4, 2020 |
L01 Chromo Basics Dr MhdZweri | 16.3 MiB | | April 4, 2020 |
L01 Chromo Dr Mohammad First Week | 4.1 MiB | Sama Altaher | February 8, 2020 |
L01 Chromo Introduction | 0.2 MiB | | April 4, 2020 |
L01 Chromo Introduction | 0.2 MiB | | April 4, 2020 |
L01 Chromo Introduction | 0.9 MiB | | April 4, 2020 |
L01 Chromo Introduction1 | 0.6 MiB | | April 4, 2020 |
L01 Clinical Biochemistry 2 | 17.2 MiB | | April 4, 2020 |
L01 Clinical-biochem Dr Yaser | 8.2 MiB | | April 4, 2020 |
L01 Clinical-Biochem Introduction Mp3 | 35.3 MiB | | April 4, 2020 |
L01 Clinical-Kinetics | 6.8 MiB | | April 4, 2020 |
L01 CLINICAL-TOXICOLOGY | 1.3 MiB | | April 4, 2020 |
L01 ClinicalBiochem2 Carbohydrates | 0.2 MiB | | April 4, 2020 |
L01 ClinicalKinetics Introduction Dr Maysaa | 19.3 MiB | | April 4, 2020 |
L01 CNS Dr Loai | 30.9 MiB | | April 4, 2020 |
L01 CNS Dr Loai | 0.4 MiB | | April 4, 2020 |
L01 CNS Dr Loai | 13.7 MiB | | April 4, 2020 |
L01 Cogno DrYahia Part1 | 2.4 MiB | Ibrahim Ahmad | September 26, 2019 |
L01 Cogno DrYahia Part2 | 17.6 MiB | Ibrahim Ahmad | September 26, 2019 |
L01 Cogno M4a2 | 39.9 MiB | | April 4, 2020 |
L01 Cognocy Introduction | 43.5 MiB | | April 4, 2020 |
L01 Cognosy Dr Mohammad-Hudaib | 1.2 MiB | | April 4, 2020 |
L01 Cognosy Dr-mohammad-Hudaib | 47.9 MiB | | April 4, 2020 |
L01 Cosmetic Introduction-and-General-Concepts | 19.7 MiB | | April 4, 2020 |
L01 Cosmetics Dr Samer | 67.8 MiB | Rema'a Abuhazeem | February 15, 2020 |
L01 Cosmetics Introduction-and-General-Concepts Dr Samer | 48.4 MiB | | December 31, 2020 |
L01 Cosmo Introduction | 9.9 MiB | | April 4, 2020 |
L01 Cosmo-Skin-care-preparation-1 | 0.4 MiB | | April 4, 2020 |
L01 Cozmo Skin | 15.4 MiB | | April 4, 2020 |
L01 Dispensing | 35.5 MiB | | December 31, 2020 |
L01 Dispensing Dispensing-Techniques | 17.8 MiB | | December 31, 2020 |
L01 Dispensing Dispensing-Techniques | 22.4 MiB | | December 31, 2020 |
L01 Dispensing DispensingTechniques | 40 KiB | | December 31, 2020 |
L01 Dispensing Dr Samer | 14.9 MiB | | December 31, 2020 |
L01 Dispensing Packaging Drdina | 23.3 MiB | | December 31, 2020 |
L01 Dispensing Techniques DrDina | 2.2 MiB | | December 31, 2020 |
L01 Dispensing Techniques.1 | 23.8 MiB | | December 31, 2020 |
L01 Dr Rana Kinetics | 19.6 MiB | | April 4, 2020 |
L01 Dr Yanal Physiology2 RenalSystem | 0.2 MiB | | April 4, 2020 |
L01 Dr Loai Physio2 M4a | 26.4 MiB | | April 4, 2020 |
L01 Dr Zweri | 0.5 MiB | | April 4, 2020 |
L01 Dr-Yanal Physiology2 | 17.6 MiB | | April 4, 2020 |
L01 Economics | 43.9 MiB | | April 4, 2020 |
L01 Economics | 9.5 MiB | | April 4, 2020 |
L01 Endocrine Dr Saleem | 27.1 MiB | | April 4, 2020 |
L01 Endocrine Dr Saleem | 42.7 MiB | | April 4, 2020 |
L01 Endocrine Dr Saleem | 0.4 MiB | | April 4, 2020 |
L01 Firstaid | 14 KiB | | December 31, 2020 |
L01 GI Dr Khatatbeh | 2.4 MiB | | April 4, 2020 |
L01 GI Dr Khatatbeh | 2.4 MiB | | April 4, 2020 |
L01 Hallucinogenic Plants Dr Yahia Tabaza | 19.7 MiB | Mohammed Altaweel | September 27, 2019 |
L01 Heart Pathology | 30.6 MiB | | April 4, 2020 |
L01 HPLC | 18 KiB | | April 4, 2020 |
L01 Hypertension Therapy1 | 2.0 MiB | zaidadnan862 | October 15, 2019 |
L01 Immuno Medical Genetics Introduction | 8.5 MiB | | April 4, 2020 |
L01 Instro Dr-emad | 5.1 MiB | | April 4, 2020 |
L01 Instru Dr Zweri | 40.6 MiB | | April 4, 2020 |
L01 Instru Dr-Emad | 6.6 MiB | Ghufran Qarara’h | September 22, 2019 |
L01 Instru DrKhanfar | 21.2 MiB | | April 4, 2020 |
L01 Instru Intoduction | 29 KiB | | April 4, 2020 |
L01 Instru Intoduction | 2.6 MiB | | April 4, 2020 |
L01 Instru Introduction | 61.7 MiB | | April 4, 2020 |
L01 Instru Introduction Dr-emad | 9.7 MiB | Ghufran Qarara’h | September 27, 2019 |
L01 Instru Introduction Dr-Imad Hamdan | 1.0 MiB | Batool Alkurdi | June 14, 2019 |
L01 Instru Sheet1 | 18 KiB | | April 4, 2020 |
L01 Instrumental Dr Emad UltravioletSpectroscopy-1 | 5.4 MiB | | April 4, 2020 |
L01 Introduction | 0.3 MiB | | December 31, 2020 |
L01 Introduction | 3.4 MiB | iSpatula | April 4, 2020 |
L01 Introduction | 0.8 MiB | | April 4, 2020 |
L01 Introduction Analytical | 1.5 MiB | Hanaasaleh | February 7, 2020 |
L01 Introduction And Terpenes | 0.2 MiB | | April 4, 2020 |
L01 Introduction Dr Faisal | 5.3 MiB | | December 31, 2020 |
L01 Introduction Instru | 0.9 MiB | Saharaldabbagh | February 3, 2020 |
L01 Introduction Instru | 0.2 MiB | | April 4, 2020 |
L01 Introduction Medicnal Plants | 0.1 MiB | | April 4, 2020 |
L01 Introduction Micro1 Pharmacy Dr Amal Albakri | 0.3 MiB | | April 4, 2020 |
L01 Introduction Pharmacokinetics | 0.2 MiB | Mohannad Alquman | February 10, 2020 |
L01 Introduction Phyto2 | 1.4 MiB | Maramghweiri | June 17, 2019 |
L01 Introduction Phyto2 | 44.4 MiB | zaidadnan862 | September 23, 2019 |
L01 Introduction Techno1 | 0.1 MiB | | April 4, 2020 |
L01 Introduction Techno1 | 0.5 MiB | | April 4, 2020 |
L01 Introduction To Pharmacology | 2.3 MiB | | April 4, 2020 |
L01 Introduction-notes Pharmacology1 | 1.1 MiB | | April 4, 2020 |
L01 Isotopes | 14.3 MiB | | April 4, 2020 |
L01 Isotopes Atomic-and-nuclear-structure-till-Interaction-of-radiation-with-matter - | 14 KiB | | April 4, 2020 |
L01 Journal Of Food Composition And Analysis 2006 | 0.3 MiB | | April 4, 2020 |
L01 Kinetics | 23.0 MiB | | April 4, 2020 |
L01 Kinetics ADME | 20.5 MiB | | April 4, 2020 |
L01 Kinetics ADME | 17.8 MiB | | April 4, 2020 |
L01 Kinetics Introduction | 7.8 MiB | | April 4, 2020 |
L01 Kinetics Introduction | 15.1 MiB | | April 4, 2020 |
L01 Lab Fundi Infection Control Dr Zyad | 1.3 MiB | | April 4, 2020 |
L01 Lectures-1-3 Phyto1 | 1.0 MiB | | April 4, 2020 |
L01 Liver-Cirrhosis | 2.2 MiB | | April 4, 2020 |
L01 LIVER-CIRRHOSIS-Fall-2016 | 1.3 MiB | | April 4, 2020 |
L01 Marketing | 24.1 MiB | | April 4, 2020 |
L01 Med-plants-1 | 32.8 MiB | | April 4, 2020 |
L01 MedChem3 Antihistamines Dr Sanaa | 0.4 MiB | | April 4, 2020 |
L01 MedChem3 Antihistamines Dr Sanaa | 0.4 MiB | | April 4, 2020 |
L01 Medicinal 1 | 55.9 MiB | | April 4, 2020 |
L01 MEDICINAL 1 DR GHADEER | 0.8 MiB | ShahdHabash | September 29, 2019 |
L01 Medicinal Ch 21.06.2015 Introduction | 27.9 MiB | | April 4, 2020 |
L01 Medicinal Ch 21.06.2015 Introduction | 0.6 MiB | | April 4, 2020 |
L01 Medicinal Chem II Beta Lactams | 0.3 MiB | MohanadRobin | June 15, 2019 |
L01 Medicinal Dr Mutasem | 5.7 MiB | | April 4, 2020 |
L01 Medicinal Dr Khanfar | 28.5 MiB | | April 4, 2020 |
L01 Medicinal-Chem-II Beta-lactams-1 | 0.6 MiB | Salah Samha | February 14, 2020 |
L01 Medicinal-Chemistry-2 Penicillin | 2.2 MiB | | April 4, 2020 |
L01 Medicinal1 Drmotasem | 20.5 MiB | | April 4, 2020 |
L01 Medicinal1 Drmotasem | 1.6 MiB | | April 4, 2020 |
L01 Medicinal2 Amioglycoside | 14.0 MiB | | April 4, 2020 |
L01 Medicinal2-Antibacterial-Penicillins | 48.1 MiB | | April 4, 2020 |
L01 Medicinal3 Introduction | 8.6 MiB | | April 4, 2020 |
L01 Medicinal3 IntroductionANS | 9.2 MiB | | April 4, 2020 |
L01 Medicinal3parasympathetic | 22.3 MiB | | April 4, 2020 |
L01 Meducunal2 Nucleic-acid | 18.1 MiB | | April 4, 2020 |
L01 Micro1 Dr Randa | 49.0 MiB | | April 4, 2020 |
L01 Micro1 Scope And History Dr Kawareek | 0.6 MiB | | April 4, 2020 |
L01 Micro2 Biocides | 0.8 MiB | | April 4, 2020 |
L01 Microbiology1 PhD Dr Randa | 102 MiB | | April 4, 2020 |
L01 Mid Material Marketing1 Pdf | 38.8 MiB | Heyam Alabbadi | July 6, 2020 |
L01 Mohd-Alham | 25.1 MiB | | April 4, 2020 |
L01 Neurophysiology Physiology2 | 0.6 MiB | | April 4, 2020 |
L01 Nutraceuticals Phyto Analysis | 17.3 MiB | zaidadnan862 | February 10, 2020 |
L01 Nutrition An-overview-of-Nutrition | 28.0 MiB | | April 4, 2020 |
L01 Nutrition An-Overview-of-Nutrition-Part1 | 3.1 MiB | | April 4, 2020 |
L01 Nutrition Introduction Dr Mohammed | 0.4 MiB | Malak Ali | February 8, 2020 |
L01 Nutrition Introduction Dr.Mohammed | 65.6 MiB | Aliya Fouad | February 5, 2020 |
L01 Nutrition Introduction Drmohammad | 52.7 MiB | | April 4, 2020 |
L01 Organic Revision DrMousa 20180203130438 | 1.7 MiB | | December 31, 2020 |
L01 OrganicChemistry1 Chapter1 Part1 Dr AlmeqdadHabashneh | 5.4 MiB | | December 31, 2020 |
L01 OTC | 34.6 MiB | | April 4, 2020 |
L01 OTC | 42.9 MiB | | April 4, 2020 |
L01 OTC Introduction | 19.2 MiB | | April 4, 2020 |
L01 OTC Self-Care 2 | 14.6 MiB | | April 4, 2020 |
L01 OTC Self Care | 17.9 MiB | | April 4, 2020 |
L01 OTC-2016 | 1.0 MiB | | April 4, 2020 |
L01 Pain-management-2017 | 1.0 MiB | | April 4, 2020 |
L01 Para Corns-and-calluses | 38.1 MiB | | April 4, 2020 |
L01 Para Corns-and-calluses | 0.5 MiB | | April 4, 2020 |
L01 PARA Cornscalluses | 31.6 MiB | | April 4, 2020 |
L01 Para Introduction | 0.3 MiB | | April 4, 2020 |
L01 Para Corns And Calluses | 82.0 MiB | Sondos Khalil | July 1, 2019 |
L01 Para Dr Eman Vitamins | 12.3 MiB | | April 4, 2020 |
L01 Para Dr Rana | 88.6 MiB | Hala Azem | February 18, 2020 |
L01 Para Vitamins Dr Eman | 13.6 MiB | | April 4, 2020 |
L01 Patho | 66 KiB | | April 4, 2020 |
L01 Patho Cell-Injury Dr-Mazin | 20.8 MiB | | April 4, 2020 |
L01 Pathology Cardiac-diseases | 0.6 MiB | | April 4, 2020 |
L01 Pathology Cellinjury1 Dr Manar | 64 KiB | | April 4, 2020 |
L01 Pathology Introduction | 22.0 MiB | | April 4, 2020 |
L01 Pathology Neoplasia-1 Dr Maram | 0.1 MiB | | December 31, 2020 |
L01 Pathology-RS-Note-Dr Maram | 60 KiB | | December 31, 2020 |
L01 Pathophysilogy 18.09.2014 Cellular Responses | 14.7 MiB | | April 4, 2020 |
L01 Pathophysio Cellular-Responses Dr Eman | 65.2 MiB | | April 4, 2020 |
L01 Pathophysio Cellular-Responses Dr Eman | 0.2 MiB | | April 4, 2020 |
L01 Pathophysio Dr Eman | 23.4 MiB | | April 4, 2020 |
L01 Pathophysio Inflammation | 43.1 MiB | | April 4, 2020 |
L01 Pathophysio Inflammation | 0.8 MiB | | April 4, 2020 |
L01 Pathophysio Inflammation Dralaa | 27.2 MiB | Sarah Degis | June 15, 2019 |
L01 Pathophysio Inflammation Dralaa | 0.5 MiB | Sarah Degis | June 18, 2019 |
L01 Pathophysio Inflammation Part1 | 1.2 MiB | | April 4, 2020 |
L01 PathoPhysio Introduction | 0.2 MiB | | April 4, 2020 |
L01 Pathophysio.02.02.2017 Inflammation | 41.9 MiB | | April 4, 2020 |
L01 Pathophysiology | 51.1 MiB | | April 4, 2020 |
L01 Pathophysiology INFLAMMATIOn DR ALA LLAHAM | 59.0 MiB | Afnan Dabobash | September 25, 2019 |
L01 Pathophysiology 18.09.0214 Cellular Responses | 0.6 MiB | | April 4, 2020 |
L01 Pathophysiology Cellular Respnses | 0.5 MiB | | April 4, 2020 |
L01 Pathophysiology Inflammation | 9.0 MiB | | April 4, 2020 |
L01 Pathophysiology Inflammation | 27.2 MiB | | April 4, 2020 |
L01 Pathophysiology Introduction Dr Alaa | 39.5 MiB | Batool Alkurdi | February 3, 2020 |
L01 Pathophysiology Sheet Inflammation | 0.4 MiB | | April 4, 2020 |
L01 Pathophysiology- Inflammation | 19 KiB | | April 4, 2020 |
L01 Pathophysiology- Inflammation 2 | 19 KiB | | April 4, 2020 |
L01 Pharma-Organic Alcohol | 8.2 MiB | | December 31, 2020 |
L01 Pharma-Organic Alcohol Dr Yosef | 3.6 MiB | | December 31, 2020 |
L01 Pharma-Organic Alcohol DrYousuf | 2.4 MiB | | December 31, 2020 |
L01 Pharma1 Introduction | 23.5 MiB | | April 4, 2020 |
L01 Pharma1 Introduction Pharmacokinetics | 16.4 MiB | | April 4, 2020 |
L01 Pharma1 Introduction-to-pharmacokinetics | 1.9 MiB | | April 4, 2020 |
L01 Pharma1 Pituitary And Hypothalamus Hormones | 1.4 MiB | | April 4, 2020 |
L01 Pharma1 Pituitary And Hypothalamus Hormones | 1.4 MiB | | October 19, 2020 |
L01 Pharma1.05.09.2016 Introduction | 57.3 MiB | | April 4, 2020 |
L01 Pharma2 Pituitary And Hypothalamus ,part1 | 1.4 MiB | | April 4, 2020 |
L01 Pharma2 Pituitary And Hypothalamus ,part1 | 1.4 MiB | | October 19, 2020 |
L01 Pharmaceutical Statistics Dr Hatem | 0.1 MiB | | April 4, 2020 |
L01 Pharmaceutical-Statistics Basic-Concepts D-Ahmad | 14.0 MiB | | April 4, 2020 |
L01 Pharmacokinetics | 17.3 MiB | | April 4, 2020 |
L01 Pharmacokinetics Introduction | 17.0 MiB | | April 4, 2020 |
L01 Pharmacology1 Introduction | 2.5 MiB | | April 4, 2020 |
L01 Pharmacotherapy 2 Dr Ala | 24.7 MiB | | April 4, 2020 |
L01 Pharmaorganic Alcohol DrAli | 7.1 MiB | | December 31, 2020 |
L01 PharmaOrganic Alcohols1.7-9-2016 | 5.5 MiB | | December 31, 2020 |
L01 PharmaOrganic DrYousef | 5.3 MiB | | December 31, 2020 |
L01 Physical 2 Introduction | 8.5 MiB | QamarSaqqa | February 7, 2020 |
L01 Physical-1 Phase-Rule-Dmais | 13.3 MiB | | December 31, 2020 |
L01 Physical1 Intermolecular-and-Intramolecular-Forces Dr Dina | 2.1 MiB | | December 31, 2020 |
L01 Physical1 Topic1 DrDina | 33.0 MiB | | December 31, 2020 |
L01 Physical2 Dr Hatem | 16.4 MiB | iSpatula | April 4, 2020 |
L01 Physical2 Dr Samer | 22.1 MiB | iSpatula | April 4, 2020 |
L01 Physical2 Firstweek | 5.9 MiB | iSpatula | April 4, 2020 |
L01 Physical2 Introduction | 23.0 MiB | iSpatula | April 4, 2020 |
L01 Physical2 Introduction-And-Partitioning | 28.5 MiB | iSpatula | April 4, 2020 |
L01 Physio2 Dr Saleem | 35.3 MiB | | April 4, 2020 |
L01 Physio2 Drlo2e | 18.0 MiB | | April 4, 2020 |
L01 Physio2 Drlo2e | 0.8 MiB | | April 4, 2020 |
L01 Physio2 Drloai | 17.1 MiB | | April 4, 2020 |
L01 Physio2 Endocrine Dr Saleem | 0.6 MiB | | April 4, 2020 |
L01 Physio2 Endocrine Drsaleem | 0.7 MiB | | April 4, 2020 |
L01 Physio2 The-Endocrine-system DrLoai | 77.8 MiB | Alaa Ziad | June 15, 2019 |
L01 Physiology Dr Loai | 0.5 MiB | | December 31, 2020 |
L01 Physiology Introduction DrLoai | 0.8 MiB | | December 31, 2020 |
L01 Physiology ll Introduction Dr.Faisal | 21.8 MiB | Qabas Mansour | February 4, 2020 |
L01 Physiology RestingPotential Dr Loai | 0.3 MiB | | December 31, 2020 |
L01 Physiology RestingPotential Dr Loai | 0.3 MiB | | December 31, 2020 |
L01 Physiology Sheet1 Introduction | 0.4 MiB | | December 31, 2020 |
L01 Physiology-1 Introduction Dr-loai | 33.7 MiB | | December 31, 2020 |
L01 Physiology1 Introduction Dr Loai | 20.1 MiB | | December 31, 2020 |
L01 Physiology1 Introduction DrLoai | 29.0 MiB | | December 31, 2020 |
L01 Physiology1 Week1 DrLoai | 1.7 MiB | | December 31, 2020 |
L01 Physiology2 Dr Loai | 24.0 MiB | | April 4, 2020 |
L01 Physiology2 DrSaleem | 36.8 MiB | | April 4, 2020 |
L01 Physiology2 RenalSystem Mp3 Qpx3xya | 0 B | | April 4, 2020 |
L01 Phyto1 | 40.1 MiB | | April 4, 2020 |
L01 Phyto2 Mevalonate Terpenes Dr Talal | 34.7 MiB | | April 4, 2020 |
L01 Phyto2. | 60.8 MiB | Maramghweiri | June 15, 2019 |
L01 Phytoanalysis | 24.5 MiB | iSpatula | April 4, 2020 |
L01 Phytoanalysis Nutraceuticals | 0.7 MiB | iSpatula | April 4, 2020 |
L01 Phytoanalysis Quality-control-of-Herbal | 23.5 MiB | iSpatula | April 4, 2020 |
L01 Phytochemical-Analysis | 54 KiB | iSpatula | April 4, 2020 |
L01 Phytochemistry1 Phenolics | 18.1 MiB | | April 4, 2020 |
L01 Practice 1 Introduction | 15.5 MiB | | April 4, 2020 |
L01 Practice Patient-education-on-insulin-injectio | 17.0 MiB | | April 4, 2020 |
L01 Practice1 | 25.8 MiB | | April 4, 2020 |
L01 Practice2 | 66.6 MiB | | April 4, 2020 |
L01 Practice2 Basic-Communication-Skills-in-Pharmacy-Practice | 13.0 MiB | | April 4, 2020 |
L01 Protein-Therapeutics-Summary-and-Pharmacological-Classification | 0.4 MiB | | December 31, 2020 |
L01 Pulse | 2.3 MiB | | April 4, 2020 |
L01 Quiz Material Part .1 | 3.2 MiB | | April 4, 2020 |
L01 Reasons-of-coating -Techno2- | 4.5 MiB | | April 4, 2020 |
L01 Renal Dr Ebaa | 0.1 MiB | | April 4, 2020 |
L01 Renal Dr Ebaa | 2.3 MiB | | April 4, 2020 |
L01 Respiration | 0.7 MiB | | April 4, 2020 |
L01 Smoking | 1.7 MiB | | April 4, 2020 |
L01 Solubility-and-Dissolution Advanced-technology | 34.2 MiB | | April 4, 2020 |
L01 Statistics Basic-Concepts | 4.2 MiB | | April 4, 2020 |
L01 Statistics Chapter1 DrAhmad | 21.7 MiB | | April 4, 2020 |
L01 Statistics Dr Ahmad | 59.8 MiB | Aya Alassi | June 16, 2019 |
L01 Statistics Introduction Dr Hatim | 0.6 MiB | | October 19, 2020 |
L01 Statistics Slide1-2-3 Dr Ahmad 2 | 9.4 MiB | | April 4, 2020 |
L01 Tablet Coating | 7.3 MiB | | April 4, 2020 |
L01 Tablet-Coating Technology2 | 65.7 MiB | | April 4, 2020 |
L01 Techno 1 Introduction Dr Hatem | 4.8 MiB | Mais Maharma | July 6, 2020 |
L01 Techno 2 Dr Dina | 22.0 MiB | | April 4, 2020 |
L01 Techno1 | 32.2 MiB | | April 4, 2020 |
L01 Techno1 Dr Lorina Topic1 Pdf | 6.9 MiB | | April 4, 2020 |
L01 Techno1 Dr Samer | 20.5 MiB | | April 4, 2020 |
L01 Techno1 Introduction | 0.5 MiB | | April 4, 2020 |
L01 Techno1 Introduction Dr Ahmad | 21.8 MiB | | April 4, 2020 |
L01 Techno1 Introduction Dr Lorina | 66.6 MiB | | April 4, 2020 |
L01 Techno1 Introduction M4a[1] | 36.2 MiB | | April 4, 2020 |
L01 Techno1 Pre-formulation Dr Lorina | 0.4 MiB | dana younes | October 2, 2019 |
L01 Techno2 Coating Dr Hatim | 21.7 MiB | Bayan Mohamad | February 8, 2020 |
L01 Techno2 Coating Dr Hatim T | 1.8 MiB | Samira.Abusaif | February 7, 2020 |
L01 Techno2 Dr Hatem | 20.4 MiB | | April 4, 2020 |
L01 Techno2 Reasons-of-tablet-coating Dr Hatem | 41.4 MiB | | April 4, 2020 |
L01 Techno2 Tablet Coating1 | 18.0 MiB | | April 4, 2020 |
L01 Techno2 Tablet-Coating 1 | 19.2 MiB | | April 4, 2020 |
L01 Technology1 Introduction | 34.2 MiB | | April 4, 2020 |
L01 Technology2 Dr-Ahmad-Bani-Jaber- | 3.3 MiB | | April 4, 2020 |
L01 Temperature | 2.1 MiB | | April 4, 2020 |
L01 The-renal-system Physiology2 | 0.7 MiB | | April 4, 2020 |
L01 Therapy 4 Pain Management DrNaila | 63.1 MiB | Farah Qaryouti | February 10, 2020 |
L01 Therapy Asthma.02.02.2016 | 0.4 MiB | | April 4, 2020 |
L01 Therapy Dr Alaa HTN | 28.1 MiB | | April 4, 2020 |
L01 Therapy1 HTN Dr Alaaallham | 16.2 MiB | | April 4, 2020 |
L01 Therapy1 Hypertension Dr-Alaa | 26.2 MiB | | April 4, 2020 |
L01 Therapy1 Hypertension Dr-Oriana | 16.6 MiB | | April 4, 2020 |
L01 Therapy2 Asthma | 28.3 MiB | | April 4, 2020 |
L01 Therapy2 Asthma | 0.6 MiB | | April 4, 2020 |
L01 Therapy2 Asthma | 69.2 MiB | | April 4, 2020 |
L01 Therapy2-02.02.2016 Asthma | 20.2 MiB | | April 4, 2020 |
L01 Therapy3 Depression | 23.9 MiB | | December 31, 2020 |
L01 Therapy3 Introduction | 67.0 MiB | Aliya Fouad | September 22, 2019 |
L01 Therapy4-Anemia | 29.7 MiB | | April 4, 2020 |
L01 Topic1 Dr Samer | 43.9 MiB | iSpatula | April 4, 2020 |
L01 TOXI-2 | 4.1 MiB | | April 4, 2020 |
L01 Toxic Plants Introduction Dr Yahia | 25.6 MiB | Shaimaa Salahat | July 9, 2019 |
L01 Toxic-Plants-1-1 | 14 KiB | | April 4, 2020 |
L01 Toxicology Introduction | 6.6 MiB | | April 4, 2020 |
L01 Toxicology Introduction | 54.2 MiB | | April 4, 2020 |
L01 ToxicPlants Slides1 | 17.7 MiB | | April 4, 2020 |
L01 Ultra Violet Spectrphotometry | 0.2 MiB | | April 4, 2020 |
L01&L02 Therapy I Hypertension-Introduction Part 2 | 0.2 MiB | MohanadRobin | October 4, 2019 |
L01&L02 Therapy I Hypertension-Introduction. | 0.1 MiB | MohanadRobin | September 28, 2019 |
L01-02-Renal-System-Dr-yanal | 3.5 MiB | | April 4, 2020 |
L01-03 Therapy4 Anemia | 1.7 MiB | | April 4, 2020 |
L01-Advanced-Physical-PM-Home-Work-Imaging-DD-Nanomedicine And Nanobiotechnology | 0.6 MiB | | April 4, 2020 |
L01-Analytical-Introduction | 0.3 MiB | Sham Hatem | July 27, 2020 |
L01-and-L02 Techno2 Tablet-coating Types-of-coating | 0.1 MiB | | April 4, 2020 |
L01-basic-concept-of-pharmacoeconomics | 0.3 MiB | | April 4, 2020 |
L01-BIOPHARMA-Introduction | 0.2 MiB | | April 4, 2020 |
L01-Cell-Membrane-Transport-Dr-Loai | 1.1 MiB | | December 31, 2020 |
L01-Cellular-response-Patho | 18.2 MiB | | April 4, 2020 |
L01-Cellular-Response-Pathology | 6.7 MiB | | April 4, 2020 |
L01-cogno-Dr-Olaimat-introduction | 30.0 MiB | | April 4, 2020 |
L01-Corns-and-calluses-Para | 43.5 MiB | | April 4, 2020 |
L01-Cs-Problem-Solving-II-Dr Lama | 0.3 MiB | | October 27, 2020 |
L01-Dandruff-2017 | 1.7 MiB | | April 4, 2020 |
L01-Dr -Rana-Dissolution 2016 | 0.3 MiB | | April 4, 2020 |
L01-Dr-Jihad | 43.7 MiB | | December 31, 2020 |
L01-Dr-Khanfar | 40.0 MiB | iSpatula | April 4, 2020 |
L01-GIT-Physio2 | 2.4 MiB | | April 4, 2020 |
L01-Hypertension 2015-final | 10.3 MiB | | April 4, 2020 |
L01-Hypertension 2015-student-part-1 | 3.7 MiB | | April 4, 2020 |
L01-Hypertension-Therpay1 | 27.8 MiB | | April 4, 2020 |
L01-hypertention | 12.4 MiB | | April 4, 2020 |
L01-Instru-Dr-Kanfar-31-1-2017 | 44.0 MiB | | April 4, 2020 |
L01-Introduction-Anatomy | 2.4 MiB | | December 31, 2020 |
L01-introduction-and-ABC-management | 0.3 MiB | | April 4, 2020 |
L01-introduction-Biopharma M4a | 10.1 MiB | | April 4, 2020 |
L01-introduction-Medecinal1 | 16.4 MiB | | April 4, 2020 |
L01-Introduction-Phyto1 | 20.8 MiB | | April 4, 2020 |
L01-introduction-Techno1 | 28.7 MiB | | April 4, 2020 |
L01-introduction-to-cellular-response-Pathophysio | 11.8 MiB | | April 4, 2020 |
L01-Introduction-to-Cellular-response-Pathophysiology | 16.5 MiB | | April 4, 2020 |
L01-Introduction-to-pharmacology-1- | 0.7 MiB | | April 4, 2020 |
L01-introuduction-Physio2 | 13.7 MiB | | April 4, 2020 |
L01-kinetics-introduction | 18.0 MiB | | April 4, 2020 |
L01-Kinetics-lab-med-Note1 | 5.4 MiB | | April 4, 2020 |
L01-L05-Diuretics | 0.7 MiB | | April 4, 2020 |
L01-l09 Kinetics-sheets | 20.7 MiB | | April 4, 2020 |
L01-l09 Kinetics-sheets | 13.5 MiB | | April 4, 2020 |
L01-Medicinal-2-Antibacterials-Penicillins | 16.5 MiB | | April 4, 2020 |
L01-medicinal-chemistry-2 | 51.8 MiB | | April 4, 2020 |
L01-Medicinal3-introduction | 10.3 MiB | | April 4, 2020 |
L01-Multivitamins-and-supplements | 45 KiB | | April 4, 2020 |
L01-Organic-chemistry-structure-and-bonding .Dr -Mohammad-mobarak- | 4.1 MiB | | December 31, 2020 |
L01-OTC-Introduction | 0.4 MiB | | April 4, 2020 |
L01-OTC-Introduction- | 14.6 MiB | | April 4, 2020 |
L01-Pancreatic-Hormones-Antidiabetic-Drugs-Part-1 | 11.9 MiB | | April 4, 2020 |
L01-Pancreatic-Hormones-Antidiabetic-Drugs-Part-1 | 11.9 MiB | | October 19, 2020 |
L01-Para-dandruff | 13.4 MiB | | April 4, 2020 |
L01-Para-Infant-formula-L01 | 39.8 MiB | | April 4, 2020 |
L01-Pathology-Introduction-Cell-Injury | 12.1 MiB | | April 4, 2020 |
L01-Pathophysio Intro | 13.0 MiB | | April 4, 2020 |
L01-Pathophysio-Dr-Alaa | 29.2 MiB | | April 4, 2020 |
L01-pathophysio-Dr-Eman | 42.2 MiB | | April 4, 2020 |
L01-Pathophysiology-21.6.2016-Inflammation | 22.5 MiB | | April 4, 2020 |
L01-pharma-organic-chemistry-Alcohol-Dr -Jehad-almaleety- | 2.7 MiB | | December 31, 2020 |
L01-Pharmacology-and-Drug | 3.3 MiB | | April 4, 2020 |
L01-Physical-1Inter-and-intramolecular-forces-Dr Dina | 29.7 MiB | | December 31, 2020 |
L01-Physio1-Dr-Loai | 14.6 MiB | | December 31, 2020 |
L01-Physio1-Handout1-Slide10-DrMohammad | 0.1 MiB | | December 31, 2020 |
L01-physiology-2-Renal-System-Dr-Ebaa | 30.6 MiB | | April 4, 2020 |
L01-Physiology-introduction-Dr-Fessal | 0.8 MiB | | December 31, 2020 |
L01-phytoanalysis-introduction-2.2.2016 | 36.9 MiB | iSpatula | April 4, 2020 |
L01-Practice-introduction | 41.6 MiB | | April 4, 2020 |
L01-Tablet-coating-Techno2 | 16.4 MiB | | April 4, 2020 |
L01-Therapy3-Major-Depressive-Disorders | 30.2 MiB | | April 4, 2020 |
L01-Therpy3-Portal-HTN-liver-cirrhosis | 20.6 MiB | | April 4, 2020 |
L01-Training-1-Basic-communication-skills | 1.2 MiB | | April 4, 2020 |
L01. PhysiologyII Introduction to CNS | 0.5 MiB | Qabas Mansour | February 6, 2020 |
L01.Biopharma.Introduction.Dr.rana | 4.1 MiB | Muzdalifa Asaad | September 26, 2019 |
L01.Biopharma.Introduction.Dr.Rana | 0.3 MiB | bashar.abdulrazeq | September 28, 2019 |
L01.Biopharma.Introduction.dr.rana | 35.4 MiB | Muzdalifa Asaad | October 2, 2019 |
L01.CAM.record | 23.2 MiB | Joodjibril98 | February 10, 2020 |
L01.Cogno.Dr.yahia | 84.2 MiB | Maha Issa | July 17, 2019 |
L01.DrAhmad.statistics | 41.4 MiB | Ahmadabukaff | February 3, 2020 |
L01.OTC.mp3 | 123 MiB | Raghad Deknash | June 20, 2019 |
L01.pathophysiology.dralaa | 0.8 MiB | Batool Alkurdi | February 21, 2020 |
L01.pathophysiology.Inflammation ByHalaSuleiman | 0.2 MiB | Muneerah Ali | September 28, 2019 |
L01.Pathophysiology.Inflammation.Dr.Ala | 1.0 MiB | rawan Abu Oss | October 20, 2020 |
L01.techno2.CoatedTablets.Dr.ahmad | 37.9 MiB | Somaya Alwishah | October 2, 2019 |
L01.TECHNO2.TABLET.COATING.DR.AHMAD | 0.4 MiB | Somaya Alwishah | September 25, 2019 |
L01.therapy2.Dr.Oriana | 32 KiB | Shayma Ahmad | February 14, 2020 |
L010 -Analytical -Dr -lina | 3.7 MiB | iSpatula | April 4, 2020 |
L010 Pathology | 23.0 MiB | | April 4, 2020 |
L010 Pharma-Organic Heterocycles-1 | 7.4 MiB | | December 31, 2020 |
L010-Cogno | 28.9 MiB | | April 4, 2020 |
L011 -Analytical -Dr -lina | 4.2 MiB | iSpatula | April 4, 2020 |
L011 Neurophysiology Physiology2 | 0.3 MiB | | April 4, 2020 |
L011 Neurophysiology Physiology2 | 0.3 MiB | | April 4, 2020 |
L011 Pharma-Organic Heterocycles-2 | 7.5 MiB | | December 31, 2020 |
L011-Cogno | 33.6 MiB | | April 4, 2020 |
L012 -Analytical -Dr -Lina -Pdf | 3.0 MiB | iSpatula | April 4, 2020 |
L012 Neurophysiology Physiology2-2 | 1.2 MiB | | April 4, 2020 |
L012 OTC Self-care | 1.0 MiB | | April 4, 2020 |
L012 Para Self-care | 0.1 MiB | | April 4, 2020 |
L012 Pharma-Organic Heterocycles-3 | 2.1 MiB | | December 31, 2020 |
L0123 HTN Notes Dr Alaa | 63 KiB | | April 4, 2020 |
L013 -Analytical -Dr -Lina | 3.3 MiB | iSpatula | April 4, 2020 |
L013 Neurophysiology Physiology2 | 0.9 MiB | | April 4, 2020 |
L013 Organic Stability-of-cycloalkanes Dr Mosa | 1.6 MiB | | December 31, 2020 |
L014 -Analytical -Dr -Lina | 3.0 MiB | iSpatula | April 4, 2020 |
L014 Chairconformation Dr Mosa | 1.1 MiB | | December 31, 2020 |
L015 -Analytical -Dr -lina | 1.0 MiB | iSpatula | April 4, 2020 |
L015 Disubstituted-cyclohexane Dr Mosa | 2.6 MiB | | December 31, 2020 |
L015 Physiology1 Nervous System2 Dr Mohammed | 47.6 MiB | | December 31, 2020 |
L016 -Analytical -Dr -Lina | 2.5 MiB | iSpatula | April 4, 2020 |
L017 -Analytical -Dr -Lina -Pdf | 2.7 MiB | iSpatula | April 4, 2020 |
L018 -Analytical -Dr -Lina | 3.0 MiB | iSpatula | April 4, 2020 |
L019 Organic Dr Mosa | 1.6 MiB | | December 31, 2020 |
L01And-L02AndL03 Techno2 Tablet-coating-notes | 1.3 MiB | | April 4, 2020 |
L01Endocrine-Physio2-Dr-Ebaa | 41.5 MiB | | April 4, 2020 |
L01L02 | 0.9 MiB | | April 4, 2020 |
L01L02-Reproductive-System-Physio2 | 3.6 MiB | | April 4, 2020 |
L01 Kinetics DrMutasim Introduction | 1.9 MiB | Muzdalifa Asaad | October 17, 2020 |
L02 | 16 KiB | | December 31, 2020 |
L02 | 14.9 MiB | | April 4, 2020 |
L02 PathoPhysiology Inflammation Dr ALa | 1.0 MiB | rawan Abu Oss | October 30, 2020 |
L02 Practice 1 | 52.2 MiB | GhaidaaMelhem | June 25, 2019 |
L02 -advanced-techno Dissolutionsolubility | 19.5 MiB | | April 4, 2020 |
L02 -Analytical -Measurements -Dr -Lina-1 | 6.4 MiB | iSpatula | April 4, 2020 |
L02 -Atrophy-and-metaplasia -Pathophysiology | 41.2 MiB | | April 4, 2020 |
L02 -Biotechnology -Definitions -Paper | 50 KiB | | December 31, 2020 |
L02 -Biotechnology -Definitions -Paper | 50 KiB | | December 31, 2020 |
L02 -Intrumental -Introduction-2 -Dr Lina-dahabiyeh | 0.3 MiB | | April 4, 2020 |
L02 -kinetics -Introduction-to-pharmacokinetics | 19.7 MiB | | April 4, 2020 |
L02 -Medicinal -Theories | 23.1 MiB | | April 4, 2020 |
L02 -Nutrition | 71.6 MiB | | April 4, 2020 |
L02 -Pathophysiology -Dr Eman- | 106 MiB | | April 4, 2020 |
L02 -Phytochemical-Analysis | 25 KiB | iSpatula | April 4, 2020 |
L02 -Scientific Paper Quiz .2 | 0.8 MiB | | April 4, 2020 |
L02 -Suger-coating -Techno2 -Dr- -Hatem | 79.9 MiB | | April 4, 2020 |
L02 Adrenergic Dr Khanfar | 3.2 MiB | Reem Hussein | September 28, 2019 |
L02 Adv Technology | 23.4 MiB | | April 4, 2020 |
L02 Adv-techno-07.02.2017 | 19.7 MiB | | April 4, 2020 |
L02 Advanced Techno Solubility And Dissolution Dr Ahmad | 0.5 MiB | jumanamufeed | February 16, 2020 |
L02 Advanced Techno Solubility And Dissolution Dr Ahmad (online-audio-converter Com) | 43.1 MiB | jumanamufeed | February 12, 2020 |
L02 Advanced Technology | 0.4 MiB | | April 4, 2020 |
L02 Advanced Technology Solubility-and-Dissolution | 0.1 MiB | | April 4, 2020 |
L02 Advanced Technology-19.9.2016 | 18.3 MiB | | April 4, 2020 |
L02 Advanced-physical Microemulsions | 2.3 MiB | | April 4, 2020 |
L02 Advanced-Phyto Method-of-separation | 26 KiB | | April 4, 2020 |
L02 Advancetechno Solubility | 0.3 MiB | | April 4, 2020 |
L02 AdvPhyto Dr Mayada | 15.4 MiB | | April 4, 2020 |
L02 AdvTechno Dr Hatem | 19.5 MiB | | April 4, 2020 |
L02 Alcohol | 4.4 MiB | | December 31, 2020 |
L02 AMP-nonaromatic Derivatives Medicinal Plants | 36 KiB | | April 4, 2020 |
L02 Analysis Of Zero And First Order | 0.4 MiB | Mohannad Alquman | February 15, 2020 |
L02 Analytical | 1.8 MiB | iSpatula | April 4, 2020 |
L02 Analytical | 3.2 MiB | iSpatula | April 4, 2020 |
L02 Analytical | 12.5 MiB | iSpatula | April 4, 2020 |
L02 Analytical Dr Khanfar M4a | 42.9 MiB | iSpatula | April 4, 2020 |
L02 Analytical Dr MKhanfar | 21.3 MiB | iSpatula | April 4, 2020 |
L02 Analytical DrLina | 5.8 MiB | iSpatula | April 4, 2020 |
L02 Analytical Introduction | 0.3 MiB | Sham Hatem | July 27, 2020 |
L02 Analytical Introduction | 0.3 MiB | shatha zakariyya | October 30, 2020 |
L02 Anatomy IntroductionEpithelium | 31.9 MiB | | December 31, 2020 |
L02 Biophama Absolute-relative Bioavailabilty M4a1 | 13.1 MiB | | April 4, 2020 |
L02 Biopharma | 21.8 MiB | | April 4, 2020 |
L02 Biopharma | 8.1 MiB | | April 4, 2020 |
L02 Biopharma 5.6.20171 | 21.6 MiB | | April 4, 2020 |
L02 Biopharma Bioavailability | 13.5 MiB | | April 4, 2020 |
L02 Biopharma Bioavailability - Physicochemical And Dosage Form Factors OK Dr Essa | 0.2 MiB | | April 4, 2020 |
L02 Biopharma Bioavailability Dr Mohammad | 35.9 MiB | | April 4, 2020 |
L02 Biopharma Dr Rana | 0.7 MiB | bashar.abdulrazeq | October 7, 2019 |
L02 Biopharma Dr Esaa | 24.8 MiB | | April 4, 2020 |
L02 Biopharma Dr Rana | 41.6 MiB | | April 4, 2020 |
L02 Biopharma Dr-ranaabudahab Cell-membrane | 18.6 MiB | | April 4, 2020 |
L02 Biopharma Sheet .1 | 21 KiB | | April 4, 2020 |
L02 Biotechno Gene-Therapy Dr Rana | 15.4 MiB | | December 31, 2020 |
L02 Biotechno Slide1 Dr Jehad | 0.2 MiB | | December 31, 2020 |
L02 Body-Fluids-Notes | 1.9 MiB | | December 31, 2020 |
L02 Boipharma Bioavailability - Physicochemical And Dosage Form Factors | 0.1 MiB | | April 4, 2020 |
L02 CAM Dr Myyadah | 29.0 MiB | | April 4, 2020 |
L02 Cam Notes Drtalal | 12.2 MiB | Joodjibril98 | February 10, 2020 |
L02 Cellular Response Pathophysiology | 0.4 MiB | | April 4, 2020 |
L02 Chemistry Of Drugs | 21.6 MiB | | April 4, 2020 |
L02 Chromatography | 22.4 MiB | | April 4, 2020 |
L02 Chromatography Dr Muhammed | 0.5 MiB | Rim Shibani | October 18, 2019 |
L02 Chromatography Dr Zweiri | 61.9 MiB | Rana.Zabalawi | February 9, 2020 |
L02 Chromatography Mass Chromatography Dr Muhammaed | 1.2 MiB | doaa mohammad | October 17, 2020 |
L02 Chromo | 33.2 MiB | | April 4, 2020 |
L02 Chromo | 33.9 MiB | | April 4, 2020 |
L02 Chromo Basics Dr MhdZweri | 13.8 MiB | | April 4, 2020 |
L02 Chromo Extraction-and-Sample-Purification | 0.8 MiB | | April 4, 2020 |
L02 Chromo HPLC | 1.0 MiB | | April 4, 2020 |
L02 Chromo HPLC | 1.0 MiB | | April 4, 2020 |
L02 Chromo Introduction | 17.1 MiB | | April 4, 2020 |
L02 Clinical Biochemistry 2 | 15.6 MiB | | April 4, 2020 |
L02 Clinical-biochem | 8.9 MiB | | April 4, 2020 |
L02 Clinical-Biochem Sample-collection | 31.4 MiB | | April 4, 2020 |
L02 Clinical-Kinetics | 12.8 MiB | | April 4, 2020 |
L02 CLINICAL-TOXICOLOGY Intro | 0.9 MiB | | April 4, 2020 |
L02 Clinicalbiochem2 Carbohydrates | 0.2 MiB | | April 4, 2020 |
L02 ClinicalKinetics TDM Dr Maysaa | 18.2 MiB | | April 4, 2020 |
L02 CNS Dr Loai | 37.6 MiB | | April 4, 2020 |
L02 CNS Dr Loai | 0.9 MiB | | April 4, 2020 |
L02 CNS Dr Loai | 6.1 MiB | | April 4, 2020 |
L02 Cogno | 65.3 MiB | | April 4, 2020 |
L02 Cogno DrYahia | 20.8 MiB | Ibrahim Ahmad | September 30, 2019 |
L02 Cogno M4a2 | 37.8 MiB | | April 4, 2020 |
L02 Cognosy- Dr-mohammad-hudaib | 24.3 MiB | | April 4, 2020 |
L02 Conosy Dr-mohammad-Hudaib | 4.2 MiB | | April 4, 2020 |
L02 COPD Sammary | 5.5 MiB | | April 4, 2020 |
L02 COPD .2016-final | 7.0 MiB | | April 4, 2020 |
L02 Cosmetics Dr Samer | 55.9 MiB | Rema'a Abuhazeem | February 15, 2020 |
L02 Cosmetics General-Concepts-and-skin-anatomy | 17.3 MiB | | April 4, 2020 |
L02 Cosmetics Introduction-and-General-Concepts Dr Samer | 41.3 MiB | | December 31, 2020 |
L02 Cosmo Basic-concepts | 20.1 MiB | | April 4, 2020 |
L02 Cosmo-skin-care-preparations-2 | 0.8 MiB | | April 4, 2020 |
L02 Cozmo Skin | 17.0 MiB | | April 4, 2020 |
L02 Descriptive Statitics-Indicators Of Central Endency Dr Alaaldin-Alkilany | 0.5 MiB | | April 4, 2020 |
L02 Diagnosis-and-history-taking-in-the-pharmacy | 0.6 MiB | | April 4, 2020 |
L02 Dillution Instru | 0.2 MiB | | April 4, 2020 |
L02 Dispensing Dispensing-Techniques | 16.8 MiB | | December 31, 2020 |
L02 Dispensing Dispensing-Techniques | 21.4 MiB | | December 31, 2020 |
L02 Dispensing Dr Samer M4a | 35.8 MiB | | December 31, 2020 |
L02 DISPENSING PACKAGING Dr Dina | 9.8 MiB | | December 31, 2020 |
L02 Dispensing Techniques | 22.2 MiB | | December 31, 2020 |
L02 Dr Rana Kinetics | 20.0 MiB | | April 4, 2020 |
L02 Dr YanalPhysiology2 RenalSystem | 0.4 MiB | | April 4, 2020 |
L02 Dr Hatem | 42.1 MiB | | April 4, 2020 |
L02 Dr Loai Physio2 M4a[1] | 27.5 MiB | | April 4, 2020 |
L02 Dr Zweri | 0.8 MiB | | April 4, 2020 |
L02 Dr-Yanal Physiology2 | 14.5 MiB | | April 4, 2020 |
L02 Economics Dr Eman | 14.0 MiB | | April 4, 2020 |
L02 Economis | 80.9 MiB | | April 4, 2020 |
L02 Endocrine Dr Saleem | 31.1 MiB | | April 4, 2020 |
L02 Endocrine Dr Saleem | 28.1 MiB | | April 4, 2020 |
L02 Endocrine Dr Saleem | 0.2 MiB | | April 4, 2020 |
L02 Final Material Marketing1 Pdf | 61.2 MiB | Heyam Alabbadi | July 6, 2020 |
L02 Firstaid | 13 KiB | | December 31, 2020 |
L02 GI Dr Khatatbeh | 2.1 MiB | | April 4, 2020 |
L02 GI Dr Khatatbeh | 2.1 MiB | | April 4, 2020 |
L02 Hallucinogenic Plants | 22.8 MiB | Mohammed Altaweel | September 30, 2019 |
L02 Hard Gelatin Capsule | 0.9 MiB | | April 4, 2020 |
L02 HPLC | 28 KiB | | April 4, 2020 |
L02 Hypertension Therapy1 | 2.0 MiB | zaidadnan862 | October 15, 2019 |
L02 Inflammation ByMuneerahAli | 0.9 MiB | Muneerah Ali | October 5, 2019 |
L02 Inflammation-2- Pathophysio | 1.0 MiB | | April 4, 2020 |
L02 Instro Dr-emad | 1.4 MiB | | April 4, 2020 |
L02 Instru Dr IMad Hamdan | 2.2 MiB | Batool Alkurdi | June 21, 2019 |
L02 Instru CalculationsAndUV | 41.0 MiB | | April 4, 2020 |
L02 Instru Dr Khanfar | 18.3 MiB | | April 4, 2020 |
L02 Instru Dr Zweri | 47.4 MiB | | April 4, 2020 |
L02 Instru Dr-Emad | 2.0 MiB | Ghufran Qarara’h | September 22, 2019 |
L02 Instru Dr-emad Spectroscopy-1 | 3.1 MiB | | April 4, 2020 |
L02 Instru Preparation-of-diluted-solutions | 34 KiB | | April 4, 2020 |
L02 Instru Secondweek Dr-emad | 10.3 MiB | Ghufran Qarara’h | October 4, 2019 |
L02 Instru Sheet2 | 22 KiB | | April 4, 2020 |
L02 Instrumental Dr Emad .2nd Week UV Spectroscopy | 4.6 MiB | | April 4, 2020 |
L02 Introduction Instru | 1.9 MiB | Saharaldabbagh | February 5, 2020 |
L02 Introduction Physiology Dr Faisal | 0.9 MiB | | December 31, 2020 |
L02 Introduction2 Techno1 | 1.2 MiB | | April 4, 2020 |
L02 Isotopes | 17.5 MiB | | April 4, 2020 |
L02 Isotopes The-rest-of-the-first-handout | 0.6 MiB | | April 4, 2020 |
L02 Kinetics | 20.1 MiB | | April 4, 2020 |
L02 Kinetics ADMEx | 25.3 MiB | | April 4, 2020 |
L02 Kinetics Dr Mutasim | 19.3 MiB | | April 4, 2020 |
L02 Kinetics Orders | 19.8 MiB | | April 4, 2020 |
L02 Kinetics Rates Of Reactions | 18.5 MiB | | April 4, 2020 |
L02 Kinetics Rates-Of-Reactions | 19.0 MiB | | April 4, 2020 |
L02 Kinetics Rates-of-reactions. | 17.2 MiB | | April 4, 2020 |
L02 Kinetics-lab-Final-note1 | 5.7 MiB | | April 4, 2020 |
L02 L03 Chromo Dr Mohammad Second Week | 12.5 MiB | Sama Altaher | February 13, 2020 |
L02 L03 TECHNO2 TABLETCOATING DRAHMAD | 0.8 MiB | Somaya Alwishah | October 2, 2019 |
L02 Lab Fundi Vital Signs-Temp Dr Zyad | 0.5 MiB | | April 4, 2020 |
L02 Lectures-4-6 Phyto1 | 1.3 MiB | | April 4, 2020 |
L02 Marketing | 19.5 MiB | | April 4, 2020 |
L02 Med-plants-2 | 32.8 MiB | | April 4, 2020 |
L02 MedChem3 Antihistamines Dr Sanaa | 0.4 MiB | | April 4, 2020 |
L02 MedChem3 Antihistamines Dr Sanaa | 0.4 MiB | | April 4, 2020 |
L02 Medecinal1 Dr Mutasem | 22.8 MiB | | April 4, 2020 |
L02 Medicinal 1 | 43.7 MiB | | April 4, 2020 |
L02 MEDICINAL 1 DR GHADEER | 0.4 MiB | ShahdHabash | October 9, 2019 |
L02 Medicinal Ch 22.06.2015 Absorption | 28.8 MiB | | April 4, 2020 |
L02 Medicinal Ch 22.06.2015 Absorption | 0.7 MiB | | April 4, 2020 |
L02 Medicinal Chem II Penicillin & Beta Lactamase Inhibitors & Mono Bactams | 0.7 MiB | MohanadRobin | June 19, 2019 |
L02 Medicinal1 | 50.0 MiB | RaneenRiyad | June 17, 2019 |
L02 Medicinal1 Drmotasem | 50.6 MiB | | April 4, 2020 |
L02 Medicinal1 Drmotasem | 2.4 MiB | | April 4, 2020 |
L02 Medicinal2 B-lactams | 0.4 MiB | Salah Samha | February 15, 2020 |
L02 Medicinal2 Nucleic-acid-and-Antimetabolites | 19.1 MiB | | April 4, 2020 |
L02 Medicinal2 Tetracyclin | 11.4 MiB | | April 4, 2020 |
L02 Medicinal3 Angina | 14.5 MiB | | April 4, 2020 |
L02 Medicinal3 Parasympathatic | 14.0 MiB | | April 4, 2020 |
L02 Micro1 Dr Randa | 46.4 MiB | | April 4, 2020 |
L02 Micro1 Microscopy And Staining Dr Kawareek | 0.9 MiB | | April 4, 2020 |
L02 Micro1 Microscopy And Staining Dr Randa | 1.1 MiB | | April 4, 2020 |
L02 Micro1 Pharmacy Dr Amal Albakri | 0.6 MiB | | April 4, 2020 |
L02 Micro2 Mode Of Action | 0.3 MiB | | April 4, 2020 |
L02 Microbiology1 PhD Dr Randa | 99.2 MiB | | April 4, 2020 |
L02 Neurophysiology Physiology2 | 1.1 MiB | | April 4, 2020 |
L02 Nuclear- Magentic Rersonance | 0.6 MiB | | April 4, 2020 |
L02 Nuclear- Magentic Rersonance | 0.6 MiB | | April 4, 2020 |
L02 Nutraceuticals Phyto Analysis | 42.2 MiB | zaidadnan862 | February 11, 2020 |
L02 Nutrition An-overview-of-Nutrition | 25.8 MiB | | April 4, 2020 |
L02 Nutrition An-Overview-of-Nutrition-PartII | 2.5 MiB | | April 4, 2020 |
L02 Nutrition Concepts-of-clinicalnu | 52.7 MiB | | April 4, 2020 |
L02 Nutrition Introduction Dr.Mohammed | 59.6 MiB | Aliya Fouad | February 8, 2020 |
L02 Nutrition Introduction Part 2 Dr Mohammed | 0.6 MiB | Malak Ali | February 10, 2020 |
L02 Organic Drkamal | 3.4 MiB | | December 31, 2020 |
L02 Organic DrMousa | 2.4 MiB | | December 31, 2020 |
L02 Organic PolarCovalentBondsAcidsAndBases Dr Mohammd-online-audio-converter Com | 66.2 MiB | | December 31, 2020 |
L02 Organic1 Sp3-hybrid-orbitals | 1.5 MiB | | December 31, 2020 |
L02 OrganicChemistry1 Chapter1 Part2 Dr AlmeqdadHabashneh | 3.4 MiB | | December 31, 2020 |
L02 OTC | 42.6 MiB | | April 4, 2020 |
L02 OTC | 12.5 MiB | | April 4, 2020 |
L02 OTC | 19.6 MiB | | April 4, 2020 |
L02 OTC Diagnosis-and-history-taking-in-the-pharmacy | 0.6 MiB | | April 4, 2020 |
L02 OTC Intoduction | 18.7 MiB | | April 4, 2020 |
L02 OTC Self-Care 2 | 14.1 MiB | | April 4, 2020 |
L02 OTC Selfcare-and-otc-pharmacotherapy-lec.3 | 15.8 MiB | | April 4, 2020 |
L02 OTC Labelling & Packaging | 22.2 MiB | | April 4, 2020 |
L02 PARA Dandruff | 6.3 MiB | | April 4, 2020 |
L02 Para Dandruff | 12.6 MiB | | April 4, 2020 |
L02 Para Dandruff | 0.1 MiB | | April 4, 2020 |
L02 Para Dermatitis | 1.3 MiB | | April 4, 2020 |
L02 Para Dandruff And Seborrhoeic | 18.8 MiB | Sondos Khalil | July 1, 2019 |
L02 Para Dr Eman | 17.8 MiB | | April 4, 2020 |
L02 Para Dr Eman Vitamins | 14.4 MiB | | April 4, 2020 |
L02 Para Dr Rana | 135 MiB | Hala Azem | April 27, 2020 |
L02 Patho | 0.5 MiB | | April 4, 2020 |
L02 Patho Inflammation Dr-mazin | 18.5 MiB | | April 4, 2020 |
L02 Pathology | 29.2 MiB | | April 4, 2020 |
L02 Pathology Blood | 23.0 MiB | | April 4, 2020 |
L02 Pathology Blood-and-lymphatic-vessels | 0.5 MiB | | April 4, 2020 |
L02 Pathology Cell NjuIry Dr Manar | 16.1 MiB | | April 4, 2020 |
L02 Pathology Cellinjury2 Dr Manar | 74 KiB | | April 4, 2020 |
L02 Pathology CVS2 Dr Maram | 0.2 MiB | | December 31, 2020 |
L02 Pathology Drmanar Cellinjury Mp3 | 38.1 MiB | | April 4, 2020 |
L02 Pathophysio Cellular-Responses -Dr -Eman | 32.8 MiB | | April 4, 2020 |
L02 Pathophysio Dr Eman | 20.7 MiB | | April 4, 2020 |
L02 Pathophysio Infalammation | 32.1 MiB | | April 4, 2020 |
L02 Pathophysio Inflammation | 1.0 MiB | | April 4, 2020 |
L02 Pathophysio Inflammation Dralaa | 29.7 MiB | Sarah Degis | June 22, 2019 |
L02 PathoPhysio Topic1 Inflammaion Part1 | 0.2 MiB | | April 4, 2020 |
L02 Pathophysio.05.02.2017 Inflammation | 39.7 MiB | | April 4, 2020 |
L02 Pathophysiology | 59.1 MiB | | April 4, 2020 |
L02 Pathophysiology 21.09.2014 Adaptive Responses | 0.6 MiB | | April 4, 2020 |
L02 Pathophysiology 21.09.2014 Adaptive Responses | 17.1 MiB | | April 4, 2020 |
L02 Pathophysiology Cellular-Responses Dr Eman | 21 KiB | | April 4, 2020 |
L02 Pathophysiology Hypertrophy And Hyperplasia | 33.7 MiB | | April 4, 2020 |
L02 Pathophysiology Inflamation-part-2-docx | 0.8 MiB | | April 4, 2020 |
L02 Pathophysiology Inflammation | 22 KiB | | April 4, 2020 |
L02 Pathophysiology INFLAMMATION Dr Ala | 64.2 MiB | Afnan Dabobash | October 2, 2019 |
L02 Pathophysiology Inflammation2 | 31.3 MiB | | April 4, 2020 |
L02 Pathophysiology Introduction Dr Alaa | 75.8 MiB | Batool Alkurdi | February 5, 2020 |
L02 Pathophysiology Of Cardiovascular Diseases | 5.7 MiB | | April 4, 2020 |
L02 Pathophysiology Sheet Inflammation | 0.4 MiB | | April 4, 2020 |
L02 Perioperative-care-2017 | 1.2 MiB | | April 4, 2020 |
L02 Pharma-Organic Alcohol Dr Yosef | 4.9 MiB | | December 31, 2020 |
L02 Pharma-Organic Alcohol DrYousuf | 2.3 MiB | | December 31, 2020 |
L02 Pharma-Organic Reactions-of-Alcohol-1 | 4.3 MiB | | December 31, 2020 |
L02 Pharma1 Pharmacodynamics | 8.4 MiB | | April 4, 2020 |
L02 Pharma1 Pharmacokineticks | 2.9 MiB | | April 4, 2020 |
L02 Pharma1 Pharmacokinetics | 2.0 MiB | | April 4, 2020 |
L02 Pharma1.07.09.2016 Introduction | 54.2 MiB | | April 4, 2020 |
L02 Pharma2 | 16.8 MiB | | April 4, 2020 |
L02 Pharma2 Thyroid And Antithyroid Drugs | 0.3 MiB | | April 4, 2020 |
L02 Pharma2 Thyroid And Antithyroid Drugs | 0.3 MiB | | October 19, 2020 |
L02 Pharmaceutical Statistics Dr Hatem | 91 KiB | | April 4, 2020 |
L02 Pharmaceutical-Statics1 -Basic-Concepts | 36.2 MiB | | April 4, 2020 |
L02 Pharmaceutical-Statistics Basic-Concepts D-Ahmad | 19.0 MiB | | April 4, 2020 |
L02 Pharmacokinetics Dr Mhmd | 19.6 MiB | | April 4, 2020 |
L02 Pharmacokinetics Introduction | 18.0 MiB | | April 4, 2020 |
L02 Pharmacokinetics-Notes Pharmacology1 | 3.0 MiB | | April 4, 2020 |
L02 Pharmacotherapy 2 Dr Ala | 30.0 MiB | | April 4, 2020 |
L02 PharmaOrganic Alcohol DrAli | 8.9 MiB | | December 31, 2020 |
L02 PharmaOrganic DrYousef | 10.2 MiB | | December 31, 2020 |
L02 Physical 2 Distribution | 9.8 MiB | QamarSaqqa | February 14, 2020 |
L02 Physical1 Intermolecular-and-Intramolecular-Forces-and-States-of-Matter Dr Dina | 2.6 MiB | | December 31, 2020 |
L02 Physical1 Topic1 DrDina | 31.0 MiB | | December 31, 2020 |
L02 Physical2 Distribution | 1.6 MiB | iSpatula | April 4, 2020 |
L02 Physical2 Distribution- | 20.9 MiB | iSpatula | April 4, 2020 |
L02 Physical2 Dr Hatem | 21.2 MiB | iSpatula | April 4, 2020 |
L02 Physical2 Dr Samer | 15.5 MiB | iSpatula | April 4, 2020 |
L02 Physical2 Dr Samer M4a | 32.7 MiB | iSpatula | April 4, 2020 |
L02 Physical2 PartitioningExtraction | 65.9 MiB | iSpatula | April 4, 2020 |
L02 Physio 2 Drlo2e | 16.5 MiB | | April 4, 2020 |
L02 Physio2 Dr Saleem | 29.2 MiB | | April 4, 2020 |
L02 Physio2 Drlo2e | 0.8 MiB | | April 4, 2020 |
L02 Physio2 Drloai | 20.0 MiB | | April 4, 2020 |
L02 Physio2 Endocrine Drsaleem | 0.9 MiB | | April 4, 2020 |
L02 Physio2 Endocrine2 Dr Saleem | 0.8 MiB | | April 4, 2020 |
L02 Physio2 Thyroid-and-Adrenal-gland DrLoai | 70.9 MiB | Alaa Ziad | June 15, 2019 |
L02 Physiology ActionPotential Dr Loai | 0.3 MiB | | December 31, 2020 |
L02 Physiology ActionPotential Dr Loai | 0.3 MiB | | December 31, 2020 |
L02 Physiology Cns Dr Faisal | 0.3 MiB | Dinazyoud | February 8, 2020 |
L02 Physiology Diffusion DrLoai | 0.7 MiB | | December 31, 2020 |
L02 Physiology Dr Loai | 0.4 MiB | | December 31, 2020 |
L02 Physiology Introduction Dr Faisal | 53.9 MiB | | December 31, 2020 |
L02 Physiology Sheet2 | 0.5 MiB | | December 31, 2020 |
L02 Physiology-1 Ch3 .1 Dr-Loai | 82.7 MiB | | December 31, 2020 |
L02 Physiology1 Chapter3 I DrLoai | 28.9 MiB | | December 31, 2020 |
L02 Physiology1 Dr | 16.2 MiB | | December 31, 2020 |
L02 Physiology1 Week2 DrLoai | 2.2 MiB | | December 31, 2020 |
L02 Physiology2 DrSaleem | 17.4 MiB | | April 4, 2020 |
L02 Physiology2 Renal-system | 31.3 MiB | | April 4, 2020 |
L02 Phyto | 20.0 MiB | | April 4, 2020 |
L02 Phyto2 | 93.9 MiB | Maramghweiri | June 16, 2019 |
L02 Phytoanalysis Dr Muhammad | 20.6 MiB | iSpatula | April 4, 2020 |
L02 Phytoanalysis Neutraceutical | 22.5 MiB | iSpatula | April 4, 2020 |
L02 Phytoanalysis Nutraceuticals | 0.8 MiB | iSpatula | April 4, 2020 |
L02 Phytochemistry1 Phenolics | 21.1 MiB | | April 4, 2020 |
L02 Practice Overview-of-the-ph -Care-process | 33.1 MiB | | April 4, 2020 |
L02 Practice1 | 26.3 MiB | | April 4, 2020 |
L02 Practice1 Overview-of-pharm Care-process | 38.5 MiB | | April 4, 2020 |
L02 Practice2 | 54.0 MiB | | April 4, 2020 |
L02 Practice2 Communication-skills-in-pharmacy-practice | 22.8 MiB | | April 4, 2020 |
L02 Quality-assurance Techno1 | 1.2 MiB | | April 4, 2020 |
L02 Quiz Material Part .2 | 2.6 MiB | | April 4, 2020 |
L02 Reference-Range-Determinatio | 0.4 MiB | | April 4, 2020 |
L02 Regular And Irregular Monoterpenes | 0.1 MiB | | April 4, 2020 |
L02 Renal Dr Ebaa | 64 KiB | | April 4, 2020 |
L02 Renal Dr Ebaa | 0.5 MiB | | April 4, 2020 |
L02 Solubility-and-Dissolution Advanced-technology- | 34.9 MiB | | April 4, 2020 |
L02 Statistics Dr Ahmad | 50.8 MiB | Aya Alassi | June 23, 2019 |
L02 Statistics Basic-Concepts | 10.7 MiB | | April 4, 2020 |
L02 Statistics Dr Ahmad | 19.0 MiB | | April 4, 2020 |
L02 Statistics Dr Hatim | 0.7 MiB | | October 19, 2020 |
L02 Statistics Slide4-5 Dr Ahmad | 1.5 MiB | | April 4, 2020 |
L02 Suger-coating -Techno2- -Dr-Hatem- | 5.2 MiB | | April 4, 2020 |
L02 Tablet-Coating Technology2 | 21.1 MiB | | April 4, 2020 |
L02 Techno 1 M4a[1] | 33.4 MiB | | April 4, 2020 |
L02 Techno 2 Dr Dina | 21.9 MiB | | April 4, 2020 |
L02 Techno Dr Hatem | 22.0 MiB | | April 4, 2020 |
L02 Techno1 | 31.2 MiB | | April 4, 2020 |
L02 Techno1 Dr Lorina Topic-2 Part-1- Pdf | 5.5 MiB | | April 4, 2020 |
L02 Techno1 DrLorina | 0.5 MiB | dana younes | October 7, 2019 |
L02 Techno1 Introduction And Preformulation Dr Hatem | 4.0 MiB | Mais Maharma | July 6, 2020 |
L02 Techno1 Preformulation | 0.9 MiB | | April 4, 2020 |
L02 Techno1 Preformulation Dr Lorina | 67.2 MiB | | April 4, 2020 |
L02 Techno1 Preformulation Dr Samer | 64.3 MiB | | April 4, 2020 |
L02 Techno1 Quality-Assurance Dr Ahmad | 23.1 MiB | | April 4, 2020 |
L02 Techno2 Coating Dr Hatim | 48.5 MiB | Samira.Abusaif | February 8, 2020 |
L02 Techno2 Coating Dr Hatim T | 5.1 MiB | Samira.Abusaif | February 7, 2020 |
L02 Techno2 Types-of-coating | 11.7 MiB | | April 4, 2020 |
L02 Technology Preformulation | 18.0 MiB | | April 4, 2020 |
L02 Technology2 Dr-Ahmad-Bani-Jaber | 4.2 MiB | | April 4, 2020 |
L02 Technology2 Tablet Coating | 38.9 MiB | | April 4, 2020 |
L02 Tecnho2 Tablet Coating1 | 37.4 MiB | | April 4, 2020 |
L02 Terpenes Phyto2 | 3.2 MiB | Maramghweiri | June 17, 2019 |
L02 Terpenes Phyto2 | 18.6 MiB | zaidadnan862 | September 24, 2019 |
L02 The Working Environment | 21.5 MiB | | December 31, 2020 |
L02 The-Renal-System Physiology2 | 1.2 MiB | | April 4, 2020 |
L02 Therapy 3 Quiz 1-1 | 61.9 MiB | | April 4, 2020 |
L02 Therapy 4 Pain Management DrNaila | 62.3 MiB | Farah Qaryouti | February 10, 2020 |
L02 Therapy Asthma.04.02.2016 | 0.5 MiB | | April 4, 2020 |
L02 Therapy HTN | 34.9 MiB | | April 4, 2020 |
L02 Therapy-1 Hypertension Dr-Alaa | 53.7 MiB | | April 4, 2020 |
L02 Therapy-2 Asthma | 19.0 MiB | | April 4, 2020 |
L02 Therapy1 HTN Dr Alaaallham | 19.2 MiB | | April 4, 2020 |
L02 Therapy1 Hypertension Dr-Oriana- | 15.7 MiB | | April 4, 2020 |
L02 Therapy2 Asthma | 25.3 MiB | | April 4, 2020 |
L02 Therapy2 Asthma | 0.6 MiB | | April 4, 2020 |
L02 Therapy2 Asthma | 70.3 MiB | | April 4, 2020 |
L02 Therapy2.04.02.2016 Asthma | 21.8 MiB | | April 4, 2020 |
L02 Therapy3 Cancer Agents | 53.0 MiB | Aliya Fouad | October 1, 2019 |
L02 Therapy3 Depression | 16.9 MiB | | December 31, 2020 |
L02 Therapy4-Anemia | 32.8 MiB | | April 4, 2020 |
L02 Topic1 Dr Samer | 44.0 MiB | iSpatula | April 4, 2020 |
L02 Toxi | 2.5 MiB | | April 4, 2020 |
L02 Toxic Plants Dr Yahia | 62.6 MiB | Shaimaa Salahat | July 9, 2019 |
L02 Toxic-Plants-2-1 | 0.1 MiB | | April 4, 2020 |
L02 Toxicology Introduction | 17.4 MiB | | April 4, 2020 |
L02 Toxicology Introduction | 53.2 MiB | | April 4, 2020 |
L02 Toxicology Toxidromes | 4.2 MiB | | April 4, 2020 |
L02 ToxicPlants Slides1and2 | 19.2 MiB | | April 4, 2020 |
L02 Traning2 The-end-of-training2-form | 0.2 MiB | | April 4, 2020 |
L02 Vaginitiss | 2.2 MiB | | April 4, 2020 |
L02 Viral-hepatitis-2016 | 3.7 MiB | | April 4, 2020 |
L02- Antihistamine- Dr Sana Bardaweel | 3.0 MiB | Nour Mohammad | July 6, 2020 |
L02-Analytical-Introduction | 1.2 MiB | | October 19, 2020 |
L02-Apoptosis-Patho | 21.5 MiB | | April 4, 2020 |
L02-assessment-of-costs-in-health-care | 0.7 MiB | | April 4, 2020 |
L02-Bioavalibility-Biopharma | 15.3 MiB | | April 4, 2020 |
L02-BIOPHARMA Bioavailability-physicochemical-and-dosage-form-factors | 0.3 MiB | | April 4, 2020 |
L02-Biopharma-Sheet | 21 KiB | | April 4, 2020 |
L02-Cell-Junctions-Anatomy | 3.8 MiB | | December 31, 2020 |
L02-Coating-Tablet-Types-Techno2 | 18.8 MiB | | April 4, 2020 |
L02-cogno-Dr-Olaimat-History-of-cogno | 32.2 MiB | | April 4, 2020 |
L02-Coma-and-altered-mental-status | 0.9 MiB | | April 4, 2020 |
L02-corns-and-calluses-2017 | 2.4 MiB | | April 4, 2020 |
L02-Cs-Problem-Solving-II-Dr Lama | 0.2 MiB | | October 27, 2020 |
L02-Dandruff-Para | 36.6 MiB | | April 4, 2020 |
L02-Dr Rana-IvIvc | 0.5 MiB | | April 4, 2020 |
L02-Dr-Jihad | 46.9 MiB | | December 31, 2020 |
L02-Dr-Khanfar | 39.9 MiB | iSpatula | April 4, 2020 |
L02-Dr-Loai-Zghoul | 15.9 MiB | | December 31, 2020 |
L02-Drug-receptor-interactions-PDs-2- | 3.6 MiB | | April 4, 2020 |
L02-Economics | 17.1 MiB | | April 4, 2020 |
L02-Endocrine-Physio2-Dr Ebaa | 17.1 MiB | | April 4, 2020 |
L02-Extraction-and-Sample-Purification | 1.0 MiB | | April 4, 2020 |
L02-GIT-Pyhsio2 | 2.1 MiB | | April 4, 2020 |
L02-Heart-Failure 2015-part-1 | 4.9 MiB | | April 4, 2020 |
L02-Heart-Failure 2015-part-2 | 3.3 MiB | | April 4, 2020 |
L02-Hypertension-Therapy1 | 7.6 MiB | | April 4, 2020 |
L02-Hypertension-Therapyy1 | 25.8 MiB | | April 4, 2020 |
L02-Hypertrophy-and-Hyperplasia-Pathophysiology | 15.2 MiB | | April 4, 2020 |
L02-Hypetrophy-Pathophysio | 16.4 MiB | | April 4, 2020 |
L02-inflammation-pathology | 3.1 MiB | | April 4, 2020 |
L02-Instru-Dr-Kanfar-5-2-2017 | 40.3 MiB | | April 4, 2020 |
L02-introduction-analytical | 1.3 MiB | Olasameeh | February 13, 2020 |
L02-Introduction-Phyto1 | 16.8 MiB | | April 4, 2020 |
L02-Introduction-preformulation-Techno1 | 45.9 MiB | | April 4, 2020 |
L02-Ion-Channels-Types-Dr-Loai | 0.7 MiB | | December 31, 2020 |
L02-kinetics ADME | 21.0 MiB | | April 4, 2020 |
L02-Liquid-Crystal-and-Emulsion | 1.2 MiB | | April 4, 2020 |
L02-Medicinal | 26.7 MiB | | April 4, 2020 |
L02-Medicinal-1 | 38.7 MiB | | April 4, 2020 |
L02-Medicinal-2-Antibacterials-Penicillins | 14.3 MiB | | April 4, 2020 |
L02-Medicinal-3-anti-histamine-part-1 | 34.2 MiB | | April 4, 2020 |
L02-medicinal-chemistry-2 | 51.6 MiB | | April 4, 2020 |
L02-Medicinal-Chemistry-2-Penicillin | 1.4 MiB | | April 4, 2020 |
L02-Medicinal2-Dr-Moatasem-Antibacterial-Penicillins | 43.1 MiB | | April 4, 2020 |
L02-mode-of-action-Micro2 | 49 KiB | | April 4, 2020 |
L02-organic-chemistry-chapter2-Dr Mohammed-Mubark | 7.2 MiB | | December 31, 2020 |
L02-Organic-polar-covalent-bonds-dr-mousa | 3.8 MiB | | December 31, 2020 |
L02-OTC-Introduction | 0.4 MiB | | April 4, 2020 |
L02-OTC-Introduction | 33.3 MiB | | April 4, 2020 |
L02-Pancreatic-Hormones-Antidiabetic-Drugs-part-two | 0.6 MiB | | April 4, 2020 |
L02-Pancreatic-Hormones-Antidiabetic-Drugs-part-two | 0.6 MiB | | October 19, 2020 |
L02-para-burns | 15 KiB | | April 4, 2020 |
L02-Para-corns-and-calluses | 19.4 MiB | | April 4, 2020 |
L02-Para-infant-formula-L02 | 43.3 MiB | | April 4, 2020 |
L02-Pathophysio Inflammation | 23.8 MiB | | April 4, 2020 |
L02-pathophysio-Dr-Alaa- | 27.7 MiB | | April 4, 2020 |
L02-pathophysio-Dr-Eman | 48.9 MiB | | April 4, 2020 |
L02-Pathophysiology-26.6.2016-Inflammation M4a | 25.0 MiB | | April 4, 2020 |
L02-pharma-organic-chemistry-Alcohol-Dr -Jehad-almaleety | 3.5 MiB | | December 31, 2020 |
L02-Pharmacokinetics- | 4.8 MiB | | April 4, 2020 |
L02-Physical-1-states-of-matter-gases-and-liquids-Dr Dina | 29.5 MiB | | December 31, 2020 |
L02-Physical1-Phase-Rule-DMais | 27.6 MiB | | December 31, 2020 |
L02-Physio1-Handout2-Slide11-DrMohammad | 0.1 MiB | | December 31, 2020 |
L02-physiology-2-renal-system-Dr-ebaa | 35.6 MiB | | April 4, 2020 |
L02-Physiology-transportation-Dr-Fessal | 0.7 MiB | | December 31, 2020 |
L02-phytoanalysis-7.2.2016 2 | 56.3 MiB | iSpatula | April 4, 2020 |
L02-Practice-Patient-Education-On-Insulin-Injection | 16.4 MiB | | April 4, 2020 |
L02-regular-and-irregular-monoterpens-Phyto2 | 23.0 MiB | | April 4, 2020 |
L02-somato-sensory-system-second-version | 8.2 MiB | | April 4, 2020 |
L02-Structure-bioavailability-Medicinal1 | 19.6 MiB | | April 4, 2020 |
L02-Tablet-coating-techno2 | 31.4 MiB | | April 4, 2020 |
L02-Therapy3-Major-Depressive-Disorders | 35.9 MiB | | April 4, 2020 |
L02-Training-1-Online-resources | 1.5 MiB | | April 4, 2020 |
L02. Physiology ll Dr.Faisal | 42.1 MiB | Qabas Mansour | February 11, 2020 |
L02.1 Microemulsion-paper | 0.3 MiB | | April 4, 2020 |
L02.Biopharma.bioavailability.Dr.Rana | 2.9 MiB | Muzdalifa Asaad | October 7, 2019 |
L02.Biopharma.bioavailabilty.dr.rana | 35.7 MiB | Muzdalifa Asaad | October 2, 2019 |
L02.CAM.record | 30.8 MiB | Joodjibril98 | February 10, 2020 |
L02.Cogno.Dr.yahia | 87.0 MiB | Maha Issa | July 17, 2019 |
L02.drAhmad.statistics | 36.7 MiB | Ahmadabukaff | February 6, 2020 |
L02.OTC.mp3 | 31.2 MiB | Raghad Deknash | June 20, 2019 |
L02.Pathophysiology.dralaa | 0.8 MiB | Batool Alkurdi | February 21, 2020 |
L02.Techno2.Tabletcoating.Drahmad | 43.6 MiB | Somaya Alwishah | October 2, 2019 |
L02.therapy2.Dr.Oriana | 0.6 MiB | Shayma Ahmad | February 14, 2020 |
L020 Organic Drmosa | 1.6 MiB | | December 31, 2020 |
L021 Kinetics Dr Mutasim | 17.3 MiB | | April 4, 2020 |
L021 Organic Drmosa | 2.1 MiB | | December 31, 2020 |
L025 Organic Alkenes Drmosa | 1.7 MiB | | December 31, 2020 |
L026 Organic Alkenes Drmosa | 1.9 MiB | | December 31, 2020 |
L027 Organic Alkenes Drmosa | 2.0 MiB | | December 31, 2020 |
L02medicinal3parasympatholytics | 8.9 MiB | | April 4, 2020 |
L02 Kinetics DrMutasim Zero&first Order | 3.4 MiB | Muzdalifa Asaad | October 18, 2020 |
L03 | 6.1 MiB | iSpatula | April 4, 2020 |
L03 | 17.3 MiB | | April 4, 2020 |
L03 | 2.5 MiB | | April 4, 2020 |
L03 Asthma | 0.5 MiB | | April 4, 2020 |
L03 Chromatography Masschromatography Dr Muhammaed | 1.4 MiB | doaa mohammad | October 23, 2020 |
L03 Medicinal Chem II Cephalosporines & Quinolones | 0.5 MiB | MohanadRobin | June 24, 2019 |
L03 Practice 1 | 95.2 MiB | GhaidaaMelhem | June 25, 2019 |
L03 Therapy I Hypertension-Management | 0.1 MiB | MohanadRobin | October 4, 2019 |
L03 - Antihistamine- Dr Sana Bardaweel | 3.0 MiB | Nour Mohammad | July 6, 2020 |
L03 -Adv-techno-14.02.2017-Brick-dust-concept-1 | 21.6 MiB | | April 4, 2020 |
L03 -Analytical -MeasurementsChemical-Equilibrium -Pdf | 4.1 MiB | iSpatula | April 4, 2020 |
L03 -Apoptosis -Pathophysiology | 21.1 MiB | | April 4, 2020 |
L03 -Biotechno -Gene-therapy -Dr -Rana | 18.9 MiB | | December 31, 2020 |
L03 -Instrumental -UV-Spectroscopy-1 -Dr Lina-dahabiyeh | 0.5 MiB | | April 4, 2020 |
L03 -Kinetics -Introduction-to-pharmacokinetics | 18.2 MiB | | April 4, 2020 |
L03 -Medicinal-1 Theories | 28.9 MiB | | April 4, 2020 |
L03 -Nutrition | 79.7 MiB | | April 4, 2020 |
L03 -Pathophysiology -Dr Eman | 106 MiB | | April 4, 2020 |
L03 -Pathophysiology Cellular-Responses Dr Eman | 30.5 MiB | | April 4, 2020 |
L03 -Phytochemical-Analysis | 73 KiB | iSpatula | April 4, 2020 |
L03 -process-of-coating- Techno-2 -Dr-Hatem | 85.0 MiB | | April 4, 2020 |
L03 -Solubility -Advanced-technology | 37.5 MiB | | April 4, 2020 |
L03 2 | 15 KiB | | December 31, 2020 |
L03 Acute-inflammation | 0.5 MiB | | April 4, 2020 |
L03 Adv Technology | 22.6 MiB | | April 4, 2020 |
L03 Adv-techno | 70 KiB | | April 4, 2020 |
L03 Advanced Techno Solubility And Dissolution Dr Ahmad | 0.6 MiB | jumanamufeed | February 16, 2020 |
L03 Advanced Techno Solubility And Dissolution Dr Ahmad (online-audio-converter Com) | 43.0 MiB | jumanamufeed | February 12, 2020 |
L03 Advanced Technology | 0.4 MiB | | April 4, 2020 |
L03 Advanced Technology Solubilty-and-Dissolution | 67 KiB | | April 4, 2020 |
L03 Advanced Technology.21.9.2016 | 60.6 MiB | | April 4, 2020 |
L03 Advanced-Phyto Method-of-separation | 23 KiB | | April 4, 2020 |
L03 AdvPhyto Dr Mayada | 13.3 MiB | | April 4, 2020 |
L03 AdvTechno Dr Hatem | 19.5 MiB | | April 4, 2020 |
L03 AKI 2016-final | 4.5 MiB | | April 4, 2020 |
L03 AKI-summary | 5.0 MiB | | April 4, 2020 |
L03 Alcohol | 6.5 MiB | | December 31, 2020 |
L03 AMP-aromatic Derivatives Medicinal Plants | 0.3 MiB | | April 4, 2020 |
L03 Analytical | 2.1 MiB | iSpatula | April 4, 2020 |
L03 Analytical | 1.5 MiB | iSpatula | April 4, 2020 |
L03 Analytical Dr Khanfar M4a | 40.1 MiB | iSpatula | April 4, 2020 |
L03 Analytical Dr MKhanfar | 18.3 MiB | iSpatula | April 4, 2020 |
L03 Analytical DrLina | 5.6 MiB | iSpatula | April 4, 2020 |
L03 Analytical Introduction | 0.4 MiB | Sham Hatem | July 27, 2020 |
L03 Analytical Introduction | 0.4 MiB | shatha zakariyya | October 30, 2020 |
L03 Anatomy Epithiliumglands | 61.7 MiB | | December 31, 2020 |
L03 ANTIDEPRESSANTS | 0.9 MiB | | April 4, 2020 |
L03 Biopharma | 20.3 MiB | | April 4, 2020 |
L03 Biopharma | 4.9 MiB | | April 4, 2020 |
L03 Biopharma Bioavailability | 10.5 MiB | | April 4, 2020 |
L03 Biopharma Bioavailability 6.6.20171 | 20.5 MiB | | April 4, 2020 |
L03 Biopharma Bioavailability Dr Mohammad | 32.1 MiB | | April 4, 2020 |
L03 Biopharma Dr Esaa | 28.8 MiB | | April 4, 2020 |
L03 Biopharma Dr Rana | 0.5 MiB | bashar.abdulrazeq | October 11, 2019 |
L03 Biopharma Dr Rana | 39.5 MiB | | April 4, 2020 |
L03 Biopharma Drranaabudahab | 19.1 MiB | | April 4, 2020 |
L03 Biopharma Physiologic Factors Related To Drug Absorption | 0.4 MiB | | April 4, 2020 |
L03 Biopharma Physiologic Factors Related To Drug Absorption Dr Essa | 0.7 MiB | | April 4, 2020 |
L03 Biopharma Sheet | 0.3 MiB | | April 4, 2020 |
L03 Biopharma Sheet .2 | 0.3 MiB | | April 4, 2020 |
L03 Burns And Sun Burn | 22.7 MiB | Sondos Khalil | July 1, 2019 |
L03 CAM | 27.8 MiB | | April 4, 2020 |
L03 Carbohydrate Cogno1 | 17.7 MiB | | April 4, 2020 |
L03 Carbohydrates .Derivatives | 82.1 MiB | | April 4, 2020 |
L03 Cellular Response Pathophysiology | 0.5 MiB | | April 4, 2020 |
L03 Cholinergic Dr Khanfar | 2.9 MiB | Reem Hussein | October 5, 2019 |
L03 Chromatography | 21.6 MiB | | April 4, 2020 |
L03 Chromatography Dr Muhammed | 1.0 MiB | Rim Shibani | October 18, 2019 |
L03 Chromatography Dr Zweiri | 60.6 MiB | Rana.Zabalawi | February 11, 2020 |
L03 Chromo | 30.2 MiB | | April 4, 2020 |
L03 Chromo | 13.6 MiB | | April 4, 2020 |
L03 Chromo Chromatography Dr MhdZweri | 11.3 MiB | | April 4, 2020 |
L03 Chromo Extraction-and-Sample-Purification | 0.8 MiB | | April 4, 2020 |
L03 Chromo Introduction | 33.3 MiB | | April 4, 2020 |
L03 Clinical Biochemistry 2 | 17.1 MiB | | April 4, 2020 |
L03 Clinical-biochem | 7.0 MiB | | April 4, 2020 |
L03 Clinical-Biochem - Ref -Range-Determination | 31.8 MiB | | April 4, 2020 |
L03 Clinical-Kinetics | 31.3 MiB | | April 4, 2020 |
L03 Clinicalbiochem2 Carbohydrates | 0.2 MiB | | April 4, 2020 |
L03 ClinicalKinetics LBF Dr Maysaa | 19.0 MiB | | April 4, 2020 |
L03 CNS Dr Loai | 45.1 MiB | | April 4, 2020 |
L03 CNS Dr Loai | 0.3 MiB | | April 4, 2020 |
L03 CNS Dr Loai | 8.0 MiB | | April 4, 2020 |
L03 Coating-process -Techno-2 Dr-Hatem- | 5.0 MiB | | April 4, 2020 |
L03 COC | 5.0 MiB | | April 4, 2020 |
L03 Cogno | 73.0 MiB | | April 4, 2020 |
L03 Cogno DrYahia | 55.2 MiB | Ibrahim Ahmad | October 2, 2019 |
L03 Cognosy Dr-mohammad-hudaib | 46.8 MiB | | April 4, 2020 |
L03 Cognosy Dr-mohammad-Hudaib | 2.7 MiB | | April 4, 2020 |
L03 Compound Error | 2.3 MiB | iSpatula | April 4, 2020 |
L03 Cosmetics Dr Samer | 61.4 MiB | Rema'a Abuhazeem | February 15, 2020 |
L03 Cosmetics Skin-anatomy-1 | 19.2 MiB | | April 4, 2020 |
L03 Cosmetics Skin-Anatomy-and-Physiology Dr Samer | 34.9 MiB | | December 31, 2020 |
L03 Cosmo Dosge-form | 17.0 MiB | | April 4, 2020 |
L03 Cosmo Skin | 15.8 MiB | | April 4, 2020 |
L03 Cosmo-skin-care-preparations-3 | 0.6 MiB | | April 4, 2020 |
L03 Descriptive Statitics Indicators Of Dispersion Dr Alaaldin-Alkilany | 1.6 MiB | | April 4, 2020 |
L03 Descriptive Statitics Indicators Of Dispersion Dr Alaaldin-Alkilany | 1.6 MiB | | April 4, 2020 |
L03 Dispebsing Dr Samer M4a | 16.3 MiB | | December 31, 2020 |
L03 Dispensing Dispensing-Techniques | 39.4 MiB | | December 31, 2020 |
L03 Dispensing Dispensing-Techniques | 22.1 MiB | | December 31, 2020 |
L03 Dispensing Packaging Drdina | 43.8 MiB | | December 31, 2020 |
L03 Dispensing Techniques | 23.8 MiB | | December 31, 2020 |
L03 Dr Rana Kinetics | 17.9 MiB | | April 4, 2020 |
L03 Dr Loai Physio2 M4a[1] | 31.7 MiB | | April 4, 2020 |
L03 Dr Mohammad Khanfar | 39.3 MiB | | April 4, 2020 |
L03 Dr-Yanal Physiology2 | 17.5 MiB | | April 4, 2020 |
L03 Economics | 90.7 MiB | | April 4, 2020 |
L03 Economics | 17.3 MiB | | April 4, 2020 |
L03 Economics Dr Eman | 14.1 MiB | | April 4, 2020 |
L03 Endocrine Dr Saleem | 27.1 MiB | | April 4, 2020 |
L03 Endocrine Dr Saleem | 0.3 MiB | | April 4, 2020 |
L03 Endorcine Dr Saleem | 31.2 MiB | | April 4, 2020 |
L03 Equipment And Selection Of Ingredients | 21.9 MiB | | December 31, 2020 |
L03 Final Extra Material Dietary Fibers | 1.5 MiB | | April 4, 2020 |
L03 Firstaid | 12 KiB | | December 31, 2020 |
L03 GI Dr Khatatbeh | 9.0 MiB | | April 4, 2020 |
L03 GI Dr Khatatbeh | 9.0 MiB | | April 4, 2020 |
L03 Hallucinogenic Plants Dr Yahia Tabaza | 19.3 MiB | Mohammed Altaweel | October 3, 2019 |
L03 HPLC Chromo | 92 KiB | | April 4, 2020 |
L03 Hypertension Therapy1 | 8.9 MiB | zaidadnan862 | October 15, 2019 |
L03 IBD-fall-2016 | 2.5 MiB | | April 4, 2020 |
L03 Instro Dr-emad-spectrometry | 5.3 MiB | | April 4, 2020 |
L03 Instru Dr Zweri | 35.5 MiB | | April 4, 2020 |
L03 Instru Dr-Emad | 23.5 MiB | Ghufran Qarara’h | September 22, 2019 |
L03 Instru Dr-emad Spectroscopy-2 | 2.4 MiB | | April 4, 2020 |
L03 Instru Thirdweek Dr-emad | 11.0 MiB | Ghufran Qarara’h | October 10, 2019 |
L03 Instru Ultraviolet-Spectroscopy | 0.1 MiB | | April 4, 2020 |
L03 Instru Uv-vis Spectroscopy Dr Imad Hamdan | 4.4 MiB | Batool Alkurdi | June 22, 2019 |
L03 Instru UVandSpectrophotometry | 39.4 MiB | | April 4, 2020 |
L03 Instrumental Dr Emad UV Spectroscopy.3rd Week | 5.1 MiB | | April 4, 2020 |
L03 Introduction | 2.1 MiB | Saharaldabbagh | February 10, 2020 |
L03 Introduction3 Techno1 | 3.2 MiB | | April 4, 2020 |
L03 Isotopes | 16.5 MiB | | April 4, 2020 |
L03 Kinetic IV-bolus | 19.8 MiB | | April 4, 2020 |
L03 Kinetics | 44.7 MiB | | April 4, 2020 |
L03 Kinetics Dr Moh'd1234825794 | 19.7 MiB | | April 4, 2020 |
L03 Kinetics Dr-2 Kinetics Dr -mutasim | 17.5 MiB | | April 4, 2020 |
L03 Kinetics DrMutasim Zero And First Or | 2.9 MiB | Muzdalifa Asaad | October 24, 2020 |
L03 Kinetics Infusion | 1.7 MiB | | April 4, 2020 |
L03 Kinetics One-Compartment-Model | 80.3 MiB | | April 4, 2020 |
L03 Kinetics One-compartment-open-model | 20.0 MiB | | April 4, 2020 |
L03 Kinetics Rate-of-reaction | 19.3 MiB | | April 4, 2020 |
L03 Kinetics Rates-Of-Reactions | 27.2 MiB | | April 4, 2020 |
L03 Lab Fundi Pulse Dr Zyad | 0.2 MiB | | April 4, 2020 |
L03 Lecture-7 Phyto1 | 1.2 MiB | | April 4, 2020 |
L03 Marketing | 6.4 MiB | | April 4, 2020 |
L03 Mass SpectrometryHPLC | 0.1 MiB | | April 4, 2020 |
L03 MedChem3 Antihistamines Dr Sanaa | 0.6 MiB | | April 4, 2020 |
L03 MedChem3 Antihistamines Dr Sanaa | 0.6 MiB | | April 4, 2020 |
L03 MEDICINAL 1 DR GHADEER | 0.2 MiB | ShahdHabash | October 9, 2019 |
L03 Medicinal 1 Ghadeer | 42.2 MiB | | April 4, 2020 |
L03 Medicinal Ch 23.06.2015 Absorption | 29.5 MiB | | April 4, 2020 |
L03 Medicinal Ch 23.06.2015 Absorption | 0.7 MiB | | April 4, 2020 |
L03 Medicinal Plant | 47.7 MiB | | April 4, 2020 |
L03 Medicinal-3 Anti-HTN | 14.7 MiB | | April 4, 2020 |
L03 Medicinal-Chem-II -Penicillin-Beta-Lactamase | 0.4 MiB | Salah Samha | February 22, 2020 |
L03 Medicinal1 | 43.8 MiB | RaneenRiyad | June 17, 2019 |
L03 Medicinal1 Dr Mutasem | 41.1 MiB | | April 4, 2020 |
L03 Medicinal1 Drmotasem | 50.8 MiB | | April 4, 2020 |
L03 Medicinal1 Drmotasem | 3.5 MiB | | April 4, 2020 |
L03 Medicinal2 Antimetabolites-and-Hormone | 18.9 MiB | | April 4, 2020 |
L03 Medicinal2 Quinolones | 10.4 MiB | | April 4, 2020 |
L03 Medicinal3 Parsymathatic | 14.7 MiB | | April 4, 2020 |
L03 Micro1 Dr Randa | 41.6 MiB | | April 4, 2020 |
L03 Micro1 Prok And Eukar Dr Randa | 1.1 MiB | | April 4, 2020 |
L03 Micro1 Prokaryotic And Eukaryotic Cells Dr Kawareek | 0.7 MiB | | April 4, 2020 |
L03 Micro2 Evaluation Of Antimicrobials | 0.8 MiB | | April 4, 2020 |
L03 Microbiology & Staining Micro1 Pharmacy Dr Amal Albakri | 1.0 MiB | | April 4, 2020 |
L03 Microbiology1 PhD Dr Randa | 90.7 MiB | | April 4, 2020 |
L03 Neurophysiology Physiology2 | 0.6 MiB | | April 4, 2020 |
L03 New-sepsis-and-septic-shock-2017-updated | 0.7 MiB | | April 4, 2020 |
L03 Nutraceuticals Phyto Analysis | 16.3 MiB | zaidadnan862 | February 18, 2020 |
L03 Nutrition An-overview-of-Nutrition-Lec2 | 29.3 MiB | | April 4, 2020 |
L03 Nutrition Concepts-of-clinical-nutrition-2- Drmohammad | 66.7 MiB | | April 4, 2020 |
L03 Nutrition Energy Yielding Nutrients Dr Mohammed | 0.3 MiB | Malak Ali | February 19, 2020 |
L03 Nutrition Energy-Balance | 4.7 MiB | | April 4, 2020 |
L03 Nutrition Lipid Dr.Mohammed | 55.4 MiB | Aliya Fouad | February 20, 2020 |
L03 One Compartment IV PK Parameters | 0.7 MiB | Mohannad Alquman | February 18, 2020 |
L03 Organic Chapter1 | 3.0 MiB | | December 31, 2020 |
L03 Organic Chapter2Complement Chapter3part2 Dr Mohammd-online-audio-converter Com | 63.5 MiB | | December 31, 2020 |
L03 Organic Drkamal | 3.3 MiB | | December 31, 2020 |
L03 Organic DrMousa | 3.5 MiB | | December 31, 2020 |
L03 OrganicChemistry1 Chapter2 Part1 Dr AlmeqdadHabashneh | 1.3 MiB | | December 31, 2020 |
L03 OTC | 13.9 MiB | | April 4, 2020 |
L03 OTC | 19.7 MiB | | April 4, 2020 |
L03 OTC Diagnoisis-in-community-pharmacy | 11.7 MiB | | April 4, 2020 |
L03 OTC Diagnosis-and-history-taking 2 | 14.1 MiB | | April 4, 2020 |
L03 OTC Diagnosis-and-history-taking-in-community | 0.4 MiB | | April 4, 2020 |
L03 OTC Diagnosis-and-history-taking-in-pharmacy Lec4 | 19.6 MiB | | April 4, 2020 |
L03 OTC Pain-and-Fever-2016 | 1.1 MiB | | April 4, 2020 |
L03 OTC Diagnosis | 21.3 MiB | | April 4, 2020 |
L03 Pain-and-Fever-2015 | 1.3 MiB | | April 4, 2020 |
L03 Para Burn-sunburn-product-part-1 NEW | 29.4 MiB | | April 4, 2020 |
L03 Para Diaper-rash | 1.1 MiB | | April 4, 2020 |
L03 Para Diaper-rash | 36.9 MiB | | April 4, 2020 |
L03 Para Diaper-rash | 0.2 MiB | | April 4, 2020 |
L03 Para Infant-formula | 0.3 MiB | | April 4, 2020 |
L03 Para Dr Eman | 18.5 MiB | | April 4, 2020 |
L03 Para Dr Eman Vitamins | 6.7 MiB | | April 4, 2020 |
L03 Para Dr Rana | 79.1 MiB | Hala Azem | February 23, 2020 |
L03 Patho Inflammation Dr-mazin | 18.7 MiB | | April 4, 2020 |
L03 Patho Inflammation-and-repair | 0.6 MiB | | April 4, 2020 |
L03 Pathology | 27.0 MiB | | April 4, 2020 |
L03 Pathology Blood | 32.7 MiB | | April 4, 2020 |
L03 Pathology Blood | 0.5 MiB | | April 4, 2020 |
L03 Pathology Drmanar | 33.4 MiB | | April 4, 2020 |
L03 Pathology Inflamation1 Dr Manar | 0.1 MiB | | April 4, 2020 |
L03 Pathology Inflammation Dr Manar | 17.2 MiB | | April 4, 2020 |
L03 Pathophysio Inflammation Dralaa | 31.0 MiB | Sarah Degis | June 17, 2019 |
L03 Pathophysio Paim | 48.3 MiB | | April 4, 2020 |
L03 Pathophysio Pain | 1.0 MiB | | April 4, 2020 |
L03 PathoPhysio Topic1 Inflammaion Part2 | 0.2 MiB | | April 4, 2020 |
L03 Pathophysio.07.02.2017 Inflammation | 40.0 MiB | | April 4, 2020 |
L03 Pathophysiology | 33.9 MiB | | April 4, 2020 |
L03 Pathophysiology 23.09.2014 Adaptive Responses & Cell Death | 16.5 MiB | | April 4, 2020 |
L03 Pathophysiology 23.09.2014 Adaptive Responses & Cell Death | 0.1 MiB | | April 4, 2020 |
L03 PathoPhysiology Cellular Repsonse To Inflammation Dr Ala | 1.2 MiB | rawan Abu Oss | November 2, 2020 |
L03 Pathophysiology Cellular-Responses Dr Eman | 28 KiB | | April 4, 2020 |
L03 Pathophysiology Iflammation-part-3 | 0.6 MiB | | April 4, 2020 |
L03 Pathophysiology Inflammation | 1.2 MiB | Muneerah Ali | October 12, 2019 |
L03 PATHOPHYSIOLOGY INFLAMMATION DR ALA | 59.6 MiB | Afnan Dabobash | October 7, 2019 |
L03 Pathophysiology Inflammation Dr Alaa | 72.8 MiB | Batool Alkurdi | February 13, 2020 |
L03 Pathophysiology Inflammation3 | 31.1 MiB | | April 4, 2020 |
L03 Pathophysiology Metaplasia & Atrothy | 36.8 MiB | | April 4, 2020 |
L03 Pathophysiology Sheet Inflammation | 0.5 MiB | | April 4, 2020 |
L03 Pharma-Organic Alcohol Dr Yousuf | 1.8 MiB | | December 31, 2020 |
L03 Pharma-Organic Preparation-of-Alcohol Dr Yosef | 5.7 MiB | | December 31, 2020 |
L03 Pharma-Organic Reactions-of-Alcohols-2 | 7.4 MiB | | December 31, 2020 |
L03 Pharma1 Cholinergic Agonists | 1.1 MiB | | April 4, 2020 |
L03 Pharma1 Pharmacodynamics Part 1 | 2.3 MiB | | April 4, 2020 |
L03 Pharma1 Pharmacodynamics Part3 | 2.9 MiB | | April 4, 2020 |
L03 Pharma1 Pharmacodynamics1 Part2 | 1.9 MiB | | April 4, 2020 |
L03 Pharma1 Pharmacokinatics | 61.5 MiB | | April 4, 2020 |
L03 Pharma1 Pharmacokinetickes- | 2.3 MiB | | April 4, 2020 |
L03 Pharma1.19.09.2016 Pharmacokinetics | 60.6 MiB | | April 4, 2020 |
L03 Pharma2 Adrenocorticosteroids And Adrenocortical Antagonists | 1.0 MiB | | April 4, 2020 |
L03 Pharma2 Adrenocorticosteroids And Adrenocortical Antagonists | 1.0 MiB | | October 19, 2020 |
L03 Pharma2 Dr Eman | 18.7 MiB | | April 4, 2020 |
L03 Pharmaceutical Statistics Dr Hatem | 1.2 MiB | | April 4, 2020 |
L03 Pharmaceutical-Statistics Data-Organization D-Ahmad | 18.5 MiB | | April 4, 2020 |
L03 Pharmacokinetics Introduction | 17.7 MiB | | April 4, 2020 |
L03 Pharmacokinetics-Notes Pharmacology1 | 2.1 MiB | | April 4, 2020 |
L03 Pharmacotherapy 2 Dr Ala | 27.2 MiB | | April 4, 2020 |
L03 Pharmacotherapy2 Dr Maysa | 19.2 MiB | | April 4, 2020 |
L03 PharmaOrganic DrYousef | 8.8 MiB | | December 31, 2020 |
L03 PharmaOrganic Phenols | 5.2 MiB | | December 31, 2020 |
L03 Phathophysiology DIABETES | 2.1 MiB | | April 4, 2020 |
L03 Physical1 Gaseous-State Dr Dina | 2.2 MiB | | December 31, 2020 |
L03 Physical1 Topic1completeAndTopic2introduction DrDina | 31.2 MiB | | December 31, 2020 |
L03 Physical2 Complexation | 9.9 MiB | QamarSaqqa | February 28, 2020 |
L03 Physical2 Distribution | 20.1 MiB | iSpatula | April 4, 2020 |
L03 Physical2 Distribution- | 2.2 MiB | iSpatula | April 4, 2020 |
L03 Physical2 Dr Hatem | 20.6 MiB | iSpatula | April 4, 2020 |
L03 Physical2 Dr Samer | 18.1 MiB | iSpatula | April 4, 2020 |
L03 Physical2 Dr Samer M4a | 27.1 MiB | iSpatula | April 4, 2020 |
L03 Physical2 Preservatives- | 73.1 MiB | iSpatula | April 4, 2020 |
L03 Physio 2 Drlo2e | 15.5 MiB | | April 4, 2020 |
L03 Physio2 Dr Saleem M4a | 33.4 MiB | | April 4, 2020 |
L03 Physio2 Drlo2e | 0.7 MiB | | April 4, 2020 |
L03 Physio2 Drloai | 18.2 MiB | | April 4, 2020 |
L03 Physio2 Endocrine3 DrSaleem | 0.4 MiB | | April 4, 2020 |
L03 Physio2 Endocrine3 DrSaleem | 0.4 MiB | | April 4, 2020 |
L03 Physio2 Enocrine Drsaleem | 1.0 MiB | | April 4, 2020 |
L03 Physio2 Pancreas-and-Pituitary-gland DrLoai | 39.4 MiB | Alaa Ziad | June 17, 2019 |
L03 Physiology Active-transport DrLoai | 0.9 MiB | | December 31, 2020 |
L03 Physiology DrLoai | 0.8 MiB | | December 31, 2020 |
L03 Physiology GradedPotential Dr Loai | 0.3 MiB | | December 31, 2020 |
L03 Physiology GradedPotential Dr Loai | 0.3 MiB | | December 31, 2020 |
L03 Physiology Sheet3 | 0.6 MiB | | December 31, 2020 |
L03 Physiology-1 Ch3 .2 DrLoai | 22.2 MiB | | December 31, 2020 |
L03 Physiology1 Chapter3 II DrLoai | 27.0 MiB | | December 31, 2020 |
L03 Physiology1 Week3 DrLoai | 1.7 MiB | | December 31, 2020 |
L03 Physiology2 Cns Dr Faisal | 0.9 MiB | Dinazyoud | February 13, 2020 |
L03 Physiology2 Dr Yanal RenalSystem | 97 KiB | | April 4, 2020 |
L03 Physiology2 Dr Loai | 36.2 MiB | | April 4, 2020 |
L03 Physiology2 DrSaleem | 19.5 MiB | | April 4, 2020 |
L03 Physiology2 Renal-system | 26.7 MiB | | April 4, 2020 |
L03 Phyto | 31.7 MiB | | April 4, 2020 |
L03 Phyto2 | 97.9 MiB | Maramghweiri | June 17, 2019 |
L03 Phytoanalysis Dr Muhammad | 19.6 MiB | iSpatula | April 4, 2020 |
L03 Phytoanalysis Neutracuetical | 21.3 MiB | iSpatula | April 4, 2020 |
L03 Phytoanalysis Nutraceuticals | 0.6 MiB | iSpatula | April 4, 2020 |
L03 Phytochemistry1 Phenolics | 18.2 MiB | | April 4, 2020 |
L03 Practice Apply-Ph -Care-Steps | 29.2 MiB | | April 4, 2020 |
L03 Practice1 | 30.1 MiB | | April 4, 2020 |
L03 Practice1 Overview-of-the-pharm Care-Continue | 20.0 MiB | | April 4, 2020 |
L03 Practice2 | 76.9 MiB | | April 4, 2020 |
L03 Practice2 Communication-Skills-In-Pharmacy-Practice | 18.7 MiB | | April 4, 2020 |
L03 Preparation-of-a-solid-self-microemulsifying | 2.1 MiB | | April 4, 2020 |
L03 RAS Para | 36.3 MiB | | April 4, 2020 |
L03 Regular And Irregualr Monoterpenes | 0.1 MiB | | April 4, 2020 |
L03 Renal Dr Ebaa | 65 KiB | | April 4, 2020 |
L03 Renal Dr Ebaa | 1.0 MiB | | April 4, 2020 |
L03 Salvia-divenorum | 59 KiB | | April 4, 2020 |
L03 Sepsis-and-septic-shock-2017-only-new-slides | 0.4 MiB | | April 4, 2020 |
L03 Softgels 2015 | 3.1 MiB | | April 4, 2020 |
L03 STAT Dr Hatem | 39.1 MiB | | April 4, 2020 |
L03 Statistics | 51.7 MiB | Aya Alassi | June 18, 2019 |
L03 Statistics Basic-concepts | 32.7 MiB | | April 4, 2020 |
L03 Statistics Dr Hatim | 0.6 MiB | | October 19, 2020 |
L03 Statistics Slide7 Dr Ahmad | 1.5 MiB | | April 4, 2020 |
L03 Tablet-Coating Technology2 | 20.1 MiB | | April 4, 2020 |
L03 Techno 2 Dr Dina | 20.6 MiB | | April 4, 2020 |
L03 Techno1 | 28.2 MiB | | April 4, 2020 |
L03 Techno1 Analysis | 1.1 MiB | | April 4, 2020 |
L03 Techno1 Dr Lorina Topic-2 Part-2- Pdf | 5.7 MiB | | April 4, 2020 |
L03 Techno1 Dr Lorina | 0.7 MiB | dana younes | October 12, 2019 |
L03 Techno1 Dr Lorina | 66.0 MiB | | April 4, 2020 |
L03 Techno1 Dr Samer | 73.8 MiB | | April 4, 2020 |
L03 Techno1 M4a[1] | 36.6 MiB | | April 4, 2020 |
L03 Techno1 Preformulation Dr Ahmad | 20.8 MiB | | April 4, 2020 |
L03 Techno2 Coating Dr Hatim Sh3 | 2.2 MiB | Samira.Abusaif | February 14, 2020 |
L03 Techno2 Dr Hatem | 21.1 MiB | | April 4, 2020 |
L03 Techno2 Film-Coating | 19.7 MiB | | April 4, 2020 |
L03 Techno2 Process And Materials-of-coating | 0.1 MiB | | April 4, 2020 |
L03 Techno2 Tablet Coating1 | 34.1 MiB | | April 4, 2020 |
L03 Technology1 Preformulation | 28.6 MiB | | April 4, 2020 |
L03 Technology2 Dr-Ahmad-Bani-Jaber | 4.6 MiB | | April 4, 2020 |
L03 Technology2 Tablet Coating | 38.5 MiB | | April 4, 2020 |
L03 Terpenes Phyto2 | 34.5 MiB | zaidadnan862 | September 29, 2019 |
L03 The-Renal-System Physiology | 0.7 MiB | | April 4, 2020 |
L03 Therapy 4 Pain Management DrNaila | 45.9 MiB | Farah Qaryouti | February 10, 2020 |
L03 Therapy HTN | 30.9 MiB | | April 4, 2020 |
L03 Therapy-1 Hypertension Dr-Alaa | 29.7 MiB | | April 4, 2020 |
L03 Therapy-1 Hypertension Dr-Alaa | 1.1 MiB | | April 4, 2020 |
L03 Therapy-1 Hypertension Dr-Oriana- | 17.2 MiB | | April 4, 2020 |
L03 Therapy.11.02.2016 Asthma | 23.7 MiB | | April 4, 2020 |
L03 Therapy.11.02.2016 Asthma . | 61 KiB | | April 4, 2020 |
L03 Therapy1 Dr Allaallham | 16.0 MiB | | April 4, 2020 |
L03 Therapy2 Asthma | 25.2 MiB | | April 4, 2020 |
L03 Therapy2 Asthma | 1.2 MiB | | April 4, 2020 |
L03 Therapy2 Asthma | 69.4 MiB | | April 4, 2020 |
L03 Therapy3 Depression | 21.7 MiB | | December 31, 2020 |
L03 Therapy3 Emesis | 47.7 MiB | Aliya Fouad | October 1, 2019 |
L03 Therapy4 Eclampsia.3-4 | 30.3 MiB | | April 4, 2020 |
L03 Toxic Plants Dr Yahia | 37.6 MiB | Shaimaa Salahat | July 9, 2019 |
L03 Toxicology Introduction | 48.1 MiB | | April 4, 2020 |
L03 Toxicology Management Dr Oriana | 15.9 MiB | | April 4, 2020 |
L03 Toxicology Nirates-and-Nitrites | 5.3 MiB | | April 4, 2020 |
L03 ToxicPlants Antidote | 15.8 MiB | | April 4, 2020 |
L03 Toxidromes | 4.3 MiB | | April 4, 2020 |
L03 UV-spectoscopy Instru | 0.2 MiB | | April 4, 2020 |
L03 Volatile Oils Phyto2 | 5.1 MiB | Maramghweiri | June 19, 2019 |
L03 Water | 0.6 MiB | | April 4, 2020 |
L03 Week-3 | 6.0 MiB | iSpatula | April 4, 2020 |
L03- Advanced-techno Methods-to-enhance-solubility- | 14.9 MiB | | April 4, 2020 |
L03-04-Renal-System-Dr-Yanal | 3.1 MiB | | April 4, 2020 |
L03-05-Therapy4-Pregnancy-Complications | 1.0 MiB | | April 4, 2020 |
L03-Adrenocorticosteroid-Adrenocortical-Antagonist | 97 KiB | | April 4, 2020 |
L03-Adrenocorticosteroid-Adrenocortical-Antagonist | 97 KiB | | October 19, 2020 |
L03-anatomy-connectivetissue-dr Ahmed | 34.9 MiB | | December 31, 2020 |
L03-and-L04 Dr Zweri | 1.1 MiB | | April 4, 2020 |
L03-ANTIDEPRESSANTS | 0.4 MiB | | April 4, 2020 |
L03-Atrophy-metaplasia-Pathophysio | 16.6 MiB | | April 4, 2020 |
L03-Basic-of-Chromatography | 0.3 MiB | | April 4, 2020 |
L03-cogno-Dr-Olaimat-classification-of-drugs | 34.1 MiB | | April 4, 2020 |
L03-Dr Rana-BioWaiver | 0.2 MiB | | April 4, 2020 |
L03-Dr-Jihad | 45.8 MiB | | December 31, 2020 |
L03-Dr-Khanfar | 37.9 MiB | iSpatula | April 4, 2020 |
L03-Dr-Loai-Zghoul | 64.2 MiB | | December 31, 2020 |
L03-Endocrine-Phsio2-Dr-Ebaa | 43.2 MiB | | April 4, 2020 |
L03-Epithelium-Anatomy | 12.4 MiB | | December 31, 2020 |
L03-GI-Physiology2 | 9.0 MiB | | April 4, 2020 |
L03-hearing-and-equili-Physio2 | 6.9 MiB | | April 4, 2020 |
L03-hemodynamic-disorder-pathology | 1.6 MiB | | April 4, 2020 |
L03-Homeostatis-Dr-Loai | 1.0 MiB | | December 31, 2020 |
L03-HYperplasia-Atrophy-metaplasia-Pathohysio | 16.2 MiB | | April 4, 2020 |
L03-Hypertension-Therapy1 | 28.1 MiB | | April 4, 2020 |
L03-Hypertension-Therpay | 12.1 MiB | | April 4, 2020 |
L03-Inflammation-Patho | 21.3 MiB | | April 4, 2020 |
L03-Instru-Dr-Kanfar-7-2-2017 | 45.6 MiB | | April 4, 2020 |
L03-Int -J -Pharmaceut -327-2006-12%E2%80%9316 | 0.4 MiB | | April 4, 2020 |
L03-introduction-analytical | 1.6 MiB | Olasameeh | February 13, 2020 |
L03-Introduction-Pathway-Phyto1 | 19.0 MiB | | April 4, 2020 |
L03-Ischemic-Heart-Disease 2015-final | 3.3 MiB | | April 4, 2020 |
L03-Lab-evaluation-of-antimicro-agents-part1-Micro | 0.1 MiB | | April 4, 2020 |
L03-Medicinal | 61.9 MiB | | April 4, 2020 |
L03-Medicinal-1 | 39.1 MiB | | April 4, 2020 |
L03-Medicinal-2-Antibacterials-Penicillins | 15.8 MiB | | April 4, 2020 |
L03-Medicinal-3-anti-histamine-part-2 | 30.7 MiB | | April 4, 2020 |
L03-medicinal-chemistry-2 | 53.3 MiB | | April 4, 2020 |
L03-Medicinal-Chemistry-2-Penicillin | 1.4 MiB | | April 4, 2020 |
L03-Medicinal2-Dr-Moatasem-Antibacterial-Penicillins | 42.6 MiB | | April 4, 2020 |
L03-Organic-chemistry-organic-compound-Dr -Mohammed-Mubarak-1 | 3.9 MiB | | December 31, 2020 |
L03-organic-compund-and-functional-group-Dr Mousa | 3.4 MiB | | December 31, 2020 |
L03-OTC-Introduction | 19.5 MiB | | April 4, 2020 |
L03-OTC-Itroduction | 0.6 MiB | | April 4, 2020 |
L03-Para-burns-part-1 | 17.6 MiB | | April 4, 2020 |
L03-para-female-complaints | 21 KiB | | April 4, 2020 |
L03-Para-infant-formula-L03 | 40.6 MiB | | April 4, 2020 |
L03-Partical-size-analysis-Tehno1 | 1.1 MiB | | April 4, 2020 |
L03-Pathophysio Inflammation | 49.2 MiB | | April 4, 2020 |
L03-Pathophysio-Dr-Alaa | 30.7 MiB | | April 4, 2020 |
L03-pathophysio-Dr-Eman | 37.7 MiB | | April 4, 2020 |
L03-Pathophysiology-27.6.2016-Inflammation M4a | 24.6 MiB | | April 4, 2020 |
L03-Pathophysiology-Inflammation | 22 KiB | | April 4, 2020 |
L03-perspective-of-pharmacoeconomics | 0.5 MiB | | April 4, 2020 |
L03-pharma-organic-chemistry-Alcohol-Dr -Jehad-almaleety- | 3.6 MiB | | December 31, 2020 |
L03-pharmacognosy-drug-evaluation | 0.2 MiB | | April 4, 2020 |
L03-Pharmacokinetics-and-absorbtion | 6.8 MiB | | April 4, 2020 |
L03-Physical-1-states-of-matter-Gases-and-Liquids-Dr Dina | 31.1 MiB | | December 31, 2020 |
L03-Physical1-Phase-Rule-DMais | 52.6 MiB | | December 31, 2020 |
L03-Physio1-Handout3-DrMohammad | 0.1 MiB | | December 31, 2020 |
L03-physiologic-factors-related-to-drug-Abs M4a | 9.9 MiB | | April 4, 2020 |
L03-Physiologic-factors-related-to-drug-absorption | 0.6 MiB | | April 4, 2020 |
L03-physiology-2-Renal-System-Dr-Ebaa | 44.6 MiB | | April 4, 2020 |
L03-Physiology-nervous-system-Dr-Fessal | 0.8 MiB | | December 31, 2020 |
L03-Phytoanalysis-9.2.2016 | 48.4 MiB | iSpatula | April 4, 2020 |
L03-Plants-containing-volatile-oil-Phyto2 | 20.8 MiB | | April 4, 2020 |
L03-Plasma-membrane-Biopharma | 14.2 MiB | | April 4, 2020 |
L03-PPT-Int J Pharm -327200612-16 | 0.3 MiB | | April 4, 2020 |
L03-Practice-Patient-Education-On-Insulin-Injection | 11.7 MiB | | April 4, 2020 |
L03-Preformulation-Techno1 | 62.8 MiB | | April 4, 2020 |
L03-Reproductive-system | 3.6 MiB | | April 4, 2020 |
L03-structure-Bioavailability-Medecinal1 | 18.6 MiB | | April 4, 2020 |
L03-Tablet-coating-tchno2 | 30.9 MiB | | April 4, 2020 |
L03-Therapy3-Hepatitis-B | 29.0 MiB | | April 4, 2020 |
L03-Therapy3-Major-Depressive-Disorders | 52.9 MiB | | April 4, 2020 |
L03-Topic1-Dr-Samer | 21.9 MiB | iSpatula | April 4, 2020 |
L03-Types-of-coating-Techno2 | 19.0 MiB | | April 4, 2020 |
L03. Physiology II Dr.Faisal | 45.6 MiB | Qabas Mansour | February 11, 2020 |
L03.0-advanced-physical- -Liquid-Crystals | 2.9 MiB | | April 4, 2020 |
L03.1-HW-Liquid-Crystal-and-Emulsion | 1.2 MiB | | April 4, 2020 |
L03.2-CosmeticsT-M-WW-Scan | 2.4 MiB | | April 4, 2020 |
L03.biopharma.bioavailability.dr.rana | 20.8 MiB | Muzdalifa Asaad | October 2, 2019 |
L03.Biopharma.bioavailability.dr.Rana | 3.8 MiB | Muzdalifa Asaad | October 7, 2019 |
L03.CAM.Notes.Drtalal | 39.2 MiB | Joodjibril98 | February 18, 2020 |
L03.CAM.record | 34.8 MiB | Joodjibril98 | February 10, 2020 |
L03.OTC.mp3 | 30.3 MiB | Raghad Deknash | June 20, 2019 |
L03.Pathophysiology.dralaa | 0.8 MiB | Batool Alkurdi | February 21, 2020 |
L03.statistics.mp3 | 40.2 MiB | Ahmadabukaff | March 2, 2020 |
L03.Techno2 Tabletcoating Drahmad | 43.4 MiB | Somaya Alwishah | October 2, 2019 |
L03.therapy2.Dr.Oriana | 34 KiB | Shayma Ahmad | February 15, 2020 |
L031 Organic Alkyne Drmosa | 2.4 MiB | | December 31, 2020 |
L032 Organic Alkylhalide Drmosa | 1.5 MiB | | December 31, 2020 |
L033 Organic .drmosa | 2.3 MiB | | December 31, 2020 |
L034 Chapter11 Organic Dr Mosa | 1.9 MiB | | December 31, 2020 |
L035 Chapter11 Organic Drmosa | 1.0 MiB | | December 31, 2020 |
L036 Chapter11 Organic Drmosa | 1.0 MiB | | December 31, 2020 |
L036 Chapter11 Organic Drmosa 2 | 1.0 MiB | | December 31, 2020 |
L037 Chapter11 Organic Drmosa | 0.7 MiB | | December 31, 2020 |
L038 Chapter11 Organic Drmosa | 1.0 MiB | | December 31, 2020 |
L039 Chapter11 Organic Drmosa | 0.7 MiB | | December 31, 2020 |
L03l04 Chromo HPLC | 0.5 MiB | | April 4, 2020 |
L03l04 Chromo HPLC | 0.5 MiB | | April 4, 2020 |
L03medicinal3 Sympathetic-agonist | 11.4 MiB | | April 4, 2020 |
L04 | 17 KiB | | December 31, 2020 |
L04 | 0.7 MiB | | April 4, 2020 |
L04 Chromatography Masschromatography Dr Muhammaed | 0.5 MiB | doaa mohammad | October 23, 2020 |
L04 Medicinal Chem II Tetracyclines | 0.3 MiB | MohanadRobin | July 12, 2019 |
L04 MEDICINAL1 DR GHADEER | 0.3 MiB | Joodjibril98 | October 14, 2019 |
L04 Part 1 Practice 1 | 31.0 MiB | GhaidaaMelhem | June 25, 2019 |
L04 Part 2 Practice 1 | 53.6 MiB | GhaidaaMelhem | June 25, 2019 |
L04 Therapy I Hypertension-Combinational Therapy | 0.1 MiB | MohanadRobin | October 4, 2019 |
L04 -Apoptosis -pathophysiology | 43.7 MiB | | April 4, 2020 |
L04 -Instrumental -UV-and-Beers-Law -Dr Lima-dahabiyeh | 0.2 MiB | | April 4, 2020 |
L04 -Kinetics -introduction-to-pharmacokinetics | 20.5 MiB | | April 4, 2020 |
L04 -Kinetics -One-Compartment-model | 21.0 MiB | | April 4, 2020 |
L04 -Medicinal-1 Theories | 28.9 MiB | | April 4, 2020 |
L04 -Nutrition- | 74.7 MiB | | April 4, 2020 |
L04 -Organic -naming-of-alkanes -Dr Mohammad | 1.2 MiB | | December 31, 2020 |
L04 -Pathophysiology -Dr Eman | 92.3 MiB | | April 4, 2020 |
L04 -Phytochemical-Analysis | 69 KiB | iSpatula | April 4, 2020 |
L04 -Therapy-2 -Asthma | 17.8 MiB | | April 4, 2020 |
L04 Acid-base-disorders-2017 | 1.0 MiB | | April 4, 2020 |
L04 Adv Technology | 22.4 MiB | | April 4, 2020 |
L04 Advanced Techno Prodrugs | 18.9 MiB | | April 4, 2020 |
L04 Advanced Techno Solubility And Dissolution Dr Ahmad | 0.7 MiB | jumanamufeed | February 20, 2020 |
L04 Advanced Techno Solubility And Dissolution Dr Ahmad (online-audio-converter Com) | 43.7 MiB | jumanamufeed | February 20, 2020 |
L04 Advanced Technology Prodrug Strategies | 0.1 MiB | | April 4, 2020 |
L04 Advanced Technology.26.9.2016 | 65.6 MiB | | April 4, 2020 |
L04 Advanced-Phyto Delas-Natural-Product | 36 KiB | | April 4, 2020 |
L04 AdvPhyto Dr Mayada | 15.7 MiB | | April 4, 2020 |
L04 AdvTechno Dr Hatem | 19.9 MiB | | April 4, 2020 |
L04 Alcohol | 2.8 MiB | | December 31, 2020 |
L04 Analytical | 3.3 MiB | iSpatula | April 4, 2020 |
L04 Analytical Buffer Dr -Lina | 8.8 MiB | iSpatula | April 4, 2020 |
L04 Analytical Dr Khanfar M4a | 39.5 MiB | iSpatula | April 4, 2020 |
L04 Analytical Dr MKhanfar | 16.0 MiB | iSpatula | April 4, 2020 |
L04 Analytical DrLina | 8.2 MiB | iSpatula | April 4, 2020 |
L04 Analytical Introduction | 0.3 MiB | Sham Hatem | July 27, 2020 |
L04 Analytical Introduction | 0.3 MiB | shatha zakariyya | October 30, 2020 |
L04 Anatomy Drahmed | 37.4 MiB | | December 31, 2020 |
L04 Anatomy Glands | 59.6 MiB | | December 31, 2020 |
L04 Arachedonic-acid-metabolism | 0.5 MiB | | April 4, 2020 |
L04 Avanced Technology | 0.4 MiB | | April 4, 2020 |
L04 Biopharma | 23.9 MiB | | April 4, 2020 |
L04 Biopharma | 8.0 MiB | | April 4, 2020 |
L04 Biopharma Bioavailability 7.6.20171 | 20.9 MiB | | April 4, 2020 |
L04 Biopharma Dr Essa | 20.1 MiB | | April 4, 2020 |
L04 Biopharma Dr Mohammed | 12.3 MiB | | April 4, 2020 |
L04 Biopharma Dr Rana | 0.4 MiB | bashar.abdulrazeq | October 24, 2019 |
L04 Biopharma Dr Rana | 34.2 MiB | | April 4, 2020 |
L04 Biopharma Physiological-factors | 12.7 MiB | | April 4, 2020 |
L04 Biopharma Sheet .3 Drug Absorbtion | 0.1 MiB | | April 4, 2020 |
L04 Biopharma The Stomach | 0.5 MiB | | April 4, 2020 |
L04 Biopharma The Stomach Dr Essa | 0.5 MiB | | April 4, 2020 |
L04 Biotechno Gene-Therapy -Dr Rana | 19.4 MiB | | December 31, 2020 |
L04 Burns And Sunburn | 23.4 MiB | Sondos Khalil | July 1, 2019 |
L04 CAM | 26.7 MiB | | April 4, 2020 |
L04 Cancer-introduction2016 | 2.7 MiB | | April 4, 2020 |
L04 Cannabinoids Part 1 Medicinal Plants | 0.2 MiB | | April 4, 2020 |
L04 Cannabinoids Part 2 Medicinal Plants | 0.1 MiB | | April 4, 2020 |
L04 Carbohydrates .Derivatives | 25.5 MiB | | April 4, 2020 |
L04 Cholinergic Dr Khanfar | 1.8 MiB | Reem Hussein | October 5, 2019 |
L04 Chromatography | 95 KiB | | April 4, 2020 |
L04 Chromatography | 19.7 MiB | | April 4, 2020 |
L04 Chromo | 17.0 MiB | | April 4, 2020 |
L04 Chromo Dr Zweiri | 60.9 MiB | Rana.Zabalawi | February 20, 2020 |
L04 Chromo Extraction-and-Sample-Purification | 0.8 MiB | | April 4, 2020 |
L04 Chromo M4a | 24.7 MiB | | April 4, 2020 |
L04 Chromo TLC Dr MhdZweri | 19.6 MiB | | April 4, 2020 |
L04 Chromo- Basic-Chromatographic-Technique | 16.2 MiB | | April 4, 2020 |
L04 CKD-modifying-therapies 2016 | 2.4 MiB | | April 4, 2020 |
L04 Clearance And AUC | 0.6 MiB | Mohannad Alquman | February 22, 2020 |
L04 Clinical Biochemistry 2 | 18.9 MiB | | April 4, 2020 |
L04 Clinical-Biochem Osmolarity | 35.2 MiB | | April 4, 2020 |
L04 Clinical-Kinetics | 25.8 MiB | | April 4, 2020 |
L04 Clinicalbiochem2 Carbohydrates | 0.2 MiB | | April 4, 2020 |
L04 ClinicalKinetics ChangesInPK Dr Maysaa | 17.7 MiB | | April 4, 2020 |
L04 CNS Dr Loai | 36.7 MiB | | April 4, 2020 |
L04 CNS Dr Loai | 0.6 MiB | | April 4, 2020 |
L04 CNS Dr Loai | 2.7 MiB | | April 4, 2020 |
L04 Cogno | 25.0 MiB | | April 4, 2020 |
L04 Cogno DrYahia | 21.8 MiB | Ibrahim Ahmad | October 6, 2019 |
L04 Cognosy Dr-mohammad-Hudaib | 23.0 MiB | | April 4, 2020 |
L04 Cognosy Dr-mohammad-hudaib | 55 KiB | | April 4, 2020 |
L04 Cont Preformulation M4a1 | 18.3 MiB | | April 4, 2020 |
L04 Cosmetic Skin-Anatomy-and-Physiology Dr Samer | 42.1 MiB | | December 31, 2020 |
L04 Cosmetics Dr Samer | 35.9 MiB | Rema'a Abuhazeem | February 20, 2020 |
L04 Cosmetics Skin-Anatomy Mp3 | 19.6 MiB | | April 4, 2020 |
L04 Cosmo Anatomy-of-skin | 16.2 MiB | | April 4, 2020 |
L04 Cosmo Skin | 15.9 MiB | | April 4, 2020 |
L04 Cosmo-skin-care-preparations-4 | 0.7 MiB | | April 4, 2020 |
L04 Cyanide- | 0.9 MiB | | April 4, 2020 |
L04 Dispensing Dispensing-Techniques | 22.8 MiB | | December 31, 2020 |
L04 Dispensing Dispensing-Techniquescalculations | 16.8 MiB | | December 31, 2020 |
L04 Dispensing Dr Samer M4a | 15.5 MiB | | December 31, 2020 |
L04 Dispensing Dr Samer M4a | 15.5 MiB | | December 31, 2020 |
L04 Dispensing Packaging Drdina | 45.5 MiB | | December 31, 2020 |
L04 Dispensing Techniques | 32.6 MiB | | December 31, 2020 |
L04 DMT | 55 KiB | | April 4, 2020 |
L04 Dr Mutasim Kinetics | 19.5 MiB | | April 4, 2020 |
L04 Dr Hatem Stat | 21.0 MiB | | April 4, 2020 |
L04 Dr Mohammad Khanfar | 15.2 MiB | | April 4, 2020 |
L04 Dr Samer Physical2 | 39.9 MiB | iSpatula | April 4, 2020 |
L04 Dr-Rana | 20.1 MiB | | April 4, 2020 |
L04 Dr-Yanal Physiology2 | 14.0 MiB | | April 4, 2020 |
L04 Economics | 84.9 MiB | | April 4, 2020 |
L04 Economics | 19.8 MiB | | April 4, 2020 |
L04 Endocrine Dr Saleem | 31.5 MiB | | April 4, 2020 |
L04 Endocrine Dr Saleem | 37.1 MiB | | April 4, 2020 |
L04 Endocrine Dr Saleem | 0.3 MiB | | April 4, 2020 |
L04 Energetics-of-solubility Advanced-technology | 32.3 MiB | | April 4, 2020 |
L04 Film-coating -Techno2 -Dr Hatem | 4.0 MiB | | April 4, 2020 |
L04 Film-Coating- -Techno2 -Dr-Hatem | 76.5 MiB | | April 4, 2020 |
L04 GI Dr Khatatbeh | 4.1 MiB | | April 4, 2020 |
L04 GI Dr Khatatbeh | 4.1 MiB | | April 4, 2020 |
L04 Hallucinogenic Plants | 46.5 MiB | Mohammed Altaweel | October 8, 2019 |
L04 Hard Gelatin Capsule | 2.0 MiB | | April 4, 2020 |
L04 HPLC Chromo | 45 KiB | | April 4, 2020 |
L04 HTN Notes | 0.3 MiB | | April 4, 2020 |
L04 HTN - Therapy11 | 60.6 MiB | | April 4, 2020 |
L04 Hypertension Therapy1 | 4.1 MiB | zaidadnan862 | October 15, 2019 |
L04 Inflammation | 0.5 MiB | | April 4, 2020 |
L04 Instru DoubleBeamSpectrophotometer | 35.5 MiB | | April 4, 2020 |
L04 Instru Dr Zweri | 35.0 MiB | | April 4, 2020 |
L04 Instru DrKhanfar | 0.3 MiB | | April 4, 2020 |
L04 Instru Spectrophotometer 20190208161516 | 4.0 MiB | | April 4, 2020 |
L04 Instru Ultraviolet-Spectroscopy | 0.2 MiB | | April 4, 2020 |
L04 Instru Uv-spectroscopy Dr Imad Hamdan | 9.1 MiB | Batool Alkurdi | June 23, 2019 |
L04 Instru.4thweek Dr-emad | 1.3 MiB | Ghufran Qarara’h | October 18, 2019 |
L04 Instrumental Dr Emad Fluorometery And Atomic Spectroscopy.4th Week | 6.2 MiB | | April 4, 2020 |
L04 Introduction Analytical | 2.3 MiB | Hanaasaleh | February 21, 2020 |
L04 Introduction4 Techno1 | 5.8 MiB | | April 4, 2020 |
L04 Isotopes | 17.2 MiB | | April 4, 2020 |
L04 Kinetics | 48.3 MiB | | April 4, 2020 |
L04 Kinetics ClearanceEvaluation-of-drug-kinetics | 20.0 MiB | | April 4, 2020 |
L04 Kinetics Rates-Of-Reactions | 28.8 MiB | | April 4, 2020 |
L04 Kinetics Vd-and-Clearance | 20.2 MiB | | April 4, 2020 |
L04 L05 Chromatography Dr Muhammed | 0.6 MiB | Rim Shibani | October 18, 2019 |
L04 L05 Chromo Dr Mohammad Third Week | 7.8 MiB | Sama Altaher | February 19, 2020 |
L04 L05 CKD-and-CKD-complication | 11.8 MiB | | April 4, 2020 |
L04 L05 TECHNO2 Polymersandcoatingprocess Drahmad | 1.1 MiB | Somaya Alwishah | October 11, 2019 |
L04 Marketing | 19.1 MiB | | April 4, 2020 |
L04 Med-Chem-Medicinal | 55.6 MiB | | April 4, 2020 |
L04 MedChem3 Antihistamines Dr Sanaa | 0.4 MiB | | April 4, 2020 |
L04 MedChem3 Antihistamines Dr Sanaa | 0.4 MiB | | April 4, 2020 |
L04 Medicinal 1 Ghadeer | 41.5 MiB | | April 4, 2020 |
L04 Medicinal Ch 24.06.2015 Absorption | 28.4 MiB | | April 4, 2020 |
L04 Medicinal Ch 24.06.2015 Absorption | 0.8 MiB | | April 4, 2020 |
L04 Medicinal Plants | 36.6 MiB | | April 4, 2020 |
L04 Medicinal-3 Steroids | 16.1 MiB | | April 4, 2020 |
L04 Medicinal-Chem-II -Penicillin-Beta-Lactamase-Inhibitorscephalosporines | 0.7 MiB | Salah Samha | February 22, 2020 |
L04 Medicinal1 | 45.3 MiB | RaneenRiyad | June 20, 2019 |
L04 Medicinal1 Dr Mutasem | 42.2 MiB | | April 4, 2020 |
L04 Medicinal1 Drmotasem | 55.4 MiB | | April 4, 2020 |
L04 Medicinal1 Drmotasim | 2.2 MiB | | April 4, 2020 |
L04 Medicinal2 Macrolides | 9.3 MiB | | April 4, 2020 |
L04 Medicinal2 Signaling-Pathway | 20.2 MiB | | April 4, 2020 |
L04 Medicinal3 Parasympathetic | 14.4 MiB | | April 4, 2020 |
L04 Micro1 Dr Randa | 41.0 MiB | | April 4, 2020 |
L04 Micro1 Growth & Culturing Bacteria Dr Randa | 2.1 MiB | | April 4, 2020 |
L04 Micro1 Growth And Culturing Dr Kawareek | 1.5 MiB | | April 4, 2020 |
L04 Micro2 Microbial Spoilage | 0.7 MiB | | April 4, 2020 |
L04 Microbiology1 PhD Dr Randa | 92.2 MiB | | April 4, 2020 |
L04 Molecularspectroscopy | 2.1 MiB | Saharaldabbagh | February 13, 2020 |
L04 Neurophysiology Physiology2 | 0.4 MiB | | April 4, 2020 |
L04 Nutraceuticals Phyto Analysis | 21.8 MiB | zaidadnan862 | February 18, 2020 |
L04 Nutrition Anthropometric-Data-Assessment | 4.1 MiB | | April 4, 2020 |
L04 Nutrition Energy Yeilding Nutrients Dr Mohammed | 0.4 MiB | Malak Ali | February 25, 2020 |
L04 Nutrition Energy-Balance | 24.2 MiB | | April 4, 2020 |
L04 Nutrition Introduction-to-clinical-nutrition-calculations Drmohammad | 49.2 MiB | | April 4, 2020 |
L04 Nutrition Lipid Dr.Mohammed | 70.5 MiB | Aliya Fouad | February 20, 2020 |
L04 Organic Chapter2 Dr Musa | 2.7 MiB | | December 31, 2020 |
L04 Organic Drkamal | 2.9 MiB | | December 31, 2020 |
L04 Organic DrMousa | 3.4 MiB | | December 31, 2020 |
L04 Organic Naming-of-alkanes Dr Mohammd | 42.3 MiB | | December 31, 2020 |
L04 OrganicChemistry1 Chapter2 Part2 Dr AlmeqdadHabashneh | 4.7 MiB | | December 31, 2020 |
L04 OTC | 11.0 MiB | | April 4, 2020 |
L04 OTC | 11.7 MiB | | April 4, 2020 |
L04 OTC -diagnosis-and-history-taking Lec5 | 19.1 MiB | | April 4, 2020 |
L04 OTC Cold-and-flu | 4.8 MiB | | April 4, 2020 |
L04 OTC Common-cold | 16.4 MiB | | April 4, 2020 |
L04 OTC Diagnoisis-and-history-in-community-pharmacy | 13.6 MiB | | April 4, 2020 |
L04 OTC Diagnosis | 20.6 MiB | | April 4, 2020 |
L04 OTC-analgesics | 1.1 MiB | | April 4, 2020 |
L04 OTC-analgesics | 1.1 MiB | | April 4, 2020 |
L04 PARA Burn-sunburn-product-part-2 NEW | 33.0 MiB | | April 4, 2020 |
L04 Para Diaper-rash | 28.5 MiB | | April 4, 2020 |
L04 Para Diaper-rash-2 | 67 KiB | | April 4, 2020 |
L04 Para Infant-faormula-and-diaper-rash | 0.3 MiB | | April 4, 2020 |
L04 Para Scaly-dermatoses | 0.2 MiB | | April 4, 2020 |
L04 Para Dr Eman | 40.5 MiB | | April 4, 2020 |
L04 Para Dr Eman Headache | 10.3 MiB | | April 4, 2020 |
L04 Para Dr Rana | 83.3 MiB | Hala Azem | February 28, 2020 |
L04 Part .2 Advanced-physical Solubility | 0.2 MiB | | April 4, 2020 |
L04 Part .2.1advanced-physical Solubility-pepar | 0.2 MiB | | April 4, 2020 |
L04 PART .3 Advanced-physical Solubility-3 | 0.7 MiB | | April 4, 2020 |
L04 Patho Neoplasia Dr-mazin | 19.4 MiB | | April 4, 2020 |
L04 Patho Acute Inflammation | 0.1 MiB | | April 4, 2020 |
L04 Pathology | 25.0 MiB | | April 4, 2020 |
L04 Pathology Dr Manar | 20.0 MiB | | April 4, 2020 |
L04 Pathology Inflamation2 Dr Manar | 0.1 MiB | | April 4, 2020 |
L04 Pathology Inflammation2 Dr Manar | 14.3 MiB | | April 4, 2020 |
L04 Pathology Inflammation2 Dr Manar 2 | 14.3 MiB | | April 4, 2020 |
L04 Pathology Respiratory-system-part2-note Dr Maram-%D9%85%D8%AD%D9%88%D9%841 | 76 KiB | | December 31, 2020 |
L04 Pathophysio Inflammation Dralaa | 26.7 MiB | Sarah Degis | June 17, 2019 |
L04 Pathophysio Inflammation1 Dr Eman | 22 KiB | | April 4, 2020 |
L04 Pathophysio Rheumatoid Arthritis | 60.4 MiB | | April 4, 2020 |
L04 Pathophysio RheumatoidArthritis | 0.5 MiB | | April 4, 2020 |
L04 PathoPhysio Topic1 Inflammaion Part3 | 0.2 MiB | | April 4, 2020 |
L04 Pathophysio.12.02.2017 Inflammation | 45.1 MiB | | April 4, 2020 |
L04 Pathophysiology | 38.5 MiB | | April 4, 2020 |
L04 Pathophysiology 25.09.2014 Apoptosis | 17.2 MiB | | April 4, 2020 |
L04 Pathophysiology 25.09.2014 Apoptosis | 0.6 MiB | | April 4, 2020 |
L04 Pathophysiology Apoptosis | 36.7 MiB | | April 4, 2020 |
L04 Pathophysiology Cellular-Responses -Dr Eman | 27.6 MiB | | April 4, 2020 |
L04 Pathophysiology Coagulation Cascade | 3.4 MiB | | April 4, 2020 |
L04 Pathophysiology Inflammastion | 52 KiB | | April 4, 2020 |
L04 Pathophysiology Inflammation | 1.4 MiB | Muneerah Ali | October 20, 2019 |
L04 Pathophysiology Inflammation Dr Alaa | 87.3 MiB | Batool Alkurdi | February 13, 2020 |
L04 PATHOPHYSIOLOGY INFLAMMATION DR Dr alaa | 77.0 MiB | Afnan Dabobash | October 9, 2019 |
L04 Pathophysiology Inflammation4 | 24.3 MiB | | April 4, 2020 |
L04 PathoPhysiology Pain Dr Ala | 1.3 MiB | rawan Abu Oss | November 14, 2020 |
L04 Pathophysiology Sheet Inflammation | 0.3 MiB | | April 4, 2020 |
L04 Pathphysio Inflammation Part4 | 0.3 MiB | | April 4, 2020 |
L04 Pharma 1 Cholinergic Agonists | 1.3 MiB | | April 4, 2020 |
L04 Pharma-Organic Alcohol Dr Yosef | 5.5 MiB | | December 31, 2020 |
L04 Pharma-Organic Alcohol Dr Yousuf | 2.3 MiB | | December 31, 2020 |
L04 Pharma-Organic Reactions-of-Alcohol-3 | 4.9 MiB | | December 31, 2020 |
L04 Pharma1 Pharmacokinatics2 | 60.6 MiB | | April 4, 2020 |
L04 Pharma1 Pharmacokinetickes | 2.0 MiB | | April 4, 2020 |
L04 Pharma1.21.09.2016 Pharmacokinetics | 68.1 MiB | | April 4, 2020 |
L04 Pharma2 Dr Eman | 20.1 MiB | | April 4, 2020 |
L04 Pharma2 Gonadal Hormones And Inhibitors | 1.1 MiB | | April 4, 2020 |
L04 Pharma2 Gonadal Hormones And Inhibitors | 1.1 MiB | | October 19, 2020 |
L04 Pharmaceutical Statistics Dr Hatem | 3.2 MiB | | April 4, 2020 |
L04 PHARMACEUTICAL SUSPENSIONS | 3.7 MiB | | April 4, 2020 |
L04 Pharmaceutical-Statistics Data-Organization D-Ahmad | 16.9 MiB | | April 4, 2020 |
L04 Pharmacokinetics Dr Mhmd | 19.7 MiB | | April 4, 2020 |
L04 Pharmacokinetics One-Compartment | 18.0 MiB | | April 4, 2020 |
L04 Pharmacokinetics-Notes Pharmacology1 | 4.9 MiB | | April 4, 2020 |
L04 Pharmacotherapy2 Dr Alaa | 27.9 MiB | | April 4, 2020 |
L04 Pharmacotherapy2 Dr Maysa | 18.7 MiB | | April 4, 2020 |
L04 PharmaOrganic DrYousef | 6.7 MiB | | December 31, 2020 |
L04 PharmaOrganic Phenols | 2.0 MiB | | December 31, 2020 |
L04 Phenols | 4.4 MiB | | December 31, 2020 |
L04 Physical 2 Complexation | 11.2 MiB | QamarSaqqa | February 29, 2020 |
L04 Physical1 Gaseous-and-Liqiud-State Dr Dina | 3.2 MiB | | December 31, 2020 |
L04 Physical1 Topic2 .DrDina | 33.1 MiB | | December 31, 2020 |
L04 Physical2 Dissociation- | 66.3 MiB | iSpatula | April 4, 2020 |
L04 Physical2 Distribution | 17.6 MiB | iSpatula | April 4, 2020 |
L04 Physical2 Distribution 2 | 13.8 MiB | iSpatula | April 4, 2020 |
L04 Physical2 Distribution- | 4.6 MiB | iSpatula | April 4, 2020 |
L04 Physical2 Dr Hatem | 21.7 MiB | iSpatula | April 4, 2020 |
L04 Physio2 Dr Loai(2) | 29.9 MiB | | April 4, 2020 |
L04 Physio2 Dr Saleem | 24.9 MiB | | April 4, 2020 |
L04 Physio2 Drlo2e | 15.5 MiB | | April 4, 2020 |
L04 Physio2 Drlo2e | 1.0 MiB | | April 4, 2020 |
L04 Physio2 Drloai | 40.0 MiB | | April 4, 2020 |
L04 Physio2 Endocrine Renal Drsaleem | 0.7 MiB | | April 4, 2020 |
L04 Physio2 Endocrine4 DrSaleem | 0.5 MiB | | April 4, 2020 |
L04 Physio2 Posterior-pituitary DrLoai | 20.5 MiB | Alaa Ziad | June 17, 2019 |
L04 Physiology Drloai | 2.5 MiB | | December 31, 2020 |
L04 Physiology Nerve Physiology Dr Faisal | 52.1 MiB | | December 31, 2020 |
L04 Physiology PropagationMuscle Dr Loai | 0.2 MiB | | December 31, 2020 |
L04 Physiology PropagationMuscle Dr Loai | 0.2 MiB | | December 31, 2020 |
L04 Physiology RestingPotential DrLoai | 0.3 MiB | | December 31, 2020 |
L04 Physiology Sheet4 | 0.4 MiB | | December 31, 2020 |
L04 Physiology-1 Ch3 .3 DrLoai | 23.0 MiB | | December 31, 2020 |
L04 Physiology1 Chapter34 I DrLoai | 31.2 MiB | | December 31, 2020 |
L04 Physiology1 Week4 DrLoai | 0.6 MiB | | December 31, 2020 |
L04 Physiology2 Cns Dr Faisal | 0.4 MiB | Dinazyoud | February 17, 2020 |
L04 Physiology2 Dr Yanal RenalSystem | 66 KiB | | April 4, 2020 |
L04 Physiology2 Dr Loai | 30.9 MiB | | April 4, 2020 |
L04 Physiology2 DrSaleem | 20.4 MiB | | April 4, 2020 |
L04 Physiology2 Gastrointestinal-system | 26.0 MiB | | April 4, 2020 |
L04 Phyto | 33.2 MiB | | April 4, 2020 |
L04 Phyto2 | 92.4 MiB | Maramghweiri | June 19, 2019 |
L04 Phytoanalysis Dr Muhammad | 21.4 MiB | iSpatula | April 4, 2020 |
L04 Phytoanalysis Nutraceutical | 2.2 MiB | iSpatula | April 4, 2020 |
L04 Phytoanalysis Nutraceutical | 20.6 MiB | iSpatula | April 4, 2020 |
L04 Phytochemistry 1 Ferns | 3.3 MiB | | April 4, 2020 |
L04 Phytochemistry1 Flavonoids | 19.9 MiB | | April 4, 2020 |
L04 Potass-hemostat | 0.5 MiB | | April 4, 2020 |
L04 Practice The-need-for-Ph -Care | 20.0 MiB | | April 4, 2020 |
L04 Practice1 | 32.0 MiB | | April 4, 2020 |
L04 Practice1 The-need-for-pharmaceutical-care | 18.1 MiB | | April 4, 2020 |
L04 Practice2 | 70.6 MiB | | April 4, 2020 |
L04 Practice2 Communication-Skills-In-Pharmacy-Practice | 18.9 MiB | | April 4, 2020 |
L04 Problem Solving | 24.3 MiB | | December 31, 2020 |
L04 Relative Calculatioins | 2.4 MiB | iSpatula | April 4, 2020 |
L04 Renal Dr Ebaa | 0.1 MiB | | April 4, 2020 |
L04 Renal Dr Ebaa | 0.1 MiB | | April 4, 2020 |
L04 Respiration Dr Zyad | 0.5 MiB | | April 4, 2020 |
L04 SEDATIVE-HYPNOTICS-part-1 | 0.5 MiB | | April 4, 2020 |
L04 Sodium- | 1.6 MiB | | April 4, 2020 |
L04 Staining Micro1 Pharmacy Dr Amal Albakri | 0.8 MiB | | April 4, 2020 |
L04 Statistics DrAhmad | 56.6 MiB | Aya Alassi | June 23, 2019 |
L04 Statistics Grapical-Presentation | 27.7 MiB | | April 4, 2020 |
L04 Statistics Slide8 DrAhmad | 2.4 MiB | | April 4, 2020 |
L04 Tablet-Coating Technology2 | 20.8 MiB | | April 4, 2020 |
L04 Techno 2 Dr Dina | 21.8 MiB | | April 4, 2020 |
L04 Techno1 | 31.9 MiB | | April 4, 2020 |
L04 Techno1 Dr Lorina Topic-2 Part-3- Pdf | 1.6 MiB | | April 4, 2020 |
L04 Techno1 Dr Lorina | 0.7 MiB | dana younes | October 19, 2019 |
L04 Techno1 Dr Lorina | 24.3 MiB | | April 4, 2020 |
L04 Techno1 Dr Samer | 16.8 MiB | | April 4, 2020 |
L04 Techno1 M4a[1] | 28.9 MiB | | April 4, 2020 |
L04 Techno1 Product-Development-Formulation-Optimization Dr Ahmad | 22.2 MiB | | April 4, 2020 |
L04 Techno1 Size Reduction | 1.0 MiB | | April 4, 2020 |
L04 Techno2 Coating Dr Hatim | 2.5 MiB | Samira.Abusaif | February 14, 2020 |
L04 Techno2 Coating Equipment And Atomization | 96 KiB | | April 4, 2020 |
L04 Techno2 Coating-EquipmentsProcess | 18.9 MiB | | April 4, 2020 |
L04 Techno2 Dr Hatem Process | 22.4 MiB | | April 4, 2020 |
L04 Techno2 Tablet Coating1 | 38.4 MiB | | April 4, 2020 |
L04 Techno2 Tabletcoatingpolymers Drahmad | 37.5 MiB | Somaya Alwishah | October 7, 2019 |
L04 Technology Particle-size-analysis | 18.9 MiB | | April 4, 2020 |
L04 Technology2 Dr-Ahmad-Bani-Jaber | 5.5 MiB | | April 4, 2020 |
L04 Terpenes Phyto2 | 33.8 MiB | zaidadnan862 | October 1, 2019 |
L04 The-Renal-System | 0.6 MiB | | April 4, 2020 |
L04 Thearpy3 Cancer Infections | 58.2 MiB | Aliya Fouad | October 4, 2019 |
L04 Therapy HTN | 30.1 MiB | | April 4, 2020 |
L04 Therapy-1 Hypertension Dr-Alaa | 28.6 MiB | | April 4, 2020 |
L04 Therapy-1 Hypertension Dr-Alaa | 0.6 MiB | | April 4, 2020 |
L04 Therapy.14.02.216 Asthma | 23.3 MiB | | April 4, 2020 |
L04 Therapy.14.02.216 Asthma | 0.4 MiB | | April 4, 2020 |
L04 Therapy1 Dr Allaallham | 19.2 MiB | | April 4, 2020 |
L04 Therapy1 Hypertension Dr-Oriana | 15.9 MiB | | April 4, 2020 |
L04 Therapy2 Asthma | 0.6 MiB | | April 4, 2020 |
L04 Therapy2 Asthma | 63.1 MiB | | April 4, 2020 |
L04 Therapy3 Depression | 22.0 MiB | | December 31, 2020 |
L04 Therapy4 Eclampsia.5-4 | 29.5 MiB | | April 4, 2020 |
L04 Therapy4 Pain And Perioperative Care DrNaila | 54.2 MiB | Farah Qaryouti | February 11, 2020 |
L04 Toxic Plants Dr Yahia | 47.6 MiB | Shaimaa Salahat | July 9, 2019 |
L04 Toxicology CarbonMonoxide | 0.5 MiB | | April 4, 2020 |
L04 Toxicology Introduction | 69.8 MiB | | April 4, 2020 |
L04 Toxicology Respiration Dr Oriana | 12.2 MiB | | April 4, 2020 |
L04 ToxicPlants GI Irritation | 10.6 MiB | | April 4, 2020 |
L04 Triterpenoids | 6.0 MiB | | April 4, 2020 |
L04 Triterpenoids Correction | 0.7 MiB | | April 4, 2020 |
L04 UV-spectroscopy-part-2 Instru | 0.5 MiB | | April 4, 2020 |
L04 Volatile Oils Phyto2 | 4.4 MiB | Maramghweiri | June 21, 2019 |
L04 Volume-of-distributionclearance | 20.0 MiB | | April 4, 2020 |
L04 Week-4 | 2.9 MiB | iSpatula | April 4, 2020 |
L04- Adv-Techno-19.02.2017 | 20.1 MiB | | April 4, 2020 |
L04- H2 Blockers - Dr Sana Bardaweel | 3.6 MiB | Nour Mohammad | July 6, 2020 |
L04-Acute-Coronary-Syndromes 2015-final | 7.6 MiB | | April 4, 2020 |
L04-Advance-techno | 0.2 MiB | | April 4, 2020 |
L04-Analytical | 3.8 MiB | iSpatula | April 4, 2020 |
L04-Apoptosis-Pathophysio | 14.8 MiB | | April 4, 2020 |
L04-Apoptosis-Pathophysio | 14.8 MiB | | April 4, 2020 |
L04-Basic-Communication-Skills-In-Pharmacy-Practice | 17.6 MiB | | April 4, 2020 |
L04-biopharma-drranaabudahab-quiz-material | 16.5 MiB | | April 4, 2020 |
L04-Biopharma-Drug-absorbtion | 0.1 MiB | | April 4, 2020 |
L04-Chronic-inflammation-and-angiogensis-phatho | 17.7 MiB | | April 4, 2020 |
L04-Coating-Equipment-Techno2 | 15.4 MiB | | April 4, 2020 |
L04-cogno-Dr-Olaimat-the-binomial-sustem | 31.3 MiB | | April 4, 2020 |
L04-Dr-Jihad | 43.2 MiB | | December 31, 2020 |
L04-Dr-Khanfar | 19.0 MiB | iSpatula | April 4, 2020 |
L04-Dr-Loai-Zghoul | 17.5 MiB | | December 31, 2020 |
L04-Endocrine-Physio2-Dr-Ebaa Wma | 17.4 MiB | | April 4, 2020 |
L04-estrogens-and-progestins | 0.3 MiB | | April 4, 2020 |
L04-estrogens-and-progestins | 0.3 MiB | | October 19, 2020 |
L04-Fluidity-to-Passive-Diffusion-Biopharma | 16.7 MiB | | April 4, 2020 |
L04-GIT-Physiology2 | 4.1 MiB | | April 4, 2020 |
L04-HSL-Para | 30.7 MiB | | April 4, 2020 |
L04-Hypertension-Therpay | 12.9 MiB | | April 4, 2020 |
L04-Instru-Dr-Kanfar-12-2-2017-UV | 46.6 MiB | | April 4, 2020 |
L04-L07-Medicinal-2-Antibacterials-Cephalosporins | 1.1 MiB | | April 4, 2020 |
L04-Lignans-Phyto1 | 20.1 MiB | | April 4, 2020 |
L04-Medicinal 3-antihistamine-part3-parasympathatic | 65.2 MiB | | April 4, 2020 |
L04-Medicinal-1 | 77.6 MiB | | April 4, 2020 |
L04-Medicinal-2-Antibacterials-Cephalosporins | 15.0 MiB | | April 4, 2020 |
L04-medicinal-chemistry-2 | 49.6 MiB | | April 4, 2020 |
L04-Medicinal-Chemistry-2-MonoBactam-Cephalosporin | 3.0 MiB | | April 4, 2020 |
L04-Medicinal2-Dr-Moatasem-Antibacterial-MonoBactamCephalosporin | 40.9 MiB | | April 4, 2020 |
L04-Metabolism- | 3.6 MiB | | April 4, 2020 |
L04-modulation-of-membran-fluidit-by-sterols M4a | 8.3 MiB | | April 4, 2020 |
L04-neoplasia-pathology | 3.8 MiB | | April 4, 2020 |
L04-Nerve-Physiology-Dr-Faisal-converted | 1.0 MiB | | December 31, 2020 |
L04-Organic-chemistry-chapter-34-Dr -Mohammed-Mubarak- | 5.6 MiB | | December 31, 2020 |
L04-Organic-conformation-of-alkanes-dr-mousa | 3.5 MiB | | December 31, 2020 |
L04-OTC-Introduction | 19.0 MiB | | April 4, 2020 |
L04-OTC-Introduction | 0.9 MiB | | April 4, 2020 |
L04-Para-burn-part-2 | 19.0 MiB | | April 4, 2020 |
L04-Para-infant-formula-L04 | 41.6 MiB | | April 4, 2020 |
L04-para-smoking-cessation | 0.3 MiB | | April 4, 2020 |
L04-Parentral-Drug-Administration 2016 | 0.4 MiB | | April 4, 2020 |
L04-Pathophysio-Dr-Alaa | 29.6 MiB | | April 4, 2020 |
L04-pathophysio-Dr-Eman | 39.0 MiB | | April 4, 2020 |
L04-Pathophysio-Inflammation | 27.1 MiB | | April 4, 2020 |
L04-Pathophysiology-28.6.2016-Inflammation | 25.2 MiB | | April 4, 2020 |
L04-Pharmacoeconomics-Types-of-economic-evaluations | 0.8 MiB | AyaatJokhan | November 9, 2019 |
L04-Pharmacognosy-and-Drug-Discovery | 8.2 MiB | | April 4, 2020 |
L04-Physical-1-States-of-matter-Gases-and-Liquids-Dr Dina | 29.2 MiB | | December 31, 2020 |
L04-Physical1-Phase-Rule-DMais | 93.2 MiB | | December 31, 2020 |
L04-physiology-2-Renal-Syatem-Dr-Ebaa | 37.9 MiB | | April 4, 2020 |
L04-Physiology-nervous-muscle-Dr-Fessal | 2.3 MiB | | December 31, 2020 |
L04-Phytoanalysis-14.2.2016 | 44.9 MiB | iSpatula | April 4, 2020 |
L04-Probability-Distributions | 1.2 MiB | | April 4, 2020 |
L04-Probability-Distributions | 1.2 MiB | | April 4, 2020 |
L04-Sesquiterpens-and-Diterpens-Phyto2 | 20.9 MiB | | April 4, 2020 |
L04-size-reduction-Techno1 | 1.0 MiB | | April 4, 2020 |
L04-smell-and-tast-physio2 | 2.6 MiB | | April 4, 2020 |
L04-Solubility-2-PharmRes1991-8-502-4 | 0.6 MiB | | April 4, 2020 |
L04-Statistics-Dr-hatim | 0.6 MiB | | October 19, 2020 |
L04-structure-bioavailability-Henderson-Medecin | 19.6 MiB | | April 4, 2020 |
L04-Tablet-coating-techno2 | 34.0 MiB | | April 4, 2020 |
L04-The-Stomach OK | 0.7 MiB | | April 4, 2020 |
L04-Therapy-3-Quiz-2 | 27.7 MiB | | April 4, 2020 |
L04-Therapy3-Major-Depressive-Disorders-Treatment | 33.0 MiB | | April 4, 2020 |
L04-TLC | 0.4 MiB | | April 4, 2020 |
L04-Topic1-Dr-Samer- | 20.5 MiB | iSpatula | April 4, 2020 |
L04-Training-1-Types-of-prescriptions-in-Jordan | 1.9 MiB | | April 4, 2020 |
L04-transdermal Drug Delivery | 0.7 MiB | | April 4, 2020 |
L04-type-of-pharmacoeconomics-evaluation-part1 | 0.6 MiB | | April 4, 2020 |
L04. Physiology ll Dr.Faisal | 23.5 MiB | Qabas Mansour | February 14, 2020 |
L04.0 Advanced-physical- Solubility | 0.7 MiB | | April 4, 2020 |
L04.1 | 14.4 MiB | | April 4, 2020 |
L04.1-Solubility-PAPER | 0.6 MiB | | April 4, 2020 |
L04.2 | 1.1 MiB | | April 4, 2020 |
L04.biopharma.bioavailability.dr.rana | 45.2 MiB | Muzdalifa Asaad | October 6, 2019 |
L04.Biopharma.bioavailability.Part1.Dr.Rana | 4.1 MiB | Muzdalifa Asaad | October 10, 2019 |
L04.biopharma.bioavailability.part2.Dr.Rana | 2.8 MiB | Muzdalifa Asaad | October 13, 2019 |
L04.CAM.Notes.Drtalal | 17.5 MiB | Joodjibril98 | February 28, 2020 |
L04.CAM.Record | 63.0 MiB | Joodjibril98 | February 12, 2020 |
L04.OTC.mp3 | 27.7 MiB | Raghad Deknash | June 20, 2019 |
L04.Part1.Therapy2.Dr.Oriana | 3.9 MiB | Shayma Ahmad | February 22, 2020 |
L04.Part2.Therapy.Dr.Oriana | 3.1 MiB | Shayma Ahmad | February 22, 2020 |
L04.Pathophysiology.dralaa | 1.0 MiB | Batool Alkurdi | February 21, 2020 |
L04medicinal-3-sympathetic-antagonists | 6.8 MiB | | April 4, 2020 |
L04 Kinetics DrMutasim Parameters | 3.4 MiB | Muzdalifa Asaad | October 24, 2020 |
L05 | 15 KiB | | December 31, 2020 |
L05 | 15.0 MiB | | April 4, 2020 |
L05 | 0.7 MiB | | April 4, 2020 |
L05 PATHOPHYSIOLOGY INFLAMMATION DR ALA | 101 MiB | Afnan Dabobash | October 14, 2019 |
L05 Physiology II Dr Faisal (online-audio-converter Com) | 45.2 MiB | Qabas Mansour | February 18, 2020 |
L05 Practice 1 | 86.1 MiB | GhaidaaMelhem | June 25, 2019 |
L05 -Advance-techno | 87 KiB | | April 4, 2020 |
L05 -Analytical Dr -Lina -Pdf | 1.6 MiB | iSpatula | April 4, 2020 |
L05 -Instrumental -Beers-law -dr Lina-dahabiyeh | 0.2 MiB | | April 4, 2020 |
L05 -Instrumental -Beers-law -dr Lina-dahabiyeh | 0.2 MiB | | April 4, 2020 |
L05 -Kinetics -IV-bolus | 19.6 MiB | | April 4, 2020 |
L05 -Kinetics Vd-Clearance | 21.2 MiB | | April 4, 2020 |
L05 -Medicinal-1 Metabolism | 27.5 MiB | | April 4, 2020 |
L05 -Medicinal-Chem-II -Cephalosporines | 1.0 MiB | Salah Samha | March 6, 2020 |
L05 -Nutrition | 65.3 MiB | | April 4, 2020 |
L05 -organic -steroisomers -Dr Mohammad | 1.5 MiB | | December 31, 2020 |
L05 -Pathophysiology -Dr Eman | 109 MiB | | April 4, 2020 |
L05 -Phytochemical-analysis | 44 KiB | iSpatula | April 4, 2020 |
L05 -Prodrug Advanced-technology | 34.5 MiB | | April 4, 2020 |
L05 -Techno1 | 22.6 MiB | | April 4, 2020 |
L05 -Therapy-2 -Asthma | 14.9 MiB | | April 4, 2020 |
L05 Acid-Base | 2.4 MiB | | April 4, 2020 |
L05 Adv Technology | 29.8 MiB | | April 4, 2020 |
L05 Advanced Techno Solubility And Dissolution Dr Ahmad | 0.6 MiB | jumanamufeed | February 24, 2020 |
L05 Advanced Techno Solubility And Dissolution Dr Ahmad (online-audio-converter Com) | 38.5 MiB | jumanamufeed | February 20, 2020 |
L05 Advanced Technology | 0.4 MiB | | April 4, 2020 |
L05 Advanced Technology Prodrug-strategies | 0.2 MiB | | April 4, 2020 |
L05 Advanced Technology.28.9.2016 | 26.9 MiB | | April 4, 2020 |
L05 Advanced-techno Prodrugs | 13.3 MiB | | April 4, 2020 |
L05 AdvPhyto Dr Mayada Dr Hatem | 16.5 MiB | | April 4, 2020 |
L05 AdvTechno Dr Hatem | 16.6 MiB | | April 4, 2020 |
L05 Alcohol PharmaOrganic | 3.4 MiB | iSpatula | April 4, 2020 |
L05 Alcohol PharmaOrganic | 3.4 MiB | | December 31, 2020 |
L05 Analytical | 2.0 MiB | iSpatula | April 4, 2020 |
L05 Analytical Dr Khanfar M4a | 42.3 MiB | iSpatula | April 4, 2020 |
L05 Analytical Dr MKhanfar | 14.1 MiB | iSpatula | April 4, 2020 |
L05 Analytical Dr.Lina | 2.1 MiB | FouadKh | October 11, 2019 |
L05 Analytical DrLina | 5.8 MiB | iSpatula | April 4, 2020 |
L05 Analytical Standardization | 0.3 MiB | Sham Hatem | July 27, 2020 |
L05 Analytical Standardization | 0.3 MiB | shatha zakariyya | October 30, 2020 |
L05 Anatomy Connective-Tissue | 31.6 MiB | | December 31, 2020 |
L05 AntidiabeticDrugs Dr Khanfar | 3.2 MiB | Reem Hussein | October 12, 2019 |
L05 Biopharma | 18.7 MiB | | April 4, 2020 |
L05 Biopharma | 3.7 MiB | | April 4, 2020 |
L05 Biopharma Dr Essa | 23.2 MiB | | April 4, 2020 |
L05 Biopharma Dr Mohammed | 8.3 MiB | | April 4, 2020 |
L05 Biopharma Dr Rana | 0.4 MiB | bashar.abdulrazeq | November 4, 2019 |
L05 Biopharma Dr Rana | 20.6 MiB | | April 4, 2020 |
L05 Biopharma Endocytosis 8.6.20171 | 20.4 MiB | | April 4, 2020 |
L05 Biopharma Gastric Emptying | 0.2 MiB | | April 4, 2020 |
L05 Biopharma Gastric Emptying Dr Essa | 0.3 MiB | | April 4, 2020 |
L05 Biopharma Oral Drugs part 1 Dr Rana | 3.8 MiB | Muzdalifa Asaad | October 26, 2019 |
L05 Biopharma Oral Drugs Part 2 Dr Rana | 1.7 MiB | Muzdalifa Asaad | October 26, 2019 |
L05 Biopharma Physiological-factor | 12.8 MiB | | April 4, 2020 |
L05 Biopharma Quiz Paper Discussion | 0.5 MiB | | April 4, 2020 |
L05 Biopharma Sheet .4 | 0.5 MiB | | April 4, 2020 |
L05 Biotechno Gene-therapy -Dr -Rana | 19.3 MiB | | December 31, 2020 |
L05 Blood Pressure Dr Zyad | 0.3 MiB | | April 4, 2020 |
L05 Calculations Part2 | 1.8 MiB | iSpatula | April 4, 2020 |
L05 CAM Dr Mayada | 28.9 MiB | | April 4, 2020 |
L05 Cancer-pain2016 | 3.4 MiB | | April 4, 2020 |
L05 Carbohydrates .Derivatives | 27.6 MiB | | April 4, 2020 |
L05 Chromatography | 19.8 MiB | | April 4, 2020 |
L05 Chromo Basic-Chromatographic-Techniques | 29.1 MiB | | April 4, 2020 |
L05 Chromo Basics-of-Chromatography-and-Column-Chromatography | 0.8 MiB | | April 4, 2020 |
L05 Chromo Dr Zweiri | 54.8 MiB | Rana.Zabalawi | February 20, 2020 |
L05 Chromo Dr Zweiri | 16.2 MiB | | April 4, 2020 |
L05 Chromo HPLC | 0.3 MiB | | April 4, 2020 |
L05 Chromo HPLC | 0.3 MiB | | April 4, 2020 |
L05 Chromo HPLC Dr MhdZweri | 14.9 MiB | | April 4, 2020 |
L05 Chromo- | 23.7 MiB | | April 4, 2020 |
L05 Clincal-Biochem Fluids-Electrolyte | 30.8 MiB | | April 4, 2020 |
L05 Clinical Biochemistry 2 | 20.7 MiB | | April 4, 2020 |
L05 Clinical-Kinetics | 21.3 MiB | | April 4, 2020 |
L05 Clinicalbiochem2 Lipids | 0.2 MiB | | April 4, 2020 |
L05 ClinicalKinetics Vd Dr Maysaa | 19.8 MiB | | April 4, 2020 |
L05 CNS Dr Loai | 41.3 MiB | | April 4, 2020 |
L05 CNS Dr Loai | 0.1 MiB | | April 4, 2020 |
L05 Cogno | 19.5 MiB | | April 4, 2020 |
L05 Cogno DrKhaled | 22.0 MiB | | April 4, 2020 |
L05 Cogno DrYahia | 21.0 MiB | Ibrahim Ahmad | October 8, 2019 |
L05 Cogno M4a1 | 42.9 MiB | | April 4, 2020 |
L05 Cognosy Dr-mohammad-hudaib | 43.3 MiB | | April 4, 2020 |
L05 Cosmetics Dr Samer | 39.6 MiB | Rema'a Abuhazeem | February 20, 2020 |
L05 Cosmetics Skin-Cleansing-Products Dr Samer | 48.1 MiB | | December 31, 2020 |
L05 Cosmetics Skin-Cleansing-Products Mp3 | 20.3 MiB | | April 4, 2020 |
L05 Cosmo Types-of-the-skin | 18.9 MiB | | April 4, 2020 |
L05 Cosmo Hair | 17.9 MiB | | April 4, 2020 |
L05 Cosmo-skin-care-preaparations-5 | 0.6 MiB | | April 4, 2020 |
L05 DescriptiveStatistics | 35.5 MiB | | April 4, 2020 |
L05 Diaper Rash | 17.1 MiB | Sondos Khalil | July 1, 2019 |
L05 Disorders-of-Na-H20-homeostasis-2017 | 1.1 MiB | | April 4, 2020 |
L05 Dispensing Calculations | 12.9 MiB | | December 31, 2020 |
L05 Dispensing Calculations | 20.7 MiB | | December 31, 2020 |
L05 Dispensing Dr Samer M4a | 13.8 MiB | | December 31, 2020 |
L05 Dispensing Packaging Drdina | 48.4 MiB | | December 31, 2020 |
L05 Dispensing Techniques | 38.5 MiB | | December 31, 2020 |
L05 Dr Yanal Physiology2 | 16.7 MiB | | April 4, 2020 |
L05 Dr Loai Physio2 | 14.0 MiB | | April 4, 2020 |
L05 Dr Zweri | 0.7 MiB | | April 4, 2020 |
L05 Dr-Rana | 19.7 MiB | | April 4, 2020 |
L05 Economics | 92.9 MiB | | April 4, 2020 |
L05 Economics | 19.8 MiB | | April 4, 2020 |
L05 Ethers | 1.4 MiB | | December 31, 2020 |
L05 Film-coating2 Techno2 Dr-Hatem | 77.5 MiB | | April 4, 2020 |
L05 Film-coating2 Techno2 Dr-Hatem | 3.5 MiB | | April 4, 2020 |
L05 GI Dr Khatatbeh | 3.4 MiB | | April 4, 2020 |
L05 GI Dr Khatatbeh | 3.4 MiB | | April 4, 2020 |
L05 Hallucinogenic Plants | 23.6 MiB | Mohammed Altaweel | October 9, 2019 |
L05 HPLC Chromo | 0.5 MiB | | April 4, 2020 |
L05 HTN Notes | 0.2 MiB | | April 4, 2020 |
L05 Hypertension Therapy1 | 3.5 MiB | zaidadnan862 | October 15, 2019 |
L05 Hypertension Therapy1 | 14.4 MiB | | April 4, 2020 |
L05 Inflammation | 0.5 MiB | | April 4, 2020 |
L05 Inflammation Pathophysiology | 42.8 MiB | | April 4, 2020 |
L05 Instru 5thweek Dr-emad | 1.0 MiB | Ghufran Qarara’h | October 25, 2019 |
L05 Instru Dr Mohammad Khanfar | 1.4 MiB | | April 4, 2020 |
L05 Instru Dr Mohamnad Khanfar | 15.8 MiB | | April 4, 2020 |
L05 Instru Dr Zweri | 70.9 MiB | | April 4, 2020 |
L05 Instru Spectrophotometer 20190215222743 | 4.8 MiB | | April 4, 2020 |
L05 Instru Ultraviolet-Spectroscopy | 32 KiB | | April 4, 2020 |
L05 Instru Uv-spectroscopy Dr-imad Hamdan | 4.7 MiB | Batool Alkurdi | June 27, 2019 |
L05 Instru UVconditions(3) | 43.7 MiB | | April 4, 2020 |
L05 Instrumental Dr Emad IR Examples | 1.7 MiB | | April 4, 2020 |
L05 Instrumental Dr Emad IR Spectroscopy | 9.8 MiB | | April 4, 2020 |
L05 Introduction Analytical | 2.0 MiB | Hanaasaleh | February 21, 2020 |
L05 Isotopes | 18.4 MiB | | April 4, 2020 |
L05 Kinetics | 48.4 MiB | | April 4, 2020 |
L05 Kinetics Dr Mutasim End Of Chapter.2 | 20.5 MiB | | April 4, 2020 |
L05 Kinetics Examples On IV Bolus | 21.3 MiB | | April 4, 2020 |
L05 Kinetics Exercises-and-Drugs-Evaluation-By-Urinary-Data | 20.8 MiB | | April 4, 2020 |
L05 Kinetics One-comp-IV-bolus-IV-infusion | 19.0 MiB | | April 4, 2020 |
L05 Kinetics Vd | 28.4 MiB | | April 4, 2020 |
L05 Marketing | 11.4 MiB | | April 4, 2020 |
L05 Material After H2 Blockers- Dr Sana Bardaweel | 35.9 MiB | Nour Mohammad | July 6, 2020 |
L05 MedChem3 Cholinergics And Anticholinergics Dr Sanaa | 0.6 MiB | | April 4, 2020 |
L05 MedChem3 Cholinergics-and-anticholinergics Dr Sanaa | 0.6 MiB | | April 4, 2020 |
L05 Medicinal 1 Ghadeer | 38.8 MiB | | April 4, 2020 |
L05 Medicinal Ch 28.06.2015 Distribution | 25.8 MiB | | April 4, 2020 |
L05 Medicinal Ch 28.06.2015 Distribution | 0.9 MiB | | April 4, 2020 |
L05 Medicinal Dr Mutasem | 44.0 MiB | | April 4, 2020 |
L05 Medicinal-3 Steroids | 18.0 MiB | | April 4, 2020 |
L05 Medicinal1 | 45.6 MiB | RaneenRiyad | June 23, 2019 |
L05 Medicinal1 Drmotasim | 0.4 MiB | | April 4, 2020 |
L05 Medicinal2 Anticancer | 19.7 MiB | | April 4, 2020 |
L05 Medicinal2.5min | 2.3 MiB | | April 4, 2020 |
L05 Medicinal3 Parasympatholytics | 16.8 MiB | | April 4, 2020 |
L05 Medicnal1 Dr Motasem | 57.2 MiB | | April 4, 2020 |
L05 Micro Sterilization | 1.4 MiB | | April 4, 2020 |
L05 Micro1 Pharmacy Dr Amal Albakri | 0.7 MiB | | April 4, 2020 |
L05 Micro1 Taxonomy Dr Kawareek | 0.9 MiB | | April 4, 2020 |
L05 Micro1 Taxonomy Dr Randa | 2.4 MiB | | April 4, 2020 |
L05 Micro2 Sterilization | 0.8 MiB | | April 4, 2020 |
L05 Microbiology1 PhD Dr Randa | 85.2 MiB | | April 4, 2020 |
L05 Midterm Phytochemical-Study | 81 KiB | | April 4, 2020 |
L05 Molecularspectroscopy2 | 1.9 MiB | Saharaldabbagh | February 18, 2020 |
L05 Monitoring Drug In Urine | 0.6 MiB | Mohannad Alquman | February 29, 2020 |
L05 Neurophysiology Physiology2 | 0.9 MiB | | April 4, 2020 |
L05 Neurophysiology Physiology2 | 0.9 MiB | | April 4, 2020 |
L05 Nitrates-and-nitrates- | 5.3 MiB | | April 4, 2020 |
L05 NP Analysis Phyto Analysis | 19.7 MiB | zaidadnan862 | February 26, 2020 |
L05 NSAIDS-brief | 1.0 MiB | | April 4, 2020 |
L05 NSAIDS-brief | 1.0 MiB | | April 4, 2020 |
L05 Nutrition Energy Yielding Nutrients Dr Mohammed | 0.6 MiB | Malak Ali | February 29, 2020 |
L05 Nutrition Energy-Balance-and-Anthro. | 27.0 MiB | | April 4, 2020 |
L05 Nutrition Lipid Dr.Mohammed | 62.6 MiB | Aliya Fouad | February 20, 2020 |
L05 Nutrition Malnutrition-Assessment | 3.0 MiB | | April 4, 2020 |
L05 Nutritionintroduction-to-clinical-nutrition-calculation2 Drmohammad | 47.6 MiB | | April 4, 2020 |
L05 Organic Drkamal | 3.8 MiB | | December 31, 2020 |
L05 Organic DrMousa 2 | 2.6 MiB | | December 31, 2020 |
L05 Organic Stereoisomers Dr Mohammd | 63.5 MiB | | December 31, 2020 |
L05 OrganicChemistry1 Chapter3 Part1 Dr AlmeqdadHabashneh | 7.5 MiB | | December 31, 2020 |
L05 OTC | 15.9 MiB | | April 4, 2020 |
L05 OTC | 14.8 MiB | | April 4, 2020 |
L05 OTC ALLERGIC-RHINITIS | 1.7 MiB | | April 4, 2020 |
L05 OTC Common-Cold 2 | 17.9 MiB | | April 4, 2020 |
L05 OTC Dealing-with-pain-and-fever-in-pharmacy Lec6 | 19.0 MiB | | April 4, 2020 |
L05 OTC Allergic Rhinitis | 20.6 MiB | | April 4, 2020 |
L05 PARA Burn-sunburn-products-part-3 | 17.7 MiB | | April 4, 2020 |
L05 Para Diaper-rash | 18 KiB | | April 4, 2020 |
L05 Para Oral-contraceptives | 35.2 MiB | | April 4, 2020 |
L05 Para Oral-Cpntraceptives-1 | 1.7 MiB | | April 4, 2020 |
L05 Para Scabies Peduculosis | 0.9 MiB | | April 4, 2020 |
L05 Para Dr Eman | 18.8 MiB | | April 4, 2020 |
L05 Para Dr Eman Headache And Vaginal | 12.0 MiB | | April 4, 2020 |
L05 Para Dr Rana | 79.7 MiB | Hala Azem | March 1, 2020 |
L05 Part1 OTC | 39.5 MiB | | April 4, 2020 |
L05 Part2 Introduction To Muscles | 0.6 MiB | | December 31, 2020 |
L05 Part2 OTC | 13.8 MiB | | April 4, 2020 |
L05 Patho Dr-mazin Neoplasia | 19.9 MiB | | April 4, 2020 |
L05 Patho Neoplasia1 | 0.4 MiB | | April 4, 2020 |
L05 Pathology Dr Manar | 17.0 MiB | | April 4, 2020 |
L05 Pathology Inflamation3 Dr Manar | 56 KiB | | April 4, 2020 |
L05 Pathology Inflammation3 Dr Manar | 12.9 MiB | | April 4, 2020 |
L05 Pathology Inflammation3 Dr Manar 2 | 12.9 MiB | | April 4, 2020 |
L05 Pathology Note-GIT2 Dr Maram . | 95 KiB | | December 31, 2020 |
L05 Pathophysio Dr Eman | 22.2 MiB | | April 4, 2020 |
L05 Pathophysio Inflammation | 0.3 MiB | | April 4, 2020 |
L05 Pathophysio Inflammation Cont | 59.0 MiB | | April 4, 2020 |
L05 Pathophysio Inflammation Dr Eman | 30.3 MiB | | April 4, 2020 |
L05 Pathophysio Inflammation Dr Eman | 30 KiB | | April 4, 2020 |
L05 Pathophysio Inflammation Dralaa | 63.5 MiB | Sarah Degis | June 21, 2019 |
L05 Pathophysio Rheumatoid Arthritis | 0.3 MiB | | April 4, 2020 |
L05 PathoPhysio Topic1 Inflammaion Part4 | 0.2 MiB | | April 4, 2020 |
L05 Pathophysio.14.02.2017 Inflammation | 42.7 MiB | | April 4, 2020 |
L05 Pathophysiology | 18.9 MiB | | April 4, 2020 |
L05 Pathophysiology | 38.2 MiB | | April 4, 2020 |
L05 PathoPhysiology Pain Dr Ala | 1.3 MiB | rawan Abu Oss | November 14, 2020 |
L05 Pathophysiology 30.09.2014 Apoptosis | 15.9 MiB | | April 4, 2020 |
L05 Pathophysiology 30.09.2014 Apoptosis | 0.6 MiB | | April 4, 2020 |
L05 Pathophysiology Asthma | 1.3 MiB | Muneerah Ali | October 26, 2019 |
L05 Pathophysiology Chronic-inflammaion | 24.3 MiB | | April 4, 2020 |
L05 Pathophysiology Inflammation Dr Alaa | 84.9 MiB | Batool Alkurdi | February 21, 2020 |
L05 Pathophysiology Inflammation. | 0.2 MiB | | April 4, 2020 |
L05 Pathophysiology Sheet Inflammation | 0.8 MiB | | April 4, 2020 |
L05 Pharma 1 Cholinoceptor Blocker | 1.2 MiB | | April 4, 2020 |
L05 Pharma-Organic Alcohol Dr Yousuf | 2.1 MiB | | December 31, 2020 |
L05 Pharma-Organic Phenols | 10.7 MiB | | December 31, 2020 |
L05 Pharma-Organic Preparation-and-Reactions-of-Alcohol Dr Yosef | 4.9 MiB | | December 31, 2020 |
L05 Pharma1 | 63.0 MiB | | April 4, 2020 |
L05 Pharma1 Pharmacodynamics | 2.2 MiB | | April 4, 2020 |
L05 Pharma1.26.09.2016 Pharmacodynamics | 65.0 MiB | | April 4, 2020 |
L05 Pharma2 Dr Eman | 19.7 MiB | | April 4, 2020 |
L05 Pharma2 Pancreatic Hormones & Antidiabetic Drugs | 3.3 MiB | | April 4, 2020 |
L05 Pharma2 Pancreatic Hormones & Antidiabetic Drugs | 3.3 MiB | | October 19, 2020 |
L05 Pharmaceutical Calculations | 21.3 MiB | | December 31, 2020 |
L05 Pharmaceutical Emulsions | 6.2 MiB | | April 4, 2020 |
L05 Pharmaceutical Statistics Dr Hatem | 0.8 MiB | | April 4, 2020 |
L05 Pharmaceutical-Statistics Indicators-of-Dispersion D-Ahmad | 16.7 MiB | | April 4, 2020 |
L05 Pharmacodinamic-Notes Pharmacology1 | 3.6 MiB | | April 4, 2020 |
L05 Pharmacokinetics Dr Mhmd | 18.0 MiB | | April 4, 2020 |
L05 Pharmacokinetics One-Compartment | 18.5 MiB | | April 4, 2020 |
L05 Pharmacotherapy2 Dr Maysa | 14.4 MiB | | April 4, 2020 |
L05 PharmaOrganic DrYousef | 3.6 MiB | | December 31, 2020 |
L05 PharmaOrganic Ethers DrAli | 4.5 MiB | | December 31, 2020 |
L05 Phusio2 Renal Drsaleem | 1.5 MiB | | April 4, 2020 |
L05 Phyisology Sheet5 | 0.7 MiB | | December 31, 2020 |
L05 Physical 2 Complexation | 10.0 MiB | QamarSaqqa | March 19, 2020 |
L05 Physical1 Liquid-State Dr Dina | 2.1 MiB | | December 31, 2020 |
L05 Physical1 Topic2 .DrDina | 35.3 MiB | | December 31, 2020 |
L05 Physical2 Complexation | 5.8 MiB | iSpatula | April 4, 2020 |
L05 Physical2 Complexation-1 | 18.7 MiB | iSpatula | April 4, 2020 |
L05 Physical2 Dissolution | 46.9 MiB | iSpatula | April 4, 2020 |
L05 Physical2 Dr Samer | 16.2 MiB | iSpatula | April 4, 2020 |
L05 Physical2 Dr Samer M4a | 27.9 MiB | iSpatula | April 4, 2020 |
L05 Physical2-dr Hatem | 21.4 MiB | iSpatula | April 4, 2020 |
L05 Physio2 Dr Saleem | 38.5 MiB | | April 4, 2020 |
L05 Physio2 Drlo2e | 17.3 MiB | | April 4, 2020 |
L05 Physio2 Drlo2e | 1.0 MiB | | April 4, 2020 |
L05 Physio2 Drloai | 36.3 MiB | | April 4, 2020 |
L05 Physio2 Reproductive-system DrLoai | 37.1 MiB | Alaa Ziad | June 18, 2019 |
L05 Physio2 Reproductive1 DrSaleem | 0.5 MiB | | April 4, 2020 |
L05 Physiology ActionPotential DrLoai | 0.8 MiB | | December 31, 2020 |
L05 Physiology Drsaleem Part1 | 0.4 MiB | | December 31, 2020 |
L05 Physiology Drsaleem Part2 | 0.9 MiB | | December 31, 2020 |
L05 Physiology Muscle2 Dr Loai | 0.3 MiB | | December 31, 2020 |
L05 Physiology Muscle2 Dr Loai | 0.3 MiB | | December 31, 2020 |
L05 Physiology Nerve Physiology Dr Faisal | 46.7 MiB | | December 31, 2020 |
L05 Physiology1 Action-potentials Dr-Loai | 76.4 MiB | | December 31, 2020 |
L05 Physiology1 Chapter4 II DrLoai | 32.6 MiB | | December 31, 2020 |
L05 Physiology1 Dr Loai | 21.9 MiB | | December 31, 2020 |
L05 Physiology1 Week5 DrFeisal | 1.1 MiB | | December 31, 2020 |
L05 Physiology2 Dr Yanal RenalSystem | 0.4 MiB | | April 4, 2020 |
L05 Physiology2 Dr Loai | 23.5 MiB | | April 4, 2020 |
L05 Physiology2 DrSaleem | 20.3 MiB | | April 4, 2020 |
L05 Physiology2 Gastrointestinal-system | 29.5 MiB | | April 4, 2020 |
L05 Phyto | 25.4 MiB | | April 4, 2020 |
L05 Phyto2 | 92.7 MiB | Maramghweiri | June 24, 2019 |
L05 Phytoanalysis Vitamins | 0.8 MiB | iSpatula | April 4, 2020 |
L05 Phytoanalysis Vitamins | 20.3 MiB | iSpatula | April 4, 2020 |
L05 Phytochemistry1 Flavonoids | 18.8 MiB | | April 4, 2020 |
L05 Practice The-need-for-Ph -Care | 22.5 MiB | | April 4, 2020 |
L05 Practice1 | 30.3 MiB | | April 4, 2020 |
L05 Practice1 Barriers-of-pharmaceutical-care | 10.9 MiB | | April 4, 2020 |
L05 Practice2 | 38.0 MiB | | April 4, 2020 |
L05 Practice2 Drug-counseling-of-Inhalers | 20.4 MiB | | April 4, 2020 |
L05 Preformulation Techno1 | 1.7 MiB | | April 4, 2020 |
L05 Renal-system | 0.7 MiB | | April 4, 2020 |
L05 Reproductive Dr Saleem | 27.5 MiB | | April 4, 2020 |
L05 Reproductive Dr Saleem | 34.7 MiB | | April 4, 2020 |
L05 Reproductive Dr Saleem | 0.5 MiB | | April 4, 2020 |
L05 SEDATIVE-HYPNOTICS Part-2 | 0.7 MiB | | April 4, 2020 |
L05 Sesquiterpenes Phyto2 | 3.6 MiB | Maramghweiri | June 26, 2019 |
L05 Statistics DrAhmad | 43.7 MiB | Aya Alassi | June 25, 2019 |
L05 Tablet-Coating Technology2 | 20.1 MiB | | April 4, 2020 |
L05 Techno 2 Dr Dina | 22.3 MiB | | April 4, 2020 |
L05 Techno Dr Lorina | 16.9 MiB | | April 4, 2020 |
L05 Techno1 Departments-of-a-pharmaceutical-firm-And-Concept-Of-Preformulation Dr Ahmad | 22.9 MiB | | April 4, 2020 |
L05 Techno1 Dr Lorina Topic-2 Part-4- Pdf | 0.9 MiB | | April 4, 2020 |
L05 Techno1 Dr Lorina | 0.7 MiB | dana younes | October 20, 2019 |
L05 Techno1 Dr Samer | 20.7 MiB | | April 4, 2020 |
L05 Techno1 M4a[1] | 40.3 MiB | | April 4, 2020 |
L05 Techno1 Mixing | 1.1 MiB | | April 4, 2020 |
L05 Techno2 Atomization And Drying | 0.1 MiB | | April 4, 2020 |
L05 Techno2 Coating Dr Hatim | 1.3 MiB | Samira.Abusaif | February 21, 2020 |
L05 Techno2 Coatingprocces Drahmad | 44.4 MiB | Somaya Alwishah | October 11, 2019 |
L05 Techno2 Dr Hatem Fill Tablet | 21.5 MiB | | April 4, 2020 |
L05 Techno2 Drying | 16.3 MiB | | April 4, 2020 |
L05 Techno2 Tablet Coating1 | 19.5 MiB | | April 4, 2020 |
L05 Technology1 ParticleSizeAnalysis | 14.5 MiB | | April 4, 2020 |
L05 Terpenes Phyto2 | 20.3 MiB | zaidadnan862 | October 11, 2019 |
L05 Thearpy3 Cancer Infections | 53.3 MiB | Aliya Fouad | October 11, 2019 |
L05 Therapy 2 Asthma&COPD | 29.5 MiB | | April 4, 2020 |
L05 Therapy 4 Perioperative Care DrNaila | 58.3 MiB | Farah Qaryouti | February 16, 2020 |
L05 Therapy CKD-complications 2016 | 3.2 MiB | | April 4, 2020 |
L05 Therapy HTN | 35.2 MiB | | April 4, 2020 |
L05 Therapy-1 Hypertension Dr-Alaa | 30.9 MiB | | April 4, 2020 |
L05 Therapy-1- Hypertension Dr-Oriana | 17.8 MiB | | April 4, 2020 |
L05 Therapy-4-10-4 | 24.8 MiB | | April 4, 2020 |
L05 Therapy.16-02.2016 Asthma | 21.7 MiB | | April 4, 2020 |
L05 Therapy.16.2.2016 Asthma | 0.2 MiB | | April 4, 2020 |
L05 Therapy1 Dr Allaalham | 15.8 MiB | | April 4, 2020 |
L05 Therapy1 Hypertension | 0.6 MiB | | April 4, 2020 |
L05 Therapy2 COPD | 66.4 MiB | | April 4, 2020 |
L05 Therapy2 COPD-2-1 | 0.6 MiB | | April 4, 2020 |
L05 Therapy3 Depression | 21.7 MiB | | December 31, 2020 |
L05 Toxic Plants Dr Yahia | 31.7 MiB | Shaimaa Salahat | July 9, 2019 |
L05 Toxic-plants | 64 KiB | | April 4, 2020 |
L05 Toxicology GastricLavag Dr Oriana | 13.5 MiB | | April 4, 2020 |
L05 Toxicology Introduction | 14.7 MiB | | April 4, 2020 |
L05 Toxicology Pesticides | 3.5 MiB | | April 4, 2020 |
L05 ToxicPlants CardiacGlycosides | 10.9 MiB | | April 4, 2020 |
L05 Training-1 -Asthma-and-COPD | 1.4 MiB | | April 4, 2020 |
L05 Triterpenoids | 3.0 MiB | | April 4, 2020 |
L05 Uv-spectrophotometer Instru | 0.2 MiB | | April 4, 2020 |
L05 Week-5 | 6.0 MiB | iSpatula | April 4, 2020 |
L05&L06 Medicinal Chem II Aminoglycosides & Polypeptides. | 0.3 MiB | MohanadRobin | July 12, 2019 |
L05&L06 Flavonoids Medicinal Plants | 0.4 MiB | | April 4, 2020 |
L05- Chromatography Masschromatography Dr Muhammaed | 1.1 MiB | | November 25, 2020 |
L05-Adv-techno-21.3.2017 | 18.3 MiB | | April 4, 2020 |
L05-anatomy-dr Ahmed | 34.5 MiB | | December 31, 2020 |
L05-and-L06-Analytical | 7.9 MiB | iSpatula | April 4, 2020 |
L05-Apoptosiscont-Pathophysio | 14.6 MiB | | April 4, 2020 |
L05-Basic-Communication-Skills-In-Pharmacy-Practice | 19.9 MiB | | April 4, 2020 |
L05-biopharma | 7.3 MiB | | April 4, 2020 |
L05-biopharma-transporters M4a2 | 8.9 MiB | | April 4, 2020 |
L05-carrier-to-ion-pair-Biopharma M4a | 9.7 MiB | | April 4, 2020 |
L05-Clearance-Half-life-and-steady-state | 4.7 MiB | | April 4, 2020 |
L05-coating-equipment-Techno1 | 16.0 MiB | | April 4, 2020 |
L05-cogno-Dr-Olaimat-slide21 | 22.4 MiB | | April 4, 2020 |
L05-DIGITALIS-TOXICITY Output | 0.2 MiB | | April 4, 2020 |
L05-Dr-Jihad | 46.0 MiB | | December 31, 2020 |
L05-Dr-Khanfar | 12.4 MiB | iSpatula | April 4, 2020 |
L05-Endocrine-Physio2-Dr-Ebaa | 21.1 MiB | | April 4, 2020 |
L05-estrogens-and-progestins | 0.1 MiB | | April 4, 2020 |
L05-estrogens-and-progestins | 0.1 MiB | | October 19, 2020 |
L05-Gastric-emptying OK | 0.4 MiB | | April 4, 2020 |
L05-GC | 0.5 MiB | | April 4, 2020 |
L05-GIT-Physiology2 | 3.4 MiB | | April 4, 2020 |
L05-HEART-DISEASIS-PATHOLOGY | 0.1 MiB | | April 4, 2020 |
L05-HEART-DISEASIS-PATHOLOGY 2 | 0.1 MiB | | April 4, 2020 |
L05-Hyperlipidemia 2015-final | 9.4 MiB | | April 4, 2020 |
L05-Hypertension-Therapy1 | 30.3 MiB | | April 4, 2020 |
L05-Instru-Dr-Kanfar-14-2-2017-UV-Fluorescence | 38.7 MiB | | April 4, 2020 |
L05-Ketoprofen-paper | 0.2 MiB | | April 4, 2020 |
L05-mechanism-of-apoptosis-Pathophysio | 15.5 MiB | | April 4, 2020 |
L05-Med-Chem-Medicinal | 47.4 MiB | | April 4, 2020 |
L05-Medicinal-1 | 73.9 MiB | | April 4, 2020 |
L05-Medicinal-2-Antibacterials-Cephalosporins | 15.1 MiB | | April 4, 2020 |
L05-medicinal-3-antihistamines-part-1 | 6.1 MiB | | April 4, 2020 |
L05-medicinal-chemistry-2 | 52.7 MiB | | April 4, 2020 |
L05-Medicinal-Chemistry-2-Cephalosporin-Quinolone | 2.0 MiB | | April 4, 2020 |
L05-Medicinal2-Dr-Moatasem-Antibacterial-MonoBactamCephalosporin | 43.9 MiB | | April 4, 2020 |
L05-Mixing-Techno1 | 1.1 MiB | | April 4, 2020 |
L05-motor-system-physio2 | 9.1 MiB | | April 4, 2020 |
L05-neoplasia-Patho | 21.1 MiB | | April 4, 2020 |
L05-Normal-Probability-Distribution | 7.5 MiB | | April 4, 2020 |
L05-Normal-Probability-Distribution | 7.5 MiB | | April 4, 2020 |
L05-organic-chemistry-chapter-45-Dr -Mohammed-Mubarak- | 2.8 MiB | | December 31, 2020 |
L05-Organic-Cycloalkanes-Dr Mousa | 2.8 MiB | | December 31, 2020 |
L05-OTC-Cold-And-Flu | 15.3 MiB | | April 4, 2020 |
L05-OTC-Introduction | 20.6 MiB | | April 4, 2020 |
L05-OTC-Introduction | 0.6 MiB | | April 4, 2020 |
L05-para-diaper-rash-part-1 | 14.4 MiB | | April 4, 2020 |
L05-Para-infant-formula-L05 | 43.9 MiB | | April 4, 2020 |
L05-parasympathatic-part2 | 62.7 MiB | | April 4, 2020 |
L05-partical-size-techno1 M4a1 | 17.9 MiB | | April 4, 2020 |
L05-Pathophysio-Dr-Alaa- | 20.4 MiB | | April 4, 2020 |
L05-pathophysio-Dr-Eman | 47.6 MiB | | April 4, 2020 |
L05-Pathophysio-inflammation | 25.3 MiB | | April 4, 2020 |
L05-Pathophysiology-10.7.2016-Inflammation M4a | 34.3 MiB | | April 4, 2020 |
L05-Period-pain-Para | 19.6 MiB | | April 4, 2020 |
L05-pharmacognosy-Photosynthesis | 1.4 MiB | | April 4, 2020 |
L05-Phenol-Phyto1 | 20.3 MiB | | April 4, 2020 |
L05-Physical-1-States-of-Matter-Gases-and-liquids-Dr Dina | 27.5 MiB | | December 31, 2020 |
L05-Physical1-Phase-Rule-DMais 2 | 41.4 MiB | | December 31, 2020 |
L05-physiologg-2-Renal-System-Dr-Ebaa | 30.9 MiB | | April 4, 2020 |
L05-Physiology-muscles-system-Dr-Fessal | 4.9 MiB | | December 31, 2020 |
L05-physiology2-cns-dr-faisal-pdf | 0.7 MiB | Dinazyoud | February 21, 2020 |
L05-Phytoanalysis-16.2.2016 | 61.1 MiB | iSpatula | April 4, 2020 |
L05-Statistics-Dr-Hatim | 0.9 MiB | | October 19, 2020 |
L05-structure-bioavailability-Medicinal1 | 18.5 MiB | | April 4, 2020 |
L05-Techno-1 | 36.1 MiB | | April 4, 2020 |
L05-Therapy-3-IBD | 11.6 MiB | | April 4, 2020 |
L05-Therapy3-Major-Depressive-Disorders-Treatment-4-12 | 31.1 MiB | | April 4, 2020 |
L05-Topic2-Dr-Samer | 20.7 MiB | iSpatula | April 4, 2020 |
L05-Triterpens-Phyto2 | 21.9 MiB | | April 4, 2020 |
L05-type-of-pharmacoeconomics-evaluation-part2 | 0.8 MiB | | April 4, 2020 |
L05.00 ADVANCED-PHYSICAL Stability | 1.5 MiB | | April 4, 2020 |
L05.01 ADVACED-PHYSICAL STABILITY-PAPER-TPN | 0.2 MiB | | April 4, 2020 |
L05.Biopharma.bioavailability.dr.rana | 20.0 MiB | Muzdalifa Asaad | October 10, 2019 |
L05.CAM.Notes.Drtalal | 21.1 MiB | Joodjibril98 | March 11, 2020 |
L05.CAM.record | 146 B | Joodjibril98 | February 18, 2020 |
L05.Therapy2.Dr.oriana | 5.2 MiB | Shayma Ahmad | February 22, 2020 |
L05L06 CNS Dr Loai | 10.1 MiB | | April 4, 2020 |
L06 | 17 KiB | | December 31, 2020 |
L06 | 0.8 MiB | | April 4, 2020 |
L06 Irregular Monoterpenes And Sesquiterpenes Phyto2 | 20.2 MiB | zaidadnan862 | October 11, 2019 |
L06 Physiology Dr Faisal (online-audio-converter Com) | 45.6 MiB | Qabas Mansour | February 20, 2020 |
L06 Practice 1 | 93.6 MiB | GhaidaaMelhem | June 26, 2019 |
L06 Standardization Analytical | 0.9 MiB | Olasameeh | February 27, 2020 |
L06 -Advance-techno | 94 KiB | | April 4, 2020 |
L06 -Analytical -Dr -Lina | 4.8 MiB | iSpatula | April 4, 2020 |
L06 -Biotechno Gene-therapy -Dr -Rana | 18.2 MiB | | December 31, 2020 |
L06 -Instrumental -Application-of-UV-spectroscopy -Dr Lina-dahabiyeh | 0.3 MiB | | April 4, 2020 |
L06 -Kinetics -Urinary-kinetic-modelling | 21.2 MiB | | April 4, 2020 |
L06 -Nutrition | 61.4 MiB | | April 4, 2020 |
L06 -Pathophysiology -Dr Eman | 103 MiB | | April 4, 2020 |
L06 -Phytochemical-Analysis | 1.3 MiB | iSpatula | April 4, 2020 |
L06 -Solubility-and-Dissolution | 33.8 MiB | | April 4, 2020 |
L06 -Therapy-2 -Asthma | 14.6 MiB | | April 4, 2020 |
L06 Adv Technology | 29.4 MiB | | April 4, 2020 |
L06 Adv-techno-26.3.2017 | 15.2 MiB | | April 4, 2020 |
L06 Advanced Techno Solubility And Dissolution Dr Ahmad | 0.6 MiB | jumanamufeed | March 1, 2020 |
L06 Advanced Techno Solubility And Dissolution Dr Ahmad (online-audio-converter Com) | 38.6 MiB | jumanamufeed | March 1, 2020 |
L06 Advanced Techno.3.10.2016 | 62.4 MiB | | April 4, 2020 |
L06 Advanced Technology | 0.6 MiB | | April 4, 2020 |
L06 Advanced Technology Solid-solutions-dispersions | 35 KiB | | April 4, 2020 |
L06 Advanced-techno | 16.1 MiB | | April 4, 2020 |
L06 AdvPhyto DrMayada | 17.5 MiB | | April 4, 2020 |
L06 AdvTechno Dr Hatem | 17.8 MiB | | April 4, 2020 |
L06 Analytical | 3.3 MiB | iSpatula | April 4, 2020 |
L06 Analytical Acid Base Titration | 0.9 MiB | Sham Hatem | July 27, 2020 |
L06 Analytical Acid-base Titration | 0.3 MiB | shatha zakariyya | November 8, 2020 |
L06 Analytical Dr Khanfar M4a | 26.2 MiB | iSpatula | April 4, 2020 |
L06 Analytical Dr MKhanfar | 33.6 MiB | iSpatula | April 4, 2020 |
L06 Analytical Dr.Lina | 2.2 MiB | FouadKh | October 11, 2019 |
L06 Analytical DrLina | 5.0 MiB | iSpatula | April 4, 2020 |
L06 Anatomy Connective-TissueFibers | 54.0 MiB | | December 31, 2020 |
L06 Antidiabetic-Antihyperlipidemic Dr Khanfar | 3.0 MiB | Reem Hussein | October 16, 2019 |
L06 ANTITHROMBOTICS Warfarin | 0.6 MiB | | April 4, 2020 |
L06 Atopic Dermatitis And Topical Steroids | 19.1 MiB | Sondos Khalil | July 1, 2019 |
L06 Bacterial Growth Chapter 6 Micro1 Pharmacy Dr Amal Albakri | 1.1 MiB | | April 4, 2020 |
L06 Biopharma | 20.0 MiB | | April 4, 2020 |
L06 Biopharma | 5.5 MiB | | April 4, 2020 |
L06 Biopharma Dr Essa | 27.5 MiB | | April 4, 2020 |
L06 Biopharma Dr Rana | 0.4 MiB | bashar.abdulrazeq | November 4, 2019 |
L06 Biopharma Dr Rana | 21.9 MiB | | April 4, 2020 |
L06 Biopharma Endocytosis 11.6.20171 | 21.4 MiB | | April 4, 2020 |
L06 Biopharma Intestinal Transit Time | 12.7 MiB | | April 4, 2020 |
L06 Biopharma Intestinal Transit Time Dr Essa | 12.8 MiB | | April 4, 2020 |
L06 Biopharma oral drugs dr rana | 6.8 MiB | Muzdalifa Asaad | November 4, 2019 |
L06 Biopharma Passive Diffusion Dr Mohammed | 5.2 MiB | | April 4, 2020 |
L06 Biopharma physiological factors affecting oral abs Dr Rana | 2.5 MiB | Muzdalifa Asaad | November 4, 2019 |
L06 Biopharma Physiological-factors | 13.2 MiB | | April 4, 2020 |
L06 Biopharma Sheet .5 | 0.6 MiB | | April 4, 2020 |
L06 Bone Mineral Homeostasis | 1.7 MiB | | April 4, 2020 |
L06 Bone Mineral Homeostasis | 1.7 MiB | | October 19, 2020 |
L06 Calcium-regulation-1 | 1.3 MiB | | April 4, 2020 |
L06 CAM Indian Med And Natural Med | 27.6 MiB | | April 4, 2020 |
L06 Cancer-emesis-2016 | 4.1 MiB | | April 4, 2020 |
L06 Carbohydrates .Derivatives | 78.8 MiB | | April 4, 2020 |
L06 Carbon-monoxide | 0.5 MiB | | April 4, 2020 |
L06 Chromatography | 1.2 MiB | | April 4, 2020 |
L06 Chromo | 39.2 MiB | | April 4, 2020 |
L06 Chromo Dr Zweiri | 49.1 MiB | | March 1, 2020 |
L06 Chromo HPLC Dr MhdZweri | 16.6 MiB | | April 4, 2020 |
L06 Chromo HPLC-Instrumentation | 33.4 MiB | | April 4, 2020 |
L06 Chromo MS | 0.3 MiB | | April 4, 2020 |
L06 Chromo MS | 0.3 MiB | | April 4, 2020 |
L06 Chromo TLC | 0.8 MiB | | April 4, 2020 |
L06 Chromo- | 26.5 MiB | | April 4, 2020 |
L06 Clinical Biochem2 | 19.4 MiB | | April 4, 2020 |
L06 Clinical-Biochem .Hypernatremia | 33.3 MiB | | April 4, 2020 |
L06 Clinical-Kinetics | 31.9 MiB | | April 4, 2020 |
L06 Clinicalbiochem2 Lipids | 0.2 MiB | | April 4, 2020 |
L06 ClinicalKinetics Revision Dr Maysaa | 17.4 MiB | | April 4, 2020 |
L06 CNS Dr Loai | 48.8 MiB | | April 4, 2020 |
L06 CNS Dr Loai | 0.7 MiB | | April 4, 2020 |
L06 Cogno | 46.0 MiB | | April 4, 2020 |
L06 Cogno DrKhaled | 24.3 MiB | | April 4, 2020 |
L06 Cogno DrYahia | 18.4 MiB | Ibrahim Ahmad | October 13, 2019 |
L06 Cogno M4a1 | 38.8 MiB | | April 4, 2020 |
L06 Cognosy -dr-mohammad-hudaib | 24.4 MiB | | April 4, 2020 |
L06 Cognosy Dr-mohammad-hudaib | 0.9 MiB | | April 4, 2020 |
L06 Common-Cold-2015 Ppt | 5.1 MiB | | April 4, 2020 |
L06 Complexation Physical2 | 10.4 MiB | QamarSaqqa | March 19, 2020 |
L06 Cosmetics Dr Samer | 43.7 MiB | Rema'a Abuhazeem | February 28, 2020 |
L06 Cosmetics Skin-Cleansing-Products Dr Samer | 45.4 MiB | | December 31, 2020 |
L06 Cosmetics Skin-Cleansing-Products Mp3 | 18.3 MiB | | April 4, 2020 |
L06 Cosmo Anti-Acne-Products | 0.4 MiB | | April 4, 2020 |
L06 Cosmo Cleansing-products | 18.1 MiB | | April 4, 2020 |
L06 Cosmo Hair | 16.6 MiB | | April 4, 2020 |
L06 Di And Tri Terpenes Phyto2 | 3.4 MiB | Maramghweiri | June 26, 2019 |
L06 Disorders-of-Ca-P-March-2017 | 0.7 MiB | | April 4, 2020 |
L06 Dispensing Calculations | 16.3 MiB | | December 31, 2020 |
L06 Dispensing Calculations | 22.1 MiB | | December 31, 2020 |
L06 Dispensing Dr Samer M4a | 16.3 MiB | | December 31, 2020 |
L06 Dispensing Routes-of-administration Drdina | 45.9 MiB | | December 31, 2020 |
L06 Dispensing Techniques | 30.7 MiB | | December 31, 2020 |
L06 Dr Hatem Stat | 14.4 MiB | | April 4, 2020 |
L06 Dr Loai Physio2 | 12.5 MiB | | April 4, 2020 |
L06 Dr Zweri | 0.6 MiB | | April 4, 2020 |
L06 Dr-Faisal Physiology2 | 17.4 MiB | | April 4, 2020 |
L06 Dr-manar- Patho Blood-vessel | 42.7 MiB | | April 4, 2020 |
L06 Dr-Rana Kinetics | 17.7 MiB | | April 4, 2020 |
L06 Economics | 44.5 MiB | | April 4, 2020 |
L06 Economics | 10.7 MiB | | April 4, 2020 |
L06 Extraction Phyto Analysis | 19.5 MiB | zaidadnan862 | February 28, 2020 |
L06 Hallucinogenic Plants | 24.1 MiB | Mohammed Altaweel | October 14, 2019 |
L06 Heart Failure Therapy1 | 5.1 MiB | zaidadnan862 | October 15, 2019 |
L06 HPLC Chromo | 0.1 MiB | | April 4, 2020 |
L06 Inflammation Pathophysiology | 23 KiB | | April 4, 2020 |
L06 Inflammation Pathophysiology | 38.8 MiB | | April 4, 2020 |
L06 Instro Dr-emad-electrochemistry | 3.8 MiB | | April 4, 2020 |
L06 Instro Spectrophotometer3 | 3.8 MiB | | April 4, 2020 |
L06 Instru 6thweek Dr-emad | 7.7 MiB | Ghufran Qarara’h | November 3, 2019 |
L06 Instru Dr Mohammad Khanfar | 0.5 MiB | | April 4, 2020 |
L06 Instru Dr Zweri | 65.7 MiB | | April 4, 2020 |
L06 Instru SystemsWithMoreThanOneAbsorber | 32.2 MiB | | April 4, 2020 |
L06 Instru Ultraviolet-Spectroscopy | 64 KiB | | April 4, 2020 |
L06 Instru Uv-spectroscopy Dr-imad Hamdan | 5.1 MiB | Batool Alkurdi | June 28, 2019 |
L06 Instrumental Dr Imad NMR Spectroscopy | 4.4 MiB | | April 4, 2020 |
L06 Isotopes | 17.2 MiB | | April 4, 2020 |
L06 Kinetics | 46.2 MiB | | April 4, 2020 |
L06 Kinetics Drug-evaluation-by-urinary-data | 35.6 MiB | | April 4, 2020 |
L06 Kinetics IV Infusion | 21.1 MiB | | April 4, 2020 |
L06 Kinetics IV-infusion | 20.5 MiB | | April 4, 2020 |
L06 Kinetics One-compartment-open-model | 31.0 MiB | | April 4, 2020 |
L06 Kinetics Sigma-Minus-and-IV-Infusion | 20.1 MiB | | April 4, 2020 |
L06 L07 Chromatography Dr Muhammed | 0.7 MiB | Malak Ali | February 4, 2020 |
L06 Lab Fundi Medication Adminstration Dr Zyad | 1.4 MiB | | April 4, 2020 |
L06 Marketing | 14.8 MiB | | April 4, 2020 |
L06 MedChem3 Cholinergics And Anticholinergics Dr Sanaa | 0.7 MiB | | April 4, 2020 |
L06 MedChem3 Cholinergics-and-anticholinergics Dr Sanaa | 0.7 MiB | | April 4, 2020 |
L06 MEDICINAL DR GHADEER | 0.6 MiB | ShahdHabash | October 26, 2019 |
L06 Medicinal Ch 29.06.2015 Pharmacokinetics | 28.9 MiB | | April 4, 2020 |
L06 Medicinal Ch 29.06.2015 Pharmacokinetics | 0.8 MiB | | April 4, 2020 |
L06 Medicinal Dr Mutasem | 41.9 MiB | | April 4, 2020 |
L06 Medicinal-1 Metabolism | 29.9 MiB | | April 4, 2020 |
L06 Medicinal-Chem-II-Tetracyclines-converted (1) | 0.5 MiB | Salah Samha | March 7, 2020 |
L06 Medicinal1 | 46.3 MiB | RaneenRiyad | June 23, 2019 |
L06 Medicinal1 Dr Ghadeer | 39.9 MiB | | April 4, 2020 |
L06 Medicinal1 Drmotasim | 4.2 MiB | | April 4, 2020 |
L06 Medicinal2 Anti-viral | 17.8 MiB | | April 4, 2020 |
L06 Medicinal2 Antifungal | 15.0 MiB | | April 4, 2020 |
L06 Medicinal3 Sympathetic | 15.9 MiB | | April 4, 2020 |
L06 Medicnal1 Dr Motasem | 64.0 MiB | | April 4, 2020 |
L06 Micro Principles-of-GMP | 0.3 MiB | | April 4, 2020 |
L06 Micro1 Viruses Dr Kawareek | 1.5 MiB | | April 4, 2020 |
L06 Micro1 Viruses Dr Randa | 2.5 MiB | | April 4, 2020 |
L06 Micro2 Sterile Products | 0.5 MiB | | April 4, 2020 |
L06 Microbiology1 PhD Dr Randa M4a | 86.8 MiB | | April 4, 2020 |
L06 Molecularspectroscopy2 Instru | 1.6 MiB | Saharaldabbagh | February 20, 2020 |
L06 Monobactams Dr Jehad | 19.6 MiB | | April 4, 2020 |
L06 Neurophysiology Physiology2 | 1.3 MiB | | April 4, 2020 |
L06 Nutrition Anthropometric-Data | 29.1 MiB | | April 4, 2020 |
L06 Nutrition Introduction-to-clinical-nutrition-calculations3 Drmohammad | 46.0 MiB | | April 4, 2020 |
L06 Nutrition IVFE Dr.Mohammed | 0.3 MiB | Malak Ali | March 6, 2020 |
L06 Nutrition IVFEs Dr.Mohammed | 62.5 MiB | Aliya Fouad | February 24, 2020 |
L06 Nutrition Lipids-Part-I | 2.8 MiB | | April 4, 2020 |
L06 Organic Cycloalkanes Dr Mohammad | 2.8 MiB | | December 31, 2020 |
L06 Organic Cycloalkanes Dr Mohammd | 100 MiB | | April 4, 2020 |
L06 Organic Drkamal | 4.3 MiB | | December 31, 2020 |
L06 Organic DrMousa | 3.4 MiB | | December 31, 2020 |
L06 OrganicChemistry1 Chapter3 Part2 Dr AlmeqdadHabashneh | 2.6 MiB | | December 31, 2020 |
L06 Osteoporosis | 7.6 MiB | | April 4, 2020 |
L06 Osteopososis 2016 -Final | 4.0 MiB | | April 4, 2020 |
L06 OTC | 35.1 MiB | | April 4, 2020 |
L06 OTC Allergic-Rhinitis | 18.1 MiB | | April 4, 2020 |
L06 OTC Analgesic-and-antipyretics | 3.3 MiB | | April 4, 2020 |
L06 OTC Pain-and-fever Lec7 | 18.3 MiB | | April 4, 2020 |
L06 OTC Allergic Rhinitis | 22.0 MiB | | April 4, 2020 |
L06 OTC- | 22.3 MiB | | April 4, 2020 |
L06 OTC-1 | 12.8 MiB | | April 4, 2020 |
L06 Pain | 0.6 MiB | | April 4, 2020 |
L06 PARA Atopic-dermatitis-part-1 | 38.2 MiB | | April 4, 2020 |
L06 Para Atopic-Dermatitis1 | 16 KiB | | April 4, 2020 |
L06 Para Fungal-infections 2015 | 1.5 MiB | | April 4, 2020 |
L06 Para Oral-contraceptives | 35.4 MiB | | April 4, 2020 |
L06 Para Oral-contraceptives-2 | 1.2 MiB | | April 4, 2020 |
L06 Para Dr Eman | 18.3 MiB | | April 4, 2020 |
L06 Para Dr Eman VaginalCandiditis | 5.7 MiB | | April 4, 2020 |
L06 Para Dr Rana | 21.1 MiB | Hala Azem | March 3, 2020 |
L06 Patho Neoplasia2 | 0.1 MiB | | April 4, 2020 |
L06 Pathology Dr Maha | 38.0 MiB | | April 4, 2020 |
L06 Pathology Hemodynamic Disorders.1 Dr Manar | 16.5 MiB | | April 4, 2020 |
L06 Pathology Hemodynamic Disorders.1 Dr Manar 2 | 16.5 MiB | | April 4, 2020 |
L06 Pathology Neoplastic Diseases Dr Maha . | 0.1 MiB | | April 4, 2020 |
L06 Pathophysio ApoptosisAndAngiogenesis | 0.8 MiB | | April 4, 2020 |
L06 Pathophysio ApotosisAngiogenesis | 41.3 MiB | | April 4, 2020 |
L06 Pathophysio Cellular Response | 1.0 MiB | | April 4, 2020 |
L06 Pathophysio Dr Eman | 22.6 MiB | | April 4, 2020 |
L06 Pathophysio Inflammation Dralaa | 41.4 MiB | Sarah Degis | June 21, 2019 |
L06 Pathophysio Inflammation2 Dr Eman | 27 KiB | | April 4, 2020 |
L06 PathoPhysio Topic1 Inflammaion Part5 | 0.2 MiB | | April 4, 2020 |
L06 Pathophysio.19.02.2017 Inflammation | 40.7 MiB | | April 4, 2020 |
L06 Pathophysiology | 42.5 MiB | | April 4, 2020 |
L06 Pathophysiology 02.10.2014 Inflammation | 16.6 MiB | | April 4, 2020 |
L06 Pathophysiology 02.10.2014 Inflammation | 0.6 MiB | | April 4, 2020 |
L06 Pathophysiology Apo-EX And Inflammation | 38.0 MiB | | April 4, 2020 |
L06 PathoPhysiology Arthritis Dr Ala | 1.1 MiB | rawan Abu Oss | November 14, 2020 |
L06 Pathophysiology Atherosclerosis | 0.8 MiB | Muneerah Ali | December 2, 2019 |
L06 Pathophysiology Inflammation Dr ALA Alham | 39.3 MiB | Afnan Dabobash | October 16, 2019 |
L06 Pathophysiology Inflammation-1 Dr Eman | 25.1 MiB | | April 4, 2020 |
L06 Pathophysiology Pain | 25.1 MiB | | April 4, 2020 |
L06 Pathophysiology Sheet Inflammation | 0.5 MiB | | April 4, 2020 |
L06 Pharma-Organic Alcohol DrYousuf | 2.1 MiB | | December 31, 2020 |
L06 Pharma-Organic Ethers-Aldehyde-Ketone | 4.5 MiB | | December 31, 2020 |
L06 Pharma-Organic Reactions-of-Alcohol Dr Yosef | 6.0 MiB | | December 31, 2020 |
L06 Pharma1 | 19.4 MiB | | April 4, 2020 |
L06 Pharma1 Adrenoceptor Agonists And Sympathomimetic Drugs Part 2 | 2.6 MiB | | April 4, 2020 |
L06 Pharma1 Adrenoceptor Antagonist | 1.4 MiB | | April 4, 2020 |
L06 Pharma1 Pharmacodynamics | 2.4 MiB | | April 4, 2020 |
L06 Pharma1.28.09.2016 Pharmacodynamics | 63.7 MiB | | April 4, 2020 |
L06 Pharma2 Dr Eman | 19.0 MiB | | April 4, 2020 |
L06 Pharmaceutical Calculations.2 | 24.4 MiB | | December 31, 2020 |
L06 Pharmaceutical Statistics Dr Hatem | 0.6 MiB | | April 4, 2020 |
L06 Pharmaceutical-Statistics Indicators-of-Dispersion D-Ahmad | 17.5 MiB | | April 4, 2020 |
L06 Pharmacokinetics Dr Mhmd | 23.7 MiB | | April 4, 2020 |
L06 Pharmacokinetics One-Compartment | 18.4 MiB | | April 4, 2020 |
L06 Pharmacotherapy2 Dr Maysa | 21.3 MiB | | April 4, 2020 |
L06 PharmaOrganic EthersAldehydeKetone | 13.0 MiB | | December 31, 2020 |
L06 Physical1 Liquid-State Dr Dina | 2.0 MiB | | December 31, 2020 |
L06 Physical2 Complexation | 19.3 MiB | iSpatula | April 4, 2020 |
L06 Physical2 Complexation | 5.0 MiB | iSpatula | April 4, 2020 |
L06 Physical2 Diffusion | 21.3 MiB | iSpatula | April 4, 2020 |
L06 Physical2 Dr Samer M4a | 32.6 MiB | iSpatula | April 4, 2020 |
L06 Physical2 DrSamer | 26.6 MiB | iSpatula | April 4, 2020 |
L06 Physical2 Interfacial Phenomena | 0.5 MiB | iSpatula | April 4, 2020 |
L06 Physio Drlo2e | 16.1 MiB | | April 4, 2020 |
L06 Physio2 Dr Saleem | 35.8 MiB | | April 4, 2020 |
L06 Physio2 Drlo2e | 0.7 MiB | | April 4, 2020 |
L06 Physio2 Drloai | 39.6 MiB | | April 4, 2020 |
L06 Physio2 Reproductive-system DrLoai | 26.6 MiB | Alaa Ziad | June 23, 2019 |
L06 Physio2 Reproductive2 DrSaleem | 0.6 MiB | | April 4, 2020 |
L06 Physiochemical Properties | 2.0 MiB | iSpatula | April 4, 2020 |
L06 Physiolgy Drsaleem | 0.3 MiB | | December 31, 2020 |
L06 Physiology Cns Dr Faisal | 1.8 MiB | Dinazyoud | February 25, 2020 |
L06 Physiology Muscle DrLoai | 1.0 MiB | | December 31, 2020 |
L06 Physiology Muscle Physiology Dr Faisal | 49.5 MiB | | December 31, 2020 |
L06 Physiology MuscleFatigue Dr Loai | 0.3 MiB | | December 31, 2020 |
L06 Physiology MuscleFatigue Dr Loai | 0.3 MiB | | December 31, 2020 |
L06 Physiology Sheet6 Muscle-Physiology | 0.4 MiB | | December 31, 2020 |
L06 Physiology1 Chapter4 III Dr Loai | 32.2 MiB | | December 31, 2020 |
L06 Physiology1 Dr Loai | 20.0 MiB | | December 31, 2020 |
L06 Physiology1 Dr-Loai | 22.5 MiB | | December 31, 2020 |
L06 Physiology1 Week6 DrFeisal | 1.7 MiB | | December 31, 2020 |
L06 Physiology2 Dr Faisal DigestiveSystem | 39 KiB | | April 4, 2020 |
L06 Physiology2 DrLoai NervousSystem | 0.5 MiB | | April 4, 2020 |
L06 Physiology2 DrSaleem | 20.8 MiB | | April 4, 2020 |
L06 Physiology2 Gastrointestinal-system | 27.8 MiB | | April 4, 2020 |
L06 Physival2 Dr Hatem | 20.0 MiB | iSpatula | April 4, 2020 |
L06 Phyto | 16.6 MiB | | April 4, 2020 |
L06 Phyto2 | 88.5 MiB | Maramghweiri | June 24, 2019 |
L06 Phytoanalysis Dr Muhammad | 21.4 MiB | iSpatula | April 4, 2020 |
L06 Phytoanalysis Vitamins | 0.7 MiB | iSpatula | April 4, 2020 |
L06 Phytoanalysis Vitamins | 22.0 MiB | iSpatula | April 4, 2020 |
L06 Phytoanalysis Vitamins 2 | 0.8 MiB | iSpatula | April 4, 2020 |
L06 Phytochemistry1 Flavonoids | 19.3 MiB | | April 4, 2020 |
L06 Plasticizer Techno2 Dr-Hatem | 2.9 MiB | | April 4, 2020 |
L06 Practice Barriers-to-Ph -Care | 30.3 MiB | | April 4, 2020 |
L06 Practice1 | 20.3 MiB | | April 4, 2020 |
L06 Practice1 Drug-information-sources | 15.5 MiB | | April 4, 2020 |
L06 Practice2 | 59.4 MiB | | April 4, 2020 |
L06 Practice2 Drug-Counseling-of-Different-dosage-forms | 18.3 MiB | | April 4, 2020 |
L06 Rate-and-Sigma-Minus-Method | 20.5 MiB | | April 4, 2020 |
L06 Reproductive Dr Saleem | 28.2 MiB | | April 4, 2020 |
L06 Reproductive Dr Saleem | 34.4 MiB | | April 4, 2020 |
L06 Reproductive Dr Saleem | 0.4 MiB | | April 4, 2020 |
L06 Signaling-Mechanisim-Notes Pharmacology1 | 2.5 MiB | | April 4, 2020 |
L06 Solution Techno1 | 6.3 MiB | | April 4, 2020 |
L06 Solvents Techno2 Dr-Hatem | 71.2 MiB | | April 4, 2020 |
L06 Statistics DecriptiveStatistics | 37.2 MiB | | April 4, 2020 |
L06 Statistics DrAhmad | 48.5 MiB | Aya Alassi | June 25, 2019 |
L06 Tablet-Coating Dr Ahmad-Bani-jaber | 4.4 MiB | | April 4, 2020 |
L06 Tablet-Coating Technology2 | 36.1 MiB | | April 4, 2020 |
L06 Techno 2 Dr Dina | 21.2 MiB | | April 4, 2020 |
L06 Techno1 | 28.1 MiB | | April 4, 2020 |
L06 Techno1 Determination-Of-Solubility Dr Ahmad | 21.8 MiB | | April 4, 2020 |
L06 Techno1 Dr Lorina | 1.0 MiB | dana younes | October 31, 2019 |
L06 Techno1 Dr Lorina Topic-3 -part-1 -pdf | 3.9 MiB | | April 4, 2020 |
L06 Techno1 Dr Lorina | 23.0 MiB | | April 4, 2020 |
L06 Techno1 Dr Samer | 21.4 MiB | | April 4, 2020 |
L06 Techno1 Granulation | 1.5 MiB | | April 4, 2020 |
L06 Techno1 M4a[1] | 34.8 MiB | | April 4, 2020 |
L06 Techno2 Coating Dr Hatim | 1.9 MiB | Samira.Abusaif | February 21, 2020 |
L06 Techno2 Coatingprocess Drahmad | 53.3 MiB | Somaya Alwishah | October 15, 2019 |
L06 Techno2 Dr Hatem Film Formation | 16.4 MiB | | April 4, 2020 |
L06 Techno2 Over-wettingcontinuous-film-formation | 17.2 MiB | | April 4, 2020 |
L06 Techno2 Tablet Coating1 | 19.4 MiB | | April 4, 2020 |
L06 Technology1 Paritcle-size-reduction | 19.1 MiB | | April 4, 2020 |
L06 Tetraterpenes And Cardiac Glycosides | 41 KiB | | April 4, 2020 |
L06 Therapy 4 Perioperative Care And Sepsis DrNaila | 59.2 MiB | Farah Qaryouti | February 19, 2020 |
L06 Therapy HTN | 30.8 MiB | | April 4, 2020 |
L06 Therapy-1 -hypertension- Dr-Alaa | 64.9 MiB | | April 4, 2020 |
L06 Therapy-1 Hypertension | 0.3 MiB | | April 4, 2020 |
L06 Therapy-4-12-4 | 27.2 MiB | | April 4, 2020 |
L06 Therapy.18.02.2016 Asthma | 19.1 MiB | | April 4, 2020 |
L06 Therapy.18.02.2016 Asthma | 0.5 MiB | | April 4, 2020 |
L06 Therapy1 Dr Allaallham | 32.2 MiB | | April 4, 2020 |
L06 Therapy1 HTN-note | 0.5 MiB | | April 4, 2020 |
L06 Therapy1 Hypertension Dr-Oriana | 15.9 MiB | | April 4, 2020 |
L06 Therapy2 COPD | 24.8 MiB | | April 4, 2020 |
L06 Therapy2 COPD | 0.7 MiB | | April 4, 2020 |
L06 Therapy2 COPD | 67.0 MiB | | April 4, 2020 |
L06 Therapy3 Anemia&VTE | 59.5 MiB | Aliya Fouad | October 11, 2019 |
L06 Therapy3 Anxiety | 21.3 MiB | | December 31, 2020 |
L06 Toxic Plants | 0.9 MiB | | April 4, 2020 |
L06 Toxic Plants Dr Yahia | 51.4 MiB | Shaimaa Salahat | July 9, 2019 |
L06 Toxicology Cyanide | 0.9 MiB | | April 4, 2020 |
L06 Toxicology Dr Oriana | 18.5 MiB | | April 4, 2020 |
L06 Toxicology Introduction | 98.3 MiB | | April 4, 2020 |
L06 ToxicPlants Castor | 13.1 MiB | | April 4, 2020 |
L06 UV-spectrophotometer-part-2 Instu | 0.5 MiB | | April 4, 2020 |
L06- Chromatography Masschromatography Dr Muhammaed | 0.7 MiB | | November 25, 2020 |
L06-Adrenoceptor-Agonists-Sympathomimetic-Drugs Fall-2015 2 | 1.9 MiB | | April 4, 2020 |
L06-Apoptosis-con Ogg | 16.6 MiB | | April 4, 2020 |
L06-Basic-Communication Role-Play-1 | 17.7 MiB | | April 4, 2020 |
L06-biopharma | 19.5 MiB | | April 4, 2020 |
L06-BLOOD-VESSELS-PATHOLOGY | 1.4 MiB | | April 4, 2020 |
L06-cancer-Patho | 20.4 MiB | | April 4, 2020 |
L06-cogno-Dr-Olaimat-slide22 | 26.9 MiB | | April 4, 2020 |
L06-Diabetes Mellitus 2015-final For Students | 7.3 MiB | | April 4, 2020 |
L06-Dr-Khanfar | 21.3 MiB | iSpatula | April 4, 2020 |
L06-Endocrine-Physio2-Dr-Ebaa | 19.0 MiB | | April 4, 2020 |
L06-Flavanoid-Phyto1 M4a | 20.6 MiB | | April 4, 2020 |
L06-Granulation-Techno1 | 1.5 MiB | | April 4, 2020 |
L06-heparin | 0.2 MiB | | April 4, 2020 |
L06-HPLC-1-introduction | 0.6 MiB | | April 4, 2020 |
L06-Hypertenaion-Therapy1 | 9.1 MiB | | April 4, 2020 |
L06-Hypertension-Therapy1 | 29.4 MiB | | April 4, 2020 |
L06-Instru-Dr-Kanfar-19-2-2017-Fluorescence-chromotography | 45.1 MiB | | April 4, 2020 |
L06-Intestinal-transit-time OK | 0.3 MiB | | April 4, 2020 |
L06-L8-ACEI | 0.4 MiB | | April 4, 2020 |
L06-Loading-and-maintenance-dose-and-dynamic | 4.4 MiB | | April 4, 2020 |
L06-lung | 1.9 MiB | | April 4, 2020 |
L06-Mechanism-of-ApoptosisconPathophysio | 18.0 MiB | | April 4, 2020 |
L06-Med -Chem -1-Medicinl | 21.6 MiB | | April 4, 2020 |
L06-Medicinal-1 | 69.0 MiB | | April 4, 2020 |
L06-Medicinal-2-Antibacterials-Cephalosporins | 14.0 MiB | | April 4, 2020 |
L06-medicinal-3-antihistamines-part-2 | 7.8 MiB | | April 4, 2020 |
L06-Medicinal-3parasympathatic-sympathetic-part-1 | 67.5 MiB | | April 4, 2020 |
L06-Medicinal-Chemistry-2-Quinolones | 1.4 MiB | | April 4, 2020 |
L06-Medicinal2-Dr-Moatasem-Antibacterial-CephalosporinQuinolone | 44.8 MiB | | April 4, 2020 |
L06-normal-skewed-distribution-techno1 M4a1 | 15.3 MiB | | April 4, 2020 |
L06-online-audio-converter Com | 27.2 MiB | | April 4, 2020 |
L06-Oral-Drug-Abosorption-Biopharma | 13.5 MiB | | April 4, 2020 |
L06-Organic-chemistry-Complete-chapter-5-dr -Mohammad-mobarak- | 4.4 MiB | | December 31, 2020 |
L06-Organic-Steriochemistry-Dr Mousa | 6.8 MiB | | December 31, 2020 |
L06-OTC-Cold-And-Flu | 15.3 MiB | | April 4, 2020 |
L06-OTC-Management-Of-Common-Cold | 0.2 MiB | | April 4, 2020 |
L06-para-diaper-rash-part-2 | 11.2 MiB | | April 4, 2020 |
L06-Para-infant-formula-diaper-rash-L01 | 23.4 MiB | | April 4, 2020 |
L06-Pathophysio-Dr-Alaa- | 26.3 MiB | | April 4, 2020 |
L06-pathophysio-Dr-Eman | 52.8 MiB | | April 4, 2020 |
L06-pathophysio-inflammation- | 44.5 MiB | | April 4, 2020 |
L06-Pathophysiology-12.7.2016-Inflammation M4a | 26.5 MiB | | April 4, 2020 |
L06-PharmaOrganic-AldehydesKetones-DrAli | 3.7 MiB | | December 31, 2020 |
L06-phyology2-Endocrine-Dr-saleem | 40.3 MiB | | April 4, 2020 |
L06-Physical1-Phase-Rule-DMais | 58.2 MiB | | December 31, 2020 |
L06-physiology-Dr-Loai-Zghoul | 20.6 MiB | | December 31, 2020 |
L06-Physiology-muscles-fluids-Dr-Fessal | 0.7 MiB | | December 31, 2020 |
L06-Phytoanalysis-21.2.2016 | 52.8 MiB | iSpatula | April 4, 2020 |
L06-Sampling-Distributions-of-the-mean | 2.0 MiB | | April 4, 2020 |
L06-Sampling-Distributions-of-the-mean | 2.0 MiB | | April 4, 2020 |
L06-Smoking-cessation-1 | 40.8 MiB | | April 4, 2020 |
L06-solvent-to-colourants-Techno2 | 17.0 MiB | | April 4, 2020 |
L06-Statistics-Dr Hatim | 0.8 MiB | | October 19, 2020 |
L06-Structure-distribution-relationship-Medicinal1 | 20.7 MiB | | April 4, 2020 |
L06-tablet-coating-techno2 | 33.1 MiB | | April 4, 2020 |
L06-Techno-1 | 36.2 MiB | | April 4, 2020 |
L06-Techno2 Over-wetting-and-film-formation | 96 KiB | | April 4, 2020 |
L06-Tetraterpenes-and-cardiac-glycoside-Phyto2 | 21.4 MiB | | April 4, 2020 |
L06-Therapy3-Anxiety-6-12 | 43.1 MiB | | April 4, 2020 |
L06-Therapy3-IBD | 22.8 MiB | | April 4, 2020 |
L06-Therapy4-RhD-Alloimmunization-Antenatal-Glucocorticoids | 0.6 MiB | | April 4, 2020 |
L06-Thyroid-antithyroid-drugs | 0.2 MiB | | April 4, 2020 |
L06-Thyroid-antithyroid-drugs | 0.2 MiB | | October 19, 2020 |
L06-Topic2-Dr-Samer | 37.3 MiB | iSpatula | April 4, 2020 |
L06-Training-1-Alarming-Medications | 0.1 MiB | | April 4, 2020 |
L06-vesicular-transport M4a1 | 4.8 MiB | | April 4, 2020 |
L06-vision-Physio2 | 8.8 MiB | | April 4, 2020 |
L06.0 ADVANCED-PHYSIACAL Rheology-and-Viscometry | 2.8 MiB | | April 4, 2020 |
L06.01 Advanced-physical- -rheology-papers | 0.4 MiB | | April 4, 2020 |
L06.CAM.Notes.Drtalal | 39.3 MiB | Joodjibril98 | March 11, 2020 |
L06.CAM.record | 65.2 MiB | Joodjibril98 | February 20, 2020 |
L06.pathophysiology.dralaa | 1.0 MiB | Batool Alkurdi | February 22, 2020 |
L06.therapy2.Dr.oriana | 3.0 MiB | Shayma Ahmad | February 28, 2020 |
L067 Aldehydeketone-CA | 12.6 MiB | | December 31, 2020 |
L067 Week-6-and-7 | 20.7 MiB | iSpatula | April 4, 2020 |
L06L07 Techno2 Filmformation Drahmad | 1.3 MiB | Somaya Alwishah | October 17, 2019 |
L06L07-Handling-the-results-of-economics-evaluation- | 0.9 MiB | | April 4, 2020 |
L06medicinalchemistry2 | 73.2 MiB | | April 4, 2020 |
L06Physical-1-States-of-matter-Gases-and-Liquids-Dr -Dina | 29.4 MiB | | December 31, 2020 |
L07 | 13 KiB | | December 31, 2020 |
L07 | 44.0 MiB | | April 4, 2020 |
L07 | 2.7 MiB | | April 4, 2020 |
L07 Chromatography Masschromatography Dr Muhammaed (2) | 1.3 MiB | doaa mohammad | January 3, 2021 |
L07 Physiology Dr Faisal (online-audio-converter Com) | 42.8 MiB | Qabas Mansour | February 25, 2020 |
L07 Practice 1 | 74.7 MiB | GhaidaaMelhem | June 26, 2019 |
L07 Therapy3 Depression & Anxiety | 20.3 MiB | | April 4, 2020 |
L07 -Acute-inflammation-pathophysiology | 38.9 MiB | | April 4, 2020 |
L07 -Advance-techno | 0.1 MiB | | April 4, 2020 |
L07 -Instrumental -Fluorescence -Dr -lina-dahabiyeh | 0.4 MiB | | April 4, 2020 |
L07 -Kinetics -Sigma-Minus-IV-Infusion | 19.1 MiB | | April 4, 2020 |
L07 -Kinetics -Urinary-data-IV-infusion | 20.2 MiB | | April 4, 2020 |
L07 -Medicinal-1 Metabolism | 28.4 MiB | | April 4, 2020 |
L07 -Nutrition | 73.2 MiB | | April 4, 2020 |
L07 -Part1 -Analytical -Dr -Lina -pdf | 1.2 MiB | iSpatula | April 4, 2020 |
L07 -Part2 -Analytical -Dr -lina | 3.6 MiB | iSpatula | April 4, 2020 |
L07 -Patho Dr Manar Blood-vessels-and-heart | 40.8 MiB | | April 4, 2020 |
L07 -Pathophysiology -Dr Eman | 103 MiB | | April 4, 2020 |
L07 -Phytochemical-Analysis | 0.8 MiB | iSpatula | April 4, 2020 |
L07 -Therapy-2 -Asthma | 15.1 MiB | | April 4, 2020 |
L07 7thweek Instru Dr Emad | 8.8 MiB | Ghufran Qarara’h | November 27, 2019 |
L07 Acid Base Titration Analytical | 1.2 MiB | Olasameeh | February 27, 2020 |
L07 Adrenoceptor-Antagonist-Drugs 2 | 1.2 MiB | | April 4, 2020 |
L07 Adv Technology | 23.4 MiB | | April 4, 2020 |
L07 Advanced Techno Solubility And Dissolution Dr Ahmad | 0.7 MiB | jumanamufeed | March 1, 2020 |
L07 Advanced Techno Solubility And Dissolution Dr Ahmad (online-audio-converter Com) | 41.1 MiB | jumanamufeed | March 1, 2020 |
L07 Advanced Technology | 0.3 MiB | | April 4, 2020 |
L07 Advanced Technology Solid-solutions-dispersion | 55 KiB | | April 4, 2020 |
L07 Advanced Technology.5.10.2016 | 75.4 MiB | | April 4, 2020 |
L07 Advanced-techno Solid-solutions-and-dispersions | 17.4 MiB | | April 4, 2020 |
L07 AdvPhyto Dr Mayada | 15.7 MiB | | April 4, 2020 |
L07 AdvTechno Dr Hatem | 16.1 MiB | | April 4, 2020 |
L07 Aminoglycosides Dr Jehad | 18.0 MiB | | April 4, 2020 |
L07 Analytical | 1.3 MiB | iSpatula | April 4, 2020 |
L07 Analytical Acid Base Titration | 2.0 MiB | Sham Hatem | August 3, 2020 |
L07 Analytical Acid-base Titration | 0.3 MiB | shatha zakariyya | November 8, 2020 |
L07 Analytical Dr Khanfar M4a | 36.0 MiB | iSpatula | April 4, 2020 |
L07 Analytical Dr MKhanfar | 15.8 MiB | iSpatula | April 4, 2020 |
L07 Analytical DrLina 2 | 3.4 MiB | iSpatula | April 4, 2020 |
L07 Anatomy Adipose-TissueCartilage | 72.0 MiB | | December 31, 2020 |
L07 Anti-tacking-agent -Techno2 | 74.0 MiB | | April 4, 2020 |
L07 Anti-tacking-and-colourant -Techno2 Dr-Harem | 4.2 MiB | | April 4, 2020 |
L07 Antihyperlipidemic Dr Khanfar | 1.3 MiB | Reem Hussein | October 16, 2019 |
L07 Application-of-UV Instru | 0.2 MiB | | April 4, 2020 |
L07 Atopic Dermatitis And Topical Steroids 2 | 16.4 MiB | Sondos Khalil | July 1, 2019 |
L07 Bacteria Micro1 Pharmacy Dr Amal Albakri | 0.9 MiB | | April 4, 2020 |
L07 Biopharma | 15.9 MiB | | April 4, 2020 |
L07 Biopharma | 4.0 MiB | | April 4, 2020 |
L07 Biopharma oral drugs Dr Rana | 44.5 MiB | Muzdalifa Asaad | November 4, 2019 |
L07 Biopharma Bioavailability - Physicochemical And Dosage Form Factors Dr Essa | 0.7 MiB | | April 4, 2020 |
L07 Biopharma Dr Essa | 27.1 MiB | | April 4, 2020 |
L07 Biopharma Dr Mohammed | 13.1 MiB | | April 4, 2020 |
L07 Biopharma Dr Rana | 0.4 MiB | bashar.abdulrazeq | December 4, 2019 |
L07 Biopharma Dr Rana | 40.8 MiB | | April 4, 2020 |
L07 Biopharma methods of studying oral abs dr.rana | 5.0 MiB | Muzdalifa Asaad | November 4, 2019 |
L07 Biopharma Oral-drug-absorption | 10.8 MiB | | April 4, 2020 |
L07 Biopharma Physicochemical And Dosage Form Factors | 0.5 MiB | | April 4, 2020 |
L07 Biopharma Sheet .6 | 0.4 MiB | | April 4, 2020 |
L07 Biotechno Gene-therapy -Dr -Rana | 13.6 MiB | | December 31, 2020 |
L07 CAM | 30.1 MiB | | April 4, 2020 |
L07 Cancer-infectionsmyeloid-growth-factors-update-2016 | 7.5 MiB | | April 4, 2020 |
L07 Carbohydrates .Derivatives | 19.4 MiB | | April 4, 2020 |
L07 Cardiovascular-disease- Pathophysiology | 28 KiB | | April 4, 2020 |
L07 Chromatography | 19.6 MiB | | April 4, 2020 |
L07 Chromo Dr Zweiri | 64.4 MiB | | March 1, 2020 |
L07 Chromo Dr Zweiri | 18.0 MiB | | April 4, 2020 |
L07 Chromo HPLC | 24.4 MiB | | April 4, 2020 |
L07 Chromo HPLC Dr MhdZweri | 26.4 MiB | | April 4, 2020 |
L07 Chromo MS | 0.3 MiB | | April 4, 2020 |
L07 Chromo MS | 0.3 MiB | | April 4, 2020 |
L07 Chromo TLC | 0.6 MiB | | April 4, 2020 |
L07 Clinical Biochemistry 2 | 18.4 MiB | | April 4, 2020 |
L07 Clinical-Biochem .Hypernatremia | 31.6 MiB | | April 4, 2020 |
L07 Clinical-Kinetics | 36.7 MiB | | April 4, 2020 |
L07 Clinicalbiochem2 Lipids | 0.2 MiB | | April 4, 2020 |
L07 ClinicalKinetics Kidney Dr Maysaa | 17.7 MiB | | April 4, 2020 |
L07 CNS Dr Loai | 39.2 MiB | | April 4, 2020 |
L07 Cogno | 47.0 MiB | | April 4, 2020 |
L07 Cogno DrYahia | 50.4 MiB | Ibrahim Ahmad | October 15, 2019 |
L07 Cogno M4a1 | 43.8 MiB | | April 4, 2020 |
L07 Cognosy Dr-mohammad-hudaib | 41.9 MiB | | April 4, 2020 |
L07 Cognosy Dr-muhammad-hudaib- | 0.7 MiB | | April 4, 2020 |
L07 Cosmetics Dr Samer | 37.1 MiB | Rema'a Abuhazeem | March 7, 2020 |
L07 Cosmetics Skin-Cleansing-and-Moisturizing-Products Dr Samer | 39.7 MiB | | December 31, 2020 |
L07 Cosmetics-Skin-Moisturizing-Products Mp3 | 18.1 MiB | | April 4, 2020 |
L07 Cosmo Skin-cleansing-products | 14.8 MiB | | April 4, 2020 |
L07 Cosmo Hair&Shampoo | 15.8 MiB | | April 4, 2020 |
L07 Decreased-crystal-packing Advanced-technology | 30.8 MiB | | April 4, 2020 |
L07 DIGITALIS-TOXICITY | 0.5 MiB | | April 4, 2020 |
L07 Disorders-of-K-Mg-2017 | 0.6 MiB | | April 4, 2020 |
L07 Dispensing Calculation | 17.2 MiB | | December 31, 2020 |
L07 Dispensing Calculation | 21.9 MiB | | December 31, 2020 |
L07 Dispensing Calculations | 15.7 MiB | | December 31, 2020 |
L07 Dispensing Dr Samer M4a | 15.2 MiB | | December 31, 2020 |
L07 Dispensing Solution Drdina | 23.6 MiB | | December 31, 2020 |
L07 Dissolution-and-solid-state-properities | 0.9 MiB | | April 4, 2020 |
L07 Diterpenes Phyto 2 | 22.7 MiB | zaidadnan862 | October 18, 2019 |
L07 Dr Loai Physio2 | 15.3 MiB | | April 4, 2020 |
L07 Dr Zweri | 1.0 MiB | | April 4, 2020 |
L07 Dr-Faisal Physiology2 | 14.6 MiB | | April 4, 2020 |
L07 Dr-Rana | 19.2 MiB | | April 4, 2020 |
L07 Economics | 19.4 MiB | | April 4, 2020 |
L07 Economics Dr Eman | 10.1 MiB | | April 4, 2020 |
L07 Economics.23.02.2016 | 44.4 MiB | | April 4, 2020 |
L07 Extraction Phyto Analysis | 18.9 MiB | zaidadnan862 | March 6, 2020 |
L07 Hallucinogenic Plants | 21.6 MiB | Mohammed Altaweel | October 21, 2019 |
L07 Heart Failure Therapy1 | 4.0 MiB | zaidadnan862 | October 25, 2019 |
L07 HPLC Chromo | 27 KiB | | April 4, 2020 |
L07 HTN Notes | 0.3 MiB | | April 4, 2020 |
L07 In-Home-testing-and-Monitoring-2015 | 2.8 MiB | | April 4, 2020 |
L07 Inflammation-and-pain | 0.7 MiB | | April 4, 2020 |
L07 Instru Dr Emad 20190222144426 | 6.9 MiB | | April 4, 2020 |
L07 Instru Dr Mohammad Khanfar | 15.9 MiB | | April 4, 2020 |
L07 Instru Dr Zweri | 71.2 MiB | | April 4, 2020 |
L07 Instru Ultraviolet-Spectroscopy | 0.1 MiB | | April 4, 2020 |
L07 Instru Uv-spectroscopy Dr-imad Hamdan | 9.9 MiB | Batool Alkurdi | July 1, 2019 |
L07 Instrumental Dr Imad NMR Spectroscopy | 3.1 MiB | | April 4, 2020 |
L07 Isotopes | 14.5 MiB | | April 4, 2020 |
L07 Kideny-functions-and-disorder | 0.8 MiB | | April 4, 2020 |
L07 Kinetics | 20.1 MiB | | April 4, 2020 |
L07 Kinetics Dr Mutasim | 19.3 MiB | | April 4, 2020 |
L07 Kinetics Dr Moh'd | 20.2 MiB | | April 4, 2020 |
L07 Kinetics Evaluation-of-drug-kinetics | 31.7 MiB | | April 4, 2020 |
L07 Kinetics IV-Infusion | 18.6 MiB | | April 4, 2020 |
L07 Kinetics IV-infusion | 17.3 MiB | | April 4, 2020 |
L07 Kinetics IV-Infusion | 19.3 MiB | | April 4, 2020 |
L07 L08 Chromo Dr Mohammad Fourth Week | 4.1 MiB | Sama Altaher | March 5, 2020 |
L07 Lab Fundi Aseptic Techniques Dr Zyad | 0.5 MiB | | April 4, 2020 |
L07 Marketing | 12.7 MiB | | April 4, 2020 |
L07 MedChem3 Cholinergics And Anticholinergics Dr Sanaa | 0.5 MiB | | April 4, 2020 |
L07 MedChem3 Cholinergics-and-anticholinergics Dr Sanaa | 0.5 MiB | | April 4, 2020 |
L07 Medicinal | 2.6 MiB | | April 4, 2020 |
L07 Medicinal 1 Dr Ghadeer | 37.7 MiB | | April 4, 2020 |
L07 Medicinal Ch 30.06.2015 Receptors | 29.3 MiB | | April 4, 2020 |
L07 Medicinal Ch 30.06.2015 Receptors | 1.2 MiB | | April 4, 2020 |
L07 Medicinal Chem II Sulphonamides | 0.2 MiB | MohanadRobin | July 13, 2019 |
L07 Medicinal Dr Mutasem | 42.9 MiB | | April 4, 2020 |
L07 Medicinal1 | 42.7 MiB | RaneenRiyad | June 27, 2019 |
L07 Medicinal1 Drmotasem | 62.1 MiB | | April 4, 2020 |
L07 Medicinal2 Anti-viral | 19.0 MiB | | April 4, 2020 |
L07 Medicinal3 Sympathetic | 13.9 MiB | | April 4, 2020 |
L07 Micro Sterile-products-2015 | 0.4 MiB | | April 4, 2020 |
L07 Micro1 Eukaryotic & Parasites Dr Randa | 1.3 MiB | | April 4, 2020 |
L07 Micro1 Parasites Dr Kawareek | 1.0 MiB | | April 4, 2020 |
L07 Microbiology1 PhD Dr Randa M4a | 94.8 MiB | | April 4, 2020 |
L07 Molecularspectroscopy2 Instru | 2.0 MiB | Saharaldabbagh | February 23, 2020 |
L07 Nutrition Introduction-to-clinical-nutrition-calculations4 Drmohammad | 46.7 MiB | | April 4, 2020 |
L07 Nutrition IVEF and Cal fluid Dr Mohammed | 0.4 MiB | Malak Ali | March 13, 2020 |
L07 Nutrition IVFEs Dr.Mohammed | 61.6 MiB | Aliya Fouad | March 5, 2020 |
L07 Nutrition Lipids-PartII | 2.0 MiB | | April 4, 2020 |
L07 Nutrition Malnutrition-assessment | 49.7 MiB | | April 4, 2020 |
L07 OA | 6.4 MiB | | April 4, 2020 |
L07 Organic Ch4-complement Ch5-part1 Dr Mohammd- | 61.0 MiB | | December 31, 2020 |
L07 Organic Ch4-complement Ch5-part1 Dr Mohammd- | 1.6 MiB | | December 31, 2020 |
L07 Organic Drkamal | 4.2 MiB | | December 31, 2020 |
L07 Organic DrMousa | 3.4 MiB | | December 31, 2020 |
L07 Organic1 Alkanes Drmosa | 0.6 MiB | | December 31, 2020 |
L07 OrganicChemistry1 Chapter4 Dr AlmeqdadHabashneh | 7.3 MiB | | December 31, 2020 |
L07 Osteoarthritis 2016 Final | 4.1 MiB | | April 4, 2020 |
L07 OTC | 14.2 MiB | | April 4, 2020 |
L07 OTC | 44.2 MiB | | April 4, 2020 |
L07 OTC Allergic-Rhinitis 2 | 13.1 MiB | | April 4, 2020 |
L07 OTC Pain-and-fever Lec8 | 18.6 MiB | | April 4, 2020 |
L07 OTC Pain-and-NSAID | 2.4 MiB | | April 4, 2020 |
L07 OTC Pain | 19.3 MiB | | April 4, 2020 |
L07 OTC- | 17.5 MiB | | April 4, 2020 |
L07 OTC17 | 12 KiB | | April 4, 2020 |
L07 PARA Atopic-dermatitis | 32.1 MiB | | April 4, 2020 |
L07 Para Foot-care | 0.6 MiB | | April 4, 2020 |
L07 Para Oral-contraceptives | 36.3 MiB | | April 4, 2020 |
L07 Para Pediculosis1 | 0.3 MiB | | April 4, 2020 |
L07 Para Smoking-cessation-2 | 15.1 MiB | | April 4, 2020 |
L07 Para Dr Eman | 8.7 MiB | | April 4, 2020 |
L07 Para Dr Eman Smooking | 14.2 MiB | | April 4, 2020 |
L07 Para Dr Rana | 44.4 MiB | Hala Azem | March 12, 2020 |
L07 Para Oral Contraceptives 3 | 0.2 MiB | | April 4, 2020 |
L07 Patho The-Gastrointestinal-Tract | 93 KiB | | April 4, 2020 |
L07 Pathology | 20.9 MiB | | April 4, 2020 |
L07 Pathology Dr Maha | 36.8 MiB | | April 4, 2020 |
L07 Pathology Hemodynamic Disorders.2 Dr Manar | 15.5 MiB | | April 4, 2020 |
L07 Pathophysio Asthma Mp3 | 49.6 MiB | | April 4, 2020 |
L07 Pathophysio AsthmaAndCOPD | 0.5 MiB | | April 4, 2020 |
L07 Pathophysio Dr Eman | 23.3 MiB | | April 4, 2020 |
L07 Pathophysio Inflammation Apoptosis | 0.2 MiB | | April 4, 2020 |
L07 Pathophysio Inflammation Dralaa | 23.6 MiB | Sarah Degis | June 28, 2019 |
L07 Pathophysio Inflammation2 Dr Eman | 56.9 MiB | | April 4, 2020 |
L07 Pathophysio Inflammation2 Dr Eman | 0.1 MiB | | April 4, 2020 |
L07 PathoPhysio Topic1 Inflammaion Part6 | 0.2 MiB | | April 4, 2020 |
L07 Pathophysio.21.02.2017 Inflammation | 43.0 MiB | | April 4, 2020 |
L07 Pathophysiology | 35.1 MiB | | April 4, 2020 |
L07 PathoPhysiology Overview Of Inflammation Dr Ala | 1.4 MiB | rawan Abu Oss | November 17, 2020 |
L07 Pathophysiology 09.10.2014 Acute Inflammation | 14.6 MiB | | April 4, 2020 |
L07 Pathophysiology 09.10.2014 Inflammation | 0.5 MiB | | April 4, 2020 |
L07 Pathophysiology AcuteInflammation | 41.5 MiB | | April 4, 2020 |
L07 Pathophysiology Dr Alaa | 1.0 MiB | Batool Alkurdi | March 8, 2020 |
L07 Pathophysiology Dyslipidemia | 1.7 MiB | Muneerah Ali | December 2, 2019 |
L07 PATHOPHYSIOLOGY INFLAMMATION Dr ALA | 77.6 MiB | Afnan Dabobash | October 21, 2019 |
L07 Pathophysiology PainInflammation | 33.9 MiB | | April 4, 2020 |
L07 Pathophysiology Sheet Inflammation | 0.6 MiB | | April 4, 2020 |
L07 Pentacyclic Phyto2 | 2.7 MiB | Maramghweiri | July 5, 2019 |
L07 Pesticides | 3.5 MiB | | April 4, 2020 |
L07 Ph Calculations | 2.0 MiB | iSpatula | April 4, 2020 |
L07 Pharma-Organic Alcohol Dr Yousuf | 2.4 MiB | | December 31, 2020 |
L07 Pharma-Organic Aldehyde-Ketone | 6.3 MiB | | December 31, 2020 |
L07 Pharma-Organic Rxn-of-Alcohol-Phenols Dr Yosef | 6.5 MiB | | December 31, 2020 |
L07 Pharma1 | 3.1 MiB | | April 4, 2020 |
L07 Pharma1 | 21.2 MiB | | April 4, 2020 |
L07 Pharma1 Adrenoceptor Antagonist Drugs | 1.6 MiB | | April 4, 2020 |
L07 Pharma1 Antihypertensive And Diuretics Agents | 8.2 MiB | | April 4, 2020 |
L07 Pharma1 Pharmacodynamics | 2.8 MiB | | April 4, 2020 |
L07 Pharma1.03.10.2016 ANS | 63.2 MiB | | April 4, 2020 |
L07 Pharma2 | 19.5 MiB | | April 4, 2020 |
L07 Pharma2 Sedative-Hypnotic-1-Drugs | 0.6 MiB | | October 19, 2020 |
L07 Pharmaceutical Calculations Part2 | 24.1 MiB | | December 31, 2020 |
L07 Pharmaceutical Statistics Dr Hatem | 0.1 MiB | | April 4, 2020 |
L07 Pharmaceutical-Statistics Probability D-Ahmad | 19.6 MiB | | April 4, 2020 |
L07 Pharmacokinetics Utilization-of-Urine | 21.2 MiB | | April 4, 2020 |
L07 PharmaOrganic AldsKetonesC As | 9.4 MiB | | December 31, 2020 |
L07 Physical1 Topic2 .DrDina | 34.9 MiB | | December 31, 2020 |
L07 Physical2 | 10.2 MiB | QamarSaqqa | March 28, 2020 |
L07 Physical2 Complexation | 19.4 MiB | iSpatula | April 4, 2020 |
L07 Physical2 Complexation | 3.4 MiB | iSpatula | April 4, 2020 |
L07 Physical2 Diffusion | 23.2 MiB | iSpatula | April 4, 2020 |
L07 Physical2 Dr Hatem | 21.8 MiB | iSpatula | April 4, 2020 |
L07 Physical2 Dr Samer | 20.6 MiB | iSpatula | April 4, 2020 |
L07 Physical2 Dr Samer M4a | 27.7 MiB | iSpatula | April 4, 2020 |
L07 Physio2 Central-Nervous-System-organization DrFaisal | 48.7 MiB | Alaa Ziad | June 24, 2019 |
L07 Physio2 Drlo2e | 18.3 MiB | | April 4, 2020 |
L07 Physio2 Drlo2e | 0.8 MiB | | April 4, 2020 |
L07 Physio2 Drloai | 37.7 MiB | | April 4, 2020 |
L07 Physio2 Drloai 2 | 37.7 MiB | | April 4, 2020 |
L07 Physio2 Nervous-system Drloai | 0.6 MiB | | April 4, 2020 |
L07 Physio2 Reproductive3 DrSaleem | 0.6 MiB | | April 4, 2020 |
L07 Physiology Drsaleem | 1.2 MiB | | December 31, 2020 |
L07 Physiology Fluid Dr Ebaa | 0.5 MiB | | December 31, 2020 |
L07 Physiology Fluid Dr Ebaa | 0.5 MiB | | December 31, 2020 |
L07 Physiology Muscle DrLoai | 7.1 MiB | | December 31, 2020 |
L07 Physiology Sheet7 | 0.3 MiB | | December 31, 2020 |
L07 Physiology1 Chapter4 IV DrLoai | 37.2 MiB | | December 31, 2020 |
L07 Physiology1 DrLoai- | 20.3 MiB | | December 31, 2020 |
L07 Physiology1 Week7 DrFaisal | 1.4 MiB | | December 31, 2020 |
L07 Physiology2 Cns Dr Faisal | 0.5 MiB | Dinazyoud | February 28, 2020 |
L07 Physiology2 Dr Faisal DigestiveSystem | 0.1 MiB | | April 4, 2020 |
L07 Physiology2 Dr Loai | 31.3 MiB | | April 4, 2020 |
L07 Physiology2 DrSaleem | 20.9 MiB | | April 4, 2020 |
L07 Physiology2 Gastrointestinal-system-and-endocrine-system | 53.9 MiB | | April 4, 2020 |
L07 Phyto | 27.4 MiB | | April 4, 2020 |
L07 Phyto2 | 86.2 MiB | Maramghweiri | June 25, 2019 |
L07 Phyto2 CardiacGlycosides | 5.2 MiB | | April 4, 2020 |
L07 Phytoanalysis Dr Muhammad | 14.9 MiB | iSpatula | April 4, 2020 |
L07 Phytoanalysis Fat-soluble-Vitamins | 0.8 MiB | iSpatula | April 4, 2020 |
L07 Phytoanalysis Vitamins | 20.6 MiB | iSpatula | April 4, 2020 |
L07 Phytochemistry1 Flavonoids | 21.0 MiB | | April 4, 2020 |
L07 Practice | 28.5 MiB | | April 4, 2020 |
L07 Practice1 | 34.6 MiB | | April 4, 2020 |
L07 Practice1 Providing-drug-Information | 14.8 MiB | | April 4, 2020 |
L07 Practice2 | 76.5 MiB | | April 4, 2020 |
L07 Practice2 Drug-Counseling | 15.7 MiB | | April 4, 2020 |
L07 Practice2 Inititation-and-titration-of-Insulin | 1.3 MiB | | April 4, 2020 |
L07 Reproductive Dr Saleem | 23.7 MiB | | April 4, 2020 |
L07 Reproductive Dr Saleem | 17.3 MiB | | April 4, 2020 |
L07 Reproductive Dr Saleem | 19.7 MiB | | April 4, 2020 |
L07 Statistics DescriptiveStatistics | 33.9 MiB | | April 4, 2020 |
L07 Statistics DrAhmad | 40.5 MiB | Aya Alassi | July 1, 2019 |
L07 Tablet-Coating Technology2 | 15.6 MiB | | April 4, 2020 |
L07 Techno 2 Dr Dina | 20.9 MiB | | April 4, 2020 |
L07 Techno1 | 15.5 MiB | | April 4, 2020 |
L07 Techno1 Dr Lorina Topic-3 -part-2 -pdf | 7.0 MiB | | April 4, 2020 |
L07 Techno1 Dr Lorina | 0.6 MiB | dana younes | October 31, 2019 |
L07 Techno1 Dr Lorina | 24.0 MiB | | April 4, 2020 |
L07 Techno1 Dr Samer | 13.9 MiB | | April 4, 2020 |
L07 Techno1 Drying | 1.1 MiB | | April 4, 2020 |
L07 Techno1 M4a[1] | 29.9 MiB | | April 4, 2020 |
L07 Techno1 Solid-State-Properties Dr Ahmad | 20.0 MiB | | April 4, 2020 |
L07 Techno2 Coating Dr Hatim | 0.6 MiB | Samira.Abusaif | February 29, 2020 |
L07 Techno2 Dr Hatem | 22.2 MiB | | April 4, 2020 |
L07 Techno2 Filmformation Drahmad | 43.0 MiB | Somaya Alwishah | October 17, 2019 |
L07 Techno2 Formulation-of-polymeric-coatings | 14.7 MiB | | April 4, 2020 |
L07 Techno2 Tablet Coating1 | 18.0 MiB | | April 4, 2020 |
L07 Techno2-Coating-ingredients | 0.2 MiB | | April 4, 2020 |
L07 Technology1 Particle-size-reduction | 21.3 MiB | | April 4, 2020 |
L07 Technology2 Dr-Ahmad-Bani-Jaber | 4.7 MiB | | April 4, 2020 |
L07 Therapy 4 Sepsis DrNaila | 57.8 MiB | Farah Qaryouti | February 23, 2020 |
L07 Therapy HTN | 35.9 MiB | | April 4, 2020 |
L07 Therapy-1 Heart-Failure Dr-Alaa | 64.3 MiB | | April 4, 2020 |
L07 Therapy-4-17-4 | 22.2 MiB | | April 4, 2020 |
L07 Therapy.23-02.2016 Asthma. | 21.6 MiB | | April 4, 2020 |
L07 Therapy.23.02.2016 Asthma | 0.7 MiB | | April 4, 2020 |
L07 Therapy1 Dr Alaaalham | 21.5 MiB | | April 4, 2020 |
L07 Therapy1 HeartFailure DrAlaa | 0.9 MiB | | April 4, 2020 |
L07 Therapy2 AKI | 73.2 MiB | | April 4, 2020 |
L07 Therapy2 COPD | 19 KiB | | April 4, 2020 |
L07 Therapy2 COPD&ARI | 28.2 MiB | | April 4, 2020 |
L07 Therapy3 VTE | 55.4 MiB | Aliya Fouad | October 18, 2019 |
L07 Toxic Plants | 37 KiB | | April 4, 2020 |
L07 Toxic Plants Dr Yahia | 45.4 MiB | Shaimaa Salahat | July 9, 2019 |
L07 Toxicology Introduction | 61.0 MiB | | April 4, 2020 |
L07 Toxicology NSAID Intoxication | 1.4 MiB | | April 4, 2020 |
L07 Toxicology Part1 Toxidromes Dr Oriana | 19.1 MiB | | April 4, 2020 |
L07 Toxicology Part2 Toxidromes Dr Oriana | 10.8 MiB | | April 4, 2020 |
L07 ToxicPlants AtropaBelladona | 13.9 MiB | | April 4, 2020 |
L07&L08 Anthraquinones Part 1 Medicinal Plants | 0.2 MiB | | April 4, 2020 |
L07&L08 Anthraquinones Part 2 Medicinal Plants | 0.8 MiB | | April 4, 2020 |
L07&L08 Anthraquinones Part 3 Medicinal Plants | 0.1 MiB | | April 4, 2020 |
L07- Signaling-Mechanisim-Notes Pharmacology1 | 3.3 MiB | | April 4, 2020 |
L07-08-Therapy4-Preterm-labour-Induction-of-labour-GDM-PPROM-PCOS-Endometriosis | 0.8 MiB | | April 4, 2020 |
L07-Adv-techno-28.3.2017 | 18.8 MiB | | April 4, 2020 |
L07-Affinityoccupancy-and-efficacy-of-drug | 2.5 MiB | | April 4, 2020 |
L07-Anterior-and-posterior-pituitary | 0.6 MiB | | April 4, 2020 |
L07-Anterior-and-posterior-pituitary | 0.6 MiB | | October 19, 2020 |
L07-Apoptosis-and-Inflammation-Pathophysio | 18.0 MiB | | April 4, 2020 |
L07-Basic-Communication -Role-Play-2 | 20.7 MiB | | April 4, 2020 |
L07-Bioavailability-physicochemical-and-dosage-form-factors | 0.8 MiB | | April 4, 2020 |
L07-Biopharma | 14.3 MiB | | April 4, 2020 |
L07-biopharma | 18.3 MiB | | April 4, 2020 |
L07-Cadioglycoside-Phyto2 | 40.4 MiB | | April 4, 2020 |
L07-cogno-Dr-Olaimat-slide23 | 15.3 MiB | | April 4, 2020 |
L07-cortex-and-neurotransmitters-Physio2 | 11.5 MiB | | April 4, 2020 |
L07-Dr-Khanfar | 37.7 MiB | iSpatula | April 4, 2020 |
L07-Dr-Loai | 39.9 MiB | | April 4, 2020 |
L07-Drying-Techno1 | 1.1 MiB | | April 4, 2020 |
L07-Endocrine-and-reproductive-physio2-Dr-Ebaa | 17.9 MiB | | April 4, 2020 |
L07-Flavanoids-Phyto1 | 18.9 MiB | | April 4, 2020 |
L07-Heart-failure-therapy1 | 19.0 MiB | | April 4, 2020 |
L07-Heart-failure-Therapy1 | 9.8 MiB | | April 4, 2020 |
L07-HEMATOLYMPHOID-SYS | 0.3 MiB | | April 4, 2020 |
L07-Instru-Dr-Kanfar-21-2-2017-chromatography | 40.9 MiB | | April 4, 2020 |
L07-introduction-of-inflammation-Pathophysio | 16.1 MiB | | April 4, 2020 |
L07-MedChem1-Medicinal | 15.3 MiB | | April 4, 2020 |
L07-Medicinal-1 | 65.4 MiB | | April 4, 2020 |
L07-Medicinal-2-Antibacterials-beta-lactamase-inhibitors | 13.6 MiB | | April 4, 2020 |
L07-medicinal-3-Anti-hyperlipidemic-drugs | 6.3 MiB | | April 4, 2020 |
L07-Medicinal-3adrenargic-antagonist-last-partadrenargic-agonist-part-1 | 59.0 MiB | | April 4, 2020 |
L07-medicinal-chemistry-2 | 50.5 MiB | | April 4, 2020 |
L07-Medicinal-Chemistry-2-Sulfonamides-Tetracyclines | 1.4 MiB | | April 4, 2020 |
L07-Medicinal2-Dr-Moatasem-Antibacterial-SulfonamidesTetracyclins | 44.0 MiB | | April 4, 2020 |
L07-Nasal-deliver | 0.3 MiB | | April 4, 2020 |
L07-Neuoplasia-Patho | 21.8 MiB | | April 4, 2020 |
L07-oral-drug-absorption M4a1 | 9.1 MiB | | April 4, 2020 |
L07-OTC-Allergic-Rhinitis | 16.2 MiB | | April 4, 2020 |
L07-OTC-Management-of-Common-Cold | 0.8 MiB | | April 4, 2020 |
L07-para-atopic-dermatitis-part-1 | 17.5 MiB | | April 4, 2020 |
L07-Para-diaper-rash-L02 | 36.3 MiB | | April 4, 2020 |
L07-pathophysio-Dr-Eman | 42.4 MiB | | April 4, 2020 |
L07-Pathophysio-Inflammation | 21.3 MiB | | April 4, 2020 |
L07-Pathophysiology-17.7.2016-Cardiovascular M4a | 30.0 MiB | | April 4, 2020 |
L07-Pathphysio-Dr-Alaa | 15.1 MiB | | April 4, 2020 |
L07-PharmaOrganic-AldehydesKetonesandCarboxylicacid-DrAli | 5.3 MiB | | December 31, 2020 |
L07-Physical-1-States-Of-Matter-Gases-and-Liquids-Dr Dina | 27.5 MiB | | December 31, 2020 |
L07-Physical-Aerosols-and-Solid-State-Dr Dina | 3.5 MiB | | December 31, 2020 |
L07-physilogical-Factor-Biopharma | 10.8 MiB | | April 4, 2020 |
L07-physiology-2-Endocrine-System-Dr-Saleem | 38.2 MiB | | April 4, 2020 |
L07-Physiology-blood-Dr-Fessal | 0.8 MiB | | December 31, 2020 |
L07-Phytoanalysis-23.2.2016 | 50.8 MiB | iSpatula | April 4, 2020 |
L07-Sampling-Distributions-of-the-mean-2 | 2.5 MiB | | April 4, 2020 |
L07-Sampling-Distributions-of-the-mean-2 | 2.5 MiB | | April 4, 2020 |
L07-sive-reduction-Techno1 M4a1 | 15.4 MiB | | April 4, 2020 |
L07-Statistics-Dr Hatim | 0.6 MiB | | October 19, 2020 |
L07-Structure-distribution-Medicinal1 | 19.8 MiB | | April 4, 2020 |
L07-tablet-cating-Techno2 | 18.2 MiB | | April 4, 2020 |
L07-tablet-coating-techno2 | 31.9 MiB | | April 4, 2020 |
L07-Techno-7 | 33.3 MiB | | April 4, 2020 |
L07-Therapy3-Anxiety-8-12 | 32.0 MiB | | April 4, 2020 |
L07-Therapy3-Cancer | 29.5 MiB | | April 4, 2020 |
L07-Topic2-Dr-Samer | 23.1 MiB | iSpatula | April 4, 2020 |
L07.00 Advanced-physical Diffusion | 1.2 MiB | | April 4, 2020 |
L07.01 Ad |